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The hereditary disease alpha1-antitrypsin deficiency (AATD), most prevalent in those 
of Northern European ancestry, is a leading genetic cause of early-onset 
emphysema and liver cirrhosis. Currently, the only effective treatment is a transplant 
of the lungs or liver. The disease is caused by mutations in the gene encoding 
alpha1-antitrypsin (AAT), which promote misfolding and aggregation into polymer 
chains. These polymers accumulate and induce cellular damage to hepatocytes, and 
the resultant lack of AAT in the circulation permits uncontrolled remodelling, and 
eventual breakdown, of lung tissue. 
The mechanism of polymerisation and the linkage between individual subunits of the 
polymer found in affected individuals is unknown. Current structural models of 
polymerisation are based on artificially-induced in vitro polymers, but their relevance 
to in vivo systems is disputed. Polymers formed by heating are believed to represent 
polymers found in patients. A structural understanding of the mechanism by which 
AAT polymerises will be useful for the development and evaluation of therapeutic 
strategies. 
Conformational-specific monoclonal antibodies and electron microscopy have been 
used in combination to study the structure of heat-induced and patient-derived 
polymers. Negative stain-electron microscopy (NS-EM) of polymers, with Fab 
fragments attached to each AAT subunit, has generated similar reconstructions of a 
dimer for both polymer types. This supports the notion that heat-induced polymers 
are a suitable model for ex vivo polymers. An initial cryo-EM reconstruction of the 
labelled ex vivo dimer and a single subunit has also been obtained, in preparation for 
a higher-resolution cryo-EM dataset. Fitting of the polymerisation models into the EM 
data best supports the C-terminal model of polymerisation. Lastly, a novel 
monoclonal antibody that is selective for AAT monomer over polymer, called 1D9, 
has been developed. X-ray crystallography reveals it binds to a region of AAT most 
exposed in the monomer; a characteristic which could mean it has future applications 




There are no drugs to treat the disease alpha1-antitrypsin deficiency (AATD). It 
results from mutations that lead to polymerisation of alpha1-antitrypsin (AAT) in the 
liver. This severely reduces AAT levels in the circulation and lungs, leading to 
emphysema. I therefore investigated the polymerisation mechanism of AAT, i) 
structurally, using the technique of electron microscopy (EM) to study artificially-
made and patient-derived AAT polymers and ii) biochemically, using monoclonal 
antibodies that have specific recognition profiles for different AAT conformations. 
Understanding the mechanism of AAT polymer formation may offer new therapeutic 
avenues. 
The applications of the EM work are wide-ranging. For the AAT field, the structures 
of the AAT polymer have been useful in testing the currently proposed models of 
polymerisation. AAT polymerisation underlies the liver and lung disease of those with 
AATD and polymerisation of related proteins (serpins) can also cause thrombosis 
and a sub-type of dementia. It is hoped insights into the polymer structure will be 
applicable to all these diseases and inform highly sought-after future therapeutic 
approaches to stop polymerisation from occurring. On a broader academic level, this 
work addressed the use of in vitro models to represent what occurs in vivo. Here, 
polymers were uniquely extracted and studied from a human liver; previous research 
has focussed on artificially-made AAT polymers. To enable this, novel purification 
methodologies from the liver tissue were developed. The importance of studying 
patient-derived material for human disease has been highlighted and must be 
considered for other diseases such as Alzheimer’s. Finally, cryo-EM of the AAT 
polymer will contribute to the wider cryo-EM community. The technique has 
significant technological promise, is attracting substantial pharmaceutical investment 
and scientists have recently been awarded the Nobel Prize for its development. The 
AAT polymer pushes the boundaries of what is currently technically possible to 
detect and structurally determine due to its small size and flexibility. It has been 
necessary to develop new methods of image analysis and workflow. At conferences, 
there has been interest from software developers in improving current image 
processing capabilities of flexible polymers. This will aid both academia and industry.
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The research also led to the creation of 30 new monoclonal antibodies with differing 
specificities against AAT conformers. These have the potential to elucidate new 
information about disease, native and artificially-made protein. One antibody, 1D9, 
was characterised in-depth and found to be unique in its specificity for the 
monomeric form of AAT. This has direct medical relevance in diagnosis, as patients 
with AATD have low levels of monomer in their bloodstream. Currently, AATD is 
underdiagnosed and 1D9 offers the possibility of commercialisation, to compliment or 
supersede the existing tools for diagnosis. To progress this, together with therapeutic 
possibilities, pharmaceutical companies are heavily engaged with the laboratory. 
This thesis contributes to the understanding of AATD and related diseases by using 
EM to characterise the structure of the AAT polymer, as well as developing 
diagnostic tools and therapeutic approaches. The work also provides a strong 













Table of contents 
1.0 	 Introduction to Alpha1-Antitrypsin ........................................ 18	
1.1 	 The serpin superfamily .............................................................................. 18	
1.2 	 The serpin fold ........................................................................................... 19	
1.3 	 The serpin mechanism of protease inhibition ............................................ 20	
1.4 	 Other hyperstable serpin conformations .................................................... 21	
1.5 	 Alpha1-antitrypsin (AAT) ............................................................................ 23	
1.6 	 Alpha1-antitrypsin deficiency (AATD) and the serpinopathies ................... 24	
1.7 	 Biochemical characterisation of polymerisation of AAT in vitro ................. 29	
1.8 	 The models of polymerisation .................................................................... 31	
1.8.1	 Evidence for the polymerisation models ............................................ 34	
1.8.2 	 Drawing the molecular models together ............................................ 39	
1.9 	 Treatment of AATD .................................................................................... 40	
1.9.1	 Current treatment of AATD for patients ............................................. 40	
1.9.2 	 Therapeutic approaches in development ........................................... 41	
1.10 	 Specific Aims and Approach .................................................................. 43	
2.0	 Introduction to Electron Microscopy (EM) ........................... 46	
2.1	 Introduction ................................................................................................ 46	
2.2 	 Optical microscopy in biology .................................................................... 46	
2.3 	 High resolution molecular techniques ........................................................ 48	
2.4 	 Imaging using electrons ............................................................................. 48	
2.5 	 The electron microscope ........................................................................... 49	
2.5.1 	 Electron sources ................................................................................ 51	
2.5.2 	 The lens system ................................................................................. 51	
2.5.3 	 Detectors ............................................................................................ 52	
2.6	 Usage of Fourier transform in EM .............................................................. 53	
2.7 	 EM sample preparation for single particle analysis ................................... 54	
2.7.1 	 Background ........................................................................................ 54	
2.7.2 	 Negative staining ............................................................................... 54	
2.7.3 	 Cryo-fixation ....................................................................................... 55	
2.8 	 Image formation ......................................................................................... 56	
2.8.1 	 Interaction of electrons with the specimen ......................................... 56	
2.8.2 	 Origins of image contrast ................................................................... 56	
  
8 
2.8.3 	 The Contrast Transfer Function ......................................................... 58	
2.9 	 Image processing – Single particle analysis .............................................. 59	
2.9.1 	 Pre-processing of micrographs .......................................................... 59	
2.9.2 	 Particle picking ................................................................................... 60	
2.9.3	 Image alignment ................................................................................ 61	
2.9.4 	 Classification of images ..................................................................... 61	
2.9.5 	 Orientation determination ................................................................... 63	
2.9.6 	 3D reconstruction ............................................................................... 64	
2.10	  Interpretations ........................................................................................... 66	
3.0 	 General methods ................................................................. 67	
3.1 	 List of manufacturers ................................................................................. 67	
3.2 	 Common buffers ........................................................................................ 67	
3.3 	 List of computational packages ................................................................. 68	
3.4 	 Protein purification ..................................................................................... 68	
3.4.1 	 Purification of monomeric and polymeric M-AAT from plasma .......... 68	
3.4.2 	 Production of in vitro polymers ........................................................... 69	
3.4.3 	 Generation of cleaved AAT ................................................................ 69	
3.4.4	 Purification of monoclonal antibodies ................................................ 69	
3.4.5 	 Fab generation and purification ......................................................... 70	
3.5 	 Protein characterisation techniques ........................................................... 71	
3.5.1 	 Polyacrylamide gel electrophoresis ................................................... 71	
3.5.2 	 Western blot ....................................................................................... 71	
3.5.3 	 ELISAs ............................................................................................... 72	
3.5.4 	 Visualisation of polymers by negative stain electron microscopy ...... 72	
4.0 	 Generation and characterisation of monoclonal antibodies 
against AAT .................................................................................. 74	
4.1 	 Introduction ................................................................................................ 74	
4.1.1	 Antibodies .......................................................................................... 74	
4.1.2 	 Generating and identifying monoclonal antibodies ............................ 76	
4.1.3 	 Monoclonal antibodies as molecular probes of conformation ............ 78	
4.1.4 	 The AAT monoclonal antibody toolkit ................................................ 79	
4.1.5	 A brief overview of X-ray crystallography ........................................... 83	
4.1.6	 Crystallography of antibodies ............................................................. 88	
4.1.7	 Aims of this screening project ............................................................ 88	
4.2 	 Methods ..................................................................................................... 89	
4.2.1 	 Production of the monoclonal antibodies ........................................... 89	
  
9 
4.2.2	 Characterisation of the mAb 1D9 ....................................................... 92	
4.2.3	 Production and purification of rAAT for crystallography ..................... 96	
4.2.4	 Crystallography methods ................................................................... 97	
4.3	 Results ..................................................................................................... 101	
4.3.1	 A screen of hybridomas identified five general groups of mAb 
reactivity profile ................................................................................................ 101	
4.3.2	 Characterisation of 1D9 specificity using the purified protein .......... 104	
4.3.3	 1D9 blocks polymerisation and the inhibitory activity of AAT ........... 105	
4.3.4	 1D9 increases the thermal stability of AAT ...................................... 109	
4.3.5	 1D9 binds near the RCL region of AAT ........................................... 110	
4.3.6	 1D9 has nanomolar affinity for monomeric AAT .............................. 114	
4.3.7	 Preparation of samples for crystallography studies ......................... 118	
4.2.8	 Determination of the 1D9 Fab structure ........................................... 124	
4.2.9	 The structure of 1D9 Fab in complex with rAAT .............................. 132	
4.2.10	 NS-EM studies of 1D9 Fab bound to polymers ................................ 141	
4.4	 Discussion ............................................................................................... 143	
4.4.1	 Monoclonal antibodies highlight the conformational differences 
between AAT species ...................................................................................... 143	
4.4.2	 Insights about AAT from the characteristics of 1D9 ......................... 144	
4.4.3	 Implications of 1D9 characteristics .................................................. 154	
5.0	 Negative stain EM (NS-EM) of heat polymers .................. 155	
5.1	 Introduction .............................................................................................. 155	
5.1.1	 Electron microscopy of serpins ........................................................ 155	
5.1.2	 Previous negative stain-electron microscopy (NS-EM) image analysis 
of the ex vivo polymer ...................................................................................... 155	
5.1.3 	 Assessing the relevance of in vitro artificial polymers to those found in 
vivo………. ...................................................................................................... 158	
5.2 	 Methods ................................................................................................... 159	
5.2.1 	 NS-EM data collection of the heat-induced polymers ...................... 159	
5.2.2	 Image processing of the heat-induced polymer using IMAGIC ........ 159	
5.2.3	 Image processing of the heat-induced polymer using Relion .......... 162	
5.2.4	 Image re-processing of the ex vivo polymer using Relion ............... 164	
5.2.5	 Generation of an initial AAT/4B12 Fab complex .............................. 165	
5.2.6	 Fitting of the polymerisation models into the NS-EM dimer 
reconstructions ................................................................................................ 166	
5.3 	 Results ..................................................................................................... 167	
5.3.1 	 Purification of AAT and production of heat polymers ....................... 167	
  
10 
5.3.2 	 Imaging of heat polymers by NS-EM ............................................... 167	
5.3.3 	 Imaging of heat polymers bound with 4B12 Fab .............................. 169	
5.3.4	 Image processing of heat polymers bound with 4B12 by IMAGIC ... 171	
5.3.5	 Image processing of heat polymers bound with 4B12 by Relion ..... 179	
5.3.6	 Re-processing of ex vivo polymers bound with 4B12 Fab using 
Relion…… ....................................................................................................... 186	
5.3.7 	 Refining the subunit model of AAT/Fab using the single subunit 
density….. ........................................................................................................ 194	
5.3.8 	 Fitting the proposed polymerisation models into the NS-EM 
reconstructions ................................................................................................ 197	
5.4	 Discussion ............................................................................................... 202	
5.4.1	 Comparing the structure of heat-induced polymers and ex vivo 
polymers… ...................................................................................................... 202	
5.4.2	 The C-terminal model is most consistent with the reconstructions .. 206	
5.4.3	 Improvements incorporated into the processing of the heat polymers 
compared to the ex vivo polymers using IMAGIC ........................................... 208	
5.4.4	 Comparison between image processing of AAT polymers using 
IMAGIC and Relion .......................................................................................... 209	
5.4.5	 Addressing concerns about model bias ........................................... 211	
5.4.6	 Monoclonal antibodies aided EM studies ......................................... 214	
5.4.7	 Conclusions and future directions .................................................... 215	
6.0 	 Cryo-EM of ex vivo AAT polymers .................................... 217	
6.1 	 Introduction .............................................................................................. 217	
6.1.1 	 AAT accumulation in the liver .......................................................... 217	
6.1.2 	 Cryo-EM of ex vivo protein aggregates ............................................ 217	
6.1.3 	 Aims of the AAT cryo-EM work ........................................................ 219	
6.2 	 Methods ................................................................................................... 220	
6.2.1 	 Purification and characterisation of ex vivo polymers ...................... 220	
6.2.2	 Preparation of samples for screening antibody strategies to reduce 
flexibility…. ...................................................................................................... 221	
6.2.3	 Cryo-EM methods ............................................................................ 222	
6.3 	 Results ..................................................................................................... 226	
6.3.1 	 Extraction of ex vivo AAT polymers ................................................. 226	
6.3.2 	 Characterisation of ex vivo AAT polymers ....................................... 226	
6.3.3 	 NS-EM of liver polymers with and without 4B12 Fab ....................... 232	
6.3.4 	 Approaches to reduce polymer flexibility ......................................... 234	
6.3.5 	 Initial cryo-EM studies ...................................................................... 237	
6.3.6 	 Extra purification of ex vivo polymers .............................................. 239	
  
11 
6.3.7 	 Cryo-EM grid optimisation ................................................................ 245	
6.3.8 	 Initial cryo-EM dataset collection ..................................................... 249	
6.3.9 	 Processing workflow for the AAT/Fab dimer .................................... 252	
6.3.10 	 Processing workflow for the AAT/Fab single subunit ....................... 259	
6.3.11	 Using the cryo-EM single subunit density to improve the AAT/4B12 
Fab model and the polymerisation models ...................................................... 263	
6.4 	 Discussion ............................................................................................... 268	
6.4.1 	 Biochemical characterisation of liver polymers ................................ 268	
6.4.2 	 Cryo-EM studies required further purification of liver polymers ....... 269	
6.4.3 	 Additional differences identified between liver polymers and heat 
polymers… ...................................................................................................... 271	
6.4.4 	 The loop-β sheet A model is not consistent with the extreme angle 
classes…. ........................................................................................................ 272	
6.4.5 	 There is a lack of a well-defined cryo-EM dimer reconstruction ...... 273	
6.4.6 	 The cryo-EM single subunit allows refinement of the 4B12 Fab/AAT 
interaction ........................................................................................................ 275	
6.4.7 	 Approaches for improvement in the next cryo-EM dataset .............. 277	
6.4.8 	 Future work ...................................................................................... 278	
7.0	 Conclusions and outlook ................................................... 280	
7.1	 The importance of studying AAT polymerisation ..................................... 280	
7.2	 AAT-specific monoclonal antibodies are useful investigative tools .......... 280	
7.3	 Heat polymers and liver polymers have more similarities than 
differences…. ...................................................................................................... 281	
7.4	 The C-terminal model of polymerisation is most consistent with ex vivo 
data….. ................................................................................................................ 282	






Table of figures 
Table 1.1. A selection of human serpins with their location and function. ................. 18	
Figure 1.1. The serpin fold. ....................................................................................... 19	
Figure 1.2. The serpin mechanism of protease inhibition. ......................................... 21	
Figure 1.3. Hyperstable serpin conformations. .......................................................... 23	
Figure 1.4. An example isoelectric focusing gel used for the identification of different 
AAT genotypes. ......................................................................................................... 25	
Figure 1.5. Inclusion bodies in CHO cells transfected with Z-AAT. ........................... 27	
Figure 1.6. Polymerogenic mutations of AAT. ........................................................... 28	
Figure 1.7. Kinetic model for the polymerisation of AAT. .......................................... 29	
Figure 1.8. The proposed models of AAT polymerisation. ........................................ 33	
Figure 2.1. The Rayleigh criterion. ............................................................................ 47	
 Figure 2.2. Scheme of an electron microscope. ....................................................... 50	
Figure 2.3. Schematics depicting the aberrations of lenses. ..................................... 52	
Figure 2.4. Image contrast. ....................................................................................... 57	
Figure 2.5. Example Fourier transforms of images. .................................................. 59	
Figure 2.6. A simplified schematic illustrating the basis of multivariate statistical 
analysis (MSA) and classification. ............................................................................. 63	
Figure 2.7. 3D reconstruction using the central section theorem. ............................. 65	
Figure 4.1. Schematic diagram of the domain structure of IgGs. .............................. 75	
Figure 4.2. Generation of mAbs using hybridoma technology. ................................. 78	
Figure 4.3. Crystallisation phase diagram. ................................................................ 84	
Figure 4.4. Examples of electron density at different resolutions. ............................. 87	
 Figure 4.5. Example of hanging drop crystallisation plates set up for the 1D9 Fab. 99	
Figure 4.6. Example of hanging drop crystallisation plates set up for the rAAT/1D9 
Fab complex. ............................................................................................................. 99	
Figure 4.7. The classification of newly generated monoclonal antibodies into 5 
groups based on antigen specificity. ....................................................................... 103	
Figure 4.8. 1D9 specificity. ...................................................................................... 105	
Figure 4.9. 1D9 blocks the polymerisation of AAT in vitro. ...................................... 107	
Figure 4.10. 1D9 binding alters the inhibitory activity of AAT. ................................. 108	
Figure 4.11. 1D9 binding stabilises the native state of AAT. ................................... 110	
Figure 4.12. 1D9 has a different epitope to 4B12. ................................................... 111	
Figure 4.13. Localisation of the 1D9 epitope. .......................................................... 113	
Figure 4.14. Further investigation of the 1D9 epitope. ............................................ 114	
  
13 
 Figure 4.15. Characterisation of the binding between monomeric AAT and 1D9 using 
SPR. ........................................................................................................................ 117	
Figure 4.16. Preparation of samples for crystallographic studies. ........................... 120	
Table 4.1. Conditions in the commercial screens tested that produced crystals for the 
three samples. ......................................................................................................... 122	
Table 4.2. Examples of the crystals formed for both the 1D9 Fab and 1D9 Fab-rAAT 
complex in the hanging drop crystallisation screens. .............................................. 123	
Figure 4.17. Data collection for the 1D9 Fab. .......................................................... 124	
Figure 4.18. Sequencing of 1D9. ............................................................................. 126	
................................................................................................................................. 128	
Figure 4.19. A Ramachandran plot of the 1D9 Fab structure. ................................. 128	
Table 4.3. Data collection and refinement statistics for 1D9 Fab. ........................... 129	
Figure 4.20. The 1D9 Fab structure. ....................................................................... 131	
Figure 4.21. B-factor analysis of the 1D9 Fab. ........................................................ 132	
Figure 4.22. Data collection for the AAT/1D9 Fab complex. ................................... 133	
Table 4.4. Data collection and refinement statistics for the AAT/1D9 Fab complex.
................................................................................................................................. 134	
Figure 4.23. The crystal structure of the 1D9 Fab-rAAT complex. .......................... 136	
Figure 4.24. Overlay of the two complex structures present in the unit cell. ........... 138	
Figure 4.25. B-factor analysis of the two complexes present within the unit cell. ... 139	
Figure 4.26. An overlay of AAT crystal structures. .................................................. 140	
Figure 4.27. Comparison of 1D9 structure in unbound and bound states. .............. 141	
Figure 4.28. Negative stain electron micrographs of ZZ liver polymers in the absence 
and presence of 1D9 Fab. ....................................................................................... 142	
Figure 4.29. Superposition of the 1D9-AAT complex structure with models of the 
three proposed polymerisation mechanisms. .......................................................... 149	
Figure 4.30. Steric clashes between the 1D9-AAT complex and protease. ............ 152	
Figure 5.1. 3D reconstructions of the AAT dimer isolated from ex vivo material and 
labelled with 4B12 Fab. ........................................................................................... 157	
Figure 5.2. Purification of AAT from plasma. ........................................................... 168	
Figure 5.3. A negative stain micrograph of heat-induced AAT polymers. ............... 169	
Figure 5.4. Generation of the 4B12 Fab. ................................................................. 170	
................................................................................................................................. 171	
Figure 5.5. A negative stain micrograph of heat-induced AAT polymers bound with 
4B12 Fab. ................................................................................................................ 171	
Figure 5.6. Particle picking from the heat polymer/4B12 Fab dataset. .................... 172	
Figure 5.7. Initial alignment of the heat polymer/Fab particles. ............................... 174	
Figure 5.8. Eigenimage analysis of heat polymer/Fab particles. ............................. 176	
  
14 
Figure 5.9. The 16° heat polymer/Fab dimer. .......................................................... 178	
Figure 5.10. Autopicking and 2D Classification of heat polymer/4B12 Fab dimer 
particles using Relion. ............................................................................................. 181	
 Figure 5.11. Workflow illustrating particle selection using 3D classification and the 
final 59° reconstruction. ........................................................................................... 183	
Figure 5.12. A comparison of structural refinements against a dimer reference or a 
monomer reference. ................................................................................................ 186	
Figure 5.13. The complete processing workflow of the ex vivo polymer data using 
Relion. ..................................................................................................................... 189	
Figure 5.14. Characterisation of the two ex vivo dimer reconstructions. ................. 192	
Figure 5.15. Attempts to identify more ex vivo reconstructions. .............................. 194	
Figure 5.16. Improving the modelling of the 4B12 Fab/AAT interaction. ................. 196	
Table 5.2. Correlations of the fits of the polymerisation models into the NS-EM 
densities. ................................................................................................................. 198	
Table 5.3. Dunn’s non-parametric multiple comparisons test evaluating the 
polymerisation model fits into the NS-EM densities. ............................................... 200	
Figure 5.17. Fits of the NS-influenced polymerisation models into the 60° liver 
polymer structure. .................................................................................................... 201	
Figure 6.1. Schematic of the folds of Tau protein in Pick’s disease and Alzheimer’s 
disease. ................................................................................................................... 218	
Figure 6.2. Method of polymer extraction from liver samples. ................................. 228	
Figure 6.3. Western blot analysis of the liver sample. ............................................. 229	
Figure 6.4. Quantification of AAT polymer in the liver sample. ............................... 230	
Figure 6.5. Deglycosylation of ZZ-AAT liver polymers. ........................................... 231	
Figure 6.6. A negative stain micrograph of ex vivo liver polymers. ......................... 232	
Figure 6.7. A negative stain micrograph of ex vivo liver polymers labelled with 4B12 
Fab. ......................................................................................................................... 233	
Figure 6.8. Negative stain micrographs of heat-induced polymers labelled with 
different antibody fragments. ................................................................................... 236	
Figure 6.9. Cryo-EM micrographs of heat polymer with 4B12 Fab bound. ............. 238	
Figure 6.10. Unidentified crystals on Lacey grids of the ex vivo polymer labelled with 
4B12 Fab. ................................................................................................................ 239	
Figure 6.11. Extra purification of ex vivo polymers. ................................................. 241	
Figure 6.12. Labelling of ex vivo polymers with 4B12 Fab. ..................................... 245	
Table 6.1. Summary of cryo-EM grid optimisation for the liver polymer/4B12 Fab 
sample. .................................................................................................................... 249	
Figure 6.13. Preliminary data collection. ................................................................. 251	
Figure 6.14. Cryo-EM workflow for image processing of the dimer. ........................ 255	
Figure 6.15. Cryo-EM class averages of dimers with inverted subunits. ................. 256	
Figure 6.16. Refinement of the dimer and single subunit from dimer particles. ...... 259	
  
15 
Figure 6.17. Cryo-EM workflow for image processing of the single subunit. ........... 261	
 Figure 6.18. Approaches trialed to improve alignment of single subunit images. .. 263	
Figure 6.19. Improving the modelling of the 4B12 Fab/AAT interaction using cryo-
EM-derived contour information. ............................................................................. 266	
Table 6.2 Correlations of the fits of the updated polymerisation models using Model 
541 into the NS-EM densities. ................................................................................. 266	
Figure 6.20. Fits of the cryo-influenced polymerisation models into the 60° liver 




2D  Two dimensional 
3D  Three dimensional 
AAT  Alpha1-antitrypsin 
AATD  Alpha1-antitrypsin deficiency 
ADC  Antibody drug conjugate 
AFM  Atomic Force Microscopy 
CCD  Charge-coupled device 
CDR  Complimentary determining regions 
CG   Covent Garden 
CMS  Culture media supernatant  
CPS1  Carbamoyl phosphate synthetase 1 
CTF  Contrast Transfer Function 
DED  Direct electron detector 
ELISA   Enzyme-linked immunosorbent assay 
EM  Electron microscopy 
ER  Endoplasmic reticulum 
ERAD  ER-associated protein degradation 
FEG  Field emission gun 
FENIB  Familial Encephalopathy with Neuroserpin Inclusion Bodies 
Fab  Fragment antigen binding 
FBS  Foetal bovine serum 
Fc  Fragment constant 
FR  Framework region 
FRET  Fluorescence resonance energy transfer 
FSC  Fourier shell correlation 
FT  Fourier transfer 
Gu-HCl Guanidine Hydrochloric acid 
HDAC  Histone deacetylase 
hIPSC  human Induced pluripotent stem cells 
HNE  Human neutrophil elastase  
HRP  Horseradish peroxidise  
IB  Inclusion body 
Ig  Immunoglobulin 
mAb  Monoclonal antibody 
ML  Maximum likelihood  
MRA  Multi-reference alignment 
MS  Mass spectrometry 
MSA  Multivariate statistical analysis 
MWCO Molecular weight cut-off 
  
17 
NMR  Nuclear Magnetic Resonance 
NS  Negative stain 
Ox-AAT Oxidised antitrypsin 
PAI-1  Plasminogen activator inhibitor-1 
PAGE  Polyacrylamide gel electrophoresis 
PAS   Periodic acid-Schiff 
PBA  4-phenylbutyric acid 
PCR  Polymerase chain reaction 
PDB  Protein Data Bank  
PEG  Polyethylene glycol 
PSF   Point spread function 
RCL   Reactive centre loop 
RMSD  Root mean squared deviation 
RT  Reverse transcription 
RU  Response units 
SAXS  Small angle X-ray scattering 
SDS  Sodium dodecyl sulfate 
SI  Stoichiometry of inhibition 
SPR  Surface plasma resonance 
SNR  Signal to noise ratio 
TEM  Transmission electron microscopy 
UA  Uranium acetate 




1.0  Introduction to Alpha1-Antitrypsin 
1.1  The serpin superfamily 
Serpins are the largest and most broadly distributed family of protease inhibitors. 
Homologues have been identified in all domains of life- animals, plants, bacteria, 
archaea and viruses with a total of more than 1,500 members1. The majority of 
serpins are serine protease inhibitors, a role after which the family is named, 
however some have activity against cysteine proteases. The inhibitory serpins have 
important roles in the regulation of proteolytic cascades such as those in the 
inflammatory (alpha1-antitrypsin, AAT), complement (C1-inhibitor), coagulation 
(antithrombin) and fibrinolytic (plasminogen activator inhibitor-1, PAI-1) pathways2. 
Other members are non-inhibitory with roles ranging from blood pressure regulation 
(angiotensinogen) to chromatin condensation (MENT)2,3. Some of the serpins 
reffered to in this thesis are listed in Table 1.1. 
 
Table 1.1. A selection of human serpins with their location and function. Table adapted 
from 4 and supplemented with 5,6.  
 
Serpin Location Activity Function
Alpha1-antitrypsin Extracellular Inhibitory Inhibition of Neutrophil elastase 
(inflammation)
Angiotensinogen Extracellular Non-inhibitory N-terminal cleavage releases the hormone angiotensin 1 
(blood pressure regulation)
Antichymotrypsin Extracellular Inhibitory Inhibition of Cathepsin G 
(inflammation)
Antithrombin Extracellular Inhibitory Inhibition of Thrombin and Factor Xa
(blood clotting)




Extracellular Non-inhibitory Transport of hormones, particularly cortisol
Heat shock protein 
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Intracellular Non-inhibitory Chaperone for collagens








Intracellular Inhibitory Inhibition of uPA
(fibrinolysis)
Protease nexin 1 Extracellular Inhibitory Inhibition of uPA and tPA
(fibrinolysis)




1.2  The serpin fold 
Serpins have a conserved tertiary fold despite a relatively low sequence identity7 
(Figure 1.1). Their structure consists in most cases of 9 ⍺-helices (sequentially 
named A to I), 3 β-sheets (named A to C) and a reactive centre loop (RCL). The RCL 
is typically 21 amino acids long, labelled P17-P4’ and in the native state is solvent-
exposed and mobile.  
 
Figure 1.1. The serpin fold. Front (left) and back (right) views of AAT (PDB ID:1QLP) shown 
in ribbon representation8. The 3 β-sheets are highlighted with β-sheet A in blue, β-sheet B in 
green and β-sheet C in purple. The RCL is shown in turquoise with the site of the common 
pathological ‘Z’ mutation shown in ball and stick representation and the P1’-P1 protease 
cleavage bond in pink. Figure made using Chimera9.  
Serpins are an exception to Anfinsen’s principle10: they fold into a kinetically trapped, 
metastable or ‘stressed’ state that can readily change conformation, rather than the 
conformation with the lowest free energy. This is important for serpin function but 
also renders the serpins susceptible to mutations that lead to misfolding and 
polymerisation. For inhibitory serpins, the metastability is predominantly resolved 
upon insertion of the RCL as a 6th strand in the central mixed parallel/anti-parallel 
five-stranded β-sheet A11. This makes β-sheet A completely antiparallel, forming the 
‘relaxed’ serpin conformation. RCL insertion releases around 50-60 kcal/mol and the 
thermal stability of the serpin increases from 50-60 to greater than 12012.  
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1.3  The serpin mechanism of protease inhibition 
The RCL of inhibitory serpins is highly flexible and its conformation has important 
biological and functional implications. Its movement is particularly central to the 
‘suicide-substrate’ and irreversible mechanism of protease inhibition (Figure 1.2)13. 
During inhibition, the RCL acts as a pseudosubstrate by presenting the P1-P1’ 
residues to the target protease in an optimal conformation14. In the case of AAT, the 
P1-P1’ residues are Met358-Ser3593. Cleavage by the protease at the P1’-P1 bond 
leads to the formation of an acyl-intermediate, with an ester bond linking the protease 
to the serpin P1 residue15. Release of the C-terminal fragment permits the RCL to 
fully insert as a 6th strand (strand 4A) in β-sheet A, flipping the protease 70Å to the 
opposite pole of the serpin and adopting the relaxed state13,16,17. In the process, the 
protease active site serine is pulled out of the catalytic triad conformation, leading to 
distortion of the active site and a 37% loss of structure in the protease through 
compression against the serpin13,18,19. The protease mechanism therefore cannot 
proceed to deacylation of the complex. This process is thermodynamically driven, 
with the resultant serpin in the lowest free energy conformation and energy 
transferred to denaturation of the protease and converting the protease back into a 
zymogen-like state13. The level of denaturation observed may vary between serpin-
protease pair as a crystal structure of porcine pancreatic elastase in complex with 
AAT showed no disorder to the protease1,20. The serpin-protease complex is then 
cleared quickly from the circulation by binding to lipoprotein receptors21.  
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Figure 1.2. The serpin mechanism of protease inhibition.The native conformation of the 
serpin (PDB ID: 1QLP) interacts non-covalently with the protease (orange) to form the 
docking complex (PDB ID:1OPH)8,22. The serpin RCL (turquoise) is cleaved by the protease 
and inserts into β-sheet A (blue). In a productive interaction, RCL-insertion translocates the 
protease to the opposite pole of the serpin, denatures the protease active site and forms a 
stable irreversible complex (PDB ID: 1EZX)13. In an unproductive interaction, the serpin is left 
inactive in a cleaved conformation and the active protease is released. Figure made using 
Chimera9. 
1.4  Other hyperstable serpin conformations 
Some serpin-protease pairs will result in a proportion of unproductive interactions. 
This is where the protease cleaves the serpin but is not covalently bound and 
therefore is not irreversibly inhibited. The serpin-protease complex dissociates; the 
protease is released to cleave other proteins but the serpin is left inactive (Figure 
1.2). The released serpin has a cleaved RCL, which similarly is fully self-inserted to 
complete β-sheet A (Figure 1.3, left)14. The cleaved serpin is thermally hyperstable.  
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The RCL can also be incorporated into β-sheet A in the absence of cleavage, 
forming the latent conformation, which is associated with a loss of inhibitory activity 
(Figure 1.3, middle)23. The formation of the latent state requires the release of strand 
1C. This locally destabilises β-sheet C and is proposed to reduce the global stability 
of latent compared to the cleaved conformation3. The latent conformation can be 
restored to the native conformation by denaturation and refolding. Some serpins 
adopt the inactive latent conformation in vivo: latent antichymotrypsin and 
neuroserpin have been detected in individuals24, however the latency transition has 
been best characterised in plasminogen activator inhibitor-1 (PAI-1). PAI-1 
undergoes this process by default, with a half-life of 1 to 2 hours; vitronectin, a 
glycoprotein present in the blood, stabilises against the transition, increasing the half-
life by between 2-16 fold depending on buffer conditions25. AAT can be artificially 
induced to form the latent conformation by heating in 0.7M citrate but this form has 
not been detected in vivo except in individuals who have received augmentation 
therapy, due to presence in the administered AAT26. The lack of latent AAT in vivo 
may be due to the relatively short RCL that does not permit complete formation of 
strand 4A27. 
RCL insertion into β-sheet A can also be incomplete or partial, as captured in a 
crystal structure of a mutant antichymotrypsin atypically stabilised by the loop C-
terminal to helix F (Figure 1.3, right)28. In this publication, the structure was proposed 
to be the polymerisation intermediate, having a stability between native and latent 
conformations. Partial insertion has also been observed with non-mutant 
antichymotrypsin and antithrombin29-31. Notably both serpins have an RCL that is 
longer than that of AAT.  
Lastly, the RCL β-sheet A interaction is proposed to be the basis for the aberrant 
intermolecular linkage present in serpin polymers that form as a result of mutations32. 
These polymers are highly stable and can have pathological consequences in vivo, 




 Figure 1.3. Hyperstable serpin conformations. The cleaved conformation (PDB ID: 1EZX) 
is formed by cleavage of the P1’-P1 bond and insertion of the RCL into β-sheet A but with 
dissociation of the protease13. The latent conformation (PDB ID: 1IZ2) is formed by insertion 
of the RCL in the absence of cleavage27. The RCL can also be partially inserted into the top 
of β-sheet A (PDB ID: 1QMN), with the bottom stabilised by unwinding of helix F into a β-
strand (yellow)28. Figure made using Chimera9. 
1.5  Alpha1-antitrypsin (AAT) 
Alpha1-antitrypsin (AAT) is a 52 kDa glycoprotein consisting of 394 amino acids. It is 
the most abundant protease inhibitor in the plasma at a concentration of 1.5-3.5g/l in 
a healthy individual3. AAT is an acute-phase protein involved in inflammation so 
levels can transiently increase 4-fold above this range3. It has a half-life of 3-5 days 
in serum, strongly dictated by the presence of its glycan chains: removal of one 
glycan reduces the half-life significantly33.  
Over 80% of AAT is synthesised in hepatocytes3. Normal physiological production of 
AAT involves co-translational translocation into the endoplasmic reticulum (ER) and 
glycosylation of three asparagine residues with branched, 14-unit oligosaccharides34. 
These appendages direct AAT into a specialised glycoprotein folding pathway aided 
by chaperones, where the glycans are trimmed and altered by various 
glucosidases35. On maturation, AAT is transported to the Golgi complex where 
further glycan processing occurs35. It is then secreted into the blood for transportation 
to the lungs. A small amount of local secretion of AAT also occurs from lung 
epithelial cells, neutrophils and alveolar macrophages36-38. Within the lungs, the main 
target of AAT is neutrophil elastase secreted by neutrophils at sites of inflammation. 
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It also inhibits proteinase-339. AAT inhibition of these enzymes serves to protect the 
alveoli from unregulated elastin breakdown. 
1.6  Alpha1-antitrypsin deficiency (AATD) and the 
serpinopathies 
Mutations within the AAT gene can alter the normal physiological production of AAT 
and result in disease.  AAT deficiency (AATD) is one of many conformational 
diseases that result from the polymerisation of mutants of members of the serpin 
superfamily. Collectively, these are known as the serpinopathies40. Each 
serpinopathy is associated with a gain-of-function phenotype caused by the 
polymerisation and retention of the serpin at the site of synthesis, or a loss-of-
function phenotype caused by the resultant deficiency, or both. For example, 
polymerisation of neuroserpin in the cerebral cortex results in an autosomal dominant 
dementia known as Familial Encephalopathy with Neuroserpin Inclusion Bodies 
(FENIB), whilst the deficiency caused by polymerisation of antithrombin results in 
thrombosis41. AATD displays both gain-of and loss-of-function effects, with the 
accumulation of polymers in hepatocytes causing liver disease and the deficiency in 
the plasma causing emphysema42.  
AATD is an autosomal co-dominant disorder and is associated with many disease-
causing mutations in the SERPINA1 gene (encoding AAT). Over 100 naturally-
occurring allelic variants of AAT have been identified and over 30 of these affect the 
in vivo function or secretion of AAT (Figure 1.6)43. AAT variants have in the past been 
classified according to their migration by isoelectric focusing (Figure 1.4), where 
proteins are separated by charge and stop migrating at the pH when their net charge 
is zero. However, modern convention is to name variants according to the 
geographical region or the hospital of their discovery. The wild-type AAT protein is 
referred to as M-AAT. The most common mutant variants are the ‘Z mutation’ or ‘Z-
AAT’, with a Glu342Lys single point mutation and S-AAT, with the Glu264Val 
mutation.  
Isoelectric focusing of plasma AAT has demonstrated that multiple glycoforms of 
AAT exist (Figure 1.4). Nine different glycoforms of M-AAT (classified as subtypes 
M0-M8) and six of Z-AAT have been identified44. The forms vary in the number of 
sialic acid residues on the glycan chains, as a consequence of different glycan 
branching patterns. Glycoanalysis comparing the isoforms of M-AAT and Z-AAT has 
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shown that there was no significant difference in the branching structure of the 
glycans, however there were more glycans on Z-AAT with a core and/or outer-branch 
fucose residue45. The exact effects of this is unknown but it has been hypothesised 
to alter AAT’s anti-inflammatory properties.  
 
Figure 1.4. An example isoelectric focusing gel used for the identification of different 
AAT genotypes. The multiple bands per AAT variant represent different glycoforms and N-
terminal truncations of AAT. Figure adapted from46. 
The Z mutation is situated at the base of the RCL and head of s5A where it anchors 
s5A to s6A through a salt bridge with Lys29047. The Z mutation is thought to promote 
polymerisation by further destabilising the native metastable conformation and 
promoting formation of the β-sheet A-opened intermediate48. Glu342 has been 
shown to be critical for proper folding, and a positive charge at this position, such as 
the Z mutation, reduces folding efficiency. However, the crystal structure of 
glycosylated Z (Glu342Lys) AAT expressed in Drosophila resembles the wildtype 
structure with minimal effects of Lys342 on packing around the hinge49. Similarly, low 
resolution AFM data found no major topographical differences between M and Z 
monomers50. A Glu342Ala AAT variant with a disulphide bond between s5A and s6A 
behaved similar to wildtype AAT in peptide binding studies, thermal stability and 
basal fluorescence, whereas the reduced form was similar to the Z form. 
Furthermore, residues on top of s5A on a Glu342Ala background, but not wildtype, 
were accessible for modification in a pegylation assay. These data indicate that the Z 
mutation results in an unstable β-sheet A in which the top half of s5A is labile51. A 
study that employed hydrogen/deuterium exchange combined with mass 
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spectrometry (MS), to probe the dynamic differences between M-AAT and Z-AAT, 
similarly concluded that the Z mutation perturbs the region around the mutation and 
even more distant regions such as B, D and I helices and β-sheet A52. Therefore, an 
aberrant conformation of Z-AAT likely arises from the loss of stabilising interactions 
of Glu34248,49. Other mutations are proposed to affect the sliding movement involved 
in the opening of β-sheet A or affect the movement of the RCL53-55. Equivalent AATD-
causing mutations have been found in other disease-causing serpins41. 
More than 95% of individuals with severe AATD are homozygous for Z-AAT. The Z 
mutation is most common in Northern European populations occurring at a frequency 
of 1 in 40, and therefore affecting 1 in 170056. The S allele occurs in 1 in 5 Southern 
Europeans, peaking in the Iberian Peninsula43,56. Individuals that are homozygous for 
the Z mutation retain 85-90% of synthesised AAT. The majority (~70%) of this protein 
is degraded by the ER-associated protein degradation (ERAD) pathway, which 
involves retrotranslocation of misfolded proteins from the ER lumen to the cytoplasm 
for degradation by the ubiquitin-proteasome pathway57. The remainder of the protein 
self-associates into polymers that are incorporated into insoluble, periodic acid-Schiff 
(PAS) positive inclusions (Figure 1.5)32,57. Consequently, there is a circulating 
deficiency of AAT monomer, and reduced antiprotease reaching the lungs. The S 
allele is less severe, with S homozygotes having AAT plasma levels of about 60% of 
that of M homozygotes55.  
Patients with AATD can present clinical symptoms involving both the liver and the 
lungs. AAT polymerisation within the hepatocyte ER causes cellular damage, 
hepatocyte proliferation and sensitisation to ER stress59,60. This predisposes 
individuals to neonatal hepatitis, liver cirrhosis and an increased risk of hepatocellular 
carcinoma. The deficiency of circulatory AAT predisposes to early-onset 
emphysema. This is due the over-activity of neutrophil elastase which breaks down 
pulmonary connective tissue and alveoli. Furthermore, the little aberrant AAT that 
reaches the lungs has been proposed to polymerise and co-localise with neutrophils, 
triggering an inflammatory response which causes additional tissue damage61. There 
is also some evidence that AAT activity is further compromised in individuals who 




Figure 1.5. Inclusion bodies in CHO cells transfected with Z-AAT. A single serial block-
face scanning electron micrograph of a CHO cell with multiple rounded inclusion bodies is 





Figure 1.6. Polymerogenic mutations of AAT. A) The structure of AAT with mutations coloured in red. B) A summary of the properties of the 
polymerogenic AAT variants. Table reproduced from 42 and supplemented with 64,65. 
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1.7  Biochemical characterisation of polymerisation of AAT 
in vitro 
As polymerisation of AAT underlies the disease, much work has focused on 
characterising the pathway to polymerisation and the structure of terminal polymers. 
The majority of experiments have studied the artificial generation of polymers from 
purified monomeric protein. Polymerisation can be induced under multiple different 
mild-denaturing conditions: by elevated temperature, incubation with denaturants 
such as Guanidine HCl (Gu-HCl) and urea, acidic pH and by cleavage of the RCL in 
non-standard positions47,66-69. The topography and periodicity of the polymers have 
been found to vary according to the method of polymerisation50. They also have 
different appearances on a non-denaturing gel69,70.  
Heat-induced polymers are formed by heating AAT between 41-65°C32,71-74. A 
multitude of spectroscopic techniques have suggested that heat-induced 
polymerisation is biphasic (Figure 1.7)71,72. Fluorescence studies using bis-ANS 
showed a fast initial increase in fluorescence followed by a slower reduction in 
fluorescence signal71. Similar findings were observed with intrinsic tryptophan 
fluorescence, fluorescence polarisation, circular dichroism and extrinsic fluorescence 
using a rhodamine probe and the ANSA dye72. Calculation of rates showed that the 
first step was unimolecular (concentration-independent) and 10-fold faster than the 
bimolecular polymerisation step under the experimental conditions used72. 
 
Figure 1.7. Kinetic model for the polymerisation of AAT. Step 1- An unstable intermediate 
(M*) is formed from monomer (M) by rate k1. Step 2- M* molecules associate to form 
polymers (P) by rate k2. 
The first step has been attributed to formation of an unstable but activated 
intermediate (M*)72. This may involve the opening of β-sheet A, potentially involving 
partial RCL insertion and s1C movement. Polymerisation did not occur when s1C 
was bound to s2C using a disulphide bond, in keeping with the conformation 
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observed for the antichymotrypsin intermediate28,71,73,74. A monomeric-sized species, 
proposed to be M*, has been characterised by MS69. It was recognised by the 
polymer-specific monoclonal antibody 2C1, which suggests it shares a 
conformational epitope present in monomeric subunits within the polymer, but absent 
in the native monomer. M* had a larger collision cross section than the monomer in 
ion mobility MS indicating the M* has an enlarged surface area compared to the 
monomer. The second phase has been attributed to insertion of the RCL during 
polymerisation. This kinetic mechanism is supported by the lag in polymer formation 
as the concentration of M* rises observed by non-denaturing gels and rhodamine 
fluorescence72. Dimers have been proposed to propagate polymerisation by having 
one exposed but partially inserted RCL as a β-strand donor and a readily opened β-
sheet as an acceptor75. 
Heat polymers are recognised by the monoclonal antibody 2C1, which also 
recognises polymers found extracted from hepatocytes of individuals with AATD76. 
They therefore share an epitope and are thought to be most physiologically relevant; 
neither polymers formed by incubation in denaturant or acid are recognised by 2C169. 
Denaturant polymers can be formed by incubation with 1-3M Gu-HCl or 4M 
urea32,47,69. Gu-HCl is thought to induce unfolding to form an intermediate that has 
local unfolding in the s5A-hI-s6A and F helix areas and incubation results in a high 
proportion of dimers rather than high-molecular weight polymers68,77. Acidic polymers 
have been formed by incubation with 0.1M sodium acetate, pH 4-4.5. They are 
proposed to form via an intermediate with a rearrangement at the top of β-sheet A 
and strand 1C and overall a 20% loss in secondary structure66. This is similar to the 
intermediate formed by heating, however polymerisation at low pH follows a three-
stage mechanism in contrast to the two-stage mechanism of heat-induced 
polymerisation66,71. Incubation at low pH formed the self-terminating antithrombin 
structure that underlies the β-hairpin model of polymerisation78. Lastly, polymers can 
be formed by cleavage of the RCL at P5-P4, P7-P6, P9-P8 or P10-P967. Residues N-
terminal to the cleavage site insert into the top of β-sheet A, opening up the bottom of 
the sheet for insertion of residues from another cleaved monomer79,80. Cleaved 




1.8  The models of polymerisation 
Polymers formed in vivo arise from a domain swap between consecutive AAT 
subunits and are hyperstable. This is consistent with an RCL-inserted 6-stranded β-
sheet A, and notably the RCL is protected from proteolysis on polymerisation32,67,81. 
Subunits are also non-covalently linked as polymers can be readily dissociated by 
1% w/v SDS81. 
The pathological mutations of AAT that lead to polymerisation occur in structurally 
distinct regions of AAT. The polymer-specific monoclonal antibody called 2C1 
recognises polymers resulting from a variety of mutations76,82. This indicates the 
polymers formed by different mutations in vivo share an epitope, which increases the 
likelihood that they are structurally similar.  
The structure of the in vivo AAT polymer is unknown. Previous studies using electron 
microscopy (EM) have shown that polymers are flexible and predominately linear, 
with beads-on-a-string morphology32,81. Polymer circlets are occasionally observed 
and their presence indicates that donor and acceptor ends are complementary, 
allowing self-terminating polymers to form. The existence of self-terminating and 
ordered polymers may explain why polymer accumulation does not activate the 
unfolded protein response (UPR)60. Early fluorescence studies using bis-ANS 
suggested that the polymer structure has newly exposed hydrophobic surfaces 
relative to the monomer and AAT must undergo a significant structural change upon 
polymerisation71. Several models of polymerisation have been proposed that differ in 
the intermolecular linkage between monomers (Figure 1.8): 
(A) The loop-β sheet A model32. This model proposes that the RCL of one monomer 
inserts into the β-sheet A of another.  
(B) The loop-β sheet C model83,84. This model proposes that the inter-subunit 
interaction occurs between the RCL of one molecule and the β-sheet C of the next. 
(C) The strand 7A model5,85. Here, the RCL forms an extra lateral strand of β-sheet 
A. 
(D) The β-hairpin model78. In this model, the intermolecular linkage is a β-hairpin, 
formed by the RCL and neighbouring strand 5 of β-sheet A.  
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(E) The C-terminal model86. The intermolecular linkage consists of three β-strands, 
formed by strand 1 of β-sheet C and strands 4 and 5 of β-sheet B.  
All models except (B) agree that the β-sheet A of AAT transitions from being 5-
stranded to 6-stranded. This explains the hyperstability of polymers and the 
protection of the RCL from proteolysis3,67. However, the models disagree on the 
involvement of strands which engage in the intermolecular linkage. Each model is 
based on a combination of structural and biochemical/biophysical data, generated 
from polymers made artificially by different in vitro methods or expressed in cells 
without glycan chains. Therefore, which, if any, model is applicable to the 
pathological context is currently unknown and this question will be addressed in this 
thesis. In fact, AFM studies comparing in vitro formed polymers (made by heating, 
acid or Gu-HCl incubation) to Z polymers isolated from the liver of a transgenic 
mouse, showed that long smooth linear polymers were a prominent and unique 
component of the sonicated insoluble fractions of liver extracts50. The loop-β sheet A, 
β-hairpin and C-terminal models have had the most backing for the polymer 
structure, although it is possible that multiple forms of polymers may be present in 
vivo. Accordingly, oligomers of topographies indistinguishable from all in vitro 
polymers were present in the ex vivo liver polymer sample, as well as the long fibres 





Figure 1.8. The proposed models of AAT polymerisation. The loop β-sheet A model was 
made by superimposing native AAT (PDB ID:1QLP8) on the AAT:TTAI ternary complex (PDB 
ID: 4PYW87). Phenix was used to simulate the P3-P8 insertion. The loop β-sheet C model is 
based on PDB ID: 1ANT83. The strand 7A model is based on PDB ID: 1B3K85. The β-hairpin 
model is based on PDB ID: 2ZNH78. The C-terminal model is based on PDB ID: 1D5S86. For 
all models, β-sheet A is in magenta, RCL in turquoise, β-sheet B in orange and β-sheet C in 




1.8.1 Evidence for the polymerisation models 
A) The loop-β sheet A model 
The loop-β sheet A model was the first proposed model of polymerisation and 
describes how the RCL of one molecule inserts into the β-sheet A of another32. The 
basis for this was the ability of RCL peptides to block polymerisation, which was later 
supported by crystal structures with peptides in the s4A position32,88. The number and 
specific residues of the RCL thought to constitute the intermolecular linkage has 
changed over the years. Initially, P12-P5 was thought to be the intermolecular linker, 
however the observation that P14-P9 peptides increase, rather than inhibit 
polymerisation, meant the model was revised to P8-P3 intermolecular insertion53,73. 
This requires s1C partially peeling away to increase mobility of the RCL and would 
leave an unfavourable gap at the top of β-sheet A. The gap is proposed to be 
satisfied by self-insertion of the RCL73, based on the crystal structure of a 
polymerogenic antichymotrypsin mutant (a serpin related to AAT but with a longer 
RCL), where partial self-insertion (P14-P12) of the RCL and opening of β-sheet A 
was observed28. The structure showed strand s1C had been distorted and the lower 
part of the sheet was stabilised by the last turn of the F-helix and a loop linking it to 
s3A. This conformation was proposed to be the intermediate conformation (M*) on 
the polymerisation pathway, however this has been disputed by the observation that 
it represents a terminally misfolded form of antichymotrypsin29. P8-P3 intermolecular 
insertion is also supported by cleavage of AAT at P9-P8 or P10-P9 resulting in 
spontaneous polymerisation67, although this cleavage would alleviate any steric 
hindrance imposed by an intact RCL.  
The loop-β sheet A mechanism has been tested by RCL mutations. Mutation of 
hydrophobic residues P8-P6 to Asp was used to investigate whether these residues 
make up the majority of the intermolecular linkage, or are just a small part of a larger 
domain swap89. These positions are oriented towards the protein core upon RCL 
insertion and would be expected to render canonical incorporation of the RCL 
unfavourable. The AAT variant did polymerise when induced with Gu-HCl, with heat 
and in transiently transfected COS-7 cells expressing AAT with a Z background. 
Further mutations at P10 and P9 were still tolerated; the conclusion was that the 
intermolecular polymeric linkage is not comprised of a partially-inserted RCL and 
instead a larger domain swap must occur. Of note, the variant was unable to 
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polymerise when incubated with small polymerisation-inducing peptides or when the 
RCL was cleaved in a region that is known to create ‘cleaved polymers’80. Another 
study similarly mutated residues along the RCL to probe the polymerisation 
pathway90. Circular dichroism, bis-ANS studies and a FRET-based assay suggested 
that P14P12 self-inserts early during the pathway, whereas P6P4 interact with β-
sheet A (either inter- or intra-molecularly) later in polymerisation. Furthermore, only 
mutations at P14P12 and P4, but not at P10, P8 or P6, resulted in a decrease in 
polymer levels in a transiently transfected COS-7 cell model. The authors argued that 
in order for these residues to be unfavourable for polymerisation, the AAT molecule 
would need to be substantially folded and hence that polymerisation proceeds from a 
‘near-native’ conformation. Similarly, a separate NMR study that characterised the 
intermediate ensemble formed by the Queen’s (K154N) mutation at physiological 
conditions found a high correlation between M-AAT and Queen’s AAT resonances, 
arguing against an unfolded intermediate82. While these studies do not rule out the 
linkages proposed by the β-hairpin and C-terminal models, it contradicts the nature of 
the intermediates hypothesised by those studies. 
Unlike the other models, there is no crystal structure of an intact loop-β sheet A 
polymer. However, the loop-β sheet A model has been evaluated for physical 
plausibility by computationally creating pentameric molecular models of AAT91. 
Increased RCL insertion in trans resulted in predicted polymer compaction and 
rigidity, in contrast to the flexible polymers observed by EM. P11-P3 was suggested 
to be the insertion limit for maintaining reasonable stereochemistry and reducing 
molecular stress. RCL self-insertion on a P8-P3 template (where P8-P3 is the inter-
molecular linkage and provided by the neighbouring subunit) was also modelled but 
self-insertion past P15 led to a highly compacted and strained polymer. Therefore, 
assuming that nearly complete β-sheet A occupancy is required for stability, self-
insertion to form M* and polymers was concluded by the authors to be implausible 
and the rigidity of the polymer formed from P11-P3 insertion concluded to be 
unlikely91. However, the extent of RCL insertion required to achieve the stability seen 
in polymers has not yet been tested. 
Different extents of a loop-β-sheet A intermolecular linkage have been observed in 
the crystal structures of cleaved polymers. An AAT polymer cleaved at the P5-P6 
position of the RCL had the P17-P6 region self-inserted into β-sheet A and the P5-P1 
region forming the β-strand linkage at the bottom of the β-sheet A of another 
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monomer80. A crystal structure with cleavage at P6-P7 showed self-insertion of P14-
P7 and the intermolecular linkage formed by P6-P3 into the β-sheet A of another79.  
B) The loop-β sheet C model 
This model was an alternative loop-sheet polymerisation mechanism originally 
proposed from the 3Å dimeric structure of antithrombin83. The structure showed one 
active molecule with an RCL self-inserted up to P14 and its P3-P7 residues replacing 
strand 1C of the other molecule, which was in the latent conformation. The authors 
postulated that polymers could form from a molecule with an opening β-sheet A that 
starts to incorporate its own RCL (i.e. on the transition to the latent state). This 
requires release of strand 1C and presents an incomplete β-sheet C to another 
molecule to allow polymerisation. Fluorescence studies have suggested that AAT 
can polymerise via the loop-β sheet A mechanism or the loop-β sheet C mechanism 
depending on the buffer conditions92. The latter is favoured by citrate buffer which 
promotes transition to the latent state, however complete formation of the latent 
conformation would block further polymerisation. This is proposed to explain the 
longer polymers formed by AAT compared to antithrombin, where antithrombin 
undergoes the transition to latency more readily.  
A similar loop-β sheet C interaction was observed in the crystal lattice of an N-
terminally truncated variant of a bacterial serpin called tengpin84. The RCL of tengpin 
was hyperinserted into its own β-sheet A, releasing s1C and presenting an exposed 
s2C for strand interactions with an exposed region of the RCL of a neighbouring 
molecule. In this structure, the strand interaction was antiparallel whereas in the 
antithrombin dimer the RCL of the active molecule linked in a parallel manner. These 
dimers dissociated readily to monomers by gel filtration in contrast to the stability 
expected of physiological polymers. The loop-β sheet C polymers are therefore 
thought to represent polymers formed by latent serpins e.g. S49P neuroserpin and 
PAI-124,84. However, the truncation of the N-terminus in this serpin was found to 
favour the latent conformation and the formation of this conformation may be due to 
crystal packing. 
C) The strand 7A model 
A strand 7A interaction was first observed in the crystal structure of a quadruple 
variant of active PAI-185. PAI-1 has a lower barrier to latency compared to other 
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serpins and spontaneously transitions to the latent conformation23. To counteract this 
in crystallisation trials, mutations were made in regions to stabilise the active form. In 
two out of the four molecules in the unit cell, the RCL was disordered and flexible. In 
the other two molecules, the RCL was constrained by crystal-packing contacts and 
added an extra β-strand (s7A) to β-sheet A. Similar to the loop-β sheet C polymers, 
the crystals could be dissolved to give active PAI-1, indicating the interaction was 
reversible.  
The s7A loop-sheet interaction was also observed in the crystal lattice of a variant 
(∆Mloop) of MENT, a serpin that plays a role in chromatin condensation5. MENT can 
be crosslinked in oligomers in complex with DNA suggesting a functional role of 
polymerisation. A 12-mer RCL peptide was able to inhibit DNA condensing activity in 
vitro5. Polymerisation was probed by incubation at 44 for 16 hours and consistent 
with the s7A loop-sheet interaction, polymerisation was reversible and the oligomers 
retained inhibitory activity, whereas incubation at 55 resulted in the formation of 
typical inactive polymers. Therefore, the s7A loop-sheet model may represent a 
reversible physiological linkage rather than a pathogenic linkage.  
D) The β-hairpin model 
The β-hairpin model is based on the crystal structure of a self-terminating 
antithrombin dimer solved to 2.8Å78. The stable dimer was formed by incubating 
plasma-derived wild-type antithrombin at pH 5.7 for 16 hours. The structure revealed 
a domain swap of around 50 residues in which strands 4 (RCL) and 5 of β-sheet A of 
one subunit were inserted into β-sheet A of the next subunit. To test the relevance of 
the structure to AAT, cysteine mutations were introduced at adjacent positions on 
strands 5A and 6A so that intermolecular disulphide bonds would only form if 
polymerisation involved such a domain swap. Polymerisation was achieved using 
Gu-HCl. This experiment demonstrated a swap of strand 5A during polymerisation, 
as the oxidised monomer did not polymerise. However, Ekeowa et al. argue that 5A 
is not involved in the linkage as peptides with homology to strand 5A did not block 
and reverse polymerisation69. Furthermore, a distinction must be made between the 
contribution of introduced disulphides to overall stability and direct interference with 
the polymerisation mechanism74. 
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The β-hairpin model for linear polymerisation as shown in Figure 1.8, was generated 
by breaking one of the intermolecular contacts observed in the crystal structure and 
placing the monomers in a head-to-tail configuration. Notably, to create a flexible 
intermolecular linker, helix I is proposed to unravel, which is a feature not seen in the 
crystal structure. This was tested using limited proteolytic cleavage by Asp-N and N-
terminal sequencing, which showed that polymers were more susceptible to 
digestion than monomer and sites around helix I were cleaved78. In direct 
contradiction to this data, Ekeowa et al. found no cleavage by Lys-C and Asp-N 
within helix I of polymers formed by heating and from polymer isolated from 
hepatocytes69. Similarly, NMR characterisation of the Queen’s AAT variant showed 
high stability in the helix I-s5A region82. As heat and liver polymers are recognised by 
the polymer-specific 2C1 monoclonal antibody and Gu-HCl polymers are not, this 
suggests a non-physiologically relevant polymer has been formed by the latter 
treatment. The β-hairpin model, as presented, also proposes an intermediate in 
which the hydrophobic β-hairpin is exposed78. Polymerisation-prone mutants, 
however, are known not to activate the UPR, which makes the presence of a grossly 
unfolded region unlikely60,69. In folding experiments, strand 5A was also shown to 
associate with the rest of the molecule before more C-terminal regions in 
contradiction to the β-hairpin polymer forming from an intermediate on the folding 
pathway93. Lastly, a study which used ion mobility MS to assess the collision cross 
section of the AAT dimer concluded that the theoretical loop- β sheet A dimer, but not 
the β-hairpin dimer, gave a collision cross section in good agreement with the 
experimental dimer values69. At the time this study was carried out, the C-terminal 
model had not been proposed. 
E) The C-terminal model 
The C-terminal model is based upon the crystal structure of a self-terminating AAT 
trimer solved to 3.9Å86. This polymer was formed from recombinant, non-glycosylated 
AAT that had an introduced disulphide to prevent the β-hairpin swap, by heating at 
60ºC for 18 hours. It was recognised by the 2C1 monoclonal antibody, demonstrating 
that is shares an epitope with the pathological polymer. The structure of the circlet 
revealed a domain swap between subunits of the C-terminal 34 residues, 
encompassing strands 1C, 4B and 5B. The RCL of each monomer was self-inserted 
into β-sheet A, consistent with polymer hyperstability. The linkage also allows 
considerable flexibility in the polymer chain, in accordance with the flexibility that is 
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observed for polymers visualised by NS-EM32,41,81,94. In the crystal structure, there 
were no exposed unfolded regions; however, the hydrophobic C-terminus must be 
exposed during formation of the linear polymer model, which would be expected to 
activate the UPR. The domain swap is supported by experiments investigating the 
folding pathway of AAT: s1C/s4B/s5B associate last with the rest of the AAT fold and 
this is critical to keeping the RCL solvent-exposed93. The structure was further 
supported by disulphide-trapping polymerisation experiments in vitro and in COS-7 
and Pichia pastoris expression systems86. However, the source of the material 
subjected to crystallography was an atypical, enriched band not normally seen in 
polymeric material by non-denaturing gels. This fact, combined with the unusual 
disulphide trapping approach, renders its relevance to a biological context unclear. 
The solution structures of Z-AAT polymers formed by Pichia Pastoris were also 
investigated by SAXS95. The trimeric, tetrameric and pentameric polymers all 
produced a scattering pattern and distance distribution curve only consistent with a 
ring-like structure. Both comparison with the theoretical scattering curve of the crystal 
structure trimer and ab initio modelling suggested a structure similar to that observed 
in the crystal structure, although not as symmetrical. This, together with a modelling 
study excluding the loop-β sheet A mechanism on the basis of rigidity preventing the 
formation of small cyclic polymers91, supports the C-terminal model of polymerisation. 
However, it is worth reiterating that the polymers isolated from livers and imaged by 
EM are mostly linear and those that form self-terminating rings are composed of 
greater than three subunits32,81.  
1.8.2  Drawing the molecular models together 
The loop-β sheet A, β-hairpin and the C-terminal models of polymerisation are all 
proposed to represent the AAT polymer formed in the liver of patients with 
AATD32,78,86. However, they have all been based on polymerisation experiments or 
crystal structures using artificial means of polymerisation. The relevance of in vitro 
polymerisation data to the in vivo polymer is unclear. It is clearly possible to form 
AAT polymers with differing inter-molecular linkages; therefore, it is of great clinical 
interest to determine the linkage in ex vivo material and which method of artificial 
polymerisation yields this linkage in order to aid laboratory studies.  
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The models agree that β-sheet A is 6-stranded in the polymer and this is due to 
insertion of the RCL. However, a major difference between them is whether the RCL 
is self-inserted and the single subunit resembles the cleaved conformation; this is the 
case for the C-terminal model but not the other two models. The linkages proposed 
either have one, two or three β-strands that are exchanged between neighbouring 
subunits32,78,86. The exchange of three β-strands from the B and C β-sheets in the C-
terminal model mean that there is only a single chain between subunits whereas for 
the loop-β sheet A and β-hairpin models there are two chain linkers. This has 
significant effect on the flexibility of these models, whereas the C-terminal model is 
the most flexible. This corresponds well to the flexible nature of polymers observed 
by NS-EM41,81. Furthermore, the species crystallised was generated by heating and 
recognised by 2C1, suggesting structural similarity to ex vivo material76,86. This 
contrasts to the β-hairpin species that was made by acid incubation and was not 
recognised by 2C178. Lastly, ex vivo polymers have mostly been observed to be long 
and linear. The C-terminal and β-hairpin models were both based on atypical self-
terminating structures that required modifications to form a linear model. There is not 
a structure of the loop-β sheet A model to make the equivalent comparisons. 
The controversy regarding the polymerisation mechanism for ex vivo polymers and 
the structural similarity between ex vivo and heat-induced polymers has been 
addressed in this thesis by using monoclonal antibody technology (Chapter 4), 
negative-stain EM (Chapter 5) and cryo-EM (Chapter 6).  
1.9  Treatment of AATD 
1.9.1 Current treatment of AATD for patients 
As AATD manifests in the lungs and the liver, close monitoring of, and therapeutic 
strategies for, both organs are required. However, there are a lack of AATD-specific 
therapies. The current treatment of patients is largely preventive and symptomatic, 
with organ transplantation suitable for end-stage disease96. Recommended 
behavioural or lifestyle changes include: smoking cessation, avoidance of 
environmental pollution, increased exercise, diet regulation and reduction of alcohol 
consumption97. Up-to-date vaccinations against influenza, pneumococcus and 
hepatitis are also recommended97. These actions help to preserve remaining lung 
and liver function. Medical therapies such as bronchodilators, corticosteroids and 
supplemental oxygen aim to relieve emphysema symptoms.  
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The only treatment that directly targets the deficiency state is augmentation therapy, 
which involves the delivery of purified intravenous human plasma AAT to correct the 
plasma deficiency96. The predominant therapeutic product historically has been 
observed to be conformationally impure26,98. Augmentation therapy is standard in the 
US and some European countries. However, evidence for lung function improvement 
is controversial and currently this is not a treatment option in the UK43. Inefficacy has 
been put down to a lack of suitably powered studies, as well as lung function being 
an inaccurate measure of disease progression43. This has been addressed by the 
recent randomised, double-blind, placebo-controlled RAPID trial. This showed that 
the rate of lung density loss, as assessed by CT scans, was significantly lower in the 
group receiving replacement AAT than in the placebo control99. There is also no 
specific treatment for the liver disease. Therefore, treatment for end-stage disease is 
transplantation. AATD accounts for 3.2% of adult lung transplants in the UK and 
3.5% and 1.1% of paediatric and adult liver transplants, respectively96. A 
transplanted liver retains its endogenous level of AAT expression and therefore may 
help to prevent the progression of pulmonary disease100,101.  
1.9.2  Therapeutic approaches in development 
With a greater understanding of the molecular basis underlying AATD, many 
therapeutic targets have been identified. These range from pathways involved in the 
intracellular processing of Z-AAT, sites on the Z-AAT molecule that can block 
intracellular polymerisation and genetic silencing or engineering of the Z mutation96.  
A) Modifiers of intracellular AAT processing 
As the Z mutation causes a misfolding of AAT, chemical chaperones have been 
investigated as therapeutics to stabilise mutant intermediates and reverse retention 
within the ER. The fatty acid, 4-phenylbutyric acid (PBA), showed modest increases 
in the secretion of active AAT in cell and transgenic mouse models of AATD, but no 
significant improvement in a small study of patients with this condition102,103.  
Correcting the inappropriate trafficking of Z-AAT has been targeted using the histone 
deacetylase (HDAC) inhibitor, suberoylanilide hydroxyicacid (SAHA). SAHA 
increased functional Z-AAT secretion to 50% of the level of M-AAT secretion from 
epithelial cell lines104. The acetylation status of cellular components via HDACs and 
histone acetyltransferases have a role in proteostasis regulatory pathways. It is 
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thought that the effect of SAHA was partly due to inhibition of HDAC7 and 
modulation of the interaction with calnexin. Calnexin is a chaperone that interacts 
with AAT in the ER by recognising monoglycosylated N-linked glycans35,105. 
The stimulation of degradation pathways is an alternative approach to the clearance 
of intracellular AAT polymers. Autophagy is one pathway activated by AAT 
accumulation and involved in the degradation of insoluble polymers106. Very high 
doses of the autophagy-stimulating drug carbamazepine were effective in decreasing 
AAT hepatocyte polymer load in a mouse model of AATD. It is now in a phase 2 
clinical trial for AATD patients96,107. Weekly-dosing of another autophagy-inducing 
agent, rapamycin also reduced intracellular accumulation of Z-AAT polymers and 
markers of hepatocellular injury in the AATD mouse model108. Finally, similar 
improvements in the mouse liver were observed by overexpression of the autophagy 
regulator, transcription factor EB, by viral vector delivery to hepatocytes109.  
B) Blocking intracellular polymerisation 
Early work found that peptides homologous to the RCL could bind into β-sheet A of 
AAT and block polymerisation in vitro32. These peptides were optimised for potential 
therapeutic delivery (by shortening to four residues) and for Z-AAT specificity110,111 . 
The most potent peptide (Ac-TTAI-NH2) has also been shown to prevent and reverse 
Z-AAT polymerisation in cellular models112, which could help treat Z-AAT related liver 
disease. All in vitro studies describe a loss of inhibitory activity of peptide treated Z-
AAT and therefore AAT replacement would need to be administered in parallel, to 
treat AAT-related emphysema110-113. There have been no human trials reported as 
there is a remaining challenge of targeting the peptides to liver cells96. 
A crystal structure of native AAT helped identify alternative sites on the molecule that 
could be targeted by drugs. Importantly, these were distinct from β-sheet A with the 
aim of preserving AAT inhibitory activity8. One hydrophobic cavity, lined by strand 2 
of β-sheet A and helices D and E, becomes occupied on transition from the native 
state to RCL-inserted state8.  Its potential as a drug target was tested by a pocket-
filling mutation, which reduced polymer formation and increased the secretion of Z-
AAT from a Xenopus oocyte model114. Virtual ligand screening identified small 
molecules termed the ‘Covent Garden (CG)’ series that targeted the cavity and 
blocked polymerisation in vitro and in a cellular model115.  These studies show the 
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potential to block AAT polymerisation through small molecules but CG-bound AAT 
was still inactive as a protease inhibitor115.  
Lastly, a monoclonal antibody named 4B12 has been developed that can reduce 
polymerisation and preserve AAT inhibitory activity both in vitro and when expressed 
as an intrabody in a cellular model116. While not seen as a viable therapeutic in its 
own right, characterisation of the epitope at helices A and I provides another site that 
could be targeted by therapeutic small molecules117.  
C) Genetic modifications 
The effects of polymerisation and accumulation of Z-AAT in the liver has directed 
approaches to silence expression of Z-AAT by small interfering RNAs. An antisense 
oligonucleotide complementary to the AAT gene has been found to inhibit AAT 
expression in mice and monkeys118. As a result, there was significantly reduced AAT 
accumulation in the liver and reduced liver disease, with even a reversal in liver 
fibrosis after long term treatment. This approach has the potential for a liver disease 
treatment but also reduces circulating levels of AAT and so would need to be 
partnered with another treatment to not exacerbate lung disease.  
Correction of the Z genetic defect has been achieved in differentiated human induced 
pluripotent stem cells (hIPSCs)119. Patient-specific hIPSC lines are another useful 
model of AATD: they have been generated from dermal fibroblasts of patients with 
the disease and differentiated into hepatocyte-like cells.  The genetic correction was 
achieved using a combination of Zinc finger nucleases and a PiggyBac DNA 
transposon. It effectively restored wildtype AAT behaviour in the cells, including after 
transplantation into a mouse model of liver injury.  It remains a promising approach 
for the future with active investigation of gene-editing tools such as CRISPR/Cas9 as 
therapeutic agents96,120. In a recent study, protein aggregation, liver fibrosis and 
inflammation were reduced in the liver of a gene-edited ZZ mouse model120. 
1.10  Specific Aims and Approach  
The objective of this thesis was to further the structural understanding of both 
artificially-made and patient-derived AAT polymers. It is hoped that this will inform 
future therapeutic approaches that target the polymerisation process directly. The 
work was primarily achieved by combining the use of conformational-specific 
monoclonal antibodies and electron microscopy. In particular, the overarching aim 
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was to determine the structure of the pathological ex vivo AAT polymer, to a high-
medium resolution (ideally around 7-10Å) using cryo-electron microscopy (cryo-EM) 
to reveal the polymer inter-subunit linkage. The material was extracted and purified 
from explant liver tissue obtained from the Birmingham BioBank, and obtainable only 
in very small quantities. Cryo-EM was the method of choice as it can accommodate 
the natural origin, high flexibility, chain length heterogeneity and glycosylation of the 
polymers. These characteristics make the polymers unsuitable for other structural 
techniques such as crystallography and NMR. A structural understanding of real 
pathogenic polymers will be crucial for rational drug-design, which will hopefully 
contribute towards the development of therapeutics that can prevent and reverse 
polymerisation and the associated liver and lung pathology. 	
To work towards the thesis objective, three branches of work were pursued that are 
covered in the three results chapters: 
1) Development and characterisation of monoclonal antibodies against AAT that 
show novel properties. The monoclonal antibody 1D9 was identified from a 
hybridoma screen to have a strong affinity for monomeric AAT, 
complementing the polymer-specific antibody 2C176. The properties of 1D9 
have been characterised in-depth using a variety of assays and techniques, 
including obtaining a crystal structure of the 1D9 Fab region alone and in 
complex with AAT. 
2) Negative-stain EM of ex vivo and heat-induced polymers. Heat-induced 
polymers share an epitope with ex vivo polymers and are thought to be a 
suitable model for the pathological polymer due to their common recognition 
by 2C176. Heat-induced and ex vivo polymers have been studied bound with 
4B12 Fab by NS-EM single particle analysis. Processing has been carried out 
with two image processing packages: IMAGIC121 and Relion122. The resultant 
low resolution structures of dimers have been assessed and compared with 
molecular models of the proposed polymerisation mechanisms. 
3) Cryo-EM of ex vivo polymers. Ex vivo polymers have been extracted and 
purified from liver samples of ZZ patients with AATD for characterisation. 
They have also been labelled with 4B12 antibody Fab domains and imaged 
by cryo-EM for the first time. Image processing using Relion122 has yielded 
low-resolution structures of the dimer and the single subunit, providing a 
strong basis for future work.  
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The primary techniques used to obtain these results - monoclonal antibody 
technology, crystallography, NS-EM and cryo-EM - will be introduced within the 




2.0 Introduction to Electron Microscopy (EM) 
2.1 Introduction 
The combination of cellular and structural biology over the last ~200 years has shed 
much insight into the mechanisms, functions and dynamics of molecules involved 
within a wide range of biological processes. Optical microscopy was the first 
technique used primarily for visualisation of cells, and later to provide information on 
inner cellular organisation. The invention of fluorophores made it possible to track the 
spatial distribution and movement of molecular complexes within cells. The 
techniques of X-ray crystallography and Nuclear Magnetic Resonance (NMR) have 
revealed detailed structures of many small proteins and their complexes with ligands. 
The information obtained by electron microscopy (EM) spans both levels of detail: 
scanning EM and transmission EM (TEM) of cellular sections or tomography can 
provide cellular details, while single particle analysis EM can achieve medium-high 
resolution and reveal different conformations of proteins and complexes. 
2.2  Optical microscopy in biology 
The human eye can resolve details up to ~0.1mm in size. Optical microscopy was 
invented to extend this limit and was based on the use of lenses to magnify images 
of objects and therefore improve the visibility of details. The first optical microscopes, 
pioneered by Robert Hooke and Antoni van Leuwenhoek in the 17th century, were 
able to provide magnified images of objects up to 250 times and could resolve 1-
10μm details123. With the development of compound microscopes that use complex 
lenses, this is now at 1500 times magnification, resolving details of 200nm in size. 
Better visualisation of cellular components was also aided by selective chemical or 
fluorescence staining, overcoming the inherently low contrast within biological 
specimens.   
The assessment of a resolution limit in the light microscope was given by Ernst 
Abbe, who has shown that the resolution (d) can be defined as the smallest 
observable distance between two separated features. It depends on the wavelength 
of the light used in the microscope (the wavelength of visible light is in range of 200-
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where NA is the numerical aperture defined as NA = nsinθ, where n is the refractive 
index of the medium and θ is half the acceptance angle of the lens/aperture (Figure 
2.1A). The criterion originates from the scattering of the illumination wave after it 
interacts with an object. An Airy disc with a central bright region and a series of 
surrounding concentric rings, rather than a perfect circle, is formed in the image 
plane when light passes through a circular aperture124. This Airy disc represents a 
point spread function (PSF) of the optical system. The resulting image of the object is 
a convolution of the PSF with the ideal image. Two points are described as resolved 
when the first minimum of the Airy disk from one point falls on the central maximum 
of the other (Figure 2.1)124. Super-resolution fluorescence microscopy has surpassed 
the limit described by Abbe, by reducing the PSF dimensions and reaching 
resolutions of ~50nm125. 
 
Figure 2.1. The Rayleigh criterion. A) The Rayleigh criterion for resolving two points. B) 
Two points (blue and green curves) appear as distinct intensity peaks in the image when they 
are far apart. C) Two points are just resolved when they are distance d apart, where the 
minima of one PSF overlaps with the maxima of another. D) Two points are unresolved when 




2.3  High resolution molecular techniques 
X-ray crystallography and Nuclear Magnetic Resonance (NMR) have structurally 
characterised thousands of proteins at an atomic resolution (1-4Å). X-rays have 
wavelengths of 1Å, close to the size of atoms. A combination of diffraction patterns 
collected at different angles, with phase information, corresponds to the 3D Fourier 
transforms of the molecular complexes from which the crystal is formed. The 
reversed Fourier transform generates electron density maps of the crystal repeating 
unit and these densities are used for model building (more details in Chapter 4.1.5). 
In contrast, NMR uses radiofrequency waves with wavelengths of centimetres-
metres to irradiate a sample and excite certain nuclei. The radiation emitted by the 
nuclei on relaxation is recorded and is specific to the structural environment of the 
nuclei. Information about the nuclei in a protein sample provides multiple structural 
constraints which can be combined with modelling and used to obtain atomic 
resolution structures. Despite their achievements, both techniques have serious 
limitations. X-ray crystallography depends on the growth of well-diffracting protein 
crystals and in NMR the spectra of proteins greater than 50kDa are difficult to 
interpret due to the overlap of nuclei peaks. These problems are generally 
exacerbated for large proteins, which means that protein complexes are more 
inaccessible to structural studies by these methods.  
TEM is uniquely suited to the study of structures greater than 100kDa and is less 
demanding in sample amount and homogeneity. This has extended the range of 
protein complexes amenable to structural determination and together with the 
technical advances, has offered an alternative route to high-resolution structure 
determination. 
2.4  Imaging using electrons 
According to the theory of dualism of particles formulated by Louis de Broglie in 
1922, electrons can also be considered as waves. Accordingly, a particle with a 
mass (m) and that moves with a velocity (v), can be scattered by matter and diffract 
according to the principles of conventional light optics. A wavelength (λ) of the 
particle is defined by: 
( = 	 ℎ,- 
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where  is the Planck constant. Since electrons are charged particles they can also 
be deflected and focused by an electromagnetic field. This principle has been used in 
construction of the electromagnetic lenses for the first transmission electron 
microscope by Ernst Ruska in the 1930s126. 
The short wavelength of accelerated electrons make them suitable for high-resolution 
structural imaging. The wavelength of electrons depends on their kinetic energy (eV 
= ½ mv2, where e is charge and V is the acceleration voltage) and can be defined by: 
( = 	 1.22/0/2 
For an accelerating voltage of 100kV and 300kV, the wavelength of the electrons is 
equal to 3.9pm and 2.2pm respectively. Then according to the Rayleigh criterion, the 
achievable resolution attainable in EM using a numerical aperture of 0.009 are 
0.26nm and 0.15nm for these two wavelengths. However, for biological specimens 
the realistic attainable resolutions are much worse due to sample preparation 
difficulties, low image contrast and signal to noise limitations. Still, in recent years 
due to technological advances in hardware and software, the resolution of EM 
reconstructions has improved up to 1.8Å127. 
The highest resolution electron density maps obtained in TEM are using the single-
particle analysis approach. Here, thousands of randomly oriented particles are 
imaged; these images represent 2D projections of individual molecules. Particle 
images that are similar to each other are grouped in classes and averaged to 
improve the signal to noise ratio (SNR). The orientations of each 2D class are then 
estimated and these images are used to reconstruct an initial 3D volume. The other 
main approach which yields lower resolution structures, but can be informative in 
terms of cellular structure and in-situ spatial organisation of particles, is electron 
tomography. This technique records multiple 2D projections of the same field of view 
at different angles to allow reconstruction of a 3D volume. 
2.5  The electron microscope  
An electron microscope consists of an electron source, electromagnetic lenses to 
make the electron beam parallel when it illuminates a specimen and then to focus the 





Figure 2.2. Scheme of an electron microscope. The condenser lenses parallelise the 
electron beam from the source to illuminate the sample. Electrons are elastically scattered 
(shown in red, blue, green) by the sample. High-angle scattered rays are blocked by the 
objective aperture. The projector lenses focus the magnified image onto a detector system.  
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2.5.1  Electron sources 
The electron source is located at the top of the microscope and produces the 
electrons used for imaging. The electron beam needs to be temporally coherent (all 
electrons are emitted with the same energy) and spatially coherent (emitted from the 
smallest area)128. This reduces the effect of lens aberrations and improves the 
achievable resolution of the microscope. The beam should also be intense and 
bright.  
Traditional electron sources are thermionic where electrons are emitted from a metal 
such as a tungsten filament, which is heated to temperatures around 2000-3000. 
The emitted electrons are then accelerated by an electric field towards an anode. 
LaB6 crystal sources have finer tips that require a lower temperature for emitting 
electrons and provide a more coherent beam. A much more parallel, brighter and 
monochromatic beam is produced by a field emission gun (FEG). Electrons are 
extracted from a single tungsten crystal, that is sharpened to a thin needle, by an 
electrostatic field and further accelerated by a voltage of 100-300 kV.  
2.5.2  The lens system 
Electron microscopes have a complex system of 5-6 lenses. The electromagnetic 
lenses used in EM are solenoid coils that can deflect an electron and whose power is 
controlled by varying the current flow within the coils. The first lenses in the optical 
system of the electron microscope are the condenser lenses, which create a parallel 
beam of electrons that irradiate a sample. The specimen is located just above the 
objective lens. The objective lens provides the primary magnification (20-50X) and 
hence its aberrations have a large impact on acquired images129. In the back focal 
plane of the objective lens the Fourier transform of the sample image is formed 
(described later). The objective aperture is located in this plane. The size of the 
aperture defines the angle at which electrons scattered by the sample will be cut off 
from formation of the image by projector lenses and is used to increase amplitude 
contrast in the image. A set of 2-3 projector lenses, located below the objective lens, 
provide the final magnification of the TEM image onto the phosphor screen or a 
recording device of the microscope. 
The quality of EM images depends on aberrations of the lenses. The most common 
aberrations are spherical, chromatic and astigmatism (Figure 2.3)129. In a perfect 
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lens, any parallel beam will be focused in one point in the back focal plane of the 
lens. Spherical aberrations of lens are related to the different focal distances for the 
rays that are passing at the periphery or through the central part of the lens. The rays 
that passed through the periphery are focused more strongly than rays closer to the 
optical axis. This means the focal length varies with distance from the optical axis. 
For chromatic aberrations, the focal length varies with the wavelength of the incident 
electron wave so that shorter wavelength electrons are focused closer to the lens. 
Astigmatism results from an asymmetrical magnetic field in the lens whose focusing 
power differs in perpendicular directions. It presents as elongation of features in one 
direction or an elliptical shape of a spherical point. 
 
Figure 2.3. Schematics depicting the aberrations of lenses. A) a perfect lens, B) spherical 
aberration, C) chromatic aberration, D) astigmatism. f is the focal length of the lens. Figure 
reproduced with permission from 129. 
2.5.3  Detectors 
The first TEM images were recorded on photographic film. This was cheap, with a 
large field of view and fine spatial resolution (pixel size of 6 μm). However, all 
micrographs had to be manually scanned for subsequent digital image processing 
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meaning the response time was slow and this limited the ability to collect high-
throughput TEM data. 
Film was replaced by charge-coupled device (CCD) cameras. These detectors rely 
on sensors that have two steps: the conversion of electrons into photons by a 
phosphorous scintillator and then the conversion of photons into charge via fibre 
coupling. A camera has an array of sensors that comprise the CCD chip. However, 
for image readout, the charges are serially transferred to a readout register and 
digitised. These cameras have several disadvantages. First, they are less sensitive 
at voltages above 120 kV. This is because high energy electrons have a reduced 
scattering cross-section and so thicker scintillators are needed to maintain the yield 
of photons. An additional problem is that secondary photons produced by electrons 
scattered within the phosphor layer, lead to registration by several adjacent sensors 
and increasing of the PSF size and noise in the image, reducing the resolution128. 
CCD sensors (pixels) are large, about 24 μm, meaning that a higher magnification is 
needed to achieve the same pixel size and thus reducing the field of view.  
High resolution TEM has become more accessible largely due to the advent of direct 
electron detectors (DEDs). DEDs consist of small (5-6 μm) sensors that can directly 
register electrons130,131. Due to the absence of an energy conversion step from 
electron to photon (where significant energy loss takes place) and shorter detection 
distance, DEDs offer a fast readout, a smaller PSF and improved SNR compared to 
CCDs. This also means they can rapidly record multiple subframes per image in the 
“movie mode” to allow for correction of sample drift, as well as finer control over the 
total electron dose that the sample has been exposed to in the images used for 
reconstruction132. They are more expensive and produce datasets that require 
greater disk space for storage and processing, however their advantages for high-
resolution structural determination are clear. 
2.6 Usage of Fourier transform in EM  
Within the microscope, a Fourier transform (FT) is formed on the back focal plane of 
the objective lens. A FT is the decomposition of a complex function into a series of 
sine waves128. Representation of a function as waves is often described as being the 
“reciprocal” space. Reciprocal (or Fourier) space and real space (the space of the 
original function) can be readily interchanged by a Fourier transformation. The 
reversed FT takes place in the microscope as the scattered wave moves through the 
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projector lenses towards the image plane, where the component waves re-interfere 
forming the image that is registered by detectors.  
Fourier decompositions or summations may not always be exact as it depends on 
the highest frequency of wave used to restore the original function128. The Nyquist 
frequency is the highest frequency component present in the calculated FT of the 
function. This is the sine wave that oscillates with a frequency half that of the 
sampling rate (i.e. the pixel size divided by 2)128. The high frequency components are 
represented near the edge of the FT, whereas the low frequency components (and 
low-resolution information) are located near the origin.  
Procedures in image processing can be carried out in real or Fourier space. There 
are fast computer algorithms to calculate the FT and convert between them. 
Furthermore, calculations are often faster in Fourier space, as it converts differential 
operators in real space into multiplication operators.  
2.7  EM sample preparation for single particle analysis 
2.7.1  Background 
The electron path is kept under high vacuum in the microscope. This is because 
electrons interact strongly with matter and otherwise their path would be impeded by 
gas particles. The vacuum requires that samples to be used for EM imaging must be 
in the solid state as any moisture from biological specimens would be evaporated 
causing structural collapse. Consequently, samples must be dehydrated or stabilised 
in a hydrated state before imaging. The chosen method for this depends on the 
sample and desired resolution of reconstruction.  
2.7.2  Negative staining 
Negative staining (NS) is the quickest and simplest method for preparing grids for 
TEM studies. It can be used to obtain low-resolution structures or for assessment of 
sample purification and homogeneity before cryo-EM.  
NS fixation involves the application of a heavy metal salt solution to the EM grid after 
application of the sample. Excess liquid is blotted away and the grid is left to air dry. 
The heavy metal atoms surround the sample molecules on the grid, creating a thin 
layer of dark granular background. Common stains are based on tungsten and 
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uranium, for example a 1-2% w/v aqueous solution of uranium acetate (UA). 
Although UA offers the best contrast, its acidic pH (~4) can lead to structural changes 
or complex disassembly and its microcrystalline structure is sensitive to the electron 
beam. This makes phosphor-tungsten acid a popular choice with its more 
physiological pH.  
NS-EM produces a 3D envelope of the molecule that reflects the shape and solvent-
exposed surface, but the obtainable resolution is limited to ~15-20Å due to the grain 
size of the metal salts133. A further consideration is that NS can also result in 
distortion of molecular shape (e.g. flattening) and dehydration can cause the 
structure to collapse124. 
2.7.3  Cryo-fixation 
Cryo-fixation allows higher resolution of structures in a more native-like state to be 
achieved due to the absence of stain. The sample suspended on an EM grid is 
rapidly cooled to liquid nitrogen temperatures (77K) by plunging into liquid ethane. 
The rapid drop in temperature preserves the water as a vitreous, non-crystalline solid 
state preventing the formation of hexagonal or cubic ice, which would damage 
biological material. Ethane must be used as it has a high heat capacity and a high 
heat conductivity providing extremely fast cooling of grids129. The liquid ethane is 
maintained at its freezing temperature by liquid nitrogen. Ethane is more efficient at 
retrieving heat from the sample than liquid nitrogen and does not boil as easily, 
therefore preventing an insulating gas layer from forming around the grid.  
The specimen is retained in a thin layer of vitreous ice as a snapshot of a solution-
like state. The contrast of cryo-EM samples is much lower than in NS-EM as the 
atoms composing biological macromolecules are very like those of water and buffer 
components. A hybrid approach is cryo-negative EM which can prevent dehydration 
and specimen collapse and increase contrast, however the attainable resolution is 
limited by the grain size of negative stain salt134,135. The typical stain used here is 
ammonium molybdate. Plunge-frozen samples must be maintained at cryogenic 
temperatures from sample preparation to grid insertion into the microscope and 




2.8  Image formation 
2.8.1  Interaction of electrons with the specimen 
There are several different outcomes from the primary electrons hitting the sample129. 
Some electrons pass through the sample without any interaction (unscattered). 
Others are deflected by the positive electrostatic field of the nucleus or the negative 
orbital electrons of specimen atoms, and some are scattered at high angles or 
backscattered after collision with atomic nuclei or electrons.  
The interactions of electrons with the sample can be classified as elastic or inelastic 
scattering. An elastic scattering event does not change the kinetic energy of the 
electron. Instead, it is deflected by an angle proportional to the nuclear charge and 
inversely proportional to its energy and distance from the nucleus. An electron 
involved in an inelastic scattering event transfers or gains some energy from the 
specimen. This has two major consequences: radiation damage to the specimen and 
the electron of altered energy being focused at a different point, leading to the 
blurring of the final image. The objective lens aperture and an energy filter can 
remove energy-loss electrons from the final image. Damage to the specimen 
structure can be through the ionisation of atoms, induction of X-ray emission, 
chemical bond rearrangement, generation of free radicals or causing secondary 
electron scattering136. Radiation damage often limits high-resolution structural 
determination as features of biological specimen can be affected at electron 
exposures as little as 10e/Å2. To alleviate the damage in recorded images, low dose 
modes (as well the recording of movies, discussed later) were introduced into 
imaging software. These use a deflection of the electron beam to a neighbouring 
region for area selection and focusing before image acquisition.  
2.8.2  Origins of image contrast 
Contrast in TEM micrographs is defined as the difference between the brightest and 
darkest pixel intensities divided by the average density in the image129. There are two 
types of contrast in biological TEM: amplitude and phase contrast (Figure 2.4). 
Amplitude contrast arises in the image from absorption of some electrons from the 
incident beam. Atoms with high atomic numbers (e.g. heavy metal stains) absorb or 
scatter electrons at high angles. These will not contribute to the final image; the latter 
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as it is blocked by the objective lens aperture. Such regions in the specimen will 
appear dark in the image. Biological specimens however produce little amplitude 
contrast as they consist of light atoms that do not absorb electrons. In general, the 
total number of electrons before and after the specimen remains nearly the same. 
However, the angle (and consequently the path length) of the scattered electrons 
relative to the unscattered electrons changes in a location-dependent manner. 
Considering electrons as waves, the angle change equates to a change in the phase 
of the scattered electrons and creates phase contrast128. Phase variations cannot be 
directly recorded in images and so are converted into detectable amplitude 
variations. This is done by introducing an additional 90º phase shift between the 
scattered and unscattered electrons using the objective lens aberrations (Figure 2.3) 
and underfocussing (Figure 2.4)128. Underfocusing or defocusing is the reduction in 
strength of the objective lens such that the electrons come to a point below the 
image plane. 
  
Figure 2.4. Image contrast.   A) Amplitude contrast results from absorption of some 
illuminating rays whereas phase contrast results from a change in direction of scattered rays. 
B) Waves can be represented as vectors where the vector length corresponds to amplitude 
and the angle 3 corresponds to phase. The resultant wave has a different phase to the 
unscattered wave but they have similar amplitudes resulting in little amplitude contrast. C) A 
±90° phase shift of the scattered wave leads to a larger difference in the amplitudes between 
the unscattered and resultant wave. This effectively converts the phase contrast into 




2.8.3  The Contrast Transfer Function  
Defocussing the objective lens, combined with its inherent spherical aberration, 
produces higher contrast, which is necessary for visualisation of biological samples. 
However, defocussing and aberrations also generate distortions in the image, as 
each point of the specimen is represented as a small blurred spot. Therefore, the 
recorded image is not a direct representation of the real structure due to a 
convolution between this blurring function (the PSF, mentioned earlier), and the real 
image. The convolution can be described in Fourier space, where the FT of the PSF 
is the contrast transfer function (CTF): 
45 6789 : = 	45 6;<=>? : 	. 45 @A4 : = 	45 6;<=>? : 	. B54 C . D(C) 
where 6789 is the recorded image wave function, : is a vector in the image plane, 6;<=>? is an ideal projection of the sample, C is the spatial frequency, CTF is the 
phase contrast transfer function and E is an envelope damping function. The 
envelope function describes the falloff of image signal at high spatial frequencies and 
is caused primarily by radiation damage. 
The CTF is an oscillating function that describes how the contributions of amplitude 
(cos term) and phase contrast (sin term) to the final image depends on spatial 
frequency128. It is defined by: 
		B54 C = 	−( 1 − H2 	sin(L C ) + H	 cos( L(C))) 
where Q is the amplitude contrast ratio (~4% for 300kV cryo images129) and L C  is 
the phase shift caused by defocussing and aberrations at spatial frequency C where 
L C = 	P(C2(∆R − B9(2C22 ) 
where S is the electron wavelength, ∆R is the defocus and B9	is the spherical 
aberration of the objective lens.  Figure 2.5 shows example CTF plots overlaid on the 
FT of images. The CTF reverses the phases of alternate dark and light rights (thon 
rings) in the FT meaning different features of the object in real space are enhanced 
or suppressed. Therefore, micrographs need to be corrected for the CTF before 
image processing (discussed later). Furthermore, where the oscillating sin/cos 
function crosses zero, the recorded image does not have any information at these 
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spatial frequencies. This information needs to be collected by recording other images 
at different defoci (which will have signal at the needed frequencies and have the 
‘zeros’ at different frequencies). 
 
Figure 2.5. Example Fourier transforms of images. Alternating light and dark rings (Thon 
rings) from the oscillating CTF curves can be seen. Image A was taken closer to focus than 
Image B, indicated by the Thon rings oscillating slower and the first zero being further away 
from the origin. The CTF plots are overlaid showing variations in the contrast contributed by 
different spatial frequencies. Dark regions between the Thon rings correspond to CTF nodes, 
where no information is collected at this spatial frequency. The amplitudes are attenuated by 
the envelope function. Image C is astigmatic and is indicated by the elongation of Thon rings 
in one direction: there is a different defocus value for the directions a and b. Figure 
reproduced from 129. 
2.9  Image processing – Single particle analysis 
2.9.1  Pre-processing of micrographs 
Micrographs recorded using DEDs have multiple subframes. The first step carried 
out during image processing is the alignment of the subframes137. This results in a 
motion-corrected total sum micrograph, reducing the blurriness of a solely averaged 
micrograph. The alignment of subframes allows for the correction of beam-induced 
motion and drift of the sample during an acquisition. The most significant movement 
is induced by the impact of the electron beam hitting the sample137. 
The averaged micrograph then needs to be corrected for the effect of the microscope 
CTF. As described previously some features of the image (at specific spatial 
frequencies) will have inverted contrast due to oscillations of the CTF. For complete 
restoration of the image data, the CTF needs to be corrected for and as the 
accelerating voltage and spherical aberration of the microscope are constant and 
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known, this means the defocus of each micrograph has to be established. 
Determination of the CTF is done by matching the experimental amplitude profile of a 
micrograph to a library of theoretical CTF profiles at different defoci129. A match 
allows the computational flipping of the phases of the correct negative-contrast 
frequencies. For each micrograph, there is no information present at spatial 
frequencies where the CTF crosses zero. However, during collection of a dataset, 
micrographs are taken are different defoci, so information at these frequencies will be 
retrieved from other images and all spatial frequencies will be sampled. More 
advanced image restoration includes the correction for amplitude decay at higher 
spatial frequencies due to the envelope function. These can be boosted to help 
achieve higher resolution structures, however a Wiener filter should also be included 
within the amplitude correction to avoid the amplification of noise at frequencies near 
CTF zeros129. 
After CTF correction, the micrographs must be normalised by scaling their densities 
to the same standard deviation and the mean value of zero. This is because images 
will have variations in contrast and grey levels in different areas of the grid and this 
could lead to misalignment138. 
2.9.2  Particle picking  
After pre-processing of the micrographs, individual particles are selected and 
extracted from the micrographs. This used to be a manual process which was time-
consuming but has been made easier through automated particle picking 
programs139,140. These use template matching to select particles from micrographs 
based on an input model or generated references. Typically, users still manually pick 
particles from a couple of micrographs, followed by alignment and classification to 
obtain 2D references (importantly the references should represent different views of 
the particle), which can be used as the templates for automated picking141. 
Automated programs allow control of the distance between picked particles, the 
threshold to select a particle and the level of filtering of the reference or micrograph. 
It is important to not use high-resolution references for automated picking to avoid 
picking ‘particles’ that are random noise142,143. 
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2.9.3 Image alignment 
The noise level in images is high due to the imaging of specimens with low electron 
doses, radiation damage, ice variations and the imperfections of the 
microscope/detector. Averaging of images of the same molecules in the same 
orientation cancels out random background noise and enhances true specimen 
signals. Extracted particles should be aligned and sorted into similar views or 
orientations of the molecules. Classes of particles representing the same view are 
averaged to improve the SNR by a factor of √N where N is the number of averaged 
images and can be used for the initial reconstruction129. 
The similarity of images is measured using cross-correlation. This scoring method 
underlies the alignment procedure. The value provides an indication of image 
similarity and the peak position of the cross-correlation function determines the 
optimal shift between the compared images. 
Particles images are first centred by translational alignment to a rotational average of 
their total sum. They are then coarsely aligned, focusing on low-resolution features 
such as particle shape. This is achieved by low-pass filtering of the images. High 
frequency information can gradually be reintroduced in an iterative process, as the 
alignment improves and the shifts are restricted. Centred particle images can also be 
masked by setting all densities outside the mask to zero and hence removing 
background noise. A soft mask must be used to avoid hard-edge artefacts, such as 
ripples, in the image129. 
2.9.4  Classification of images 
Classification methods are used to identify and cluster particle images into groups of 
identical views. In electron microscopy, image processing packages either use 
multivariate statistical analysis (MSA) (also known as principal component analysis) 
or K-means clustering combined with maximum likelihood (ML) to classify images. 
MSA allows the dimensionality of the dataset to be reduced and identifies the major 
differences between images (principal components) (Figure 2.6)144. Each image of m 
x n pixels is represented as a point in an mn-dimensional hyperspace according to its 
pixel density values. Similar images correspond to the points located close to each 
other within the cloud of images. The largest variation within the dataset is identified 
by the largest distances within the cloud in the hyperspace coordinate system, so a 
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new system should be reoriented using the directions of biggest variations as a new 
axis. Further major components define new axes, which are orthogonal and therefore 
uncorrelated and independent to the previous. Identification of the major principal 
components (also called eigenvectors) simplifies the analysis of the large dataset, 
with smaller variations attributed to noise. In image processing, eigenvectors are 
represented as eigenimages, which indicate the density variability of pixels in the 
images. Images that are localised in the hyperspace are then clustered into a 
specified number of classes. This is achieved either by hierarchical ascending 
clustering, where each image starts out defining a class and similar images are 
merged together or divisive clustering, where all images initially belong to one cluster 
and are then separated into smaller groups based on image differences129. 
The other approach is K-means clustering. In this method, a specified number (K) of 
random seed images are chosen to define the classes and the other images are 
systematically compared to the seeds and assigned to the most similar. The seeds 
are redefined by averaging of the class members and the process is iterated until the 
differences between classes are maximised and differences within a class are 
minimised. K-means clustering has been combined with the ML method145, where 
instead of an image being assigned to a single class, there is an estimate calculated 
of how likely it is that the image belongs to that cluster. This means that a single 
image belongs to multiple clusters with different weights, until the final iteration when 
the classification is definitive. ML methods can also be used in the generation of 
multiple 3D reconstructions from a single dataset to help sort particle heterogeneity 




Figure 2.6. A simplified schematic illustrating the basis of multivariate statistical 
analysis (MSA) and classification. A set of two-pixel images (i) are subjected to MSA and 
are represented as points in a two-dimensional hyperspace according to the densities of pixel 
1 and 2. The two main differences between images are represented by two orthogonal, 
uncorrelated eigenvectors. The points are sorted into two classes (red and green) of similar 
images according to position in the hyperspace. An outlying point (blue) remains unclassified. 
2.9.5  Orientation determination 
Using multiple different 2D projection views, a 3D electron density can be 
reconstructed. To do this, the views are assigned space angles using one of three 
methods: random conical tilt147, projection matching148 or angular reconstitution149.  
The random conical tilt method that provides orientations of particle images is the 
experimental approach129,147. Tilt pair images are taken during data collection, where 
an area of the EM grid is imaged twice at a predefined rotation about the axis 
perpendicular to the electron beam. The untilted particles are aligned and classified 
into similar views. The similar particles are then located in the tilted micrograph. As 
the angle of tilt is known and the in-plane rotations/shifts have been calculated from 
the untilted micrograph, the orientation of the particles in space is defined.  
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Projection matching is a computational approach for orientation determination148. It 
requires an initial model to be projected in multiple orientations, followed by the 
systematic comparison of the reprojections (used as a references) to the 
experimental particle images or class averages. The highest cross-correlation 
between reprojection and particle image indicates their consistency and the angles of 
that reprojection are assigned to the image. A new model is generated using the 
images with assigned angles and the process of the angular assignment iterated with 
a new set of reprojections until the particles/classes and model converges. Projection 
matching can also be carried out in reciprocal space, where 2D FTs of projections 
and model reprojections are compared150. 
Angular reconstitution is an alternative computational approach that identifies 
‘common’ lines (1D projections) between 2D projections149,151. This method can also 
be carried out in reciprocal or real space. In reciprocal space, the FTs of 2D 
projections are planes that pass through the centre of the 3D FT of the object. This is 
known as the central section theorem (Figure 2.7). The line of intersection between 
two 2D central sections of FTs is the common line between the two FTs of 2D 
projections. A third 2D projection (and its FT) is needed to determine the angle 
between the two intersecting planes and the orientations of the projections129. In real 
space, a 1D projection is calculated by summation of pixels from a 2D projection 
along different directions151. The 1D projections from a set of 2D projections are then 
compared to each other by cross-correlation to find the common line between 
projections.  
2.9.6  3D reconstruction  
After angular assignment, the 2D projections are used to calculate the 3D structure 
of the specimen. Reconstructions can also be calculated in real or Fourier space. In 
real space, the back-projection method is used where 2D projections are stretched in 
the projection direction along the volume to be reconstructed129. Each pixel in the 2D 
projection effectively becomes a ray in the 3D volume after stretching. The density of 
each pixel in the 3D reconstruction is estimated by the summation of rays that pass 
through it. However, the 3D reconstruction is limited due to a low frequency 
background artefact caused by the stretching of projections. Background artefacts 
can be mitigated by filtering, either of the 2D projections prior to back-projection or 
the 3D object after back-projection (known as the filtered back-projection method)152.  
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Algebraic methods are another real space approach to 3D reconstruction153. These 
use 2D projections to approximate the densities of pixels in 3D space. The newly 
created 3D model is reprojected and compared to the experimental projections. The 
comparisons are used to make corrections to the calculated 2D projections and 
improve the 3D reconstruction approximation. The processes of approximation and 
correction are iterated and can be achieved in two ways129,153. New projections can 
be sequentially incorporated into the approximation, the differences between the 
projection and reprojection calculated and corrections made to the previous 
approximation. Alternatively, differences between all projections and reprojections 
can be simultaneously assessed to make corrections to the 3D approximation. 
The Fourier approach to 3D reconstruction is based on the central section theorem 
(Figure 2.7)129. Three-dimensional Fourier space is filled with the FTs of multiple 2D 
projections. The central sections do not cover all the pixels in Fourier space. 
Therefore, there is missing information between them and the data must be 
interpolated between known pixels. The inverse FT is taken of the 3D FT, yielding 
the electron density distribution of the 3D object154.  
 
Figure 2.7. 3D reconstruction using the central section theorem. FT denotes a Fourier 




The angular distribution of images can affect the quality of the reconstruction. This 
distribution is represented by points on the Euler sphere, where the points denote the 
view directions of the object. Ideally, 2D projections used in a 3D reconstruction 
should be evenly sampled across the Euler sphere and the resulting reconstruction is 
isotropic in resolution. In practice, samples exhibit preferential orientations on the 
grid and the reconstruction can suffer from the absence of information in certain 
directions129. To rectify this experimentally, grid supports, buffer components and 
treatment of support films (e.g. positive glow-discharge) can be varied156. 
Computationally, the impact of projections on the final structure can also be weighted 
(for example higher weighting of orientations that are less populated). 
Resolution of the 3D reconstruction is determined by assessing the Fourier Shell 
Correlation (FSC)157. This is useful to evaluate the quality of the structure and identify 
at what level the structure can be reliably interpreted. FSC assessment involves 
division of the dataset into two random subsets, calculation of separate 3D 
reconstructions and their comparison by cross-correlation in spatial frequency shells. 
Correlation is assessed against spatial frequency, which falls from 1 at low 
resolutions to 0 at high resolutions. The spatial frequency at the threshold of 0.5 
correlation or 0.143 is used as the global resolution estimate157,158. It is also important 
to reproject the model at the same angles as the assigned 2D class averages/images 
and check for their similarity to ensure correct angular assignment. However, the 
most robust method is by assessing structural features using atomic models for fitting 
in the map. Local resolution of maps can also be assessed using software such as 
Resmap159, which can reflect structural flexibility. 
2.10  Interpretations 
The level to which EM density maps can be interpreted largely depends on the 
attained resolution. Often, atomic models are docked as rigid bodies into the maps to 
aid interpretation. Low resolution maps (15-30Å) are useful in the definition of 
domains and protein interfaces in complexes. At resolutions below 10Å α-helices can 
be identified as rods and below 4.5Å, β-strands become apparent. This level of 
structural detail can be useful to aid the designing of experiments and allows flexible 
fitting of models. At high resolutions below 3Å, the polypeptide can be traced and 
side chains may be resolved for building of an atomic model.  
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3.0  General methods 
Listed below are methods that are applicable to more than one results chapter. 
Methods specific to chapters are incorporated within the relevant results chapter.  
3.1  List of manufacturers 
Agar Scientific  Stansted, UK  Chemicals and reagents 
Agilent Technologies Santa Clara, CA, USA Chemicals and reagents 
Electron Microscopy Sciences Hatfield, PA, USA  EM grids 
Expedeon San Diego, CA, USA Chemicals and reagents 
GE Healthcare Chicago, IL, USA  Chemicals and reagents 
Greiner Bio-One Kremsmünster, Austria Chemicals and reagents 
Hampton research Aliso Viejo, CA, USA Crystallisation screens 
LI-COR Biosciences Lincoln, NE, USA  Chemicals and reagents 
Life Technologies Carlsbad, CA, USA Chemicals and reagents 
Millipore Burlington, MA, USA Chemicals and reagents 
Molecular Dimensions Newmarket, UK  Crystallisation screens 
NewEngland Biolabs Ipswich, MA, USA Chemicals and reagents 
Qiagen Hilden, Germany  Chemicals and reagents 
Quantifoil Großlöbichau, Germany EM grids 
Roche  Basel, Switzerland Chemicals and reagents 
Sigma-Aldrich St. Louis, MO, USA Chemicals and reagents 
Takara Bio Inc. Kusatsu, Japan  Chemicals and reagents 
Thermo Scientific Waltham, MA, USA Chemicals and reagents 
VWR International Randor, PA, USA  Chemicals and reagents 
3.2  Common buffers  
PBS pH 7.4: made from tablets according to the manufacturer’s instructions  
PBST: PBS buffer with the addition of 0.05% v/v Tween 20 
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Tris-based buffer: 50mM Tris pH 7.4, 50mM NaCl, 5mM EDTA, 0.02% w/v sodium 
azide 
3.3  List of computational packages  
ApE    DNA sequence analysis 
BLAST    Sequence alignment 
CCP4160   X-ray crystallography data processing 
Chimera9    Structural visualisation 
Coot161    Structural visualisation 
FIJI (ImageJ)   Image processing 
GraphPad (Prism)  Statistical analysis 
IMAGIC162   Electron microscopy image processing  
Pymol163    Structural visualisation 
Relion122   Electron microscopy image processing  
PyRosetta164   Protein modelling 
3.4  Protein purification 
3.4.1  Purification of monomeric and polymeric M-AAT from plasma 
Plasma from a wild-type (PiM) AAT individual was centrifuged at 12,000 g for 20 
minutes to pellet any remaining cells and debris. The supernatant was filtered using 
glass fibre prefilters and cellulose acetate filters. The filtered plasma was diluted 1:1 
in binding buffer (20mM Tris, 150mM NaCl, pH 7.4) before loading onto the Alpha1- 
Antitrypsin Select column (GE Healthcare) pre-equilibrated in binding buffer. The 
column was washed in binding buffer until a baseline UV signal was reached. M-AAT 
(wild-type AAT) was eluted from the column using elution buffer (20mM Tris, 2M 
MgCl2, pH 7.4). Protein-containing fractions, as analysed by SDS-PAGE, were 
pooled. The protein was dialysed into 20mM Tris, pH 8 overnight at 4°C. The 
dialysed sample was loaded onto a 5ml HiTrap Q HP column (GE Healthcare) pre-
equilibrated in buffer A (20mM Tris, pH 8). The column was washed with 30 ml of 
buffer A with 20mM β-mercaptoethanol to reduce M-AAT dimer, and then buffer A 
alone until a UV baseline was reached. M-AAT was eluted using a 0-50% gradient of 
buffer B (20mM Tris, 1M NaCl, pH 8) over 80 ml. Protein-containing fractions were 
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analysed using SDS-PAGE and a non-denaturing gel (to identify polymers) and were 
pooled accordingly. Monomer was buffer exchanged into PBS with 0.02% w/v azide 
using a 30kDa MWCO Amicon Ultra-15 Centrifugal Filter unit (Millipore) by 
centrifugation at 3000 g. Protein concentration was estimated by the absorbance at 
280nm using an E1% extinction coefficient of 5.2. 
3.4.2  Production of in vitro polymers 
All types of in vitro polymers were prepared from monomeric plasma M-AAT at 0.2 
mg/ml. Heat-induced polymers were prepared by heating M-AAT in PBS at 55°C for 
48 hours. Denaturant (urea and Guanidine-HCl) and acid polymers were incubated at 
25°C or 37°C for 48 hours. Urea polymers and Guanidine-HCl polymers were 
prepared at a concentration of 4M urea and 3M Guanidine-HCl respectively in 40mM 
Tris-HCl pH8 buffer. Acid polymers were prepared using 0.1M sodium acetate pH 
4.5. All polymers were purified from any remaining monomer using a 1ml HiTrap Q 
HP column (GE Healthcare) as in 3.4.1 but using a 0-100% gradient elution of buffer 
B over 20ml. Polymeric fractions were pooled and buffer exchanged into PBS pH 7.4 
using centrifugation.  
3.4.3  Generation of cleaved AAT 
Plasma M-AAT was concentrated to 10mg/ml in 0.1M ammonium bicarbonate pH8 
buffer. Endoproteinase Glu-C from S. aureus strain V8 was added at a ratio of 3:100 
(w/w) enzyme to substrate and incubated at 37°C for 16 hours. Cleavage was 
stopped by addition of cOmplete Protease inhibitor and confirmed by SDS-PAGE. 
Cleaved AAT was purified from Glu-C using a Hi Trap Q HP column (GE Healthcare) 
and buffer exchanged into PBS.  
3.4.4 Purification of monoclonal antibodies  
The supernatant containing secreted IgG from hybridoma cells was diluted 1:1 in 
Pierce Protein G IgG binding buffer (Thermo Scientific) which had been equilibrated 
to room temperature. The diluted supernatant was loaded onto a 1ml or 5ml HiTrap 
Protein G HP column (GE Healthcare) pre-equilibrated in five column volumes of 
binding buffer. Bound material was eluted using Pierce IgG elution buffer (Thermo 
Scientific). Protein-containing fractions were neutralised by addition of 100 µl/ml 1M 
  
70 
Tris pH 9 and pooled. IgG was buffer exchanged into PBS using an Amicon Ultra-15 
Centrifugal Filter unit (Millipore) with 30kDa MWCO by centrifugation at 3000 g. 
Sodium azide was added at 0.02% w/v and purified mAb aliquoted and snap frozen 
using liquid nitrogen for storage at -80°C.  
3.4.5  Fab generation and purification  
The fragment antigen binding (Fab) domain of IgG was produced using the Pierce 
Mouse IgG1 Fab and F(ab’)2 Preparation Kit (Thermo Scientific). An immobilised ficin 
column was prepared by addition of 0.75 ml of 33 % ficin slurry into a 0.8 ml spin 
column and centrifugation at 5000 g for 1 min. The resin was equilibrated in digestion 
buffer prepared for Fab generation (25mM cysteine/HCl). 0.5 ml of sample containing 
4 mg of IgG was added to a Zeba Spin Desalting Column pre-equilibrated in 
digestion buffer and centrifuged at 1000 g for 2 min. The prepared IgG sample was 
added to the equilibrated immobilised ficin and incubated for 5 hours with end-over-
end mixing at 37°C. The column was centrifuged at 5000 g for 1 min to separate the 
digest from the immobilised ficin. The ficin was washed with 0.5 ml Protein A binding 
buffer 3 times and flow-through pooled to a total of 2 ml. The digested antibody 
sample was added to a NAb Protein A column pre-equilibrated in Protein A binding 
buffer and incubated at 25°C with end-over-end mixing for 10 min. The column was 
centrifuged at 1000 g for 1 min. The flow-through contained Fab fragments. The 
column was washed with Protein A binding buffer twice and flow-through pooled with 
eluted Fab. 1 ml of Elution buffer was applied to the Protein A spin column and 
centrifuged; this was repeated twice. The elution fractions contained undigested IgG 
and the Fc fragments and each was neutralised with 100 µl of 1M Tris pH 8. The 
Protein A column was regenerated by washing in PBS with 0.02% w/v azide four 
times. Fab protein concentration was estimated by measuring the absorbance at 
280nm using an extinction coefficient of 1.4.  
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3.5  Protein characterisation techniques 
3.5.1  Polyacrylamide gel electrophoresis 
3.5.1.1  SDS-PAGE 
SDS-PAGE was performed using a NuPAGE 4-12% w/v acrylamide Bis-Tris gel (Life 
Technologies)70. Samples containing 2-4 µg of protein were prepared by mixing 1:4 
with NuPAGE lithium dodecyl sulphate sample buffer (Life Technologies) and heated 
at 95°C for 5 min. The Spectra multicolor broad range prestained molecular weight 
ladder (Thermo Fisher scientific) was run alongside samples. Gels were run in 1X 
NuPAGE running buffer at a constant 170V for 50 minutes at room temperature. If 
samples were reduced, 50 mM DTT was added prior to heating. Protein bands were 
stained with Instant Blue Coomassie stain (Expedeon) with gentle rocking for 30 
minutes to allow visualisation of protein bands.  
3.5.1.2  Non-denaturing PAGE 
Native gel electrophoresis was performed using a NativePAGE 3-12% w/v 
acrylamide Bis-Tris gel (Life Technologies)70. Samples containing 2-4 µg of protein 
were prepared by mixing 1:4 with a 50% v/v glycerol, bromophenol blue sample 
buffer. The gel was run in 1X NativePAGE running buffer at 30 mA for 35 minutes at 
room temperature.  
3.5.2  Western blot 
0.2 µg of protein was loaded per lane for electrophoresis on a NuPAGE 4-12% w/v 
acrylamide or NativePAGE 3-12% w/v acrylamide Bis-Tris gel (Life Technologies)70. 
The gel was electroblotted onto a PVDF membrane using the iBlot Dry Blotting 
System (Life Technologies) for 7 min. The membrane was soaked in PBS for 10 min 
and blocked with 5% w/v nonfat dry milk in PBS for 1 hour. The primary antibody for 
total AAT (rabbit polyclonal anti-AAT, made in house) and polymer AAT (mouse 
monoclonal 2C1) was diluted to 0.8 µg/ml and 0.2 µg/ml, respectively in PBS, 0.1% 
v/v Tween 20, 5% w/v BSA and 0.1% v/v sodium azide and incubated overnight at 
4°C on a rocker. The membrane was washed six times in PBS, 0.1% v/v Tween 20 
prior to incubation with the secondary antibodies. The Odyssey donkey anti-rabbit IR 
Dye 680RD and donkey anti-mouse IR Dye 800CW (LI-COR Biosciences) secondary 
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antibodies were diluted 1:10,000 in PBS, 0.1% v/v Tween 20 and 5% w/v nonfat dry 
milk and incubated for 1 hr, protected from light. The membrane was washed six 
times with PBS, 0.1% v/v Tween 20 and six times with PBS, in the dark prior to 
scanning using the LICOR Odyssey scanner.  
3.5.3  ELISAs 
For sandwich ELISAs, flat-bottomed 96 well EIA/RIA plates (Costar 3590) were 
coated overnight at room temperature with 50 µl per well of antigen purified rabbit 
polyclonal anti-antitrypsin antibody at 2 µg/ml in PBS, pH 7.470. The wells were 
washed three times with 300 µl per well of washing buffer (0.9% w/v NaCl, 0.05% v/v 
Tween20) and blocked overnight at 4°C with 300 µl per well of blocking buffer (PBS, 
0.25% w/v BSA, 0.05% v/v Tween20, 0.1% w/v sodium azide). Standards (heat 
polymer) and unknown samples were serially diluted across the plate in blocking 
buffer. Samples were incubated for 2 hours at room temperature and then washed 
three times with washing buffer. The binding antibodies 3C11 (total) or 2C1 (polymer) 
were diluted 1:100 or 1:50 respectively from culture media supernatant in blocking 
buffer and 50 µl incubated at room temperature for 2 hours. After washing, bound 
monoclonal antibodies were detected with rabbit anti-mouse HRP-labelled antibody 
diluted 1:20,000 in blocking buffer without sodium azide for 1.5 hours protected from 
light. The wells were washed and the reaction developed for 10 min with 50 µl TMB 
substrate solution. The reaction was stopped with 50 µl of 1M sulphuric acid and the 
absorbance at 450nm measured in a plate reader. For competition ELISAs, plates 
were coated with 2 μg/ml of antigen (e.g. plasma M-AAT monomer), binding 
antibodies were serially diluted from 2 μg/ml across the plate and HRP-labelled 
antibodies were added at 0.03 μg/ml. 
3.5.4  Visualisation of polymers by negative stain electron microscopy  
3.5.4.1  AAT polymer sample preparation for EM  
AAT polymers were buffer exchanged into Tris-based buffer using an Amicon Ultra 
Centrifugal Filter unit (Millipore) with 30kDa MWCO by centrifugation at 10,000 g.  
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3.5.4.2  Labelling of AAT polymers with Fab for visualisation by NS-EM 
A three times molar excess of Fab was incubated with AAT polymer for 3 hours at 
room temperature. The sample was dialysed at 4°C overnight into Tris-based buffer 
using a pre-conditioned 1ml 300 kDa MWCO Float-A-Lyzer G2 Spectra/Por dialysis 
device (Fisher Scientific) to remove unbound Fab. The sample was concentrated 
using a 10kDa concentrator to around 0.2 mg/ml. 
3.5.4.3  Preparation of grids for NS-EM  
The continuous carbon film of 400 mesh copper (CF400-Cu) grids (Electron 
Microscopy Sciences) was glow-discharged at 30 mA for 1 min using a PECLO 
easiGlow Glow Discharge Cleaning System (Ted Pella)70. 4 µl of ~0.04mg/ml sample 
was applied to the grid and incubated for 1 min before blotting away excess solution 
with filter paper. The grid was rapidly washed twice with 4 µl deionised water before 
negative-staining. 4 µl of 2% w/v uranyl acetate (UA), which had been centrifuged to 
pellet precipitate, was applied to the grid for 1 min and excess stain blotted. The 
staining step was repeated and the grid allowed to air dry before imaging.  
3.5.4.4  NS-EM imaging  
Negatively-stained grids were visualised using a Tecnai 100kV or Tecnai 120 kV field 
emission gun (FEG) equipped with a Gatan CCD MultiScan Camera. Samples were 
assessed at 44,000X or 67,000X nominal magnifications for the Tecnai 100kV or 




4.0  Generation and characterisation of monoclonal 
antibodies against AAT  
4.1  Introduction 
4.1.1 Antibodies 
Immunoglobulins (Ig) play an important role in the adaptive immune system, through 
highly specific binding to their cognate foreign antigens and subsequent effector 
functions. There are five classes of immunoglobulins: IgG, IgM, IgA, IgD and IgE that 
differ in the type of heavy chain and their oligomeric state. IgG is the predominant 
class, accounting for 10-20% of serum protein165. Antibodies are produced by B cells, 
where each different B cell produces a unique antibody166.  
Antibodies consist of two identical heavy (H) and two identical light (L) chains (Figure 
4.1). Each light chain consists of two globular domains, the N-terminal variable 
domain VL and constant domain CL. Similarly, each heavy chain consists of a 
variable domain, VH, and three constant domains CH1, CH2 and CH3. The variable 
domains, VL and VH, are involved in antigen binding and together with CH1 and CL 
form a Fab (fragment antigen-binding) arm. CH2 and CH3 are involved in binding 
immune response effector molecules and form the Fc (fragment constant)166. A 
flexible hinge in the heavy chain connects the Fab arms to the Fc region. The hinge 
imparts flexibility to the molecule and influences the relative conformations of the Fab 
arms and the Fc region165. All the domains are folded into a characteristic IgG fold, 
consisting of 2 β-sheets that are arranged into a β-barrel166. 
IgG can be further divided into four subclasses, IgG1, IgG2, IgG3 and IgG4, listed in 
order of decreasing abundance in serum. These subclasses are highly conserved, 
being more than 90% identical at the sequence level but differ in their heavy chain 
isotype and structure, particularly in their hinges and upper CH2 domains165. These 
regions are involved in binding molecules of the innate immune system and therefore 
the different subclasses have different effector functions such as activation of 
complement or binding to Fc receptors166. The exact role of the four IgG subclasses 
in the immune response is not fully understood, however generally IgG1 and IgG3 
are thought to be potent inducers of effector functions whereas IgG2 and IgG4 trigger 




Figure 4.1. Schematic diagram of the domain structure of IgGs. The heavy chains are 
composed of VH, CH1, CH2 and CH3 domains and the light chains of VL and CL domains. A 
flexible hinge links the Fab fragments to the Fc fragment. 
The variable domains are responsible for specific antigen recognition and 
consequently this region has the highest sequence diversity. Diversity is created by 
complex gene rearrangements and somatic hypermutation after exposure to 
antigen167. In particular, in each variable domain (VL and VH), there are three 
hypervariable loops, called complementary determining regions (CDRs) that make 
the majority of contacts with the antigen (L1, L2, L3, H1, H2, H3). H3 is the most 
variable of the CDR loops in sequence and length and is described as being the 
most important for antigen interactions168,169. The loops are flanked by regions of 
relatively constant sequence termed the framework regions (FRs). 
Generally, the CDRs form the paratope (the site on the IgG at which the antigen 
binds) and contact around 5-8 amino acids on the protein surface. The specific 
region on an antigen that an antibody recognises is called the epitope. Epitopes are 
generally referred to as being linear/continuous or conformational/discontinuous166. A 
linear epitope exists on a single polypeptide chain and therefore persists after the 
protein is denatured or in smaller protein fragments. A conformational epitope is 
made up of amino acids brought together by 3D structure and so is only present 
when proteins are properly folded. A further type of epitope is a cryptic or neoepitope 
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in which an epitope becomes exposed or newly-formed upon a conformational 
change170. Antibodies against neoepitopes are useful in the probing of different 
activation states of molecules and may induce protein activation170.  
Antibodies are invaluable tools in the study of proteins in research and diagnostics. 
They are routinely used in laboratories through techniques such as western blot, 
immunohistochemistry and ELISAs. They are also critical components of diagnostic 
assays that detect infections or measure concentrations of biological markers, for 
example pregnancy tests work by detection of hCG hormone using an antibody171.  
The high specificity and selectivity of antibodies has also led to the development of 
monoclonal IgG-based drugs for therapeutic applications for a range of diseases, for 
example adalimumab is a mAb used for the treatment of autoimmune diseases172. As 
of May 2018, the FDA has approved 80 therapeutic mAbs173. Most of these 
antibodies act as therapeutics alone, whereas a few act as vehicles to deliver 
cytotoxic drugs to a target site174. The latter are called antibody-drug conjugates 
(ADCs) which have had particular interest in the treatment of cancer; more than 60 
ADCs are in clinical trials175. Therefore, antibodies have useful applications in the 
areas of research, diagnostics and therapeutics.  
4.1.2  Generating and identifying monoclonal antibodies  
Serum contains many different antibodies that are specific for a variety of antigens.  
Antibodies that are specific for a single antigen but recognise different epitopes on 
the protein are called polyclonal antibodies, as they are secreted from different B-cell 
lineages. The mixed specificities and affinities of polyclonal antibodies made 
immunochemical studies more difficult. Therefore, a method to produce monoclonal 
antibodies (one type of antibody that originates from a single B-cell lineage and 
recognises a specific epitope) was developed176. Hybridoma cell lines provide a 
permanent and stable source of homogenous monoclonal antibodies (mAbs)176,177. 
The most common method of mAb generation results from the fusion of single 
antibody-secreting B lymphocytes (providing the antibody specificity) and B 
lymphocyte tumour cells (providing the immortality) (Figure 4.2)178. MAbs generated 
by this method often exhibit strong binding affinities for their antigen, removing the 
need for additional modifications to improve potency177. 
  
77 
To generate a mAb against a specific protein, mice are immunised at regular 
intervals with the purified protein to stimulate an immune response. The spleen cells 
of the immunised mouse are then isolated and fused with cultured myeloma cells to 
generate hybridoma cell lines178. Fusion of the plasma membranes of the two cell 
types is generally mediated by PEG176. A selective medium (HAT) allows the growth 
of successful hybridoma fusions; it contains the inhibitor aminopterin which blocks 
the major nucleotide biosynthetic pathway, meaning cells must use a pathway for 
nucleotide synthesis that is defective in the myeloma cells but present in the mortal 
lymphocytes177. Fusion is an inefficient process: only ~1% of starting cells are fused 
and only 1 in 100,000 form viable hybridomas176. Furthermore, as hybridoma cells 
have two nuclei, during cell division the abnormal number of chromosomes may not 
be segregated equally and chromosomes may be lost. This means hybridoma cell 
lines can be considered unstable with loss of antibody production often resulting from 
loss of the chromosome carrying the functional IgG gene176. 
Antibodies are secreted into the cell media and the supernatants of the resulting 
hybridomas are screened using ELISA against the purified protein. Positive 
hybridoma clones are then redistributed to ~1 cell per well by limited dilution, 
iteratively cloned and re-tested by ELISA to ensure a single hybridoma clone 
producing a mAb with the desired characteristics has been generated176. The 
hybridoma can then be expanded as a cell line for continuous mAb production. 
Antibody yields after an affinity chromatography step using a Protein G column can 




Figure 4.2. Generation of mAbs using hybridoma technology. Mice are immunised with 
the antigen of interest and the spleen cells are isolated for fusion with myeloma cells. Positive 
fusions are selected by growth in HAT media. Antibodies are screened for the desired activity 
using ELISA and positive hits are cloned to ensure that only one mAb is produced. 
Hybridomas are then propagated for antibody production. Figure adapted from180. 
4.1.3  Monoclonal antibodies as molecular probes of conformation 
MAbs are useful molecular probes. Often, mAbs have conformational-selectivity, 
informing on the presence of specific epitopes but they can also exhibit functional 
activity, altering the behaviour of their cognate antigen181. They have been used to 
investigate a variety of proteins that undergo activation and/or conformational 
changes as part of their natural function or in disease states. MAbs specific for the 
polymeric structures of transthyretin, α-synuclein and Aβ-42 have revealed structural 
changes that must occur to form the aggregated state, from their binding to cryptic 
epitopes not present in the native monomer182-184. In the case of α-synuclein, the 
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mAbs were able to identify small, previously-uncharacterised aggregates in brain 
sections of patients with Parkinson’s disease and Dementia with Lewy bodies, 
helping to inform disease pathology183. 
The conformational changes that occur within serpins in their native mechanism of 
protease inhibition has also been studied using mAbs. MAbs against different regions 
of plasminogen-activator inhibitor type-1 (PAI-1) have protected or promoted PAI-1 
inhibitory activity against inactivation185,186. A mAb that delayed the transition to the 
latent conformation was found to cause structural changes in β-sheet A and the RCL, 
yet bound on the opposite face of the molecule185. This highlighted the 
communication between secondary elements of the serpin fold. Inactivation of anti-
proteolytic activity has been achieved by mAbs that sterically block protease binding, 
convert PAI-1 to an inactive conformation or induce substrate-like behaviour186-188. 
One such mAb has been reported to have antithrombotic effects in the rat by binding 
to the bottom of the molecule and converting PAI-1 to a non-inhibitory substrate187. 
These studies have been important in informing the development of compounds 
targeting PAI-1 for anti-thrombosis treatment. 
4.1.4  The AAT monoclonal antibody toolkit 
MAb generation has been valuable in the conformational studies of AAT. Their 
properties have been highly informative with regards polymer structure and the 
polymerisation pathway but also have had wider applications such as in screening 
methods, detecting molecular forms in vivo and optimising drug preparations. 
ATZ11 – specific for the Z variant of AAT 
The first mAb generated against AAT was ATZ11 in 1984189. Mice were immunised 
with globular AAT inclusions (likely comprised of polymers) purified from the 
explanted liver of a ZZ patient. ATZ11 displayed Z specificity when plasma samples 
were analysed and this promoted its use in the identification of Z gene carriers, 
particularly heterozygotes, in an ELISA alongside isoelectric focusing. Later work 
using competition ELISAs showed ATZ11 interacts specifically with Z polymers and 
elastase-complexed AAT but lacks affinity for native, latent or RCL-cleaved AAT190. 
Accordingly, ATZ11 has a conformation-dependent neoepitope that is non-linear. 
Higher concentrations of antibody also resulted in the recognition of M polymers 
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formed in vitro, which indicates that it is able to bind this form, albeit with low 
affinity190. Thus, ATZ11 is specific for the polymeric and complexed form of Z-AAT. 
2C1 – selective for polymers 
The polymer-specific antibody 2C1 was developed by immunising mice with Z-AAT 
polymer made by heating purified patient-derived Z-AAT monomer76. 2C1 was 
identified to specifically recognise the polymeric form of AAT but no other 
conformation tested (native, trypsin-complexed, RCL-cleaved and latent) and hence 
was more specific than ATZ11. The polymeric epitope has recently been identified 
and localised to helices E and F using a protection assay with a thiol-reactive 
fluorescent probe191. This is consistent with the lack of 2C1 binding to polymer with 
the G117F mutation; this mutation causes a downward displacement of the F helix192.  
2C1 provided the first evidence of structural differences between AAT polymers of 
different origins. 2C1 binds to in vivo and in vitro heat-induced polymers but not 
denaturant-induced polymers. It also binds to polymers formed by different single 
point mutations of AAT e.g. the Z, the S, S53F Siiyama, G225R Brescia and H334D 
King’s mutations suggesting that they share a similar structure26,76. However, 
polymers produced by the rare E75V Trento variant had a 10-fold reduced 
recognition by the 2C1 mAb and had a polymer size distribution more similar to 
denaturant polymers, suggesting different polymer forms could form in vivo191.  
The specificity of 2C1 has been useful in the investigation of polymer dynamics. It 
identified the presence of quantifiable polymers in the circulation of all ZZ-AAT   
homozygote patients tested101. They had an average concentration of 36.3 µg/ml 
AAT circulating polymer101. Plasma polymers decreased rapidly in an individual after 
an orthotopic liver transplantation indicating their origin from the liver. Polymer 
secretion from cells was demonstrated by the co-localisation of 2C1 with antibodies 
against proteins present in the secretory pathway in a cellular model193. The 
properties of 2C1 also make it suitable to use in the development of a diagnostic tool 
for the quantification and imaging of in vivo AAT polymers.  
4B12 – a mAb with polymerisation-blocking activity 
The 4B12 mAb was produced from a hybridoma screen, where the mice were 
immunised with monomeric Z-AAT purified from the plasma of a ZZ homozygote. It 
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blocks polymer formation with limited effects on the inhibitory activity of AAT against 
neutrophil elastase and trypsin116,117. The 4B12 mAb and 4B12 Fab blocked heat-
induced polymerisation of AAT in vitro at a 1:1 molar ratio. A scFv4B12 intrabody, 
based on the antigen-binding variable light and heavy chains, reduced 
polymerisation by ~60% in a COS-7 cell model of disease as assessed by pulse-
chase using radioactive 35S-Met/Cys and immunoprecipitation with 2C1. It also 
increased the secretion of Z-AAT.  
4B12 is not conformationally selective and able to bind to the native, RCL-cleaved, 
latent and polymeric conformations of AAT. This suggests that the epitope of 4B12 is 
invariant between these different conformational states. However, 4B12 does not 
bind to SDS-denatured material, indicating the epitope is discontinuous. Recently the 
epitope has been mapped using PEGylation assays and EPR to encompass 
residues on helix A and helix I117. This region is on the opposite face of the molecule 
to β-sheet A. As 4B12 activity was antagonised upon tethering helix I, its polymer-
blocking activity is thought to arise from mAb binding causing a propagation of 
induced molecular changes, along the helix I-β-sheet A axis, to prematurely open β-
sheet A.  
4B12 has been useful in identifying a region of AAT that can allosterically regulate β-
sheet A dynamics as a target for small-molecule intervention. Its antigen-altering 
activity has also aided in the investigation of extracellular polymer origin by 
preventing polymerisation of secreted monomer in cell culture medium193.  
5E3 – a mAb that recognises the polymerisation intermediate 
The mAb 5E3 was identified in the same screen as 4B12 but with opposite effects on 
AAT116. 5E3 increases the rate of polymerisation of M-AAT in a dose-dependent 
manner181. It also displays conformational specificity, with a preference for polymer 
over monomer but no clear selectivity between denaturant and heat-induced 
polymers.  Arginine-scanning mutagenesis identified its cryptic epitope to be in the 
post-helix A loop and strand 4C, which appears after monomer activation and in the 
resulting polymers. As 5E3 does not alter the stability of the native state, nor reduce 
the energetic barrier to polymerisation, it is thought to facilitate conformational 
conversion between the monomer and intermediate and represents a means to 
probe polymerisation intermediates. 
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1C12 – selective for the self-inserted conformation of AAT 
The 1C12 mAb has been useful in investigating the presence of latent AAT in 
polymerisation experiments, biological samples and augmentation therapy. It 
displays specificity for the latent conformer (M or Z) and no detection of native, RCL-
cleaved and polymeric AAT26. Latent AAT could be promoted in vitro but its kinetics 
and relative quantities to polymer suggested it was a by-product of polymerisation, 
not a precursor. Furthermore, latent AAT was not detected in a cellular model, and 
only little amounts were found in liver tissue samples. It was however present in 
augmentation therapy and the plasma of patients who had recently received this 
treatment. This highlights a need to optimise drug preparations to contain more 
inhibitory-active AAT and less inactive latent AAT.  
6C7-5 and 3F4 – selective for oxidised AAT 
The 6C7-5 and 3F4 mAbs detect oxidised AAT (ox-AAT), but not native AAT nor 
RCL-cleaved/protease-complexed AAT194,195. The oxidation of the P1 methionine 
residue of AAT in the lung is thought to result from cigarette smoking, yielding a 
defective inhibitor62,63. This is thought to contribute to the progression of lung 
disease. The mAbs have been used to detect the presence, and measure 
concentations of, ox-AAT in biological samples; the concentration of ox-AAT in 
serum samples from patients with inflammatory diseases were higher than healthy 
individuals195. Therefore, mAbs against ox-AAT may be useful markers for evaluating 
oxidative stress. 
5G11 – specific to peptide C-36 
The C-terminal 36 residues of AAT are specifically recognised by the mAb 5G11196. 
The C-36 peptide may result from cleavage by non-target proteases in vivo and has 
been reported to stimulate pro-inflammatory activity in vitro197. 5G11 was able to 
detect the C-36 peptide for the first time in human lung tissue196. This supports the 
hypothesis that AAT peptides contribute to inflammation in vivo.  
9C5 and 3C11 – non-selective mAbs 
The 9C5 and 3C11 mAbs are also conformationally non-specific mAbs, binding to 
monomer and polymer with high affinity. 9C5 was identified in the same screen as 
2C176. The epitope of 9C5 is not known but it can bind to AAT at the same time as 
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4B12 as a HRP-linked 9C5 was used in the sandwich and competition ELISAs in the 
identification of 4B12116. The epitope of 3C11 has not been fully characterised but it 
competes with 4B12 for binding to AAT so is likely to have an overlapping epitope.  
4.1.5 A brief overview of X-ray crystallography 
4.1.5.1  Crystallisation 
For X-ray diffraction experiments, protein molecules must be induced to form well-
ordered crystals. This requires the sample to have high homogeneity, purity and 
solubility at relatively high concentrations (generally 5-10 mg/ml). The protein is 
brought to the point of supersaturation in a controlled manner124. This is done by slow 
equilibration of a small drop of protein (either in a sitting or hanging drop format) with 
a reservoir containing precipitant. Crystal formation follows two stages: nucleation 
where microcrystals form, and growth of a larger crystal around a nuclear seed. This 
process can be understood from a solubility diagram, in which a solubility curve 
corresponds to concentrations at which the protein solution is in equilibrium with 
precipitant and divides undersaturated and supersaturated states (Figure 4.3)198,199. 
The supersaturation state can be divided into 3 subzones: the precipitation zone 
where excess protein forms amorphous aggregates, the nucleation zone where 
excess protein forms crystalline aggregates and the metastable zone where crystal 
growth occurs. The growth of a large, well-ordered crystal should follow the red path 
on the solubility diagram; a small number of nuclei form in the nucleation zone and 
as the crystals grow, the solution returns to the metastable region for slow growth198. 
Crystallisation conditions cannot be accurately predicted for a given protein and so to 
increase the chances of success, multiple sample and reservoir conditions are 
trialled124. Robots such as the Mosquito have enabled nanolitre protein volumes to be 
accurately pipetted, making the process less tedious and allowing a wide range 




Figure 4.3. Crystallisation phase diagram. The solubility curve divides the undersaturated 
and supersaturated states of protein solution, and the supersaturation state is further divided 
into metastable, nucleation and precipitation zones. Well-ordered proteins should follow the 
red arrow. Figure adapted from 198. 
A well-formed crystal lattice is a regularly repeated arrangement of protein 
molecules. The smallest and simplest translationally-related repeating unit of the 
lattice is called the unit cell. The unit cell can consist of a single protein molecule or 
several identical molecules related by rotational symmetry199. One protein 
molecule/complex is called the asymmetric unit. In theory, the diffraction pattern from 
one molecule contains all the information to generate a structure, however in practice 
a crystal of ordered proteins is needed to increase the SNR124.  
4.1.5.2  Data Collection 
Formed crystals are soaked in cryoprotectant and flash frozen into liquid nitrogen. 
The frozen crystals are mounted on a nylon loop in an X-ray beam for data collection 
and kept cool by a stream of liquid nitrogen gas. The low temperature of the crystal 
reduces X-ray-induced damage, mostly caused by free radicals200. The most 
common source of X-rays used to determine structures are synchrotrons. In a 
synchrotron, electrons are accelerated in a circular orbit by magnetic and electric 
fields124. Intense and parallel X-rays are emitted in tangential directions to the beam 
as the electron path curves. 
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The X-ray beam irradiates the crystal and typically several hundred to several 
thousand diffraction patterns are collected on rotation of the crystal199. Diffraction 
patterns are most commonly recorded on CCD detectors. They comprise of a large 
phosphor screen that converts the diffracted X-rays into optical photons and then 
charge, which is the readout124. Depending on the crystal symmetry, a rotation less 
than a full 180° may be required for a complete dataset. However, the intense beams 
produced by third-generation synchrotrons combined with rapid high-resolution 
detectors mean that it is possible to collect highly redundant datasets in minutes, 
providing an increase in accuracy of weak reflections and the ability to account for 
radiation damage. 
When X-rays irradiate atoms in a crystal, scattering occurs at all angles, although 
only certain angles (according to Braggs’ law) will result in constructive interference 
and finite intensity124. These are called diffraction spots, or reflections, and form the 
recorded diffraction pattern. The spot positions in the diffraction pattern reflect the 
lattice and unit cell dimensions124. The dimensions are inversely related to the 
distance between neighbouring spots on the diffraction pattern. The intensities of 
each spot reflect a combination of all molecular information within the asymmetric 
unit.  
4.1.5.3  Determination of molecular structure  
As in EM, the reconstruction of a structure involves the interchange between real and 
reciprocal space by Fourier transformation. The crystal is an array of atoms in real 
space with atomic position being described by Cartesian coordinate system xyz. The 
diffraction pattern is recorded in Fourier space with coordinate system hkl199. The 
structure of a molecule can be determined by the summation of diffracted waves 
from the planes of the crystal lattice, each characterised by an amplitude and phase. 
Each spot in the diffraction pattern with positioning hkl has a measured intensity 
(amplitude is intensity1/2) but with an unknown phase124. Phases are not recorded by 
the detector and must be determined by other methods to generate a structure. 
Phases can be determined by experimental approaches or using homologous protein 
structures199. Multiple isomorphous replacement involves introducing heavy atoms, 
which are strong X-ray scatterers, into the crystals and then collecting diffraction 
patterns. The heavy atom changes the intensities of the reflections and the 
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differences between native and heavy reflection intensities can be used to identify 
the position of the heavy atoms in the crystal199. The amplitudes and phases of the 
heavy atom diffracted waves can then be interpreted and together with another 
different isomorphous replacement (hence the name multiple), can be used to phase 
the other reflections. Another experimental phasing approach is multiple anomalous 
dispersion. Selenium can be readily incorporated into the protein as 
selenomethionine and is an anomalous scatterer; it absorbs X-rays with wavelength 
~0.98Å and so diffracted X-rays have a different phase from other atoms in the 
crystal124. Locating the anomalous scatterers within the unit cell can then be used to 
calculate phases of reflections. The most common phasing method due to the large 
number of structures in the PDB is molecular replacement124. This uses the structure 
of a similar protein (from which phases can be calculated) to estimate the phases of 
unknown structure. It is done by rotating and translating the known structure, 
calculating the FT of intensities (the Patterson function) and comparing to the FT of 
the measured intensities.  
With complete amplitude and phase information of the diffracted waves, the electron 
density of the structure in real space can be computed. The quality of the map 
depends on the diffraction pattern data and the phase estimations199. High frequency 
waves are required to obtain high resolution. These are the reflection spots furthest 
from the centre of the diffraction pattern. The phase estimations can be improved 
through refining the atomic model built into the density199. 
4.1.5.4  Model building and refinement 
A known sequence of amino acids can be built into the calculated electron density 
map using standard bond lengths and geometries as constraints. More accurate 
models can be built at higher resolution. At resolutions of 5Å α-helices appear as 
defined rods, at 4Å β-sheets can be traced, at 2-3Å the chain fold and sidechain 
positions can be identified and close to 1Å side chains are well-resolved and even 




Figure 4.4. Examples of electron density at different resolutions. At high resolution 
(1.0Å) atomic spheres of density can be seen and this progressively becomes more tube-like 
at lower resolutions. Figure adapted from199. 
Once a model is built into the density, a theoretical set of reflections can be 
calculated. This can be compared to the experimental diffraction pattern. The 
similarity between the two is reflected in the R value (lower equals greater similarity) 
defined by:  
C = 	∑( 4789 − 4U>?U )∑|4789|  
where Fobs is the observed or experimental data and Fcalc is the calculated data124. 
The model can then be adjusted and improved to minimise the differences between 
the calculated and experimental diffraction patterns in an iterative refinement 
process. The adjustments at each refinement round change the coordinates and 
phases of the model to better match the data. Generally, an R value of 0.2 can be 
obtained from 2.5Å data124. To avoid over-refinement of a structure, some reflections 
(5-10%) are excluded from the model refinement process. The similarity of these 
reflections to the model are represented by an R free value which is typically 5-10% 
higher than the R value124.  
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After refinement, structures are validated. This involves ensuring backbone dihedral 
angles are favoured, assessing the distribution of hydrophobic and hydrophilic amino 
acids and evaluating side chain rotamers. The atoms within the refined model can 
also be assigned B-factor values. B-factors are a measure of disorder and are 
obtained from analysis of the angular dependence of the diffraction pattern. Large B-
factors indicate higher mobility and can reflect static disorder (structural differences 
between unit cells in the crystal) or dynamic disorder (molecular motion/flexibility)199. 
4.1.6 Crystallography of antibodies 
The size and complexity of IgGs has limited structural analysis of the full-length 
proteins. Only two murine full-length IgG1 and IgG2a structures, one human full-
length IgG1 and one human full-length IgG4 have been determined201. The flexibility 
of the hinge region and the resulting varied domain arrangements is thought to be 
the major reason for not obtaining well-diffracting crystals or clear electron density for 
antibodies. Accordingly, there have been structures of hinge-deleted antibodies202,203. 
Similarly, there are hundreds of structures of Fab or Fc regions, alone or in complex 
with binding partners that have been obtained. These have helped to determine the 
sequence of Fab hypervariable loops, define antigen epitopes and explain Fc effector 
functions.  
4.1.7 Aims of this screening project 
The aim of the hybridoma screening project was to produce mAbs that ideally would 
show novel characteristics in their recognition of AAT conformers. The intention was 
that these new mAbs would complement the existing mAb toolkit and provide 
information about polymer structure, polymer types and/or the polymerisation 
pathway through characterisation of their epitopes.  An improved 2C1 antibody was 
also of interest as 2C1 has a relatively low affinity for polymer and is secreted by a 
low-mAb-producing hybridoma cell line. In this project, mice were immunised with 
either a mixture of plasma M-AAT-based acid- and urea-induced polymers or plasma 
polymers isolated from the plasma of donors homozygous for the Z allele. MAbs of 
interest were characterised immunologically, biochemically and structurally. 
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4.2  Methods 
4.2.1  Production of the monoclonal antibodies  
4.2.1.1  Immunisation 
Mice immunisations and isolation of the spleens were carried out by Juan Perez 
(University of Malaga) as previously described204. A total of 12 mice were immunised, 
six of those with plasma ZZ-AAT polymers and six with a mixture of plasma M-based 
acid/urea polymers. Each mouse was immunised on five occasions spaced three 
weeks apart and each with 10 μg of protein. The first dose was intraperitoneal (IP) 
with the protein emulsified in Freund´s complete adjuvant. The following three doses 
were also IP but emulsified in Freund´s incomplete adjuvant and the last dose (three 
days before collecting the spleen cells) was intravenous in PBS. Serum samples 
taken seven days after each dose were analysed by ELISA for the titre and 
specificity of the antisera. 
4.2.1.2  Fusion of myeloma and spleen cells 
The fusion of myeloma and spleen cells was carried out by Juan Perez (University of 
Malaga) and Elena Miranda (University of Rome). A week prior to the fusion, the 
P3X63Ag8.653 myeloma cells were prepared by expansion into DMEM-20 (78% v/v 
DMEM with high glucose, 20% v/v foetal bovine serum (FBS), 1% v/v HEPES 
solution and 1% v/v Penicillin-Streptomycin (all components from Sigma)) plus 1mM 
sodium pyruvate. The myeloma cells were split every other day, including the day 
before fusion, to grow enough cells for the reaction. On the fusion day, myeloma cell 
cultures (total 200ml) were centrifuged for 5 min at 500g and the pelleted cells 
resuspended in 20ml of pre-warmed serum-free DMEM. The washing step was 
repeated twice. Thawed spleen cells were also mixed with serum-free DMEM and 
washed by centrifugation as above. After washing, both cell types were resuspended 
in 5ml and counted.  Myeloma and spleen cells were mixed at a 1:3 ratio and extra 
DMEM added. The cell mixture was centrifuged at 500g, 5 min and the supernatant 
aspirated away. 1ml of prewarmed 50% w/v PEG (Sigma) was slowly (1ml/min) 
added dropwise to the pellet stirring gently with the pipette tip, followed by 2ml of 
prewarmed DMEM and a further 10ml of prewarmed DMEM. The mixture was 
centrifuged and the cell pellet resuspended in 50ml of HAT-20 medium 
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(hypoxanthine-aminopterin-thymidine (Sigma) reconstituted in DMEM and 
supplemented with 20% v/v FBS, 1% v/v HEPES solution, 1% v/v Penicillin-
Streptomycin and 10% of fusion and cloning supplement (Roche) at room 
temperature. Around 125µl of cell suspension was added per well of 2 96-well flat-
bottom fusion plates and the remaining 25ml of cells diluted 1:2 with HAT-20 to fill 
two more fusion plates. The process was repeated to complete 5 pairs of fusion 
plates.  Cells were cultured in a humidified 37°C, 5% v/v CO2 incubator. Every 2-3 
days hybridomas were fed by replacing half of the medium with fresh medium. 
4.2.1.3  Screening of supernatant media 
The hybridoma clones were screened by antigen ELISA, using 50μl of supernatant 
medium collected from each well after 10-15 days of culturing. A mixture of AAT 
monomer and polymer at 4 µg/ml was used as the antigen to coat the plates. The 
plates were blocked as described in ELISA (3.5.3) and incubated with 50µl of 
hybridoma supernatant medium as the binding antibody step. The ELISA was 
incubated with anti-mouse IgG conjugated with HRP and developed as before. 
Positive wells (i.e. hybridoma colonies producing anti-AAT antibodies) were 
expanded by transferring them into a 24-well plate with 1ml HT medium 
(hypoxanthine-thymidine (Sigma) reconstituted in DMEM and supplemented with 
20% v/v FBS, 1% v/v HEPES solution, 1% v/v Penicillin-Streptomycin and 10% of 
fusion and cloning supplement (Roche)).  
4.2.1.4  Cloning 
Selected clones were subcloned by limiting dilution. Briefly, each of the positive 
clones in the 24-well plate was progressively diluted 1:2 in column A of a 96-well 
plate in HT medium. Each row was then diluted 1:2 across the plate to obtain wells 
with one hybridoma cell. The wells were then screened again using antigen ELISA 
with a positive result indicating a single hybridoma clone producing anti-AAT 
antibodies. 
4.2.1.5  Expansion 
Positive single clones were expanded once confluent into 1 ml of DMEM-20 media 
supplemented with 10% v/v cloning supplement, in one well of a 24-well flat bottom 
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plate. This was done by resuspending the cells with a pipette to detach any from the 
surface of the plate and diluting in fresh media. Once confluent again, these cells 
were expanded into up to four wells in the plate (total 4 ml). These could then be 
expanded at a 1:5 dilution into T75 flasks (4ml + 16ml fresh DMEM-20). If the cells 
were expanded too early, the cells struggled to grow and to overcome this, the 
hybridoma cloning supplement (Roche) was added at a 1:20 dilution. From the T75 
flask, cells were expanded into T175 flasks. Hybridoma cell lines were frozen as 
soon as possible in the expansion and the media changed to ultra-low IgG DMEM-20 
media (78% v/v DMEM with high glucose, 20% v/v low immunoglobulin FBS, 1% v/v 
HEPES solution and 1% v/v Penicillin-Streptomycin (all components from Sigma)) for 
antibody production. 
4.2.1.6  Production of monoclonal antibody supernatant 
The mAb hybridoma cell lines were cultured in ultra-low DMEM-20, in a humidified 
37°C incubator with 5% v/v CO2. On reaching 90-100% confluency, cultures were 
split into new cell culture flasks with fresh media to continue the line, or left to die and 
lyse releasing maximum IgG into the supernatant. The supernatant was collected 
and 0.02% w/v sodium azide added. Monoclonal antibodies were purified as 
described in the method 3.4.4. 
4.2.1.7  Freezing of hybridoma cells 
Hybridoma cells were frozen once confluent. They were detached from the flask by 
washing using a pipette and the suspension centrifuged at 500g for 5 min. The 
supernatant was poured off and kept for IgG purification or ELISA. The cell pellet 
was resuspended in 2ml of freezing media (50% v/v FBS, 5% v/v DMSO, 45% v/v 
DMEM-20) and 1ml aliquoted into cryovials. The cryovials were placed in a freezing 
container (Thermo Scientific) which allowed the cells to cool down slowly and put in 




4.2.1.8  Thawing of hybridoma cells 
Hybridoma cells were thawed by putting the cryovial into a 37ºC water bath. When 
the cells were almost thawed, the vial was moved to the hood and the cells were 
rapidly transferred into culture medium. 
4.2.1.9  Isotyping of monoclonal antibodies 
Cell supernatents were diluted 1:10 into PBS and isotyped using the IsoStrip Mouse 
Monoclonal Antibody Isotyping Kit (Sigma-Aldrich) by following the manufacturer’s 
instructions. 
4.2.2 Characterisation of the mAb 1D9 
1D9 mAb was purified as in method 3.4.4 and plasma M-AAT was purified as in 
method 3.4.1.  
4.2.2.1  Sequencing of the mAb 1D9 
RNA was extracted from ~5 million hybridoma cells using the RNeasy Mini Kit 
(Qiagen) according to the manufacturer’s instructions. The Two-Step RT-PCR Kit 
(Takara) was used to generate DNA encoding for 1D9. The reverse transcription 
reaction utilised the polyT primer as a reverse primer. For the PCR step, degenerate 
primers based on the heavy chain IgG1 constant region and the heavy chain FR1 
region205, and the kappa chain constant region and the kappa chain FR1 region205 
were used for the heavy and light chain, respectively. The polyT reverse primer was 
also used in the PCR step (together with relevant forward primers) to produce DNA 
products that could be sequenced using a polyT primer. All PCR products were 
confirmed by running a 5µl sample on a 2% w/v agarose gel stained with SYBR Safe. 
If one DNA band was visible, amplified DNA was treated with the Enzymatic PCR 
Cleanup Kit (NEB). If multiple undesired bands were visible, the whole sample was 
run on a 2% w/v agarose gel, the DNA band excised and purified using the QIAquick 




4.2.2.2  Epitope mapping using CPM 
25 different previously-purified single-cysteine rAAT mutants were tested for the 
accessibility of the engineered cysteine to conjugate with a thiol-reactive multimodal 
coumarin fluorophore (CPM) in the presence and absence of purified 1D9 mAb. 40μl 
of each mutated rAAT at a concentration of 0.2 mg/ml in PBS was added to two wells 
in a μclear-plate black 96 well microplate (Greiner Bio-One). 1D9 was added to a 
final concentration of 0.6 mg/ml (1:1 molar ratio) to one of each pair of wells. The 
plate was incubated at room temperature with shaking for 10 minutes to allow the 
complex to form. 40μl of 1:5000 CPM reagent in PBS (20nM final concentration) was 
rapidly added to each well and fluorescent readings recorded every 30 seconds for 
30 minutes at room temperature using a SpectraMax M5 plate reader. Excitation was 
at 390nm and emission at 470nm. The fluorescence curves for each residue, with 
and without 1D9, were integrated and the difference plotted.  
4.2.2.3  Thermal shift  
Plasma-derived M-AAT was diluted to 0.2 mg/ml in PBS, pH 7.4 and 10 µl aliquoted 
into wells of a MicroAmp Optical 96-well reaction plate (Thermo Fisher Scientific). 
1D9 mAb or Fab was added in 0, 0.25, 0.5, 1, 2, and 4-fold molar ratios and the 
complex allowed to form for 15 minutes at room temperature. 1D9 was also added to 
10 µl PBS in the same ratios to obtain unfolding curves of antibody alone and as a 
control for buffer, 10 µl PBS was also included. 10 µl of a 1:2500 dilution of Sypro 
Orange (Life Technologies) was added to each well and mixed. The plate was sealed 
using MicroAmp Optical Adhesive Film (Thermo Fisher Scientific) and heated from 
25°C to 85°C, increasing by a 0.5°C increment every 30 seconds using an 
Eppendorph Real4 thermal cycler. Fluorescence was recorded at 605±15 nm. The 
data were normalised and fit to a two-component melting equation. Satisfactory fits 
were obtained with the Tm of one component set to that determined for 1D9 alone. 
4.2.2.4  AAT inhibitory assay 
To test the effect of 1D9 on inhibitory activity of M-AAT on chymotrypsin, plasma M-
AAT was diluted to a concentration of 0.1 µM in activity buffer (20mM Tris pH8, 0.1% 
w/v PEG 8000, 100mM NaCl, 20mM CaCl2, 0.02% w/v sodium azide) and was pre-
incubated with an 8-fold molar excess of 1D9 mAb for 15 minutes at room 
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temperature. As a control, plasma M-AAT without 1D9 was included in the assay at 
the same concentration. Samples were pipetted in increasing 1 µl increments from 0 
µl to 10 µl in a 96 well plate, in duplicate. A constant 10 µl volume of chymotrypsin at 
0.1 µM (made up in activity buffer) was added to all wells and incubated for 20 
minutes with shaking. Well volumes were brought up to 20 µl with activity buffer, 
before addition of 180 µl chymotrypsin substrate, succinyl-Ala-Ala-Pro-Phe-p-
nitroanilide (AAPF), diluted to 200 µM in activity buffer to all wells. Absorbance 
readings at 405nm were recorded every 30 seconds, over a 10 minute time course to 
monitor the reaction. The experiment was repeated with 20-fold less of the 
chymotrypsin (0.005 µM) for the M-AAT/1D9 sample. The data were analysed using 
GraphPad: Nonlinear regression was used to find the concentration of inhibitor at 
which there was no residual protease activity. This value was normalised such that 
the value obtained for M-AAT alone was equal to 1.  
M-AAT inhibitory activity against human neutrophil elastase (HNE) was also 
assessed using the same method but with N-methyoxysuccinyl-Ala-Ala-Pro-Val-p-
nitroanilide (AAPV) as the substrate and 2-fold less HNE (0.05 µM) for the M-
AAT/1D9 sample.  
4.2.2.5  Polymerisation assay with 1D9 
Plasma M-AAT with the endogenous Cys232 was previously labelled with Alexa 
Fluor 488 maleimide or with Alexa Fluor 594 maleimide (Life Technologies) and 
labelling efficiency assessed by Dr J. Irving74. The two differentially labelled M-AAT 
were mixed in equal concentrations of label and diluted to 0.2 mg/ml in PBS. 70 µl of 
M-AAT mixture was added in to wells of a white 96-well semi-skirted PCR plate 
(Thermo Fisher Scientific) and 1D9 added in 0.5-fold, 1-fold and 2-fold molar ratios. 
Polymerisation was induced by heating across a temperature gradient from 50°C to 
65°C using a thermal cycler. The fluorescence signal at 520 nm, 550 nm, 580 nm 
and 605 nm was measured over a 16 hour time course. The acceptor fluorescence 
(at 605 nm) was expressed as a ratio of donor fluorescence (at 520nm) and non-
linear regression performed using GraphPad.   
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4.2.2.6  Surface Plasmon Resonance with 1D9 
Binding experiments between 1D9 mAb and plasma derived M-AAT was carried out 
using the Biacore X100 system (GE Healthcare Life Sciences) and the Biacore X100 
control software. A new CM5 sensor chip (GE Healthcare) was primed by running 
filtered PBS pH 7.4 over the chip before pH scouting, monitoring electrostatic 
interactions to find the optimal pH for 1D9 immobilisation. 1D9 was diluted to 1 µg/ml 
in 50mM sodium acetate buffers at pH 4, 4.5, 5 and 5 and each condition was run 
over the chip with a contact time of 180s. The relative response of each buffer 
condition was measured and surface regeneration was achieved between runs by 
50mM sodium hydroxide. 50mM sodium acetate pH 4.5 was deemed to be the 
optimal pH for 1D9 immobilisation. The Amine Coupling Kit (GE Healthcare) was 
used to immobilise 1D9 on the chip by an EDC/NHS activation step, followed by 1D9 
binding and an ethanolamine wash. The concentration of 1D9 was optimised to be 
25 µg/ml in 50mM sodium acetate pH 4.5 with an immobilised target of 500 RU. The 
final response of immobilised 1D9 on the chip was 339.5 RU. A test run to determine 
contact time and dissociation time parameters for plasma M-AAT binding to 1D9 was 
run using 25 µg/ml M-AAT in PBS pH 7.4 with a contact time of 540s. This indicated 
binding was near-complete within 180s and dissociation was slow, requiring longer 
times than the 600s allowed. Regeneration of the chip was achieved to baseline 
response using 10mM glycine pH 2. A multicycle run with plasma M-AAT at 
concentrations 3.125, 6.25, 12.5 and 25 µg/ml and a regeneration step between each 
concentration was run with a contact time of 180s and dissociation time of 2400s. 
The data best fit to a heterogeneous ligand binding model and yielded affinity 
constants of 2 nM and 12 nM.  
4.2.2.7  Peptide inhibition ELISA experiment 
A sandwich ELISA was carried out as in 3.5.3 with monomeric M-AAT serially diluted 
across the plate. 1D9 was used as the binding antibody, which had been incubated 
for an hour with a 10- or 100-fold molar excess of peptide either with the RCL 
sequence (EAAGAMFLEAIPMS(Lys(biotin))) or the C-terminal sequence 
(SIPPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQK). 1D9 alone was used as a 
control. Detection was carried out as in 3.5.3.  
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4.2.3 Production and purification of rAAT for crystallography 
4.2.3.1  The plasmid encoding AAT 
The plasmid used for recombinant AAT expression was based on the pQE-30 
plasmid (Qiagen). The open reading frame encoding for wild-type AAT was 
incorporated but with a single point mutation to remove the only cysteine (C232S). 
The pQE-30 plasmid incorporates a His6-tag on the N-terminus of the construct, 
which was removed for crystallographic studies using PCR by A. Jagger.  
4.2.3.2  Transformation 
1µl of pre-formed plasmid was added to 50µl of Escherichia coli XL1-blue 
supercompetent cells (Agilent Technologies) and incubated on ice for 30 min. The 
cells were heat-shocked for 45 seconds at 42°C and put back on ice. 200µl of SOC 
broth was added and the cells were incubated for 1 hour at 37°C. The cells were 
then plated onto LB-agar supplemented with ampicillin at 100 µg/ml for incubation 
overnight at 37°C. 
4.2.3.3  Bacterial growth conditions  
Liquid cultures of E. coli were grown at 37°C with shaking in LB broth. When single 
colonies were required, E. coli were plated onto 1.5% (w/v) LB-agar and incubated 
overnight at 37°C. Ampicillin was added at 100 µg/ml. 
4.2.3.4  Expression of recombinant AAT 
A total of 4L of Terrific Broth media (Formedium) supplemented with 100 µg/ml 
ampicillin was inoculated 1:50 with overnight culture. The cultures were grown to 
OD600nm=0.6 at 37°C shaking before being induced by the addition of 1mM 
IPTG.  Expression was carried out for 24 hours at 24°C with shaking. The cells were 
pelleted by centrifugation at 3000g for 20 min at 4°C and the pellet resuspended in 
PBS with lysozyme at 1 mg/ml for freezing at -80°C. 
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4.2.3.5  Purification of recombinant AAT without a His tag 
The resuspended pellet was defrosted and DNase I and cOmplete Protease inhibitor 
cocktail tablets (EDTA-free) added. The cells were lysed on ice by sonication for 10 
minutes. Lysates were centrifuged at 10,000g for 30 min at 4°C. The supernatant 
was diluted 1 in 4 in binding buffer (20mM Tris, 150mM NaCl, pH 7.4) and 0.45μm 
filtered prior to column loading. A 5ml pre-packed Alpha-1-Antitrypsin Select resin 
(GE Healthcare) column was pre-equilibrated in binding buffer and sample loaded at 
2 ml/min. The column was washed with binding buffer until the UV reading reached 
baseline. The protein was eluted using elution buffer (20mM Tris, 150mM NaCl, 2M 
MgCl2, pH 7.4). Fractions were analysed by SDS-PAGE, pooled and dialysed. The 
dialysed sample was loaded at 1 ml/min onto a 5ml Hi Trap Q HP column (GE 
Healthcare) pre-equilibrated in 20 mM Tris, pH 8. The column was washed until UV 
baseline was reached prior to protein elution using a 0-50% gradient of 20mM Tris, 
1M NaCl, pH 8. Fractions were analysed by SDS-PAGE and pooled accordingly.  
4.2.4 Crystallography methods  
4.2.4.1  Formation and purification of rAAT/1D9 Fab complex 
Purified rAAT was incubated for 2 hours at room temperature with a 2 times w/w 
excess of 1D9 Fab. The complex was filtered by a 0.22μm-centrifugal filter before 
being purified by size exclusion chromatography using a Superdex 200 Increase 
10/300 GL column (GE Healthcare) that had been pre-equilibrated in 10mM Tris pH 
7.4, 50mM NaCl, 0.02% w/v azide. Protein-containing peaks were run on non-
denaturing PAGE to assess the presence of the complex. Relevant fractions were 
pooled and concentrated by centrifuging at 3,000g using a Pall Microsep Advance 
Centrifugal Device 30K MWCO. An extinction coefficient of 9.9 yielded a final 
concentration of 10.2 mg/ml. 
4.2.4.2  Extra purification of 1D9 mAb and 1D9 Fab for crystallography 
1D9 mAb or 1D9 Fab were diluted into 50mM sodium acetate pH 4.5 (binding buffer) 
and loaded onto a 5ml HiTrap SP HP cation exchange column (GE Healthcare) pre-
equilibrated in binding buffer. The column was washed until UV baseline was 
reached prior to elution using a 0-100% gradient of 50mM sodium acetate pH 4.5, 
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1M NaCl. Fractions were analysed by SDS-PAGE and pooled accordingly. Proteins 
were concentrated by centrifugation using a Pall Microsep Advance Centrifugal 
Device 10K MWCO to 10.1mg/ml for 1D9 mAb and 5 mg/ml for 1D9 Fab. 
4.2.4.3  Sitting drop crystallisation screens 
The rAAT/1D9 Fab complex, 1D9 Fab and 1D9 mAb were subjected to crystallisation 
trials at their respective concentrations. Sitting drop trays were set up in a selection 
of sparse matrix crystallisation screens. 80 μl of each crystallisation condition well 
was transferred to a 96-well MRC crystallisation plate (Molecular Dimensions) using 
an I-PETTE liquid handling system (Fluid X). Sitting drops of 100 nl protein, 100 nl 
crystallisation condition were set up using the Mosquito liquid handling system (Fluid 
X). Plates were sealed and stored at 16°C and monitored using a Rock Imager 1000 
system (Formulatrix) set to a Fibonacci imaging schedule.  
4.2.4.4  Hanging drop crystallisation screens 
Larger scale hanging drop crystallisation screens were set up using 24-well VDX with 
sealant plates and 22 mm siliconised glass coverslips (Hampton Research) to screen 
around positive hits. A well volume of 0.5ml was used with 0.75μl protein to 0.75μl 
reservoir drops. Plates were stored at 16. 
For the 1D9 Fab: Plates were set up varying concentrations of MgCl2 and PEG 3350 





Figure 4.5. Example of hanging drop crystallisation plates set up for the 1D9 Fab.  For 
the rAAT/1D9 complex: Plates were set up varying concentration of PEG 4000 and the pH of 
sodium cacodylate such as in Figure 4.6. Finer gradations of PEG 4000 (w/v) were also 
trialled (10%, 11.25%, 12.5%, 13.75%, 15%, 16.25%).  




4.2.4.5  Freezing of crystals 
Crystals were fished from the drops using synthetic cryo-loops and dipped into cryo-
protectant of mother liquor augmented with 20% w/v MPD or 20% w/v PEG 400, 
before being flash frozen in liquid nitrogen. Some crystals were frozen directly from 
the crystallisation drops.  
4.2.4.6  Data collection 
For the 1D9 Fab crystals: Frozen crystals were shipped to the Diamond Light Source 
(Oxfordshire, UK). Data were collected on the I03 beamline with a λ=1Å, beam size 
of 50 x 20 μm, transmission of 50% and exposure of 0.25s. 720 images were 
collected by rotating the crystal with a 0.5º oscillation per image, providing a 
redundant 360° dataset. 
For the 1D9-rAAT crystals: Frozen crystals were shipped to the ESRF (Grenoble, 
France). Data were collected on the ID30B beamline with a λ=0.97Å, distance of 600 
mm, transmission of 100% and exposure of 0.1s. 360 images were collected by 





4.3.1 A screen of hybridomas identified five general groups of mAb reactivity 
profile 
Mice were immunised with patient plasma Z-AAT polymers or a mixture of plasma M-
AAT-based acid/urea polymers by Dr J. Perez (U Malaga, Spain). Hybridoma cell 
lines derived from the mouse spleen cells were first screened for AAT recognition by 
ELISA, in collaboration with Dr E. Miranda and Dr J. Perez. A total of 31 hybridoma 
cell lines secreting antibodies exhibiting this reactivity were generated. The culture 
media supernatant (CMS) from each cell line, which contains the secreted mAbs, 
was then more thoroughly screened for antigen selectivity using a sandwich ELISA. 
Six different antigens were used in this screen: patient plasma Z-AAT polymers, 
plasma Z-AAT-based heat-induced polymers, plasma M-AAT-based urea polymers, 
plasma M-AAT-based acid polymers, plasma Z-AAT monomer and plasma M-AAT 
monomer. Due to the high number of both hybridoma cell lines and antigens in the 
screen, end-point absorbances were measured using a single 1:200 dilution of CMS, 
rather than a full concentration range. This value was chosen based on previous 
experience with similar targets. It is important to note that the CMS was taken from 
hybridoma lines at different stages of culture and the absolute values of absorbance 
have not been normalised for antibody concentration.  
The mAbs were grouped based on demonstration of a similar conformational 
preference profile against the six tested antigens (Figure 4.7). The antibodies 
belonging to Group 1 (14 mAbs) exhibited a preference for all the polymeric species 
tested over the monomers. The polymer-specific mAb 2C1 was included for 
comparison76. The group was subdivided into 1a (9 mAbs) and 1b (5 mAbs), where 
the latter had higher recognition for the monomer (based on the highest polymer 
signal being less than 5 times greater than the highest monomer signal). Group 2 (7 
mAbs) also showed high polymer recognition but also exhibited a preference for the 
Z monomer over the M monomer. Group 3 (5 mAbs) had similar recognition for all 
the AAT conformers tested, much like the controls of 9C5, 3C11 and 4B1276,116. 
Group 4 (1 mAb) displayed a unique specificity profile with high recognition of ZZ 
plasma polymers, M acid polymers, Z monomer and M monomer and low recognition 
of Z heat polymers and M urea polymers. Group 5 (4 mAbs) had higher recognition 
of M acid polymers, M urea polymers and M monomer in comparison to the Z-AAT 
  
102 
antigens tested, suggesting that these antibodies were specific for M-AAT. The 
differing antigen recognition profiles of the mAbs against AAT conformers highlights 
the presence of structural differences between the species and the potential to gain 
structural or mechanistic insight through characterisation of their epitopes.  
While the main goal of this part of work was to identify novel reactivities, an ancillary 
aim was to develop a replacement to the 2C1 polymer-specific antibody with 
improved characteristics, in particular a hybridoma line with increased secretion 
efficiency and an antibody tolerant of higher concentration. It was therefore promising 
to see monoclonal antibodies that were 2C1-like (Group 1). However, the 
hybridomas producing these antibodies failed to show the improvements desired. 
The most interesting generated mAb was the unique clone 1D9 that formed Group 4. 
This profile represents the converse of 2C1. Consequently, 1D9 was characterised 
in-depth using a combination of immunological, biochemical and structural 




Figure 4.7. The classification of newly generated monoclonal antibodies into 
5 groups based on antigen specificity. A) End-point absorbance measurements 
from a sandwich ELISA are graphed for each mAb against: heat-induced Z-AAT 
polymer, urea-induced M-AAT polymer, acid-induced M-AAT polymer, Z-AAT 
monomer and M-AAT monomer antigens. mAbs identified from previous screens 
which were used as controls are marked by an asterisk. B) The average reactivity 
of the groups against antigen. Individual absorbances for a mAb were normalised 
by dividing all measurements by the highest. Error bars are the SD. 
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4.3.2 Characterisation of 1D9 specificity using the purified protein 
The monoclonal antibody 1D9 stood out in the screen for its unique combination of 
AAT conformer specificities. The hybridoma cell line was expanded for antibody 
production and 1D9 was purified from the supernatant after two weeks of secretion. 
1D9 was isotyped and found to belong to the IgG1 subclass with a κ light chain. 1D9 
was tested again in a sandwich ELISA with a further two antigens (plasma M-AAT 
cleaved between sites P4-P5 by Staphylococcus aureus protease GluC and liver 
polymers isolated from the liver of a patient homozygous for the Z allele) over a 
range of antigen concentrations. The running profile of these antigens on a non-
denaturing gel are shown in Figure 4.8A. 1D9 was compared to the mAb 3C11 as a 
control, which is known to have a similar specificity for all AAT antigens. The ELISA 
results show that 1D9 has a 10-fold preference to monomeric AAT over polymeric 
forms (M monomer and Z monomer had IC50s of 17±2 and 12±2 ng/ml respectively 
compared to IC50s of 151±55, 113±20, 194±35 and 168±60 ng/ml for ZZ plasma, M-
based acid, M-based urea and ZZ liver polymers respectively) (Figure 4.8B). The 
recognition of RCL-cleaved M-AAT was intermediate between monomer and polymer 
with an IC50 of 45±16 ng/ml. Together, these suggest that the 1D9 epitope is less 
available in the AAT polymer than the monomer and that part of this reduction is due 
to the insertion of the RCL into β-sheet A. 1D9 also displayed a surprisingly low 
affinity for heat-induced M-AAT polymers (IC50 of >400 ng/ml) compared to the other 
polymers. Heat-induced Z-AAT polymers and ZZ plasma/ZZ liver polymers have 
previously been suggested to be similar in structure76. These results provide the first 
suggestion, based on antibody reactivity, that there may be structural differences 
between these polymer forms. In order to interpret these differences in reactivity 






Figure 4.8. 1D9 specificity. A) Non-denaturing gels of the eight AAT antigens screened 
against using sandwich ELISA. These were: M-AAT monomer, Z-AAT monomer, M-based 
heat-induced polymers, ZZ-AAT plasma polymers, M-based acid-induced polymers, M-based 
urea-induced polymers, M-AAT cleaved and ZZ-AAT liver polymers. B) Sandwich ELISA of 
3C11 and 1D9 as the detection antibody against different antigens. Error bars are the 
standard deviation (n=3).  
4.3.3 1D9 blocks polymerisation and the inhibitory activity of AAT 
As 1D9 displays selectivity for AAT monomer over polymer, it was rationalised that 
mAb binding could stabilise monomer-specific structural elements and thereby 
interfere with the process of polymerisation and/or the inhibitory mechanism of AAT. 
Previously the mAbs 4B12 and 5E3 have been found to block or increase 
polymerisation of AAT in vitro respectively116,181. 1D9 was tested to see whether it 
exhibited any functional activity towards AAT. Recombinant AAT was labelled with 
Alexa Fluor-488 or Alexa Fluor-594, mixed in equal amounts and the increase in 
FRET efficiency, reporting primarily polymerisation, measured over time at different 
temperatures. Incubation of AAT with and without a 1:1 molar ratio of 1D9 at five 
different temperatures is shown in Figure 4.9. In the absence of 1D9, the FRET 
efficiency and the rate of change that is reporting polymerisation, increased with 
  
106 
higher temperatures. The greatest increase in signal was between 53.0°C and 
56.8°C, indicating this temperature range encompasses the temperature required for 
the monomer to polymer structural transition. The formation of AAT polymers was 
confirmed by a fluorescent non-denaturing gel (Figure 4.9). On addition of increasing 
molar equivalents of 1D9, the general trend followed that the FRET efficiency and the 
rate of change of the FRET signal was reduced, indicating polymer formation was 
blocked. The greatest change in rates in the absence and presence of 1D9 was at 
56.8°C, where the FRET signal and change over time was significantly reduced in 
the latter. At this temperature, 1D9 effectively blocked polymerisation, as 
demonstrated by the decrease in polymeric bands and the appearance of the 1D9-
complexed monomer (marked by an asterisk) in the non-denaturing gel. The FRET 
signal at 60.8°C was also reduced but to a lesser extent, indicating partial 1D9 
polymerisation-blocking activity at this temperature. At 63.9°C, there was little 
difference in signal with and without 1D9, suggesting that the higher temperature 
strongly drives polymerisation and/or disrupts 1D9 binding. The lowest temperature 
that polymerisation occurred changed from 56.8°C to 60.8°C in the absence and 
presence of 1D9 respectively, indicating that 1D9 is an effective inhibitor of heat-
induced polymerisation, similar to the activity observed for 4B12116.  
The in vivo function of AAT is to inhibit proteases (predominantly neutrophil elastase) 
in the lungs, preventing excessive lung tissue destruction. AAT acts as a pseudo-
substrate for the protease, and after RCL cleavage and subsequent insertion into β-
sheet A, distorts the catalytic triad of the protease. Although not a biological target of 
AAT, chymotrypsin is often used in in vitro studies to assess inhibitory activity64,98. 
The structural rearrangement of AAT is key to its inhibitory activity206 and if the 
binding of 1D9 interferes with this process then it would be expected to alter the 
inhibitory capacity of the protein. The inhibitory activity of AAT against chymotrypsin 
and human neutrophil elastase (HNE) was tested in the presence and absence of 
1D9. AAT activity was measured indirectly by monitoring the rate of colorimetric 
substrate cleavage, which will be proportional to the amount of free protease present 
in solution. In the absence of 1D9, AAT was a stoichiometric inhibitor of 
chymotrypsin. However once bound to 1D9, AAT retained only about 4% of its 
inhibitory activity, with a stoichiometry of inhibition of 23±0.7:1 inhibitor (Figure 4.10). 
This suggests that the RCL is inaccessible for complex formation with chymotrypsin. 
In contrast, 1D9-bound AAT was still able to inhibit HNE relatively effectively, with a 
I:E of 1.8±0.04 (Figure 4.10). The extreme contrast between the SI’s against HNE 
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and chymotrypsin is a little surprising, however the mechanism of inhibition is known 
to be highly sensitive to small changes, and differences in SI have been observed for 
the same serpin against different proteases previously207-209.  
The blocking of inhibitory activity has not been observed in any of the AAT mAbs 
before; although 4B12 had polymerisation-blocking activity, it only marginally 
increased the stoichiometry of inhibition116,191. This suggests the epitope includes 
structural elements related to the inhibitory mechanism, such as the RCL, β-sheet A 
and helix F186,210,211 or the resting site of the protease185. 
 
Figure 4.9. 1D9 blocks the polymerisation of AAT in vitro. A fluorescence non-denaturing 
gel (top) of AAT incubated with increasing molar equivalents of 1D9 at three different 
temperatures. FRET analysis of fluorescently-labelled AAT molecules during heat-induced 
polymerisation are shown at the bottom of the figure in the absence (left) and presence of 
1D9 (right). The 1D9-complexed monomer is apparent in the 56.8°C condition (marked by an 





Figure 4.10. 1D9 binding alters the inhibitory activity of AAT. Activity assays are shown 
of AAT against chymotrypsin (left) and human neutrophil elastase (right) in the absence and 
presence of 1D9. The graphs represent three experimental repeats. To account for the 
presence of a proportion of inactive protease molecules, the X-axis has been normalised 




4.3.4 1D9 increases the thermal stability of AAT 
The transition of native AAT to the polymerisation intermediate can be analysed in a 
thermal shift experiment74. Monomeric AAT was incubated over a temperature 
gradient from 25°C to 95°C in the presence of the environment-sensitive dye SYPRO 
Orange. SYPRO Orange undergoes an increase in fluorescence upon binding to 
hydrophobic regions in partially unfolded (intermediate-like) or denatured proteins. 
SYPRO Orange fluorescence was monitored as a function of temperature for AAT 
unfolding, in the absence and presence of 1D9 (Figure 4.11). In the absence of 1D9, 
M-AAT had a Tm of 60.7±0.4°C. The unfolding of 1D9 mAb and Fab was also 
measured, yielding Tm values of 70.0±0.2°C and 71.2±0.4°C, respectively. The 
fluorescence signal in the presence of 1D9 was deconvoluted using a two-state 
unfolding equation for the two-protein system to determine the midpoint of 
denaturation (Tm) of AAT, which can report on native state stability. In the presence 
of increasing molar equivalents of 1D9 mAb, the Tm of AAT increased up to a 
maximum of 64.8±0.6°C (SD, n=6) for four molar equivalents. Similarly, in the 
presence of four molar equivalents of 1D9 Fab, the Tm of AAT increased to 
64.8±0.5°C (SD, n=4). The similarity of these values, despite the difference in the 
appearance of the curves of the complexes, is most likely due to the greater 
contribution to the fluorescence signal of the 150kDa mAb with respect to the 50kDa 
Fab. Together, these results indicate that 1D9 stabilises AAT from progressing to the 





Figure 4.11. 1D9 binding stabilises the native state of AAT. Thermal shift experiments 
using SYPRO Orange fluorescence to measure the melting curves of M-AAT, M-AAT with 4-
fold molar excess of 1D9 mAb and 1D9 Fab. Binding of AAT by 1D9 mAb (left) and 1D9 Fab 
(right) were measured. Error bars denote the SD, n=6 for the 1D9 mAb experiments and n=4 
for the 1D9 Fab experiments.  
4.3.5 1D9 binds near the RCL region of AAT 
The effects on inhibition and polymerisation suggest 1D9 inters with conformational 
change of the AAT molecule. To investigate how 1D9 affects the behaviour of AAT, 
epitope mapping of 1D9 was carried out. First, a competition ELISA between 1D9 
and 4B12 was used to see whether these antibodies had overlapping epitopes, as 
both mAbs have polymerisation-blocking activity. M-AAT monomer was used as the 
antigen, the antibody to be tested for competition was serially diluted and 4B12-HRP 
added at constant concentration was used for the detection system. 4B12 is known 
to have residues on helix A and helix I in its epitope from PEGylation and EPR 
experiments116,191. Unlabelled 4B12 was included as a positive control for competition 
against itself. 9C5 and 3C11 were also included for comparison, where 3C11 has 
previously been shown to compete with 4B12 and therefore indicates that 4B12 and 
3C11 have overlapping epitopes. 1D9 did not compete with 4B12 binding, similar to 
that seen with 9C5 (Figure 4.12). Therefore, 1D9 binds to AAT at a different site from 





Figure 4.12. 1D9 has a different epitope to 4B12. A competition ELISA between mAbs and 
4B12-HRP shows that 1D9 and 4B12 do not compete for AAT binding. The residues coloured 
in red on the AAT structure (PDB ID: 1QLP8) indicate the location of the 4B12 epitope. Error 
bars represent SD for n=2. 
As 1D9 also abrogated inhibitory activity of AAT against chymotrypsin, this 
suggested that 1D9 might bind near to the β-sheet A or the RCL of AAT. To localise 
the 1D9 epitope, the same protection assay using the thiol-reactive fluorophore 7-
diethylamino-3-(4-maleimidophenyl)-4-methylcoumain (CPM) that had localised the 
2C1 epitope, and confirmed the 4B12 epitope, was used191. This molecule becomes 
fluorescent upon reaction of the maleimidyl group with a free cysteinyl thiol. A range 
of single-cysteine recombinant mutants covering the AAT molecule were tested. 
Each mutant was incubated with or without 1D9 antibody and the fluorescence 
emission on conjugation of CPM to the cysteine residue followed over 30 minutes. 
The difference between the integrals of the two fluorescence curves (± 1D9) was 
plotted (Figure 4.13). The majority of residues tested showed negligible effect of 1D9 
binding on fluorescence intensity (curves for residue 43 on helix A are shown). 
However, residues 283 and 360, in s2C and the RCL respectively, showed a much 
slower increase in fluorescence intensity in the presence of 1D9. This indicates a 
reduced degree of fluorophore conjugation due to the interference by 1D9 and thus 
that they constitute part of the 1D9 epitope. Residue 346 at the N-terminal end of the 
RCL displayed the opposite effect; fluorophore conjugation appeared to increase in 
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the presence of 1D9, potentially suggestive of 1D9 binding making 346 more 
exposed.  
The 1D9 epitope was further probed by western blot and ELISAs. A denaturing 
western blot showed that 1D9 recognised all AAT antigens tested, at a similar 
intensity to a rabbit total polyclonal antibody, except for cleaved AAT (Figure 4.14A). 
Binding of an epitope after denaturation is suggestive of a predominantly linear, 
rather than conformational epitope. The lack of recognition of cleaved AAT by a 
denaturing western blot suggests that the 1D9 epitope is at least partly encapsulated 
by the 40 residues lost after GluC-cleavage of AAT at position 354. This region would 
be separated from the molecule by SDS-PAGE but would still be present under 
native conditions, explaining the recognition of cleaved AAT by ELISA (Figure 4.8) 
and a non-denaturing western blot (not shown). This finding is in keeping with the 
identification of residue 360 being near or within the epitope.  
To identify whether 1D9 bound to the C-terminal fragment of AAT or more specifically 
the RCL, ELISAs were carried out against M-AAT monomer after pre-incubation of 
1D9 with a 10-fold or 100-fold molar excess of a peptide corresponding to the RCL or 
corresponding to the C-terminal 35 residues. The results showed that neither peptide 
affected the recognition of monomer by 1D9 (Figure 4.14B). Therefore, it is unlikely 






Figure 4.13. Localisation of the 1D9 epitope. The fluorescence of the CPM dye was 
monitored over time as it bound to single cysteine mutations in AAT, in the presence and 
absence of 1D9 mAb. The difference between the integrals of the fluorescence curves was 
plotted. The cartoon structure of AAT highlights the position of positive epitope hits (283 and 
360), as well as 346 and negative control 43. Error bars represent SD for n=2. The individual 
fluorescence curves for 4 residues are shown below in the absence (blue) and presence (red) 





Figure 4.14. Further investigation of the 1D9 epitope. A) A denaturing western blot of 10 
AAT antigens (M-AAT monomer, Z-AAT monomer, M-based heat-induced polymers, ZZ-AAT 
plasma polymers, M-based acid-induced polymers, M-based urea-induced polymers, M-AAT 
cleaved, ZZ-AAT liver polymer, Z-based heat-induced polymers and M-based MPD-induced 
polymers) detected with a rabbit polyclonal antibody and 1D9 monoclonal antibody. The ratios 
of the band intensity for each antigen as detected by 1D9 and the rabbit polyclonal antibody 
were calculated using Fiji and were plotted. RCL-cleaved M-AAT was not recognised by 1D9. 
B) A competition ELISA using 1D9 mAb pre-incubated with peptides corresponding to the C-
terminal residues S359-K394 (blue) or RCL residues E346-S359 (green) of AAT. Both the C-
terminal and RCL peptide did not interfere with 1D9 binding to M-AAT.  
4.3.6 1D9 has nanomolar affinity for monomeric AAT 
Surface plasmon resonance (SPR) is a powerful technique to detect binding events 
and was used to characterise the binding of 1D9 to monomeric M-AAT. In SPR, 
polarised light, shone at a certain angle, undergoes total internal reflection through a 
glass prism124. The backside of the glass prism is covered with a gold film, together 
forming the sensor chip. Light is absorbed by electrons in the gold film causing them 
to resonate (known as surface plasmons). This results in an intensity loss in the 
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reflected beam at the detector. In an SPR experiment, a ligand is attached to the 
gold side of the sensor chip, whilst the analyte molecule is free in solution and is 
passed over the sensor. As molecules bind to ligand, the refractive index close to the 
chip changes. This in turn alters the angle of minimum reflective intensity in a 
manner which is proportional to the mass bound, allowing binding events to be 
detected in real time. 
As antibodies are routinely attached to sensor chips in SPR experiments, 1D9 mAb 
rather than AAT was immobilised via amine coupling. Firstly, the pH at which to dilute 
1D9 for immobilisation was investigated (Figure 4.15A). This was done by measuring 
the increase in response units (RUs, reporting a change in the refractive index) solely 
from electrostatic interactions. It is desirable to have the highest interaction with the 
sensor at the most neutral pH. At pH 5.5, 1D9 did not alter the surface properties of 
the chip, indicating at this pH, the antibody was not sufficiently positively charged to 
interact with the negatively-charged carboxylate groups on the sensor chip surface. 
At pH’s 5.0, 4.5, 4.0 there was an interaction with the chip surface indicated by the 
increase in RU. Therefore, at these pHs, 1D9 had a high enough positive-charge to 
promote interactions with the chip. As the interaction was similar between pH 4.5 and 
4.0, and greater than at pH 5.0, pH 4.5 was selected for the immobilisation protocol. 
Immobilisation uses a 3-step procedure involving EDC/NHS, 1D9 and ethanolamine 
washes (Figure 4.15B). The EDC/NHS activates the chip by modifying the 
carboxymethyl groups of the dextran to N-hydroxysuccinimide esters. 1D9 is then 
flowed over the chip in small injections and covalently attaches to the esters via 
amine groups. The baseline RU between injections is measured until a value near 
the specified signal is met (in this case it was 500RU). The ethanolamine wash 
deactivates excess carboxylate reactive groups on the chip (as it is also a primary 
amine) and dissociates any remaining electrostatically bound 1D9 molecules to give 
the 1D9 immobilised on the chip (339RU).  
Monomeric M-AAT at 25 μg/ml was flowed over the chip with the immobilised 1D9 to 
determine estimations for the contact time (association) and PBS wash time 
(dissociation) required for the interaction (Figure 4.15C). From this test run, it was 
apparent that the association rate was very quick, reaching the maximal RU after 
around 180 seconds. This signal was around 125RU indicating that not all the 
immobilised 1D9 was able to bind monomer. The dissociation time was much slower 
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with the RU reducing in value by only 35% in 600 seconds. Together, these 
association and dissociation times indicated 1D9 had a high affinity for AAT. 
A binding experiment with a range of AAT concentrations was carried out with a 180 
second contact time and 2400 second dissociation time, based on the times 
discovered in the test run. These binding curves reproduced what was previously 
seen: a fast association and slower dissociation (Figure 4.15D). The sensorgrams 
showed significant curvature, meaning the rates of binding and dissociation were 
measurable. Therefore, kinetic analysis was carried out using the Biacore software 
using various binding models. The simplest model (1:1 binding) was tested first with 
progressively more complex binding models. The heterogeneous ligand model gave 
the best visual fit across all concentrations with the smallest residuals. This model 
represents independent binding of one analyte species to two different ligand sites 
and is in keeping with an antibody and its two antigen-binding domains if the two 
binding events are treated as independent. This would be the case if the cross-
linking reaction resulted in changes to the binding site of a sub-population of the 
molecules. The analysis yielded one binding site with ka1= 6.0x104M-1s-1 and 
kd1=7.0x10-4s-1 and the second binding site with ka2=4.6x105M-1s-1 and kd2=8.6x10-
5s-1. This gives binding constants of KD1=1.9nM and KD2=11.6nM, respectively. 
Similar results were observed when the binding experiment was carried out with a 
fresh sensor chip. Affinity analysis was not carried out with these data as the 
sensorgrams did not reach a steady state. This is an alternate method for deriving an 
affinity constant by measuring the response of an interaction that has reached 
equilibrium at differing analyte concentrations. In theory, the same KD values would 






Figure 4.15. Characterisation of the binding between monomeric AAT and 1D9 using 
SPR. A) A sensorgram measuring electrostatic binding of 1D9 diluted in 50mM sodium 
acetate at different pHs to the sensor chip. B) A sensorgram displaying the three-stage 
immobilisation protocol resulting in 339RU of 1D9 immobilised. C) A sensorgram of AAT 
binding to immobilised 1D9 with 540s association time and 600s dissociation time. D) Kinetic 




4.3.7 Preparation of samples for crystallography studies 
A structural understanding of the interaction between 1D9 and monomeric AAT 
would be highly informative in elucidating how 1D9 exerts its functional effects on 
AAT. To this end, the complex between recombinant AAT and the Fab fragment of 
1D9 was made and purified for crystal trials. 
Native AAT is glycosylated at three sites and has a single Cys residue at Cys232 that 
can form disulphide-linked dimers. Both these properties are not conducive for 
crystallisation. In addition, the typical recombinant protein used in the laboratory has 
an N-terminal hexahistidine tag for facilitating purification; there is a chance that this 
tag may interfere with crystallisation. For these reasons, a recombinant Cys232Ser 
AAT variant without a hexahistidine tag was expressed in E. coli. C232S AAT was 
purified using a two-step purification protocol with the Alpha1-Antitryspin select 
column followed by a Q-sepharose column (Figure 4.16A). The 1D9 mAb was 
purified from the culture media of the 1D9 hybridomas using a Protein G affinity 
column (Figure 4.16B). Pure 1D9 mAb was digested by Ficin into Fab and Fc 
fragments, and then the Fc component was removed by passing the sample through 
a Protein A column. Fab fragments form a 1:1 complex with rAAT and as they lack 
the hinge regions and divalent binding of the source antibody, they provide a better-
defined, less flexible complex for crystallography. The rAAT-1D9 Fab complex was 
formed by mixing an excess of Fab fragment with rAAT and incubating for two hours. 
The complex was then purified using size-exclusion chromatography (Figure 4.16D). 
A non-denaturing gel was used to assess complex formation. Eluted fractions 
showed the presence of 1D9 Fab-rAAT complex together with either the presence of 
some free rAAT or partial dissociation of the complex on the gel. The fractions 
containing the highest proportion of complex were concentrated to 10.2 mg/ml for 
crystallography trials.  
The 1D9 mAb and 1D9 Fab were also subjected to crystallography trials as a 1D9 
structure could be used to model the rAAT interaction if the complex did not produce 
usable crystals. In test runs of an extra purification step of 1D9 Fab using size-
exclusion chromatography, it was apparent that the Fab was interacting with the 
column beads and this affected the separation (not shown). Furthermore, the 1D9 
Fab did not appear to interact with the Q-sepharose column, unlike the 4B12 Fab, at 
pH values of 8 and 8.7 (not shown). Therefore, an S-sepharose column was used to 
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purify the 1D9 mAb and 1D9 Fab by cation-exchange chromatography (Figure 
4.16C). Antibodies are generally regarded as stable at low pH for sufficiently short 
periods of time and this was confirmed from the regeneration step in the SPR 
experiments described above. Smaller molecular weight contaminants could still be 
observed by SDS-PAGE after elution, particularly in the 1D9 Fab sample. As no such 
products were observed during size-exclusion chromatography of the complex, they 






Figure 4.16. Preparation of samples for crystallographic studies. UV absorbance traces 
of elution and denaturing gels of pooled elution fractions (red) are shown. A) Recombinant 
AAT was purified by elution from the Alpha1-Antitrypsin Select column followed by elution 
from a Q-column. B) 1D9 mAb was purified by elution from a Protein G column followed by 
elution from a S-column. C) 1D9 Fab was generated by Ficin digestion and purified from the 
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flow-through of a Protein A column. It was further purified by elution from an S-column. D) 
The rAAT-1D9 Fab complex was incubated for two hours and purified by size-exclusion 
chromatography. Fractions were run on a non-denaturing gel to assess complex formation 
(marked by the red line), next to controls of rAAT and 1D9 Fab. The sample prior to 
purification was also run (load). 
The three samples - 1D9 Fab-rAAT complex, 1D9 mAb and 1D9 Fab - were 
concentrated to 10.2 mg/ml, 10.1 mg/ml and 5 mg/ml respectively in a low-salt buffer. 
They were subjected to sparse matrix crystallisation screens in a sitting-drop format 
by combining 100nl protein solution with 100nl precipitant solution and with vapour 
diffusion against 80µl of the latter buffer. The screens trialled were ProPlex 
(Molecular Dimensions), Structure Screen 1+2 (Molecular Dimensions), PACT 
(Molecular Dimensions), Index screen 1 (Hampton Research), Salt Rx A1 (Hampton 
Research) and JCSG Screen A1 (Qiagen). These screens cover a broad range of 
previously successful crystallisation conditions for other proteins with a variety of 
buffers, pH, precipitants and additives.  
The commercial screens showed a good variety of drop appearances, ranging from 
clear to light or heavy precipitate, indicating that the concentrations of the proteins 
were suitable for crystallography. The 1D9 Fab-rAAT complex commercial screens 
contained one condition where crystals formed after 12 days and continued to grow 
for another 26 days (Table 4.1). The crystals were long and needle-like. The 
condition was 0.1M sodium cacodylate pH 6.0, 15% w/v PEG 4000. A larger-scale 
hanging drop screen was set up around this condition, with equilibration of a 
0.5µl:0.5µl protein: precipitant solution against 500µl of the latter, varying the 
concentration of PEG 4000 (10% to 20% w/v in 1.25% intervals) and the pH of 
sodium cacodylate (pH 5 to pH 7 in 0.5 unit intervals) as in Figure 4.6. Crystals 
formed in multiple conditions, favouring PEG 4000 concentrations of 13.75%-16.25% 
w/v and pH values of 6-6.5 (Table 4.2). These crystals formed after around 7 days 
but were very fragile. Protein solubility varies with temperature and so equivalent 
crystal trays were also set up at 4. These crystals took longer to form but some 
appeared thicker.			 
The 1D9 mAb did not produce any crystalline hits in the commercial screens. This is 
not surprising: there are a lack of mAb crystal structures in the PDB, most likely due 
to the flexible loops and varied domain conformations of the Fab and Fc regions212 
and glycosylation of the Fc region. 
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The 1D9 Fab produced multiple crystalline hits in the screens and encouragingly, 
they were similar to conditions in different screens (Table 4.1). The conditions 
generally used PEG 3350 as the precipitant, with magnesium chloride and covering a 
range of pHs. The crystals either formed in clusters of long needles or were very 
intercalated, indicating multiple lattices could form from single nuclei. Crystal 
nucleation could be observed after one day. Custom hanging drop screens, like that 
shown in Figure 4.5, were again set up around the lead conditions, varying PEG 
3350 concentration, magnesium chloride concentration and pH to produce bigger 
crystals. Intercalation and over-nucleation was still apparent in some wells but better-
formed crystals were also apparent (Table 4.2). The concentration of 1D9 Fab 
subjected to crystallisation was also halved to attempt to reduce the rate of 
nucleation and intercalation. However, this appeared to not make a significant 
difference to the crystals that formed.  
Screen Well Precipitant Buffer 
1D9 mAb 
/ / / / 
1D9 Fab 
Structure C9 30% w/v PEG 4000 0.2M MgCl2, 0.1M Tris-HCl pH 8.5 
JCSG H11 25% w/v PEG 3500 0.2M MgCl2, 0.1M Bis-Tris pH 5.5 
Index G10 25% w/v PEG 3500 0.2M MgCl2, 0.1M Bis-Tris pH 5.5 
Index G11 25% w/v PEG 3500 0.2M MgCl2, 0.1M Bis-Tris pH 6.5 
Index G12 25% w/v PEG 3500 0.2M MgCl2, 0.1M Hepes pH 7.5 
Index H1 25% w/v PEG 3500 0.2M MgCl2, 0.1M Tris-HCl pH 8.5 
Index H12 30% w/v PEG MME 2000 0.15M Potassium Bromide 
1D9 Fab-rAAT complex 
ProPlex B9 15% w/v PEG 4000 0.1M Sodium Cacodylate pH 6 
Table 4.1. Conditions in the commercial screens tested that produced crystals for the 






Precipitant Buffer Image 
1D9 Fab 
20% PEG 
3350 0.1M MgCl2, 0.1M Bis Tris pH 6.5 
 
25% PEG 
3350 0.2M MgCl2, 0.1M Bis Tris pH 6.5 
 
30% PEG 
3350 0.2M MgCl2, 0.1M Hepes pH 7.5 
 
15% PEG 
3350 0.2M MgCl2, 0.1M Bis Tris pH 6.5 
 
1D9 Fab-rAAT complex 
15% PEG 
4000 















0.1M Sodium Cacodylate 
pH 6 
4°C  
Table 4.2. Examples of the crystals formed for both the 1D9 Fab and 1D9 Fab-rAAT 
complex in the hanging drop crystallisation screens.  
Prior to data collection, some of the larger 1D9 Fab crystals were tested on the in-
house X-ray source for diffraction. This was to confirm the crystals contained protein 
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and most usefully to test different cryo-protectants for the freezing of the crystals. 
Previous crystal structures of Fabs had used a variety of cryo-protectants ranging 
from 10-20% v/v ethylene glycol, 10-20% v/v glycerol and 15-25% w/v PEG 400 
additions to the crystal reservoir solution213-215. When crystals of the 1D9 Fab were 
soaked using either 10% v/v ethylene glycol or 10% v/v glycerol as cryoprotectants, 
hairline fractures and cracks started to form in the crystals indicating instability. The 
crystal appearance did not visibly alter when soaked in the cryoprotectants 20% w/v 
PEG 400 and 20% w/v MPD conditions and so the majority of crystals were frozen in 
these conditions. Some crystals were also directly frozen into liquid nitrogen as the 
reservoir conditions had a relatively high level of PEG 4000 or PEG 3500 (≥15% 
w/v).  
4.2.8 Determination of the 1D9 Fab structure 
X-ray diffraction data were collected for the 1D9 Fab as detailed in methods 4.2.4.6. 
The highest resolution dataset came from a single crystal grown from equilibration 
against 0.05M MgCl2, 20% w/v PEG 3350 and 0.1M Hepes pH 6.5. The crystal was 
120µm by 80µm by 30µm in size and was frozen without any extra cryo-protectant 
(Figure 4.17A, B). This may explain why there are visible water rings in the diffraction 








Figure 4.17. Data collection for the 1D9 Fab. A) and B) show the crystal in the drop and on 
the cryoloop respectively. The crystal was 120μm by 80μm by 30μm. C) shows one diffraction 




Recorded data were processed and assessed for quality on the beamline using 
FastDp software216. Data were recorded in the resolution range 27.05-1.85Å with an 
overall 95% completeness. X-triage217 highlighted one ice-ring related warning at 
2.24Å. An initial space group of P 2 2 2 was obtained. 
The merged data were used as input against a representative Fab structure (PDB ID: 
1MF2218) for molecular replacement using CCP4 Phaser219. The 1MF2 Fab was also 
a IgG1 kappa chain Fab and had shown high sequence identity (97%) to the 1D9 
light chain from initial sequencing results (Figure 4.18B)218. One molecule was found 
in the unit cell and the space group was revised to P 2 21 21.  
To aid with structural determination, 1D9 was fully sequenced. The encoding RNA 
was isolated from the hybridoma cell line and converted to cDNA by reverse 
transcription using a polyT primer against the polyA transcription sequence. The 
individual chains were then amplified by PCR using forward degenerate primers and 
the poly T reverse primer. Specific amplification was confirmed by running the PCR 
products on an agarose gel before sending for DNA sequencing (Figure 4.18A). A 
lower sequence identity was found between 1MF2 and the 1D9 heavy chain (83%, 
compared to 97% for the light chain). Sequence modifications for both chains were 
made during the structure refinement process, whilst considering the observed 
electron density. At three residues, the 1MF2 sequence was modelled instead of the 
1D9 sequence, based on a better fit with the electron density. These residues were 
Met→Leu (1D9→1MF2) at light chain position 4, Glu→Asp at heavy chain position 1 
and Glu→Val at heavy chain position 5. The electron density was at a high enough 
resolution to allow their unequivocal identification with respect to known sequence 
propensity (Figure 4.18D). The sequence mismatches may be the product of 
sequencing errors as they are at the start of the chains and near the binding site of 
the degenerate primers. The sequence of the 1D9 heavy chain was also incomplete 
towards the conserved C-terminus of the chain; these residues were also 
unambiguously identified from comparison with known antibody sequences based on 




Figure 4.18. Sequencing of 1D9. A) A 2% w/v agarose gel showing PCR amplification of the 
light chain (L) and heavy chain (H) of 1D9 using degenerate forward primers and a polyT 
primer. B) and C) A sequence alignment between 1MF2218 (a IgG1 kappa Fab) and 1D9. 
1MF2 was used as a model for molecular replacement. D) Electron density of residues that 
retained the 1MF2 sequence over the sequence identity proposed from sequencing of 1D9.   
The crystal structure of the 1D9 Fab was solved to 1.85Å resolution and is shown in 
Figure 4.20. Restrained refinement was performed using CCP4 Refmac5220 and 
Phenix221. Structural visualisation and manipulation was performed using Coot161. 
During the refinement process, there were spikes in both the R value and R free in 
resolution shells that coincided with ice rings, reflecting poor data quality in these 
regions. These narrow slices of data were therefore excluded from consideration.  
In the final refined structure, there were 3880 atoms comprising two protein chains 
(the heavy and light chain), 584 unique water molecules (589 including alternate 
conformations) and 1 magnesium ion (Table 4.3). The light chain consisted of 216 
residues and could be fully built into the density whereas there was missing electron 
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density for 6 residues (139-144) out of the 225 residues comprising the heavy chain. 
Some residues were not resolved at both chain C-termini. There was also missing 
density for 23 surface-exposed side chains, which are spread throughout the 
structure. Most of these residues are charged or have long side chains (Lys, Arg, 
Glu, Asp, Gln, Asn) suggesting that are most likely not resolved due to flexibility or 
radiation damage222. A Ramachandran plot shows 99% of residues are in 
energetically favoured regions, with the remaining 1% in energetically allowed 
regions (Figure 4.19). There are no rotamer outliers, 1.8% RSRZ outliers (real-space 
R-value Z score, a measure of the fit to the density) and a low clash score of 2. The 
overall structure has a B-factor of 19, which corresponds to an uncertainty of around 
0.5Åper atom124.  This is considered to reflect low disorder within the crystal and is 






Figure 4.19. A Ramachandran plot of the 1D9 Fab structure. Nearly 99% of residues are 
in energetically favoured regions and the remaining 1% in energetically allowed regions. Plot 








General/Pre-Pro/Proline Favoured General/Pre-Pro/Proline Allowed
Glycine Favoured Glycine Allowed
Number of residues in favoured region (~98.0% expected) :  421  (98.1%)
Number of residues in allowed region (~2.0% expected) :  8  (1.9%)
Number of residues in outlier region :  0  (0.0%)
RAMPAGE by Paul de Bakker and Simon Lovell available at http://www-cryst.bioc.cam.ac.uk/rampage/ 
Please cite: S.C. Lovell, I.W. Davis, W.B. Arendall III, P.I.W. de Bakker, J.M. Word, M.G. Prisant, J.S. Richardson & D.C. Richardson (2002)
Structure validation by Cα geometry: φ/ψ and Cβ deviation. Proteins: Structure, Function & Genetics. 50: 437-450
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Wavelength () 1.0 
Resolution range () 27.05  - 1.852 (1.919  - 1.852) 
Space group P 2 21 21 
Unit cell      a, b, c () 
α, β, " (°) 54.103 85.257 89.427 90 90 90 
Total reflections 431326 (35044) 
Unique reflections 34101 (2951) 
Multiplicity 12.6 (11.9) 
Completeness (%) 94.71 (83.82) 
Mean I/sigma(I) 16.16 (2.90) 
Wilson B-factor (2) 19.06 
R-merge 0.1191 (0.8111) 
Reflections used in refinement 34003 (2938) 
Reflections used for R-free 1718 (155) 
R-work 0.1860 (0.2986) 
R-free 0.2221 (0.3724) 
  




Protein residues 435 
RMS(bonds) 0.005 
RMS(angles) 1.04 
Ramachandran favored (%) 98.83 
Ramachandran allowed (%) 1.17 
Ramachandran outliers (%) 0.00 
Rotamer outliers (%) 0.00 
Clash score 2.19 












Table 4.3. Data collection and refinement statistics for 1D9 Fab. Table generated from 
the Protein Data Bank (PDB) validation server, deposited PDB ID: 6GXX. Statistics for the 




The 1D9 Fab is composed of two variable domains (VL and VH) and two constant 
domains (CL and CH1), which each follow the typical β-sandwich immunoglobulin 
fold. The fold is stabilised by four pairs of disulphide bridges (in the heavy chain: 
Cys22-Cys96 and Cys152-Cys207, in the light chain: Cys23-Cys92 and Cys138-
Cys198) according to the Kabat numbering scheme224. All but Cys23-Cys92 showed 
alternate conformations within the lattice owing to discrete disorder. The cysteines 
that are involved in the inter-chain disulphide between the heavy chain and light 
chain in the Fab region (Cys227 and Cys218 on the heavy and light chain 
respectively) were not resolved in the structure.  
The proposed magnesium ion is hydrogen-bonded between Tyr144 and Tyr177 on 
the light chain and several water molecules in octahedral geometry. The magnesium 
is unlikely to have a functional or structural role in the Fab but merely present 
because of the composition of the crystallisation buffer.  
The complementarity-determining regions (CDRs) form the antigen binding site and 
in the 1D9 structure are well-determined. They are labelled L1 to H3 and were 
identified based on a consensus between the Kabat and Chothia numbering 
schemes224. H3 is generally thought to be the most important CDR for antigen 
binding and hence is the CDR that has the biggest variation in length between 
antibodies (between 3-25 residues)225,226. In the case of 1D9, H3 is 16 residues from 
Ala99 to Thr114. The CDRs have larger B-factors than the rest of the structure (up to 
a maximum of 58.5), particularly H3 (Figure 4.21). This indicates a high atomic 
displacement of atoms, reflective of atomic mobility and flexibility of the chain. The 
CDRs are not involved in extensive crystal contacts probably contributing to their 
disorder. Half of the RSRZ outliers, where the RSRZ is a measure of the geometric fit 
between a residue and the electron density, are in H3 from Thr103-Thr106. The 
poorly resolved electron density in this region again can reflect flexibility as small 
differences between copies of the protein in the crystal lattice will tend to ‘blur’ the 
density. The other RSRZ outliers are residues at the chain break in the heavy chain 
or the C-termini. In these regions, there are similarly high B-factors which helps to 
explain why electron density was not apparent for the missing residues. Lastly, 
electrostatic potential surface analysis shows the antigen binding surface is weakly 
negatively charged which may have a role in electrostatic interactions between 1D9 




Figure 4.20. The 1D9 Fab structure. A side and top view of a cartoon representation of the 
1D9 Fab made using Chimera9. The heavy chain (H) is coloured in dark blue and the light 
chain (L) in light blue. The constant and variable domains are as labelled. The 3 heavy chain 
CDRs are coloured in yellow and the 3 light chain CDRS are coloured in orange. The 
electrostatic potential surface shows the negative charge for the antigen-facing side of the 
Fab. The panel at the bottom shows an example of an alternative disulphide bond 
conformation (left), coordination of the magnesium ion (centre) and the crystal packing of the 




Figure 4.21. B-factor analysis of the 1D9 Fab. The Fab has been coloured from blue to 
white to red together with increased chain thickness in order of increasing B-factor values 
using PyMOL163. A side and top view are shown and indicate that areas of high B-factors are 
in the loops, particularly the CDRs and at chain breaks/termini. 
4.2.9 The structure of 1D9 Fab in complex with rAAT 
Diffraction data were collected as detailed in methods 4.2.4.6, on around 20 crystals, 
which typically showed diffraction to around 5-11Å, making them unusable for 
structure determination. A single plate-like crystal of the 1D9 Fab-rAAT complex 
measuring 280µm by 30µm by 20µm in size, yielded diffraction to better than 3Å. The 
crystal was grown from equilibration against 15% w/v PEG 4000, 0.1M sodium 
cacodylate pH 6 and was frozen in 20% w/v MPD as a cryoprotectant. In comparison 




Figure 4.22. Data collection for the AAT/1D9 Fab complex. A) The crystal of the complex 
on the cryoloop with the collection area highlighted in green. B) One diffraction pattern of the 
crystal.  
Recorded data were processed using XDS to yield an initial space group of C 1 2 1. 
Data were recorded in the resolution range 49.2-2.9Å with an overall 99% 
completeness. X-triage217 did not detect any ice-ring related problems. The data 
appeared moderately anisotropic. Molecular replacement was run using CCP4 
Phaser219 with native AAT (PDB ID:1QLP8) and the previously solved 1D9 Fab (PDB 
ID:6GXX) as search models8. Two molecules of each (i.e. two complexes) were 
present in the asymmetric unit. 
The final structure was refined to 2.95Å (Figure 4.23). Restrained refinement was 
performed using CCP4 Refmac5220 and Phenix221 and the structure was built using 
Coot161. Due to the low resolution, non-crystallographic symmetry restraints were 
used in the refinement process and refinement of two B-factors per residue was 
attempted but discarded in favour of one B-factor per atom. 
Translation/Libration/Screw (TLS) rigid-body descriptions were also tried during 
refinement, but as they did not seem to make a difference to the quality of the 
structure, the final model was refined in their absence. The statistics for the 
integration of the diffraction data were representative of a high-quality dataset, yet 
one copy of the complex showed fairly extensive gaps in the density. Crystal defects 
such as twinning, pseudosymmetry and mis-indexing were excluded as reasons for 
this. The solvent content of the crystal was close to the lower end of the range 
typically observed for protein crystals, and it may be that the high packing density 
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resulted in molecules constrained in slightly different configurations resulting in 
blurring of the density.  
Wavelength () 1.0 
Resolution range () 49.2  - 2.95 (2.95- 3.00) 
Space group C 1 2 1 
Unit cell      a, b, c () 
α, β, " (°) 247.48 36.75 201.78 90 126 90 
Total reflections 102568 (4738) 
Unique reflections 31780 (1472) 
Multiplicity 3.2 (3.2) 
Completeness (%) 99.1 (93.3) 
Mean I/sigma(I) 10.3 (1.4) 
Wilson B-factor (2) 66.8 
R-merge 0.095 (0.894) 
Reflections used in refinement 30,277 




Number of non-hydrogen atoms 11031 
Protein residues 1,503 
RMS(bonds) 0.25 
RMS(angles) 0.48 
Ramachandran favored (%) 95 
Ramachandran allowed (%) 5 
Ramachandran outliers (%) 0 
Rotamer outliers (%) 2 
Clash score 6 
Average B-factor (2) 77.0 
  
Table 4.4. Data collection and refinement statistics for the AAT/1D9 Fab complex. Table 
generated from the preliminary Protein Data Bank (PDB) validation server. Statistics for the 
highest-resolution shell are shown in parentheses. 
There was a total of 11,031 atoms comprising four unique molecules and six protein 
chains (two AAT chains, two 1D9 heavy chains and two 1D9 light chains) (Table 4.4). 
The AAT chains consisted of 350 and 332 residues each, with three and six chain 
breaks respectively. Particularly for the latter AAT molecule, this is a high level of 
missing information, as mentioned above. These chain breaks and missing residues 
were throughout the structure (residues 103-108, 120-130, 136-140, 173-179, 312-
325 and 346-353). The heavy 1D9 chains consisted of 222 and 210 residues – each 
with one chain break – and the light 1D9 chains were complete with 217 and 212 
residues. Missing residues in the Fabs were mainly at the chain termini. 
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Ramachandran analysis showed 95% of residues are in energetically favoured 
regions and 5% in allowed regions. The structure has a rotamer outlier score of 2% 
and clash score of 6.  
The orientation of the molecules clearly identified the epitope that is recognised by 
1D9 Fab. 1D9 Fab binds to the top of the AAT molecule, interacting with the C-
terminal end of the RCL, β-sheet C (mostly s1C and s2C) and part of β-sheet B (s1B 
and s2B) of AAT. This was in agreement with the results from the earlier epitope 
mapping experiments (4.3.5). The interaction between 1D9 Fab and AAT formed an 
average solvent-accessible surface of 888Å2 between the two copies of the complex. 
This was calculated in Chimera by generating the molecular surfaces for the complex 
and for the individual components, and dividing the difference by two9. This is in the 
typical range of interface region surface areas (1103 ± 244Å2) between antibodies 




Figure 4.23. The crystal structure of the 1D9 Fab-rAAT complex. Two copies of the 
complex were present in the asymmetric unit (top) as displayed in cartoon format using 
Chimera9. AAT molecules are coloured in blue and cyan, the 1D9 Fab heavy chains (1D9-H) 
in yellow and magenta and the 1D9 Fab light chains (1D9-L) in red and green. The insert 
shows a zoomed-in interface between AAT and 1D9 in complex 1, highlighting the CDRs and 
the areas of interaction in AAT. The panel at the bottom shows the interactions between AAT 
and 1D9 in complex 1. Hydrogen bonds, aromatic contacts and van der Waals interactions 
were all calculated using Chimera9. 
The structure analysis tool in Chimera was used to look at the specific interactions 
between AAT and 1D9 Fab9. This was carried out for the complex with better-
resolved RCL residues to ensure that the interaction analysis was more complete 
(complex 1). All of 1D9’s CDRs apart from L2 are involved in antigen recognition of 
AAT, however most contacts are made by residues in H2, H3 and L3. Since the 
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model was built without hydrogen atoms, hydrogen bonds were inferred when a 
donor and acceptor were within 3.5Å of each other228.A total of seven hydrogen 
bonds were found between the two molecules with distances between 2.6Å and 3.4Å
(Figure 4.23). Four of these involved H3 residues hydrogen bonding to residues in 
the RCL, s1B and s2C (Thr103-His231, Thr106-His231, Thr106-Arg282 and Tyr110-
Pro361). The other hydrogen bonds were made from Ser52 and Ser53 in H2 both to 
Glu363 in s1C and Val98 in L3 to Met358 in the RCL. One aromatic contact was 
identified involving Phe101 and Trp107 in H3 and Trp238 in s2B. No salt bridges 
were identified and electrostatic potential surface analysis of the top surface of AAT 
showed there were areas of both positive and negative charge. A total of 76 van der 
Waals contacts between atoms were recognised. In total the number of residues 
involved in any interaction were as follows: for 1D9, H1:1, H2:5, H3:5, L1:1, L2:0, 
L3:4, and for AAT, RCL:5, β-sheet C:6, β-sheet B:3. Of the residues in the 1D9 
paratope, Tyr and the other aromatic residues dominated the interactions, which has 
been observed in a systematic review of antigen-antibody interaces227. 1D9 Fab did 
not interact with AAT using residues from any of the framework regions that flank the 
CDRs in keeping with their primary role as a scaffold226.  
PyMOL was used to assess the structural differences between molecules by 
calculating the root mean square deviation (RMSD). The two complexes in their 
entirety within the asymmetric unit were first compared (Figure 4.24). The 
superimposition of the two complexes yielded a RMSD of 0.8Å. The AAT molecules 
superimposed well with RMSD of 0.5Å indicating high structural similarity. The 
major areas of variation between the two AAT structures are a shift of helix D and 
variations in the chain position in loops or at chain breaks. More specifically the latter 
included the loop between helix F and s1A, the loop between helix F and s3A, the 
chain break before s4A and the chain break in the RCL. The variable domains of the 
Fabs also superimposed well, including all loops, but there was more variation in the 
constant domains. This indicates there is relative flexibility between the constant and 
variable domains of the Fab as has been seen before in other Fab structures168.  
Despite their structural similarity, there was a large difference in the B-factors 
between the complex structures as highlighted by the heat map in Figure 4.25. In 
complex 1, all Fab residues had low B-factors, whereas in complex 2, the Fab 
constant domain generally had high B-factors. Of note however, is that the CDRs in 
both complexes had low B-factors, which contrasts with the high B-factor of H3 in the 
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unbound Fab structure (Figure 4.21). For AAT, helix D and F had the highest B-
factors in complex 1 but these regions were stable in complex 2. Instead, in complex 












Figure 4.24. Overlay of the two complex structures present in the unit cell. Complex 1 is 
shown in dark blue and Complex 2 in cyan. PyMOL was used to align the structures and 






Figure 4.25. B-factor analysis of the two complexes present within the unit cell. The 
molecules were coloured from blue to white to red, together with increased chain thickness, in 
order of increasing B-factor values in PyMOL163.  
Complex formation causes structural variations in both antigen and antibody229. 
Therefore, the AAT structures in the complexes were also compared to previously 
solved crystal structures of native AAT. As the AAT structures within both complexes 
of the unit cell shared a relatively low RMSD and therefore were structurally similar, 
only the AAT in complex 1 was assessed. AAT was compared to the crystal 
structures of intact, native AAT (PDB ID: 1QLP and 3NE4)8,230. Both these previous 
native structures have an RMSD of 0.3Å between each other and hence 1QLP was 
used as a representative. The RMSD between 1QLP and the AAT of complex 1 was 
0.9Å. There were 3 main areas of variation: a shift in helix D, a tilt of helix F and an 
altered conformation of the RCL (Figure 4.26). These areas also had the highest B-
factor in complex 1, reflective of intrinsic movement and are known to be particularly 
mobile components of the serpin structure1,231-233. Their altered conformations may 
be a result of 1D9 binding to AAT229 or simply conformational mobility influenced by 
  
140 
crystal packing. Allosteric changes have been noted for other serpins that transmit 
binding events between helix D and the RCL, in particular the breach region234. 
 
Figure 4.26. An overlay of AAT crystal structures. In orange is 1QLP8 and in dark blue is 
AAT from complex 1. The 3 areas (Helix D, Helix F and the RCL) of biggest variation are 
highlighted. Structural comparison and the RMSD calculation was carried out using 
PyMOL163.  
Lastly, the 1D9 Fab structures in the unbound and antigen-bound states were 
compared to ascertain structural changes resulting from complex formation. The 
superimposition of the 1D9 Fab structure on the 1D9 Fab in the first complex showed 
a RMSD of 1.2Å	 This indicates a small conformational change between the two 
states consistent with what is frequently observed for antibody interactions229,235. 
Deviations were observed at the chain termini, the flexible loops linking β-strands 
and in the CDRs. H1, H2 and particularly H3 all showed high RMSD relative to the 
rest of the structure. H3 has been documented to show significant binding-related 
conformational changes in a third of antibodies168. In the light chain, only L1 showed 
a significant chain deviation. The deviations and high superimposition of L2 and L3 
between the structures can be seen in Figure 4.27. There were no obvious 
conformational changes in the relative orientations of the heavy and light chains, the 
elbow angle between the constant and variable domains nor the first loop in the CH1 
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domain, which has been observed in multiple antibody structural comparisons168. The 
superimposition of the Fab domains associated with each complex showed a RMSD 
of 1.4Å. Similar conformational shifts were observed for loops and again were 
highest for the CDRs, in particular H2, H3 and L1. The slightly higher RMSD between 
the complexes with respect to that seen with AAT is most likely due to the greater 
amount of missing density in complex 2; this leads to a greater uncertainty in model 
building at these areas.  
 
Figure 4.27. Comparison of 1D9 structure in unbound and bound states. The unbound 
Fab structure is shown in blue and the bound Fab structure from Complex 1 is shown in red. 
Side and top views are displayed with the CDRs labelled. Structural comparison and RMSD 
calculation was carried out using PyMOL163. 
4.2.10 NS-EM studies of 1D9 Fab bound to polymers  
Although 1D9 has a higher affinity for the AAT monomer, it does still bind to AAT 
polymers. This is despite the 1D9 epitope being in a region of AAT that is intrinsically 
linked to polymerisation. This may provide clues as to the structure of the polymer. 
To characterise this interaction, purified polymer from the liver of a ZZ-AAT 
homozygote was incubated with 1D9 Fab and visualised by NS-EM (Figure 4.28). 
The appearance of the Fab-incubated polymer was not visually distinct from the 
polymer in its absence. This indicates that the 1D9 Fab is likely not binding to every 
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AAT subunit, as observed for 4B12 Fab (Figure 6.7). This is also in accordance with 
the 10-fold lower affinity for polymer than monomer calculated from the ELISA 
against different conformers. However, in the incubated polymer chains there are 
protrusions that are reminiscent of Fab-bound subunits (marked by yellow asterisks 
in Figure 4.28). This suggests a proportion of Fab can bind but that the epitope may 
be obscured in the polymer. The polymer sample was also incubated with a five-fold 
excess of Fab to see whether Fab labelling increased, however the appearance of 
polymer chains did not change (not shown). Unfortunately, the data were too 
inconclusive to compare to the equivalent experiment with heat-induced polymers to 
try and visually explain how heat polymers have a much lower recognition than liver 
polymers by 1D9. 
 
Figure 4.28. Negative stain electron micrographs of ZZ liver polymers in the absence 
and presence of 1D9 Fab. The micrographs were imaged on a Tecnai 100kV with a CCD 
camera at nominal magnification of 64,000X. Scale bar of 50nm is shown. The yellow 





4.4.1 Monoclonal antibodies highlight the conformational differences 
between AAT species 
The mechanism of AAT polymerisation and the structure of AAT polymers from 
different origins have not yet been fully determined. Conformation--specific 
antibodies represent tools that have been used to investigate these characteristics of 
AAT pathology. For example, the development of 2C1 demonstrated that heat-
induced polymers and liver polymers share an epitope that is absent from urea- and 
acid-induced polymers and epitope mapping of the polymerisation-blocking antibody 
4B12 revealed a propagation of conformational changes that occurs throughout the 
AAT molecule during polymerisation76,116,117.  
The usefulness of these antibodies in characterising the AAT polymerisation pathway 
led to the current project: the development of new AAT-specific mAbs that displayed 
novel or improved characteristics against different AAT antigens. Previously, mice 
were immunised with monomeric Z-AAT or heat-induced Z-AAT polymers76,116. 
However, in this hybridoma screen, with a view to produce antibodies with different 
reactivities, the immunising antigens were either Z-AAT polymers purified from 
patient plasma or a mix of acid- and urea-induced polymers. A total of 31 antibodies 
were developed and their specificity was characterised by a screening ELISA. They 
were categorised into five groups that showed distinctive selectivity against four 
polymeric species and two monomeric species. The breadth of the observed 
reactivities (preference for polymers over monomer, monomer over certain polymers, 
Z monomer over M monomer and M-based AAT species over Z-based AAT species) 
highlights the multiple structural differences that exist between different AAT 
conformers. Indeed, it is well documented that the monomer undergoes structural 
changes during polymerisation, that the Z mutation causes increased structural 
lability compared to M-AAT and that polymers vary structurally depending on their 
method of induction or origin48-52,69-72,76. These differences are also reflected by the 
running profile of AAT conformers on a non-denaturing gel69,70.  
Antibodies with similar reactivity to previously developed mAbs were generated in 
this screen in groups 1 (2C1-like) and 3 (9C5/4B12/3C11-like). The group 3 
antibodies were not characterised further as they did not display novel reactivities. 
Secretion levels from a hybridoma cell line in group 1 (1A3) was estimated, to 
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determine whether a 2C1-like antibody could be identified that had a higher 
expression level but 1A3 levels were not significantly improved. Antibody production 
by hybridomas is an unstable phenotype and there is a natural variation in secretion 
levels of clones179. Culture conditions, particularly the growth media, have been 
shown to have an effect236,237. Based on hybridoma culture in the lab, antibody levels 
in the CMS can vary significantly from 1mg/100ml to 20mg/100ml. Loss of antibody 
productivity exhibited by hybridomas over time has been associated with growth of a 
non-producing subpopulation that no longer synthesises the heavy chain236. Low-
producing lines can try to be recloned by limiting dilution to find high-producing 
clones179, but this has not worked with 2C1.  
Most interesting were the groups which displayed novel reactivity, such as group 4 
(preference for monomer and plasma ZZ-AAT polymers) and group 5 (preference for 
M-AAT over Z-AAT). As with previous screens, there was not a direct correlation 
between the conformational state of the immunising antigens and the reactivity 
observed in the newly-generated antibodies. For example, no antibodies were 
generated that showed specific selectivity against the urea- or acid-induced 
polymers, which are believed to be structurally different69, despite their use as 
antigens. Furthermore, 1D9 in group 4 displayed a strong preference for monomers 
despite mice being only immunised with polymers and yet no such antibody was 
generated when mice were immunised with only monomers (E. Miranda, personal 
communication). M-AAT specific antibodies have not previously been generated and 
they complement the ATZ11 antibody, which displays specificity against Z-AAT. This 
is the first published AAT antibody screen that used M-AAT-based antigens for 
immunisation, and group 5 antibodies showed preference for this wild-type variant. 
4.4.2 Insights about AAT from the characteristics of 1D9 
The 1D9 mAb was selected for in-depth characterisation based on its unique 
reactivity profile against AAT antigens. Insight into its epitope would provide some 
degree of structural information on the region that distinguishes the conformations it 
recognises from those it does not. Monoclonal antibodies have provided insight into 
the inhibitory mechanism of serpins238, the regulation of stability against 
conformational change in PAI-1185,186, structural differences between AAT 
polymers69,76, the kinetics of intermediate formation181  and allosteric regulation of 
stability117. From the screen, 1D9 was identified as having a preference to 
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monomeric AAT over polymeric forms. This is the first time that a monomer-selective 
antibody has been developed and potentially provides a direct complement to the 
polymer-specific 2C1 mAb.  
4.4.2.1  The 1D9 epitope is most exposed in the native AAT monomer 
The 1D9 mAb displayed a 10-fold preference for monomeric AAT over most polymer 
types of AAT. It also had an intermediate recognition of RCL-cleaved AAT. This was 
suggestive of a site of binding that was variant between the 5-stranded native 
monomer and 6-stranded cleaved AAT and most likely involved at least part of the 
RCL or β-sheet A strands 3 and 5. The reduced recognition of polymers compared to 
monomer was also in keeping with all the currently proposed polymerisation models, 
which agree that RCL insertion (regardless of being inter- or intra-molecular) is 
integral to the polymerisation mechanism32,78,86.  
Epitope mapping with the CPM fluorescent probe identified residues 360 and 283, 
out of the 25 AAT cysteine-mutants tested, to be part of the 1D9 epitope. These 
residues, in the RCL and s2C respectively, displayed a reduced conjugation 
efficiency to the probe in the presence of 1D9, indicating 1D9 was precluding 
labelling of these residues. This suggested that 1D9 was binding at the top end of 
AAT, in the vicinity of the so-called RCL ‘distal hinge’ region in a location distinct from 
the epitopes of other characterised AAT antibodies. 
The crystal structure of the rAAT-1D9 Fab complex unambiguously defined the 
interaction between the molecules. It confirmed the epitope mapping findings and 
determined that the epitope is discontinuous (also referred to as conformational). 
1D9 binds to the top end of the AAT molecule and interacts with residues on the C-
terminal end of the RCL, s1C, s2C, s1B and s2B. This region of the molecule is 
suggested to be mobile, as it moves during the transition to the latent conformation 
and polymerisation23,73. Residues 283 and 360 identified from the CPM assay were 
involved in van der Waals interactions and neighbouring residues formed hydrogen 
bonds with 1D9. From the crystal structure, no other residues tested in the assay 
would be predicted to reduce conjugation efficiency, indicating the robustness of the 
epitope mapping technique. Interestingly, residue 346 at the N-terminal end of the 
RCL became slightly more exposed to CPM fluorophore with 1D9 binding. An overlay 
of native monomer (PDB ID:1QLP8) and the complex structure offers a possible 
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explanation of this observation; 346 in the complex appears more solvent-exposed, 
away from the body of the AAT structure (Figure 4.13). These two observations 
combined suggest that in solution, 1D9 binding may have a subtle effect on RCL 
conformation. 
The structure of the 1D9 Fab and AAT complex is the first deposited crystal structure 
of AAT bound to an antibody. In fact, the 1D9 Fab alone is also the first structure of 
an antibody fragment specific for AAT. Both structures were equally important for 
model building and the structural analysis of the binding interaction between 1D9 and 
AAT. The high resolution of the Fab alone, together with sequencing results, meant 
that regions of sequence ambiguity in the antibody variable regions could be 
determined. Furthermore, as the complex was relatively low-resolution for X-ray 
crystallography, the Fab served as a reliable template in the complex structure. 
There are a large number of Fab structures in the PDB, such as the 1MF2 structure 
used during the structural determination of 1D9, which display the well-described β-
sandwich immunoglobulin fold seen in the 1D9 structure218. 
The complex data were a little problematic in that there were large gaps in the 
electron density. This was particularly true for more peripheral regions of the AAT 
structure. It is unknown why there were such gaps given the good statistics of the 
data. It is possible that the high packing density of the crystal environment caused 
common crystal defects to lead to structural perturbations in different AAT molecules 
and this would explain the contrasting 50% difference in average B-factors between 
the two complexes. The crystal environment has been demonstrated to influence the 
structure of many other proteins239. Nevertheless, the complex structure was good 
enough to reveal the 1D9 epitope and the structural changes that occur on binding in 
both AAT and 1D9. 
Being the most variable region in sequence, the complementarity-determining 
regions (CDRs) of antibodies form the antigen binding site. All but the L2 CDR of 
1D9 formed contacts with the AAT molecule. Therefore, it is not surprising that the 
CDRs were the areas of largest conformational change (according to RMSD) and 
showed the greatest reduction in B-factor between the 1D9 free and bound states. 
The H3 CDR is often noted as being most important for antigen interactions and in 
this case, it made the most number of interactions with AAT, along with H2168. A 
change in the relative orientation between the variable and constant domains was 
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apparent between the complex structures in the asymmetric unit. Aside from that, 
other structural changes that have been observed in other antigen-antibody 
interactions, such as in the first loop of the CH1 domain, were not apparent168. 
Therefore, antigen binding does not appear to be associated with conformational 
changes in 1D9 far away from the antigen binding site168.  
The AAT structure also showed some conformational changes when comparing 
native and 1D9-bound structures. Predictably, the RCL that interacts with 1D9 was in 
an altered conformation between the two states. However, there were also structural 
changes in helix F and helix D which are at sites distant from the epitope. 
Conformational changes at sites involved in and distinct from the binding interface 
have also been observed in antigens upon complex formation229,235. It may be that 
these movements are the result of 1D9 binding or are simply in varied conformational 
states. There is an allosteric connection between the ‘breach region’ at the top of β-
sheet A and helix D in heparin-binding serpins such as antithrombin and the 
hormone-binding protein corticosteroid binding globulin3,234,240. These helices are also 
in variant positions in crystal structures of serpins and structural plasticity of helix F 
has been observed in molecular dynamics simulations and biochemical 
studies28,231,232.  
The apparent contradictory results from the western blot and peptide-blocking ELISA, 
regarding the nature of the 1D9 epitope can also be explained from the complex 
crystal structure. Most of the AAT residues involved in interactions with 1D9 are in 
the RCL and s1C, residues which are continuous in sequence. Loss of some of the 
peripheral interactions in s2c, s1B and s2B in a denatured state may have an impact 
on affinity but provided a sufficiently high concentration is present in an assay, this 
difference may not be observed. The importance of the RCL/s1C interaction and their 
encapsulation in the 1D9 epitope is highlighted by the lack of recognition of cleaved 
AAT by 1D9 in the denaturing western blot: in the denatured state, the residues after 
the GluC cleavage site (354), are lost from the main body of AAT and hence cleaved 
AAT is not detected. The failure to prevent recognition of monomeric AAT by 1D9 
that had been pre-incubated with a peptide corresponding to the C-terminus (359-
394) at significantly higher molar ratios, probably reflects an increased avidity from 
the additional interactions outside of strand 1C. This indicates that these interactions 
observed in the crystal structure are also an important component of the binding 
interaction. The strong affinity that the 1D9 mAb has for AAT (2-12nM as measured 
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by SPR) is likely to out-compete weaker binding to a peptide that only partly 
constitutes the epitope. The affinity for 1D9 mAb and the peptides could be tested by 
SPR to assess the contribution of this linear part of the epitope, with the peptides 
conjugated to the chip and the antibody as the analyte. 
Similarly, the affinity of 1D9 mAb for cleaved AAT could be measured by SPR. The 
anticipated higher binding constant can be structurally reasoned from knowledge of 
the 1D9 epitope. The protease GluC cleaves in a non-canonical position, 4 residues 
N-terminal to the site targeted by neutrophil elastase. Therefore, despite all of the 
residues identified as components of the epitope remaining in place, it is striking that 
1D9 has a lower affinity for this form. One key difference is that the RCL is no longer 
constrained in the so-called ‘canonical’ conformation8. This in turn would suggest that 
the increased flexibility and lability of the RCL/s1C region disfavours binding, 
possibly by increasing the entropic cost of conformational selection 241.  
The head-to-tail nature of polymers is likely to obstruct 1D9 binding to subunits, 
reducing the affinity of 1D9 to polymers. The major component of the 1D9 epitope - 
the distal hinge of the RCL - in the three polymerisation models is predicted to be 
perturbed relative to the native monomer but the known flexibility of the inter-subunit 
linkage may not prevent binding. For the C-terminal model, the epitope is similar to 
that for cleaved AAT except the epitope is comprised from residues in adjacent 
subunits (e.g. 360 from subunit n and 283 from subunit n+1). If this model was 
representative of in vivo polymers, the reduced affinity for polymers compared to 
cleaved AAT could potentially be reasoned by obstruction of 1D9 binding by 
neighbouring subunits (Figure 4.29). For both the loop-β sheet A and β-hairpin 
models, the epitope is formed from residues in one subunit. However, the epitope 
would be predicted to be significantly disrupted in the loop-β sheet A model of 
polymerisation due to the insertion of RCL residues into the neighbouring subunit. In 
the β-hairpin model, the extrusion of s5a into the neighbouring subunit would clash in 
the position that 1D9 Fab binds. Both these alternatives, would predict a lower affinity 
of 1D9 for polymers compared to monomers.  
The 2C1 antibody has been able to shed some light onto aspects of the 
polymerisation mechanism69,76,191 and it was considered whether the specificity of 
1D9 could also provide such information. The epitope indicates that the most likely 
point of interaction with a polymer would be at the donor end. If the loop-β sheet A 
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mechanism is representative of the polymers considered, then each polymer would 
present a single native-like RCL which should be recognised well by the antibody, 
and in the β-hairpin model a similar region would be available as part of a more 
extensive extruded pair of β-strands. In contrast, the C-terminal model presents an 
unbound region, reminiscent of the peptide that failed to block antigen recognition, 
and would likely be recognised similarly poorly.  
 
Figure 4.29. Superposition of the 1D9-AAT complex structure with models of the three 
proposed polymerisation mechanisms. The crystal structure of the 1D9-AAT complex 
(grey) was superposed onto one AAT subunit (green and blue) for each polymerisation 
model. The residues 360 and 283 in the epitope region are highlighted in red.  
4.4.2.2  The RCL and s1C are important for polymerisation and inhibitory 
activity of AAT 
1D9 is the second mAb that has been found to exhibit polymerisation blocking 
activity in vitro. Thermal shift experiments showed that the binding of 1D9 to AAT 
stabilised the native state from progressing to the intermediate during heat-induced 
polymerisation. Considering the 1D9 epitope, this activity is not surprising. Insertion 
of the RCL into β-sheet A is a common feature between the polymerisation models. 
Release of s1C in polymerisation has also been documented and accordingly heat-
induced polymerisation did not occur when s1C was disulphide-bonded to s2C73,74. 
Therefore, 1D9 binding is likely to stabilise these monomer-specific structural 
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elements, stop conformational changes and prevent RCL insertion. This mechanism 
of action is in contrast to a mAb against transthyretin, which inhibits fibril formation by 
binding to the misfolded intermediate, rather than stabilising the native state242. 
Experiments with 1D9 were conducted for polymerisation induced by heating; it 
would be interesting to investigate whether 1D9 also blocked polymerisation induced 
by acid or denaturant. This would indicate whether the RCL and s1C are also 
important features of these polymerisation mechanisms. Likewise, 1D9 activity has 
not been tested on polymerisation of different disease variants of AAT.  However, as 
mutations are believed to have similar structural effects, it is likely the action of 1D9 
is translatable65,82.  
The mode of action of 1D9 is quite different to that of the polymer-blocking mAb 
4B12. 4B12 lacks conformational selectivity and binds to helices A and I on the 
opposite side of the AAT molecule to 1D9, an area which is relatively invariant 
between AAT conformations116,117. This area was not previously associated with 
conformational modulation but 4B12 binding is believed to prematurely open β-sheet 
A, antagonising polymerisation as a result. Therefore, antibodies binding at very 
different sites on AAT can cause the same outcome, highlighting the interrelationship 
between structural elements of the AAT fold. When 1D9 and 4B12 were directly 
compared using an ELISA to monitor polymerisation of the Z variant under milder 
conditions than considered in the FRET experiments, 1D9 was shown to be the more 
efficient polymerisation blocking mAb of the two (personal communication, Dr E. 
Miranda and J. Perez). The centrality of the RCL to the polymerisation mechanism 
offers an explanation of this. An engineered single-chain variant of 1D9 co-
transfected with Z-AAT in a cellular model could provide information on the 
conformational state of the RCL prior to polymerisation, similar to that carried out 
with 4B12116,117.  
RCL insertion into β-sheet A is key to AAT’s physiological function of inhibiting 
proteases. Therefore, it was of no surprise when 1D9 binding efficiently stopped 
AAT’s ability to inhibit chymotrypsin activity. The stoichiometry of inhibition (SI) for 
chymotrypsin was reduced to 23 in the presence of 1D9. This is the first time that a 
mAb has nearly eliminated the inhibitory activity of AAT. Despite 4B12 and 1D9 both 
being able to block polymerisation, 4B12-bound AAT nearly completely retained 
inhibitory activity against neutrophil elastase and trypsin116,117. MAbs against other 
serpins have however been developed that target serpin anti-proteolytic activity186,238. 
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These antibodies have employed three different mechanisms: sterically blocking 
protease binding to the RCL, converting the serpin into an inactive conformation and 
inducing serpin substrate-like behaviour186,238,243. Based on the 1D9 epitope and 
superposition of the proteases with the 1D9-AAT complex (Figure 4.30), 1D9 is 
proposed to act through a mechanism of steric interference. This could be tested by 
determining association rate constants between AAT and protease in the presence of 
different amounts of 1D9. Antibodies against PAI-1 have bound in a similar location, 
with epitopes comprising the distal hinge of the RCL188. Similarly to 1D9, they react 
preferentially with the native rather than cleaved conformation and are proposed to 
interfere with formation of the protease-serpin complex188,243. An antibody against 
PAI-1 has also bound the N-terminal end of the RCL, in a region removed from the 
protease cleavage site and therefore distinct from that of 1D9244.  
A more unexpected result was the drastic difference of the anti-proteolytic activity of 
1D9-bound AAT against neutrophil elastase compared to chymotrypsin. The SI 
compared to unbound AAT was still reduced but only to 1.8. It is worth noting that 
antibody binding is a reversible, equilibrium process, whereas the serpin mechanism 
of inhibition is an irreversible process. By definition, given sufficient time, the latter 
will always win over the former. The superposition of neutrophil elastase on trypsin 
from the trypsin-AAT complex structure (PDB ID: 1OPH22) with the 1D9-AAT complex 
structure appears to show a similar level of steric clash between 1D9 Fab and 
chymotrypsin (Figure 4.30). However, multiple studies have highlighted the sensitivity 
of the inhibitory mechanism and SI to single point mutations, changes in RCL length 
and protease identity207-209,245. For example, mutations in s1C have been documented 
to have opposite effects on the inhibitory activity of AAT: mutation of P10’ did not 
alter activity towards thrombin but mutations at P6’-P8’ caused the serpin to become 
a substrate rather than inhibitor246. Decreased inhibitory activity is reflected by a 
natural variant of antithrombin causing the deficiency associated with thrombosis247. 
Similarly, the importance of the length of the RCL and consequently, the rate of RCL 
insertion has also been demonstrated207,208. Lastly, variations in the SI have been 
observed when different proteases are inhibited by the same serpin207,208,245. This is 
thought to be due to the differential rates of deacylation associated with protease 
activity, which affects the balance between substrate and inhibitory behaviour of 
serpins209. Therefore, subtle changes in the interaction between AAT and 




It is worth noting that the effect of 1D9 on the inhibitory activity of AAT against trypsin 
has not been tested yet and that the inhibitory activity of 4B12-bound AAT cannot be 
tested against chymotrypsin. Preliminary experiments showed that 4B12 itself 
reproducibly inhibited chymotrypsin (personal communication, Dr J. Irving). 
Therefore, it is unknown whether 4B12 does not affect AAT inhibitory activity against 
all proteases. 
 
Figure 4.30. Steric clashes between the 1D9-AAT complex and protease. The 1D9-AAT 
crystal structure (purple and light blue respectively) is superposed with the trypsin-AAT 
structure (PDB ID: 1OPH22, orange and dark blue respectively). Chymotrypsin (green, PDB 
ID: 1CA0248) and neutrophil elastase (red, PDB ID: 3Q76249) were superposed on the trypsin 
structure using Chimera.  
4.4.2.3  1D9 provides the first evidence that liver and heat-induced 
polymers are distinct 
A further interesting characteristic regarding the reactivity of 1D9 with different AAT 
species was the lack of recognition of heat-induced polymers in comparison to the 
other AAT polymers tested. Particularly noteworthy, is the large difference between 
the IC50s of the plasma ZZ-AAT and liver ZZ-AAT polymers (151 and 168 ng/ml 
respectively) to the M heat polymers (> 400 ng/ml). Based on 2C1 reactivity, these 
polymer types have always been regarded as being similar in structure76. From the 
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2C1 epitope mapping, it is known a region of structural similarity is helices E and 
F191. Yet, 1D9 provides the first evidence that a different region of the polymer is 
structurally variant between the two forms. The 1D9 epitope mapping localises this 
difference to the RCL/s1C area of AAT which has implications for the polymerisation 
mechanism between heat-induced and ex vivo polymers. It has been proposed that 
the heat-induced polymer adopts the C-terminal configuration, although this study is 
complicated by use of a stabilising disulphide and the use of denaturant86. This form 
would not be expected to have an intact full 1D9 epitope at the terminus, while the 
loop-β sheet A model, and to some extent the β-hairpin model, would. However, an 
inter-subunit interaction would be more likely to occur with the C-terminal and β-
hairpin models due to their increased flexibility. 
In an attempt to use the 1D9 Fab to visualise the origins of the structural difference, 
liver ZZ-AAT polymers with and without prior 1D9 incubation were subjected to NS-
EM. Unlike labelling of polymers with the 4B12 Fab (Chapter 5 and 6), no uniform 
labelling of polymers (identified by protrusions from the AAT chain) was observed 
with 1D9 Fab. The micrographs with and without 1D9 labelling could not be 
distinguished, indicating a low level or lack of labelling, and so the equivalent 
experiment for heat polymers was not carried out. The low labelling could be for 
several reasons. The 1D9 Fab may have a low affinity for polymers (the affinity 
constant for polymers was not measured by SPR) and at the dilutions used for NS-
EM dissociated. A potential solution could be to crosslink the Fab to polymers, yet 
concentrations of crosslinker must be optimised to limit crosslinking of polymer 
chains and extensive aggregation. An alternative is that there may indeed be 
labelling, yet the size of the Fab and lack of repetitive labelling on each subunit may 
be too difficult to identify by NS-EM. Indeed, there are occasional protrusions that 
resemble Fab binding (Figure 4.28). This could be tested using a gold-labelled 1D9 
Fab to provide an easily-identifiable intense spot of electron density, similar to what 
was done to verify polymer identity in early EM studies41,81. Lastly, the pH sensitivity 
of the 1D9 Fab-AAT interaction has not been investigated and the acidic pH (4.5) of 
uranyl acetate may dissociate the complex. A neutral negative stain such as 
phosphotungstic acid could be tried.  
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4.4.3 Implications of 1D9 characteristics 
A therapeutic that can prevent polymerisation of AAT is desired for the treatment of 
AATD. Although 1D9 shows the desired activity, much like 4B12, its use as a 
therapeutic is limited due to the inaccessibility of antibodies to the ER of hepatocytes. 
The most promising and useful characteristic of 1D9 is through its monomer-
selective reactivity. Currently, there is not a method to directly measure a patient’s 
level of active AAT in the clinic. Instead, the total AAT concentration, irrespective of 
conformer, is calculated by nephelometry using a polyclonal antibody. Based on 
correspondence with the product support team of a major clinical assay provider, it 
appears that the influence of the presence of polymers on the value obtained has not 
been considered or established (J. Irving, personal communication). Therefore, 1D9 
could have application as a diagnostic reagent. To test its suitability, plasma ZZ-AAT 
samples will be quantified for different AAT conformers using ELISA with 1D9, 2C1 
and 3C11 as detection antibodies. 
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5.0 Negative stain EM (NS-EM) of heat polymers 
5.1 Introduction 
5.1.1 Electron microscopy of serpins 
The structure of the AAT monomer and other serpins in varying conformations have 
been solved to high resolution by X-ray crystallography8,49,82, including as circular 
polymers and in dimeric configurations that appear to be the result of contacts 
formed within the crystal lattice5,78,84-86. These latter structures have been generated 
using recombinant material, polymerised under artificial conditions, and lacking 
complex glycosylation states. Linear AAT polymers, particularly those obtained from 
human tissue, have characteristics that make them unsuitable for X-ray 
crystallography or NMR: large size, flexibility, glycosylation and heterogeneity in 
length. Electron microscopy (EM) and modern single-particle reconstruction 
approaches provide a means by which structural information can be obtained from 
such heterogeneous samples.  
NS-EM has previously been used to visualise polymers of AAT, anti-chymotrypsin 
and neuroserpin, which show a beads-on-a-string appearance32,41,81,94. Polymers 
have also been immunolabelled with colloidal gold-conjugated antibodies confirming 
their identity41,81. There are no published 3D reconstructions of polymers from EM 
data but prior work in the lab has yielded 3D reconstructions of a dimeric repeating 
subunit in polymers purified from patient tissue by NS-EM. These were of low 
resolution (~30Å) and cryo-EM of this material has the potential to obtain higher 
resolution envelopes (Chapter 6). High molecular weight, symmetrical and rigid 
molecules generate the highest contrast in EM images and facilitate alignment of 
particles. However, the small size of the AAT subunit, combined with flexibility in the 
polymer and lack of symmetry or strong features produces low signal-to-noise 
images, and presents significant challenges to image processing. 
5.1.2 Previous negative stain-electron microscopy (NS-EM) image analysis of 
the ex vivo polymer  
In a prior study, polymers were purified from the liver of a Z-AAT homozygote and 
decorated with the Fab domain of the 4B12 mAb250. This antibody was selected due 
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to its lack of conformational preference (which might introduce bias as to the 
components of the sample that are bound), and biochemical data indicating the site 
of the epitope116,117. The antibody fragments increased the size of the subunits, 
aiding particle picking and also helping to determine the orientation of particles 
during 3D reconstruction. NS-EM using 2% w/v uranyl acetate showed polymers 
were mainly linear, with a few being circular, in agreement with early EM studies.  
This NS-EM dataset was processed using the IMAGIC image processing software121. 
A total of 8120 dimer particles were manually selected from longer polymers for 
single particle analysis and aligned to one monomer. The dimer is the smallest 
polymer subunit and so reduces – but does not eliminate – the impact of the flexibility 
of the inter-subunit linkage with respect to longer polymers. Eigenimage analysis 
indicated that the images were better divided into two subsets, a ‘compact’ and an 
‘elongated’ dimer of 54% and 46% frequency, respectively. Using a starting model 
based on duplication of the cleaved crystal structure of AAT (used as a surrogate for 
a hyperstable, 6-stranded β-sheet A subunit conformation) and information on the 
epitope of 4B12, initial models were generated to seed 3D reconstructions for each 
subset. After multiple rounds of refinement, the resulting envelopes were strongly 
resolution-limited to around 30Å, though still permitted an assessment of the 
compatibility of different models of polymerisation due to the asymmetry introduced 
by the bound Fab molecules. The calculated distance between the centres of mass 
of the subunits for the compact subset was 68Å with a rotation of 16° between them. 
For the elongated subset, this was 73Å and 11°, respectively (Figure 5.1). It is not 
known whether these distinct forms are interspersed within polymer chains or 
between chains. Furthermore, the significance of these two populations in vivo is 
unclear; it is possible they represent two extremes of a continuum of conformations, 




Figure 5.1. 3D reconstructions of the AAT dimer isolated from ex vivo material and 
labelled with 4B12 Fab. Two subsets were identified, termed elongated (left) and compact 
(right) and a model of cleaved AAT in complex with 4B12 Fab was fitted into each. Axes were 
drawn through the middle of the complexes and used to determine the distances between 
subunit centres. Work carried out by Dr S. Faull, Dr J. Irving and Prof E. Orlova and figure 
reproduced with permission250. 
The three major proposed polymer models were fitted into the envelopes determined 
from the NS-EM using the PHENIX software package221. As the envelopes are low-
resolution, the fitting could only be informative in identifying models that are 
inconsistent with the data. This analysis showed that the loop-β sheet A model was 
poorly accommodated within the densities of both subsets, the β-hairpin could be 
modelled into the compact dimer density but not easily in the elongated density and 
the C-terminal model could be modelled into both subsets. Therefore, the C-terminal 
model was the most favoured out of the three by the NS-EM data. This work 
represented the first time that 3D reconstructions of ex vivo AAT polymers from EM 
data had been performed.  
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5.1.3  Assessing the relevance of in vitro artificial polymers to those found in 
vivo 
Most research into the mechanism of AAT polymerisation has used artificial means 
to generate polymers. This is achieved by heating or incubating monomeric AAT with 
acid or denaturant47,66,68,69. It is believed that different polymeric forms are generated 
by the different methods and this is what underlies the proposal of three different 
inter-subunit linkages in the major polymerisation models32,50,69,78,86. There have been 
disagreements in the literature about which method of artificial polymerisation 
represents that which occurs in vivo. However, the common recognition of heat-
induced polymers and ex vivo polymers by the mAb 2C1 favours heating as a 
suitable artificial method of polymer formation69,70,76. Polymers formed by Gu-HCl or 
acid incubation are not recognised by 2C1 and therefore the β-hairpin model, based 
on the crystal structure of an antithrombin dimer formed at low pH, is believed to be 
unrepresentative of in vivo polymerisation69. Understanding whether heat-induced 
polymers are formed by the same linkage as ex vivo polymers would greatly aid 
laboratory research.  
The aim of this chapter was to obtain NS-EM 3D reconstructions of heat-induced 
AAT polymer and structurally compare the two types of polymers.  Image processing 





5.2  Methods 
Sample preparation, NS-EM grid preparation and NS-EM imaging are covered in 
method 3.5.4.  
5.2.1  NS-EM data collection of the heat-induced polymers 
The heat polymer/4B12 Fab dataset was collected on a Tecnai 200 kV FEG with a 
Direct Electron (DE-20) direct detector. A dataset of 169 micrographs was recorded 
at 29,000X nominal magnification with a defocus range of 0.2-1µm. The pixel size for 
images was 1.54Å and movies with 18 subframes (1.8s total exposure) were 
collected and aligned using EMAN2251 and IMOD252.  
5.2.2 Image processing of the heat-induced polymer using IMAGIC  
5.2.2.1  CTF correction and particle picking 
The images resulting from the movie subframe alignment were corrected for the 
contrast transfer function (CTF) using CTFFIND3253. CTF correction and astigmatism 
was manually checked using the Fourier transform of images. No micrographs were 
discarded. CTF-corrected images were visualised in EMAN1 Boxer and a 5x5 
median filter applied to aid selection of polymer particles254. Helix mode – a semi-
automated process in which the start and end of linear sections of polymers were 
manually selected – was used, where particles were picked into a 200x200 pixel box, 
and neighbouring boxes had a 140-pixel overlap. Box coordinates were saved for 
each micrograph and applied to the unfiltered CTF-corrected images to create the 
dataset of a total of 17,994 boxed particles (AAT/Fab tetramers) for single particle 
analysis processing in IMAGIC.  
5.2.2.2  Alignment of particles 
Particle images were normalised to 1σ using a circular variance mask and band-pass 
filtered to remove high-frequency background. They were rotationally and 
translationally aligned to a 55x200 pixel low-pass filtered vertical rectangle. They 
were then classified and averaged by multivariate statistical analysis (MSA). The 10 
“best” class averages that represented different views of the tetramer particles and 
had well delineated polymer subunits were used as references in multi-reference 
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alignment. The images after the second alignment were re-subjected to MSA. 
Eigenimages were used to reveal the major variations in the dataset. Images were 
classified according to selected eigenimages with visually interpretable features, for 
example those that showed vertical misalignment or horizontal misalignment. The 
subsequent alignment and classification round then focused on the corresponding 
translation and was against class average references or the total sum. Improvements 
in the alignment were apparent in the increasing definition of subunits in the total 
sum of individual classes. Permitted translations were decreased gradually at each 
iteration from 40 pixels to 5 pixels. At this stage, there were four subunits per image.   
After six rounds of alignment the aligned tetramer images were trimmed to focus on 
the central dimer. The total sum of all particles guided the boundaries that were 
selected to yield the dimer: the tetramer box length was cut off at 45 pixels to 145 
pixels. The dimer was then centred in a 200x200 pixel box and a soft-edged 100x180 
pixel rectangular mask applied to focus alignment on the dimer. The alignment of the 
dimer was improved in a similar manner to the tetramer, using MSA and 
classification based on selected eigenimages that reflected the dominant basis for 
the variability in the subset. “Dimer” particles that only had one AAT/Fab subunit in 
the particle box, or that were poorly defined, were removed after sorting by MSA, 
resulting in 12,823 particles. 
5.2.2.3  Division of the dimer particles into “small-angle” and “big-angle” 
subsets 
The remaining 12,823 dimer particles were classified into class averages with 25 
particles per class, based on 6 active eigenimages. They showed that there were 
differences between the images in respect to the angle between the subunits. The 
class averages were divided into two subsets, the small-angle and the big-angle 
subsets, by visual inspection of the position of the Fab fragments. The class 
averages were low-pass filtered to aid selection. Those that could not be categorised 
initially in this way were selected for re-classification. The raw particles comprising all 
the selected classes were extracted resulting in 6,036 particles in the small-angle 
subset and 2,643 in the big-angle subset. 
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5.2.2.4  Projection matching for the small-angle subset  
The elongated 11° dimer model generated from the prior ex vivo NS-EM dataset250 
was low-pass filtered to 30Å in IMAGIC and used as a starting model for projection 
matching to the small-angle subset images. This involved projection at 10° 
increments around the " axis between 0-360° and between 70-110° around β to 
produce 180 2D references that were normalised to 1σ. The α angle was kept at 0° 
(the α, β and " angles referred to are according to the IMAGIC Euler angle 
convention). The small-angle subset class averages (25 images per class) 
underwent projection matching to these references based on cross-correlation 
scores and thereby assigned Euler angles. The assigned projections were used to 
reconstruct an initial 3D model, and a subsequent 3D model was created based on 
the top 50% of class averages according to a 3D-error score. The model was 
masked in IMAGIC, converted to the “.mrc” map format and assessed in Chimera. 
This model was then low-pass filtered, reprojected and matched in an iterative 
process. During this process, the number of images per class average was reduced 
to 10 and the reprojections were sampled at finer 5° intervals. After the angle 
between subunits stopped changing significantly, the process was stopped. 
5.2.2.5  Analysis of the final 3D reconstruction for the small-angle subset   
The final model was visualised in Chimera9. A threshold was applied to the volume at 
a value of 360Å3: corresponding to 200 kDa (expected molecular weight of the AAT 
dimer bound to Fab), multiplied by 50% (a ‘fudge-factor’ taking account for negative 
stain and glycans) multiplied by 1.2 (an approximate value of Å3/Da for globular 
proteins255). The atomic coordinates of a model of cleaved AAT bound with 4B12 Fab 
was fitted into each subunit in the dimer in head-to-tail orientation. The atomic 
models were also positioned in the opposite direction and the best fit was selected 
based on the cross-correlation score. An axis through the central mass of each 
AAT/Fab complex was used measure the distance and rotation between subunits. 
The resolution was assessed in IMAGIC by randomly dividing the dataset into two 
groups, generating 3D reconstructions and comparing them by Fourier Shell 
Correlation. GraphPad prism was used to plot the FSC curve and fit a sigmoidal 
function. This was used to calculate the resolution at threshold values of 0.5 and 
0.143, both of which are in common use122,157.  
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5.2.2.6  Attempts at projection matching for the big-angle subset   
Initial models for projection matching were created in Chimera9. Density for a single 
AAT/Fab subunit was created by excising, superimposing and averaging the 
individual subunits of the prior 11° ex vivo dimer. The average subunit was 
duplicated and translated 70Å based on the inter-subunit distance from 
measurements of the class averages. One subunit was rotated 90°-160° in 10° 
increments relative to the other, to generate 8 initial models at different orientations. 
These were then reprojected at 10° increments around the " axis between 0-360° 
and between 80-100° around β to produce 108 2D references. The reprojections 
were used as references for competitive projection matching to the big-angle subset 
class averages. The number of matches to each set of references was computed 
and was greatest for models between 140-160° rotation. Projection matching to 
these models was undertaken and the resultant 3D reconstructions assessed in 
Chimera. No attempts yielded a model with two defined subunits, however.  
5.2.3 Image processing of the heat-induced polymer using Relion 
5.2.3.1  Particle picking and 2D classification 
The motion-corrected and CTF-corrected micrographs used in the IMAGIC 
processing were imported into Relion v2.1122. An early 50Å low-pass filtered 3D 
reconstruction from the Relion ex vivo polymer data processing (detailed in 5.2.4.1) 
was used to generate 30 projections as references for autopicking. The parameters 
used for autopicking were a picking threshold of 0.05, minimum inter-particle 
distance of 60Å and maximum standard deviation noise of 1.5. Particles were 
extracted into a 150-pixel box, masked by a 190Å circle and the subset pruned over 
several rounds of 2D classification into 100 classes with manual subset selection. 
This left 25,323 particles.  
5.2.3.2  3D classification 
The particles were used as input into a 3D classification job using the Relion ex vivo 
polymer 60° model (detailed below) which had been filtered to 30Å as a reference. 
Five reconstructions were generated. The best reconstruction was subjected to a 
threshold at a volume corresponding to 1.5x molecular weight and 1.2Å3/Da, filtered 
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using Chimera and used as a reference in another round of 3D classification against 
all 25,323 particles. Particles from the best reconstruction were selected (6,923 
particles).  
5.2.3.3  3D refinement and structural assessment 
The 6,923 particles were refined against a 30Å low-pass filtered monomeric subunit 
reference (AAT/Fab) to generate the final reconstruction of the dimer. This was 
generated by erasing one of the subunits of the Relion ex vivo polymer 60° model in 
Chimera9. Model measurements was made as described in method 5.2.2.5. A mask 
was created in Relion based on the refined structure, to which a threshold and a 
Gaussian filter had been applied (with a standard deviation of 10Å) and a 20-pixel 
soft boundary added in Relion. This mask was used in the Relion post-process 
function for the estimation of the resolution using the FSC.  
The 6,923 particles were subjected to 2D classification into 50 classes. A 3D ab initio 
reconstruction, based on the top 99% of the 6,923 particles when ordered by 
posterior probability computed during the 3D refine job, also generated a similar 
reconstruction to the final model. Further sub-classification of the 6,923 particles by 
3D classification into 2 and 4 classes yielded structures with similar characteristics to 
the final model. 
5.2.3.4  Further Relion jobs to identify other reconstructions 
The 25,232 particles were used as input for a 3D classification job against the Relion 
ex vivo 88° model or the IMAGIC heat 16° model as a reference. Out of the 5 
classes, images were selected that comprised the best-defined reconstructions. 
These images were used an input for a ‘gold-standard’ 3D refinement using the 
monomer subunit as a reference but no reasonable dimer reconstructions resulted. 
The 6,036 particles that had been selected during the IMAGIC processing also did 
not provide a consistent reconstruction when refined against a monomer reference.  
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5.2.4 Image re-processing of the ex vivo polymer using Relion 
5.2.4.1  Particle picking and 2D classification 
The motion-corrected and CTF-corrected micrographs that had been collected 
previously and used for processing in IMAGIC250 were imported into Relion v2.1. The 
11° ex vivo IMAGIC dimer was filtered to 50Å and reprojected at angles distributed 
around the Euler sphere using the Relion command line. Twelve references were 
generated for autopicking from the micrographs using a 0.025 picking threshold, 60Å 
minimum inter-particle distance and no maximum standard deviation of noise (-1). 
Only 3,512 particles were obtained and extracted into a 150-pixel box. They were 
masked with a 180Å circular mask and classified in 2D into 25 classes. Classes were 
selected with dimer particles, yielding 1,962 particles. These were used as input for a 
3D classification job into 3 classes using the same 11° ex vivo IMAGIC dimer as a 
reference. One output poorly-defined model was low-pass filtered to 50Å. Particle 
picking and particle extraction was then carried out as in method 5.2.3.1. A total of 
176,957 particles were extracted and pruned using several rounds of 2D 
classification into 100 classes with manual subset selection. A set of 68,528 particles 
and a more-refined set of 15,911 particles resulted.  
5.2.4.2  3D classification 
The more-refined set of particles (15,911) were used as input into a 3D classification 
job using the poorly-defined autopicking model as a reference. Four reconstructions 
were generated. The best reconstruction was thresholded at volume corresponding 
to 1.5x molecular weight (in this case molecular weight was judged to be 150kDa as 
one subunit had Fab density missing) in Chimera. It was then filtered to 40Åand 
used as a reference in the next round of 3D classification of the 68,523 particles to 
generate eight reconstructions. Classes were judged on visual appearance of the 
reconstructions, their constituent particles selected, and the process repeated. The 
particles were then classified twice in 3D against a single subunit reference – made 
by erasing the second subunit from one of the reconstructions in Chimera – to 
generate four reconstructions. 
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5.2.4.3  3D refinement and structural assessment 
The 6,848 particles and 9,239 particles that corresponded to the well-defined models 
resulting from the 3D classification job were selected. They were refined and 
structurally assessed by ab initio reconstruction as in method 5.2.3.3 with the 
exception that no removal of particles based on the posterior probability score was 
undertaken.  
5.2.4.4  Further Relion jobs to identify other reconstructions 
The remaining unclassified particles (14,892) were used as input for a 3D 
classification job against the monomer or the IMAGIC ex vivo 11° model as a 
reference. No reasonable reconstructions were generated after image selection and 
refinement. The 8,120 particles that made up the IMAGIC ex vivo dimers also did not 
return a comparable dimer model when refined against a monomer reference.  
5.2.5 Generation of an initial AAT/4B12 Fab complex  
During assessment of the NS-EM reconstructions, a molecular model of the complex 
between AAT and the 4B12 Fab was used. This was based on the crystal structure 
of the cleaved monomeric AAT, after removal of the protease coordinates from PDB 
entry 1EZX13. Polymers isolated from liver have high-mannose glycans and those 
made from purified plasma protein contain mature glycosylation. Thus, glycan chains 
were added using the GlyProt server to residues 46, 83 and 247256. This AAT 
structure was chosen as the polymer models with the greatest supporting evidence 
all propose that the RCL is in the inserted conformation. The 4B12 Fab model had 
been produced previously using Rosetta Antibody modelling software based on the 
sequence of 4B12 variable regions. Modelling of the interaction between AAT and 
4B12 Fab was carried out using PyRosetta software164, which used the NS-EM 
single-subunit density, calculated as the average of both subunits in the NS-EM 60° 
liver reconstruction, and known interactions between residues in the 4B12 epitope 
(32, 43, 306, 261 and 266) and the paratope as constraints. One thousand atomic 
models were generated with randomly oriented subunits and were assessed by their 
fit into the EM density (expressed in Rosetta as a score roughly equivalent to the 
cross-correlation). The 20 best fitting models were analysed and the top models with 
AAT in opposite directions were chosen. 
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5.2.6 Fitting of the polymerisation models into the NS-EM dimer 
reconstructions 
The three AAT polymerisation models had been generated for the previous NS-EM 
study250. Briefly, the C-terminal polymer model was prepared by rearranging the 
breaks between polypeptide chains in PDB entry 1D5S80, which corresponds with a 
cleavage-induced polymer, resulting in a domain swap involving the C-terminal 35 
amino acids. The β-hairpin model was prepared starting with the structure of cleaved 
antitrypsin (1EZX13), and unravelling and reconnecting strands s4A and s5A using 
Coot161, with optimisation of geometry using PHENIX221. The loop-β sheet A model 
was based on the structure of intact AAT incorporating two peptides (of sequence 
FLAA) in the centre of β-sheet A250. Removal of the peptides and incorporation of the 
RCL was undertaken with Coot161 and PyRosetta164. The best subunit models (329 
and 787) were superimposed onto the linear polymerisation models to redefine the 
AAT/Fab interaction using Chimera. PyRosetta was used to randomly generate 500 
starting models that differed in the relative positioning of subunits164. The AAT/Fab 
subunits were treated as rigid bodies and the linkers defined as flexible regions. The 
models were allowed to optimise into the reconstructions that were thresholded to a 
volume of 360Å3 and were given a score based on the fit which was proportional to 
the cross-correlation and reflected the linkage-specific restraints. The fits of the 
models to the densities were evaluated for significance using the Dunn’s non-
parametric multiple comparisons test using GraphPad. To do this, the initial 329 or 
787 subunit structures were superimposed over the two subunits in each top 10 
scoring dimer, generating a starting CC value, using the superpose program in 
CCP4. Phenix real space refine was used to optimise the superimposed subunits into 
the density without the restraints imposed by the different polymer models and 
resulted in a resulting CC. The similarity between each model-restrained dimer and 
the final optimised model-free subunit positions was calculated as a fraction and the 
values averaged for each combination. A significance test was carried out assuming 
a common mechanism between liver polymers by combining the 60° and 88° fits. A 
second test was carried out assuming a common mechanism between liver polymers 




5.3  Results 
5.3.1  Purification of AAT and production of heat polymers  
Native AAT was purified using a two-step purification from plasma that had been 
rejected by the National Blood Service. The first step used the commercial Alpha1-
Antitrypsin Select resin (GE Healthcare) consisting of camelidae-derived single 
domain antibody fragments that are selective for AAT (Figure 5.2A, B). Elution was 
achieved by a high concentration of MgCl2 and a denaturing gel showed large 
amounts of protein at a molecular weight consistent with AAT (52kDa). Fractions 3-9 
were pooled and subjected to a Q-sepharose column to further purify AAT away from 
higher molecular weight contaminants (Figure 5.2C, D, E). A denaturing gel of the 
elution fractions showed pure monomeric AAT protein in earlier fractions with a 
possible covalent dimeric band appearing in later fractions. A non-denaturing gel 
subsequently showed fractions 16-18 to be predominately polymeric. Purified 
monomeric AAT was buffer exchanged into PBS and polymerisation induced by 
heating at 55°C and a concentration of 0.2 mg/ml for 48 hours. These conditions 
were sufficient to achieve near-complete polymerisation of the sample74. A distinct 
laddering pattern was seen on a non-denaturing gel for the heat polymer, whereas 
native polymer purified from plasma using an identical process showed a laddering 
pattern at a lower molecular weight but more of a smear at longer polymers (Figure 
5.2F).  
5.3.2  Imaging of heat polymers by NS-EM 
Polymers of AAT formed by heating are the only in vitro induced polymer that shares 
an epitope with those extracted from hepatocytes, indicating at least a degree of 
structural similarity76. Polymers of Z-AAT isolated from hepatocytes and heat-induced 
polymers have been visualised previously by NS-EM and appear to have a 
qualitatively comparable ultrastructure32. However, a more detailed comparison 
between the two at the level of a 3D reconstruction has never been carried out.  
The heat polymer, undecorated by Fab, was imaged by NS-EM. The heat polymers 
had the characteristic beads-on-a-string appearance (Figure 5.3), with a high degree 
of flexibility. Numerous small circular polymers were observed. Individual subunits 
could be distinguished within the polymer chain and appeared to have some but 
limited visual asymmetry.  
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It was deemed that obtaining a 3D reconstruction of the polymer by EM would be a 
substantial challenge as the AAT subunit is small and relatively featureless making 
the determination of angles of the 2D projections difficult. This is partly why an 
approach had previously been adopted where a molecule with a known binding site – 
the 4B12 Fab – has been added to ex vivo polymer samples prior to visualisation in 
EM experiments.  
 
Figure 5.2. Purification of AAT from plasma. A) A chromatogram showing a purification 




represent plasma proteins that do not bind to the column. Elution with MgCl2 was started once 
a baseline had been reached following sample loading; a sharp peak is seen. B) A 4-12% w/v 
acrylamide reducing SDS-PAGE of elution fractions 3-9 showing a high concentration of 
protein at ~52kDa. C) The chromatogram for the Q-sepharose column. Three absorbance 
peaks can be seen, eluting from the column at approximately 200, 300 and 400mM NaCl 
concentrations. D) A 4-12% w/v acrylamide SDS-PAGE gel of fractions 7-18 showing the AAT 
band, as well a potential dimer band. E) A 3-12% acrylamide non-denaturing gel showing 
fractions 7-13 comprise monomeric protein whereas 16-18 contain polymers. F) A 3-12% 
acrylamide non-denaturing gel showing the characteristic laddering pattern of heat polymer.  
Figure 5.3. A negative stain micrograph of heat-induced AAT polymers. The sample at 
0.06 mg/ml was stained with 2% w/v uranyl acetate stain. The sample was visualised using a 
Tecnai T12 microscope equipped with a CCD camera at a nominal magnification of 67,000X. 
Scale bar, 50nm.  Single polymer chains are shown on the right70.  
5.3.3  Imaging of heat polymers bound with 4B12 Fab 
Previous work undertaken by Dr S. Faull involved single particle analysis and 3D 
reconstructions of ex vivo polymers bound with 4B12 Fab250. In vitro heat polymers 
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are thought to represent a good model of ex vivo polymers due to the presence of a 
common epitope, as recognised by the 2C1 antibody76. However, this does not 
demonstrate structural similarity, it merely does not exclude heat-induced polymers 
as an appropriate model. This is particularly the case as a typical epitope covers only 
a small proportion of the total surface area (up to ~1,000 Å2 or about ~5%)227.  
To allow a direct comparison between low-resolution structures, heat polymers were 
labelled with 4B12 Fab and imaged by NS-EM. The 4B12 Fab molecules are ~50kDa 
in size and were generated from the full-length mAb by ficin digestion and a protein A 
column purification step. Fab fragments do not bind to a protein A column, and thus 
are present in the flow-through whereas the Fc region (also ~50kDa) and undigested 
mAb (~150kDa) are retained (Figure 5.4).  
 
Figure 5.4. Generation of the 4B12 Fab. An SDS-PAGE (non-reducing) gel showing in lane 
1 the monoclonal antibody, in lane 2 the ficin digest, in lane 3 the flow-through from the 
Protein A column (Fab) and in lane 4 the elution from the Protein A column (Fc and 
undigested mAb). 
Binding of the 4B12 Fab to the polymers increased the size and changed the 
appearance of the particles (Figure 5.5). The Fabs could be distinguished from AAT 
on the majority of subunits and added visible protrusions from the polymer chain. 
These identifiable features should help the assignment of angles to the 2D 
projections that is required in the process of generating 3D reconstructions. 
Examples of the Fabs lined up on one side of the polymer, and where they appeared 
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on alternating sides, could be observed, highlighting the flexibility in the polymer 
chain and the linkage. Circular polymers were still observed. As polymers are 
extremely stable – they dissociate in around 6 M guanidine and have a melting 
temperature above 100°C – it is unlikely that the polymer linkage is modified due to 
the binding of the antibody, although its orientation on the grid in the presence of 
stain may be. 
 
Figure 5.5. A negative stain micrograph of heat-induced AAT polymers bound with 
4B12 Fab. Sample at 0.07mg/ml was stained with 2% w/v uranyl acetate and visualised using 
a Tecnai T12 microscope at nominal 67,000X magnification. The micrograph was recorded at 
1µm defocus. Yellow and red arrows highlight where Fab fragments are lined up on the same 
or opposite sides of the polymer, respectively. Scale bar, 50nm. 
5.3.4 Image processing of heat polymers bound with 4B12 by IMAGIC 
IMAGIC is an image processing software that has been in development since the 
1980s121,162. It uses a command-line format to run different programs (such as 2D 
alignment and 3D reconstruction) to efficiently process EM images. Image 
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processing is carried out in real space and it implements multivariate statistical 
analysis (MSA) and eigenvectors to simplify the analysis of image variations within 
large datasets.  IMAGIC requires greater user-input and knowledge of image 
processing than more recent software, however it has flexibility and transparency in 
processing jobs.  
5.3.4.1  Selecting AAT particles from micrographs 
A NS-EM dataset of the heat polymer with bound 4B12 Fab was collected using a 
Tecnai 200 kV FEG microscope with a DE-20 detector. For single particle analysis, 
linear regions of polymer chain were selected using the helical picking function of 
EMAN1 Boxer (Figure 5.6)254. Just under 18,000 particles were manually picked from 
169 CTF-corrected micrographs. The box size was chosen to be 200x200 pixels as 
this would accommodate the Fab fragment bound on either side of the AAT 
molecule. There was an overlap of 140 pixels between boxes. Examples of the 








Figure 5.6. Particle picking from the heat polymer/4B12 Fab dataset. An example 
negative stain micrograph of heat-induced AAT polymer with 4B12 Fab bound, imaged using 
a F20 microscope at 29,000X magnification. Movies comprising 18 subframes were collected 
over a 1.8 second exposure and summed. The summed image was CTF-corrected using 
CTFFIND3 and median filtered (shown) to aid particle picking. The polymers were boxed 
using EMAN1/Boxer with a box size of 200 pixels (pink squares) and a helix overlap of 140 




5.3.4.2  Iterative 2D alignment of picked particles  
The picked particles were extracted from the micrographs for input into IMAGIC121. 
As at this stage they were all in different orientations, an initial alignment was 
required. The first alignment of the boxed particles against a low-pass filtered 55x200 
pixel rectangle allowed rotational and translational shifts (Figure 5.7A). This rectangle 
size was chosen as several measurements of the diameter of the particles from the 
micrographs were 55 pixels (84.7Å). The alignment oriented all the polymers 
vertically through the centre of the box and required a large shift from the orientation 
they were picked in the micrographs. The particles were then subjected to 
multivariate statistical analysis (MSA) and classification, which groups and averages 
similar images. The class averages had an improved SNR compared to the individual 
images. They clearly showed that four subunits were present along the length of the 
box. In some of the class averages, the position of the 4B12 Fab could be discerned. 
Some of the best class averages that had good subunit delineation, but represented 
different views, were chosen as the references for multi-reference alignment (MRA) 
(Figure 5.7B).  
The process of alignment, MSA and classification was repeated six times until 
satisfactory alignment of the tetramer had been achieved. Eigenimages which report 
on the major variations in the dataset were used to direct the alignments. For 
example, a horizontal striping pattern in an eigenimage indicates vertical 
misalignments between images; images were then classified based on such 
eigenvectors and aligned class sums or the total sum were used as references for a 
round of vertical image alignment. The amount of movement allowed in each iteration 
was gradually restricted to allow a more focused alignment. Horizontal alignment of 
the images was improved in a similar manner. Improvements in the alignments after 
several rounds were apparent from the total sums of the images, in which the 
subunits in the tetramer became better defined. Defined density for the Fab could not 
be seen in the total sums, but at this stage was not of concern as this would be 
averaged out from the different orientations. The total sum after round 6 was used to 
measure the size of subunits: the width of each subunit was on average 47 pixels, 
corresponding to 72Å, and the height was ~42 pixels corresponding to 64.7Å. The 
width of AAT is ~35Å in its shortest dimension and so the increased width in the 
class sum likely reflected horizontal misalignment and the presence of Fab, which 
has a length of ~60Å when viewed at an angle orthogonal to the variable loops. The 
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height of AAT is ~70Å which was in good agreement with the measured height from 
the total sum. Distances between subunits were also measured using the total sum 
by plotting grey values against distance in pixels: the average distance was 43.3 
pixels, corresponding to 66.7Å (Figure 5.7C). This is in rough agreement with the 














Figure 5.7. Initial alignment of the heat polymer/Fab particles. Boxed particles were 
initially aligned to a vertical 55 by 200-pixel rectangle (top left) B) Particles were iteratively 
aligned: eigenimages produced from multivariate statistical analysis showed major variations 
in the data, these were used to generate class averages, which were then used as references 
in the next round of alignment. C) The class sum after 6 rounds of alignment was used to 




5.3.4.2  Focusing 2D alignment on the AAT/Fab dimer 
After horizontal and vertical alignment of the tetramer had been achieved, it was 
apparent from both the class averages and eigenimage analysis that the next major 
variations within the dataset was the presence or absence of the 4th subunit and the 
flexibility within the chain. Flexibility in particular would interfere with the optimum 
alignments of the images and consequently the accuracy of 3D reconstruction. 
Therefore, as before with the processing of the ex vivo NS-EM dataset, processing 
was focused on the smallest polymeric unit – the dimer – to limit the heterogeneity 
this produces. The aligned tetramers were trimmed to focus on the central dimer. 
The alignment-MSA-classification procedure was iterated again to improve vertical 
and horizontal alignments, as well as removing images that only had one subunit in 
the dimer. This left 12,823 particles.  
Further heterogeneity was observed in the aligned dimer class averages. In some of 
the projection orientations with visible Fab electron density, it was clear that the AAT 
subunits either had a small angle between them (i.e. the Fabs were protruding from 
the same side of the AAT main chain) or a larger angle between them (for example 
there was Fab density on one subunit, but not on the other, or the Fabs were 
protruding from opposite sides of AAT). Combining these images for 3D 
reconstruction would also not yield a true structure. The images were classified 
according to eigenimages thought to represent this difference and then split by eye 
into two subsets. Examples of the class averages selected into the small-angle and 
big-angle subsets are shown in Figure 5.8. As there were side-view class averages 
where the AAT subunits had a near 180° rotation between them, images with two 
bright spots (only AAT visible, no Fab protrusions – marked by an * in Figure 5.8) 
were included in both subsets. Class averages that were difficult to assign to a 
subset were ignored. A total of 6,036 images belonged to the small-angle subset and 





Figure 5.8. Eigenimage analysis of heat polymer/Fab particles. A) Eigenimages and class 
averages of the tetramer showing the major variations are in the 4th subunit and in polymer 
flexibility. B) Eigenimages of the dimer where red boxes indicate variations in the Fab 
position. Images were classified into classes based on these eigenimages. C) Examples of 
the class sums that made up the small-angle and big-angle subsets. Class sums where the 
inter-subunit angle could not be determined (marked with an asterisk) were included in both 
subsets. 
5.3.4.3  Projection matching to generate a 3D structure  
With a more homogenous set of images, it was possible to obtain a sensible 3D 
reconstruction of the small-angle subset. Angular assignment to 2D class averages 
was achieved using projection matching to references made from an initial model. 
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One of the ex vivo dimer reconstructions was used as the initial model. The 
elongated model with an 11° angle between the subunits was chosen as it had 
better-defined Fab density and had a linkage between subunits in comparison to the 
compact model (Figure 5.1). It was projected around the " angle between 0-360° and 
around β between 70-110° (tilt) both in 10° increments to generate references that 
the images were aligned to (Figure 5.9A). This ‘belt’ of Euler angles was chosen 
because the polymers were flattened on the NS-EM grid and side-views of the 
polymer dominated the experimental projections. The generated 3D reconstruction of 
the best-matched class averages (as assessed by 3D-error) had well-defined density 
for both subunits and an angle of 17° between them. This model was then 
reprojected and matched to the images in an iterative process until convergence on 
16° was achieved. The number of images within the class averages were gradually 
reduced from 25 to 10 and the references (reprojections from the model) were 
sampled at finer angles to refine angular assignment. The output models were 
assessed for angular distribution, visual comparison between reference reprojections 
and equivalent assigned class averages and model appearance (Figure 5.9C). 
Refinement was stopped after convergence had been achieved.  
The final reconstruction was assessed by docking two copies of the AAT/Fab atomic 
model into the density using Chimera. The atomic model consisted of RCL-inserted 
AAT with the bound 4B12 Fab that had been modelled using the epitope mapping 
data as restraints117. Axes through the central masses of the AAT/Fab subunits were 
used to measure the distance and angle of rotation between subunits. The distance 
between subunits was measured to be 64Å and the rotation between the subunits 
was measured to be 16° (Figure 5.9B). The resolution of the 3D reconstruction was 
assessed to be 33Å or 26Å by Fourier shell correlation (FSC) with a cut-off of 0.5 or 




Figure 5.9. The 16° heat polymer/Fab dimer. A) The 11° ex vivo dimer was used to 
generate references for projection matching against the experimental class averages. B) The 
final 16° dimer shown from side and top views. Two copies of AAT/Fab (in blue and purple) 
were fitted into the density using Chimera. Axes through their centres of mass were used to 
measure the inter-subunit distance of 64Å and rotation of 16°. C) Class averages (top) 
compared to their assigned reference projections (bottom). D) Resolution was assessed 
using Fourier Shell Correlation (FSC).  
To check for the possibility of model bias, the class averages with 10 particles per 
class were matched against the projections of multiple starting models of the dimer 
with different inter-subunit angles. Models were created in Chimera: the density of 
AAT/Fab subunits from the dimer model were superposed and averaged to create a 
single subunit model, the single subunit was duplicated and translated 70Å (based 
on an average measured distance from 8 class sums) and then one subunit was 
rotated in 10° increments. Models with a 0°, 10°, 20°, 30°, 40°, 50° and 60° subunit 
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rotation were made. Each of these models was then used as the basis for a single 
round of Euler assignment of class averages by MRA and subsequent 3D 
reconstruction. The angles between subunits in the resulting models, analysed in 
Chimera, differed by up to 15° from their starting point; the 50° MRA resulted in a 
model with a 35° subunit rotation and the MRA against the 10° and 20° models had 
the smallest angle difference. It appeared that there was a convergence towards an 
angle between 10 and 20°. This quick test suggests that the 16° angular information 
is representative of the data and the final angle is not dominated by bias from the 
reference.   
The big-angle subset was also used in projection matching in an attempt to generate 
a 3D reconstruction. However, no suitable initial model existed for a dimer with a big 
angle between subunits. Initial models were created in the same way as above by 
rotating one subunit in 10° increments between 90° and 160°. This generated 8 initial 
models that were reprojected to make references for a competitive multi-reference 
alignment to the class averages. The greatest number of matches were to references 
with a 140-160° rotation and so projection matchings to a 140°, 150° and 160° model 
were carried out. The 3D reconstruction generated from the matches to the 140° 
reference had poor density for one subunit, indicating an incorrect angle between 
subunits. The 3D reconstructions based on the 150° and 160° references had a 
better second subunit and measured inter-subunit angles of 148° and 145°, 
respectively. Projection matching to a 145° model was carried out but the second 
subunit became less well-defined in the 3D reconstruction. It was therefore deemed 
not possible to get an accurate big-angle reconstruction, most likely due to the small 
number of images going into the reconstruction and the remaining heterogeneity 
between images.  
5.3.5 Image processing of heat polymers bound with 4B12 by Relion 
The same NS-EM dataset of heat polymer with bound 4B12 Fab was processed 
using the program Relion, to assess whether other 3D reconstructions were present 
within the data and/or validate the model obtained by IMAGIC. This analysis was 
carried out in parallel to the Relion processing of the ex vivo polymer with bound 
4B12 Fab, which had also previously been analysed using IMAGIC (5.1.2). 
Therefore, in some of the steps described in this section, there was use of models 
generated from the ex vivo data.  
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Relion is an image processing system created in 2012 that is primarily based on 
maximum likelihood (ML) principles122. It can be operated via the graphical user 
interface, which lists the major image processing tasks in a standard workflow or via 
the command line. Many of the algorithms behind the programs are based on those 
found in other software such as xmipp122. The processing tasks are carried out in 
Fourier space. K-means clustering with ML methods underlie the classification 
steps258. Relion has addressed the problem of sample heterogeneity with a 3D 
classification pipeline, where multiple 3D structures can be reconstructed at once259. 
Relion was intended to increase the automation of image processing and be more 
accessible to the less-experienced electron microscopist122. This means some 
parameters are pre-set, minimising decisions of the user but with a concomitant loss 
in processing flexibility.   
5.3.5.1  Autopicking and 2D classification of dimer images  
The CTF-corrected micrographs used above were subjected to automated particle 
picking within Relion. References used for autopicking were generated from an early 
model in the ex vivo processing workflow (described below), made from a small 
sample of ~1000 particles and hence with little subunit definition (Figure 5.10A). It 
provided an adequate template to pick dimer particles. This model was projected 
around the Euler sphere to generate references of different views and maximise the 
chance of picking particles in all orientations (Figure 5.10A). The autopicking 
threshold used was low, again to pick as many particles as possible and the 
minimum inter-particle distance was set to 60Å to pick adjacent dimers from within 
the polymer chain (subunits are ~70Å apart). Picked particles were extracted in a 
150-pixel box (230Å) and masked with a circle of 190Å diameter to allow space for 
Fab density either side of the polymer chain. They were then subjected to several 
rounds of 2D classification and selection to separate dimer particles from background 
noise (picked due to the low threshold) and single subunits. A set of 25,323 dimer 
particles was the result. The class averages had an average distance of 73Å 
between subunits and, based on the position of the Fab fragments, showed that the 




Figure 5.10. Autopicking and 2D Classification of heat polymer/4B12 Fab dimer 
particles using Relion. A) The low-resolution model that was reprojected to produce 
example references for autopicking. B) Example class averages of dimers in a 150-pixel box 
and 190Å diameter circular mask.  
5.3.5.2  A reconstruction of the dimer using 3D classification to account 
for heterogeneity  
From the 2D class averages generated in both IMAGIC and Relion, it was clear that 
the data were heterogeneous and there were differing rotations between subunits 
within the dimer. 3D classification attempts to address such structural heterogeneity 
by separating images according to the distinct 3D objects from which they arise259. 
The 25,323 particles were first sorted into 4 and then 8 models using a monomeric 
subunit (AAT/Fab) as a starting reference. A monomer was used as a starting 
reference to remove bias inherent in providing a dimer with a particular rotation 
between subunits. As such, if any of the resulting reconstructions contained a second 
subunit, this will have been built in purely based on the data. This reference came 
from one of the subunits of the Relion ex vivo polymer 3D dimer reconstructions and 
was filtered to 40Å. However, the 3D reconstructions generated were all poorly 
defined, with only one subunit formed, if any.  
One of the Relion ex vivo dimer 3D reconstructions (discussed later in 5.3.6.3), which 
has a 60° angle between subunits, was then used as a reference in the generation of 
5 models. Model 2 was the only model with two well-defined subunits (Figure 5.11A). 
However, as it was so similar to the input reference, it appeared likely that it was 
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formed as a result of initial model bias. A threshold was applied to this model, it was 
smoothened and low-pass filtered in Chimera and then used as a reference against 
the same 25,323 particles to produce several more 3D classes, again one of which 
was reasonable. This process was iterated to produce reconstructions more 
dependent on the data and less biased towards the first reference.  
The 6,923 particles that comprised the best-formed class were refined against a 
reference of a single-subunit reference to ensure that the second subunit and the 
angle between them was inherent in the particles. A well-formed dimer was produced 
indicating that this was the case. The atomic model of the AAT-Fab complex was 
fitted into the two subunits and their central mass axes used to make measurements. 
There was a 67Å separation between the subunits and they were related by a 59° 
rotation (Figure 5.11A). The 3D reconstruction was masked with a soft-edge and the 
resolution assessed using FSC within the post-processing function in Relion. The 
resolution was 22Å or 27Å using a cut-off of 0.143 or 0.5, respectively (Figure 
5.11B). An angular distribution plot of the particles constituting the reconstruction 
shows that side views around the ‘belt’ of the Euler sphere are well-populated 
whereas top views looking down the polymer axis are lacking (Figure 5.11C). To 
some extent, this was expected from the long length of AAT polymers and the 
flattening effect of negative stain. This anisotropic angular assignment however is 
likely to influence the reconstruction. For the purpose of verification, the 6,923 
particles used in this final reconstruction were sorted by 2D classification to produce 
class averages (Figure 5.11A). From the position of the Fabs, it is clear the averages 











Figure 5.11. Workflow illustrating particle selection using 3D classification and the final 
59° reconstruction. A) 25,232 dimer particles were sorted into 5 reconstructions using the ex 
vivo 60° dimer reconstruction as a reference. The best reconstruction (Model 2) was then 
used as a reference in another round of 3D classification. The constituent 6,923 particles 
were refined against a monomer reference to produce the final map, displayed in side and top 
views. The molecular models of AAT in complex with 4B12 Fab (dark blue) were fitted into the 
structure using Chimera and the axis through the centre of mass (pink) used to make 
measurements. The 6,923 particles were visualised using a 2D classification. B) The 
resolution of the masked final model was assessed by FSC. C) A side and top view of the 
final model showing the angular distribution of projections that made up the reconstruction. 
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To safeguard against model bias, the particles were used as input into an ab initio 
reconstruction in Relion. This function does not need a reference and so the 
produced reconstruction is purely from the data. Using all 6,923 particle images did 
not produce a reasonable reconstruction. This is not entirely surprising; while mis-
assigned classes will be down-weighted during 3D classification and refinement, they 
can confound the ab initio algorithm. However, when the top 90%, 95% and even 
99% of images (selected based on the probability score calculated for each during 
the 3D refinement) were used as input, after only five iterations, a similar model with 
a 68Å separation and 62° rotation resulted. This indicates the structure is real and 
highlights that a small proportion (1%, 70 particles) of junk particles can significantly 
influence the output in the ab initio reconstruction.  
As a last verification, the 6,923 particles were classified by 3D into 2 or 4 classes 
against the filtered monomer reference. This was to assess whether any further 
separation of heterogeneity was possible. All of the generated reconstructions were 
reasonable in appearance. After fitting of the atomic models and making 
measurements, the distance between subunits only varied between 63-67Å, and the 
rotation varied between 56-60°. Therefore, it can be concluded that these particles 
cannot be divided any further and they are consistent with the 67Å separation and 
59° rotation model generated.  
Of interest, the 6,923 particles that contributed to the final reconstruction could not be 
refined against a reference of either one AAT subunit lacking a Fab or two AAT 
subunits without Fab domains. This suggests that without the Fab density as an 
anchor point, Relion struggles with the alignment of images. This is probably due to 
the featureless shape of the AAT molecule and emphasises the utility of the 4B12 
Fab in providing asymmetry in the EM studies.  
5.3.5.3  Attempts to identify more structures within the data 
The particles that comprised the heat-induced 59° model were selected based on a 
3D classification using the ex vivo 60° model as a reference. Therefore, the other 
models with different angular relationships were used as references in the 3D 
classification with the 25,232 particles, to select those belonging to other structures. 
Using the heat 16° IMAGIC model (5.1.2) or the ex vivo 88° Relion model (described 
in section 5.3.6.3) as references in 3D classifications, one out of the five output 
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structures bore resemblance to the reference (not shown). As before, the 3D 
classification was iterated, updating the reference each time with the best candidate 
from the previous round. However, when the images were selected based on the 
best model, they did not yield a dimer during refinement if provided with a monomer 
subunit reference, neither for the 16° nor 88° attempts (Figure 5.12). Both refined 
only to a sensible (but reasonably noisy) model with a dimer reference of their 
respective angles. However, this is likely due to a reference bias given a 2D 
classification of their constituent components was not consistent with the inter-
subunit angles. The models were therefore discounted. The same process was 
carried out against the remaining particles not present in the heat 59° reconstruction 
(25,232 – 6,923) but the output did not change. The remaining particles were also 
used in a 3D classification against the monomer reference to try pull out other 
angular relationships but this also did not produce any reconstructions. Finally, a 
further selection of the best particles by 2D classification, followed by equivalent 3D 
classifications were attempted but were unsuccessful.  
As a last attempt, the particles that were manually picked and comprised the heat 
16° dimer IMAGIC reconstruction were entered into Relion. These 6,036 particles 
refined to some extent against a small angle dimer reference but never against the 
monomer reference, even after a further selection of particles (Figure 5.12). 
Therefore, the processing using Relion was not able to reproduce the IMAGIC 16° 





Figure 5.12. A comparison of structural refinements against a dimer reference or a 
monomer reference. Attempts were made to find other reconstructions with differing angular 
relationships within the data. Images were selected based on a similar approach to that for 
the 60° model but the particles never refined to a sensible model with just a monomer 
reference. This was also true for the particles that made up the IMAGIC model.  
5.3.6 Re-processing of ex vivo polymers bound with 4B12 Fab using Relion 
The NS-EM dataset of ex vivo polymers bound with 4B12 Fab that had yielded the 
elongated and compact 3D reconstructions of the dimer by IMAGIC processing, was 
also re-processed using Relion. Given the known heterogeneity of dimer 
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conformations, this was again to search for other dimer populations within the data. 
This was predominantly carried out prior to the re-processing of the heat dataset and 
therefore at points, a slightly different approach was taken. 
5.3.6.1  Automated particle picking and classification of 2D particles 
The Relion processing workflow was started at the automated particle picking stage 
as motion-correction and CTF-correction of micrographs had previously been carried 
out by MotionCorr2 and CTFFIND3, respectively253. The 11° ex vivo dimer generated 
by IMAGIC was reprojected at angles distributed around the Euler sphere and these 
projections were used as references for autopicking. The picking threshold was low, 
yet only a small number of particles (~3500) were selected. This was most likely due 
to the disparate grey intensity scales between IMAGIC and Relion; it is advised that 
reference-based auto-picking in Relion works best from references generated from 
the same dataset139. Nonetheless, the small number of particles were classified into 
25 2D classes with a 180Å circular mask and the best classes representing dimers 
selected (~2000). These were used as input into a 3D classification job using the 11° 
model as a reference, where one of the models generated was in Figure 5.10A. It 
had little subunit definition but had two subunits an appropriate distance apart and 
was now on the correct intensity scale for another attempt at autopicking. Its 
projections (Figure 5.10A) were used to automatically pick particles from the whole 
dataset, again with a minimum inter-particle distance of 60Å to pick adjacent dimers 
and a low threshold to maximise particle numbers. It was reasoned that junk 
‘particles’ could easily be identified and excluded by several rounds of 2D 
classification. A total of 176,957 particles were extracted into a 150-pixel box. 
Several rounds of 2D classification removed background noise and single subunit 
particles resulting in 68,538 good dimer particles (Figure 5.13). There were almost 
three times more dimer particles in this dataset than the heat polymer dataset, 
despite less micrographs, due to a higher concentration of polymer per micrograph. 
The class averages had two clearly defined subunits with an average distance of 74Å 
between them. A shape resembling the Fab could also be seen extending from the 
AAT chain on some of the subunits but interestingly, very few classes showed Fab 
density on both subunits in the dimer as would be expected from a side view of a 
small-angle dimer. To generate a 3D reconstruction that could be used as a 
reference for a 3D classification of the 68,538 particles, the very best dimer particles 
were further selected based on 2D classification, resulting in 15,911 particles.   
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5.3.6.2  3D classification rounds identify two different reconstructions 
Several rounds of 3D classification were used to sort and separate the 2D particles 
into more homogenous subsets. First, a 3D classification job of the best 15,911 
particles against the poorly-defined autopicking reference was carried out to 
generate four models. One of these (circled in Figure 5.13) stood out as having a 
well-formed bottom subunit with good shape complementarity to the AAT-Fab 
complex. The top subunit was stump-like, with no Fab density but the model was 
considerably less noisy than the others that were generated. This was the first model 
produced from the new particle set and it was hypothesised that the Fab definition of 
the top subunit may be lost due to an incorrect angle between subunits in the 
reference. Therefore, this new model served as a more accurate reference in the 
subsequent round of 3D classification against the full 68,538 particles. Furthermore, 
the lack of the top subunit Fab meant that little reference bias for inter-subunit 
rotations was introduced into the classification.  
Due to a higher number of particle images and the expected heterogeneity within the 
AAT system, eight models were generated (Figure 5.13). These varied greatly in 
appearance; some (models 1, 4) had excellent single subunit contours, some had 
subunits well-positioned but less nicely defined (models 2, 5, 7, 8) and others were 
extremely noisy (models 3, 5).  All but the latter, which did not constitute a ‘sensible’ 
model, were selected for their corresponding particles. This was to maximise particle 
numbers for later rounds of 3D classification. The same process was repeated once 
more with the stump-like model and then once the particles were deemed good 
enough, the reference for 3D classification was changed to be a well-defined single 
subunit. This single subunit was created in Chimera by erasing density for the 
second subunit from the stump-like model. The single subunit completely removed 
second subunit bias from the reference and meant the appearance of the second 
subunit in the classification output was entirely from the data. A dataset of 30,979 
particles that resulted from this sequence of classifications was divided into four 
models. Two of these (models 2, 4) had excellent definition of both AAT/Fab subunits 
within the dimer and differed in the relative angle between subunits. The other two 
(models 1, 3) had only one well-defined subunit, and a stump for the other. 





Figure 5.13. The complete processing workflow of the ex vivo polymer data using 
Relion. Projections of a poorly-defined model were used to automatically pick 179,957 
particles from the micrographs. Particles were ‘cleaned’ by several rounds of 2D classification 
and selection. 15,911 dimer particles were sorted into 4 reconstructions using the poorly-
defined reference as a model. The best reconstruction (model 2) was then used as a 
reference for 3D classification against 68,538 particles. After several rounds of 3D 
classification, the strategy was tweaked, and a single subunit was used as the reference 
instead. From this, two reconstructions were obtained in which Fab density was clearly visible 
(model 2 and 4). All structures were visualised and checked for fits by a molecular model of 




5.3.6.3  Characterisation of the two reconstructions 
The particles that corresponded to the two well-defined models were subjected to 
‘gold-standard’ 3D refinement individually using the filtered single subunit reference, 
and the resulting final reconstructions analysed.  
The first reconstruction resulted from the 6,848 particles belonging to model 2 
(Figure 5.14A). As before, two copies of the atomic model of RCL-inserted AAT 
bound to 4B12 Fab were fitted into the dimer reconstruction using Chimera. 
Measurements were made using the axes through the centres of mass of the 
subunits. There was a 73Å distance between the two subunits in the dimer and they 
were related by an 88° angle. The post-processing function in Relion was used to 
add a soft-edged mask to the reconstruction and estimate its resolution. The FSC 
with a cut-off of 0.143 or 0.5 estimated a resolution of 22Å or 27Å, respectively. An 
angular distribution plot showed there was a strong preference for projections on one 
side-view face of the reconstruction. The 6,848 particles were also sorted by 2D 
classification to allow visualisation of the particles that constituted the reconstruction; 
it is clear the particles correspond to a dimer with a near 90° rotation between 
subunits.  
The second reconstruction resulted from the 9,239 particles belonging to model 4 of 
the 3D classification step (Figure 5.14B). The subunit distance and relative angular 
rotation were measured to be 69Å and 60°, respectively. The resolution was 
estimated to be 16Å or 23Å using an FSC cut-off of 0.143 or 0.5, respectively. The 
increased resolution compared to the 88° model probably reflects the higher number 
of particles images making up this reconstruction and possibly particles with a higher 
informational content. An angular distribution plot showed the same preference for 
projections as for the 88° model but for this model the angles were determined more 
successfully and therefore were sampled on a finer grid. 2D classification of the 
constituent particles also showed from the positions of the Fabs that the angle was 
intermediate between planar subunits (0-20° rotation) and the near-90° rotation 






Figure 5.14. Characterisation of the two ex vivo dimer reconstructions. The particles 
belonging to the best reconstructions after 3D classification were refined against a monomer 
reference to produce the final reconstruction, displayed in side and top views for A) the 88° 
dimer and B) the 60° dimer. The models of AAT/Fab (dark blue) were fitted into the structures 
using Chimera and the axes through the centres of mass (pink) were used to make distance 
and angle measurements. The constituent particles were also visualised by 2D classification. 
The resolution of each reconstruction was assessed by FSC and the angular distribution of 
projections is shown plotted on side and top views. 
Both reconstructions could almost be completely regenerated using five iterations of 
an ab initio reconstruction in Relion using their respective particle sets. For the 88° 
particles, the output of the initial model job yielded a reconstruction with a 73Å 
subunit distance and 78° subunit rotation. For the 60° particles, the output of the 
initial model job yielded a reconstruction with a 68Å subunit distance and 58° subunit 
rotation. This gives further confidence that the 2D particles are true projections of 
their 3D reconstructions. In comparison to the Relion processing of the heat polymer, 
no filtering of particles based on the probability score was required. This might 
indicate the particles were of a higher quality or that less ‘junk’ particles were present 
in the liver polymer dataset influencing the refinement. 
The particles constituting each reconstruction were also subclassified by 3D into 4 
classes against the single subunit reference to assess homogeneity of the particles. 
For the 88° particles, the reconstructions were similar but with a degraded quality. 
The distances between subunits varied between 66-74Å and the rotation angle 
varied between 75-86°. The same was true for the 60° particles with the distances 
varying between 67-70Å and the rotation angle varying between 59-68°. These 
results concluded that there was no further subclassification of particles and the 
particles are consistent with their respective models. It is expected that these inter-
subunit angles are enriched components of a continuum, which would suggest that 
some of the constituent particles arise from dimers with rotations distributed around 
these central points. 
5.3.6.4  Attempts to obtain other reconstructions within the dataset 
The 14,892 particles (30,979 – 6,848 – 9,239) that did not make up the two final 
reconstructions were further tested to see whether another reconstruction was within 
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the data. They were reclassified against the monomeric subunit reference into 
between 2, 4 and 10 classes (Figure 5.15A). In all the generated classes, a second 
Fab-bound subunit was not obtained at a different angle to the already determined 
reconstructions; they all had a well-formed single subunit and a stump for the 
second. Therefore, no further models with different angular relationships could be 
found. The 60° and 88° model did appear again, indicating that firstly, not all the 
particles corresponding to their projections had been identified and secondly, that the 
previously-determined reconstructions were credible. Projections of the 60-88° 
dimers are apparent in the class averages of the remaining particles (Figure 5.15A).  
The 14,892 unassigned particles were also classified in 3D against the previously-
obtained IMAGIC-derived reference map with a small angle (11°) between subunits 
(not shown). Some of the generated models had a small angle between subunits but 
when images were selected from the models on this basis, they did not refine against 
a monomeric subunit. This suggests the appearance of a small angle dimer is largely 
due to reference bias. Even when the initial 68,538 particles were classified against 
the small angle dimer reference and the same selection process repeated, no 
unbiased small-angle model resulted.  
The 8,120 particles that were manually picked and formed the two small angle 
models using IMAGIC were also tested in Relion. They were refined against the 
monomeric subunit but a sensible model was not produced (Figure 5.15B). They 
even did not yield a good model when refined against the 11° IMAGIC model. Further 
selection of images and updating of the reference from job outputs did not make a 
difference. When the particles were analysed by 2D classification, they were well-
defined but some resembled projections of a model with an angle more similar to 60° 




Figure 5.15. Attempts to identify more ex vivo reconstructions. A) Unassigned Relion 
particles were visualised by 2D classification and subjected to 3D classifications. No new 
angular relationships were identified in the generated models. B) The manually-picked 
IMAGIC particles were visualised by 2D classification and failed to refine to a sensible model.  
5.3.7  Refining the subunit model of AAT/Fab using the single subunit density 
The NS-EM reconstructions generated by Relion had greater subunit definition, 
which allowed the model of the interaction between 4B12 Fab and AAT to be 
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improved. An average subunit density was made from the two subunits in the Relion 
60° dimer reconstruction as this was the structure with the highest resolution. The 
interaction between cleaved AAT (PDB ID:1EZX13) and the 4B12 Fab was refined 
using PyRosetta with the help of Dr J. Irving164. A number of “rule-based” restraints 
were included in the modelling: residues 32, 306, 43, 36, 266 in AAT (identified from 
epitope mapping studies) had to be within interaction distance of the 4B12 Fab and 
the heavy or light chain CDRs of the Fab had to be within interaction distance of 
AAT. A set of 1000 randomised starting models of AAT and Fab were optimised and 
fit as rigid bodies into the density. The resulting subunits models were sorted based 
on the cross-correlation score measuring their fit to the NS-EM single subunit 
density. A histogram of the cross-correlation scores shows the distribution of models 
was bi-modal (Figure 5.16A). Models with lower cross-correlation scores were visibly 
worse in their fit to the electron density; examples are shown where the Fab region is 
not in the density or the structure is flipped around such that AAT is in the density for 
the Fab and vice versa. In the top 20 structures (the highest scoring bin), with the 
exclusion of one model where the AAT molecule was wrongly positioned in the Fab 
density, all models favoured the Fab heavy chain and light chain in particular 
orientations (Figure 5.16B). This suggests there is structural discrimination in the Fab 
region of the electron density. The orientation of the AAT molecule was not so easily 
discriminated (13 ‘up’ vs. 6 ‘down’ orientations). Therefore, the highest-scoring of 
each AAT orientation was chosen – model 329 and model 787 (Figure 5.16C) – and 
used to create two different versions of each polymerisation model for the fitting 





Figure 5.16. Improving the modelling of the 4B12 Fab/AAT interaction. A) 1000 random 
models were created and fit as a rigid body into an average density of the single subunit. The 
cross-correlation score measured the fit to the electron density and the histogram shows the 
spread of model fits. Example models with differing scores are shown. B) The top 20 models 
with AAT in blue, the heavy chain in red and the light chain in green. Glycans are in black and 
the average density is thresholded at a volume corresponding to 1.5x the expected molecular 




5.3.8  Fitting the proposed polymerisation models into the NS-EM 
reconstructions 
The loop-β sheet A, β-hairpin and C-terminal models of polymerisation have all been 
proposed to represent the linkage that exists between subunits in in vivo 
polymers32,78,86. The models are based on different biochemical and structural data of 
serpin polymers formed artificially but it is unclear if they represent the structure of 
liver polymers. The three polymerisation models were fit into the NS-EM 
reconstructions generated from the ex vivo polymer data, as well as those generated 
from the heat-induced polymer data to see whether they were compatible with the 
structures. It was the assessment of whether the polymerisation models could 
accommodate such an angle between subunits that was important, rather than the 
presence of such a dimer in the sample.    
The three polymer models had been generated for fitting into the liver polymer 
IMAGIC models, previously250. Briefly, the loop-β sheet A model was modelled with 
an RCL insertion of 6 residues (P8-P3). This minimal linkage was chosen to 
maximise the flexibility of the loop-β sheet A model and likelihood of fitting the 
structures, but represents a departure from the fully-inserted RCL proposed in early 
papers which would result in rigid, truncated polymers91. The β-hairpin model was 
generated in a linear conformation, and in contrast to the published linear model, was 
produced with a folded I-helix based on the finding that this element is involved in 
4B12 Fab binding69,78,117. The C-terminal model was also generated in a linear 
conformation by altering the connectivity of the structure of the cleaved polymer of 
AAT86. The AAT/Fab subunit models generated in 5.3.7 (model 329 and model 787) 
were used to redefine the AAT/Fab interaction in the polymerisation models. All the 
NS-EM density reconstructions (60° liver, 88° liver, 16° heat, 59° heat) were 
compared against both a 329-version and a 787-version of each polymerisation 
model. Both subunit models were used because the direction of AAT in the density 
could not be accurately determined in the fitting of the single subunit.  
A molecular modelling protocol was developed to perform rigid-body modelling of the 
AAT/Fab subunits, with defined flexibility in the connecting polymerisation linkers. 
This  was carried out in PyRosetta164 with the help of Dr J. Irving. A total of 500 
randomly perturbed starting models were generated, optimised into the densities and 
given a score based on the cross-correlation of the model to the NS-EM structure. 
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The starting models covered a wide range of conformations between subunits and 
the highest 10 scoring structures were all similar with a small standard deviation 
between scores. This showed that in each discrete run, the models had converged 
onto a similar solution, which gave confidence in the robustness of the modelling. 
The average cross-correlation scores of the top 10 models for each polymerisation 
run are shown in Table 5.2. 
 
Table 5.2. Correlations of the fits of the polymerisation models into the NS-EM 
densities. Modelling was carried out using PyRosetta and correlations were calculated 
between the models and the NS-EM structures. Values are the average of 10 models, all runs 
had a standard deviation of ≤ 0.03. The highest score for each structure are highlighted in 
grey. 
The correlation scores are a measure of the ability of the different models to fit the 
density. They reflect the restraints conferred by the different linkages on the 
translational and rotational flexibility of the individual subunits. For all four NS-EM 
structures, fit with a specified version of the polymerisation model (i.e. 329 or 787), 
the C-terminal model of polymerisation always had the highest score, with one 
exception, and hence best fit the density. The loop-β sheet A model always had the 
lowest score and the β-hairpin model, the intermediate score. The fitting was also 
able to suggest the most compatible orientation of AAT in the densities. When 
comparing the scores between the 329- and 787-versions of the polymerisation 
models for each structure, the 329-version always had the highest score. Especially 
  
Version 









329 40.55 44.08 46.71 
787 33.88 43.39 45.25 
88° 
329 43.34 43.43 46.41 




329 32.25 31.70 34.01 
787 27.11 32.51 32.16 
59° 
329 42.41 43.24 46.58 
787 30.50 42.33 43.74 
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for the loop-β sheet A model, the difference between scores was substantial. This 
suggests that the direction of AAT can be determined when modelling into the dimer 
structures due to the extra constraints of the neighbouring subunit (in contrast to the 
modelling into the single subunit structure in 5.3.7). 
An evaluation of whether the fits of the different models were statistically different 
was undertaken. The original 329 or 787 individual subunits were superimposed over 
the two subunits in each of the 10 top-scoring dimers for each polymerisation model 
to calculate a starting cross correlation (CC). The superimposed subunits were then 
optimised into the respective density without any restraints imposed by the polymer 
models to calculate a resulting unrestrained CC. This approach was taken as the 
polymerisation models involve different structural elements (particularly at the 
termini) which can lead to intrinsic differences not directly related to the fit. The 
restrained CC (from the optimised dimer models) was calculated as a fraction of the 
unrestrained CC (from fitting the individual subunits) for all the model combinations. 
Two separate non-parametric tests of significance were carried out, testing whether 
the individual subunits were significantly different to the best-fitting polymerisation 
model. This effectively tested the ability of a polymerisation model to converge on an 
optimal solution despite its restraints. The first test concerned only liver polymers and 
assumed a common mechanism resulted in both the liver 60° and the liver 88° 
structures. The 60° and 88° fits were combined into one score for 329 or 787, and 
the highest similarity dimer combination was the C-terminal (CT) 329-model. 
Applying the Dunn’s non-parametric multiple comparisons test, there was a 
significant difference (p < 0.0001) between the CT-329 model and all the β-hairpin 
(BH) and loop-β sheet A (LS) models (Table 5.3, left). The second test assumed that 
a common mechanism resulted in the liver and the heat structures and the scores 
were combined accordingly. The highest scoring dimer combination was again the 
CT-329 model and this was statistically different (p < 0.0001) to all the BH and LS 
models (Table 5.3, right). Furthermore, CT-329 was also significantly different (p < 
0.01) to the CT-787 model. Overall, this analysis suggests that the C-terminal model 









Table 5.3. Dunn’s non-parametric multiple comparisons test evaluating the 
polymerisation model fits into the NS-EM densities. The 60° and 88° liver dimers were 
assumed to result from the same polymerisation linkage on the left, and the liver dimers and 
heat dimers were assumed to result from the same polymerisation linkage on the right. The 
similarity values represent the restrained CC value as a fraction of the unrestrained CC value. 
LS = loop-β sheet A model, BH = β-hairpin model, CT = C-terminal model, **** denotes 
significance p < 0.0001 and ** denotes p < 0.01. 
The order of scores was also apparent when visually assessing the fits; the fits into 
the liver 60° model as a representative is shown in Figure 5.17. For example, the 
linker in the loop-β sheet A model is constrained such that one AAT subunit (blue) is 
pulled out of the main body of electron density. The linker is already minimally-
inserted (only 6 residues) and therefore the loop-β sheet A model as originally 
proposed with a complete RCL swap, would be incompatible with all structures. The 
6-residue swapped version can broadly fit the structures but considering it is the 
lowest scoring model, and the minimal-insertion is unlikely to confer the high known 
stability of AAT polymers, the findings suggest this linkage may not be correct. The 
modified β-hairpin model cannot be discounted based on these fits as it could 
reasonably accommodate the geometric restraints provided by the structures and 
resulted in an adequate score. Although the C-terminal model is the most flexible 
model and therefore it is inherently most likely to fit the structures, these findings 
suggest that the reconstructions of the liver polymer and the heat polymer are best 
described by the C-terminal linkage of polymerisation86. A definitive analysis however 
would require higher resolution structures.  
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Figure 5.17. Fits of the NS-influenced polymerisation models into the 60° liver polymer 
structure. AAT subunits are shown in red, blue with the neighbouring AAT linkage in orange 
and the Fab subunits are in teal. Modelling was carried out using PyRosetta and visualised 





5.4.1 Comparing the structure of heat-induced polymers and ex vivo 
polymers  
5.4.1.1  The two polymer types have similar ultrastructure 
Heat-induced in vitro polymers and liver/ex vivo polymers, but not in vitro polymers 
formed by other methods (acid and denaturants), are recognised by the mAb 2C176. 
This indicates that heat polymers and liver polymers share a common epitope and 
therefore share at least some degree of structural similarity. However, the extent of 
this similarity has not been investigated.  
Negative stain EM (NS-EM) is a convenient means by which to visualise protein 
samples and has been used previously to visualise AAT polymers. Polymers isolated 
from the liver of a patient undergoing transplantation for Z-AAT cirrhosis, plasma-
purified Siiyama AAT and heat-induced polymers have all been reported to consist of 
flexible chains with bead-like subunits32,81. This morphology has been observed also 
in this study when considering heat-induced polymers (Figure 5.3) and ex vivo 
polymers isolated from the liver of a Z-AAT homozygote (Figure 6.6), with a view to 
extending these analyses to infer structural information. In the images that have been 
collected, individual subunits can be clearly defined, with polymer chains ranging 
from 4-20 subunits. For the heat polymer sample, linear and circular polymers can be 
seen, both present in significant amounts, whereas fewer circles were observed in 
the ex vivo micrographs (Figures 5.3 and 6.6). In fact, a quick assessment that 
classified over 2000 polymers, from both the heat-induced and liver samples, as 
circular or linear showed that there was an 81%/19% split of linear to circular 
polymers in the liver polymer sample compared to 67%/33% in the heat polymer 
sample. Polymers are known to have complementary ends as circular polymers have 
been reported in the ex vivo samples before, however only as the minority species32. 
While it is possible that these circular values are over-estimations – there may be 
linear polymers that have adopted a circular shape – the number of circular polymers 
counted here, particularly for the heat polymers, represents a substantial component. 
As polymerisation involves inter-molecular interactions, it is by definition a kinetic 
process, and there would be competition between monomer addition and 
circularisation. It is likely that the means by which polymerisation is induced, the 
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presence of mutations, and the concentration of the components would all influence 
how well-favoured elongation is over circularisation. Thus, studies that draw 
conclusions regarding the importance of circularisation must be interpreted with 
care86,95. 
The featureless shape and small size of the AAT subunit makes alignment of 2D 
projections and generation of a 3D reconstruction of the polymer challenging. Binding 
of the 4B12 Fab to the polymer not only increases the size of the repeating unit but 
as the antibody binds a specific epitope, its position provides information on subunit 
rotation relative to each other. Binding of the 4B12 Fab to liver ex vivo polymer 
facilitated the generation of 3D reconstructions of the dimer in previous work250 
(Figure 5.1). The 4B12 Fab was bound to heat polymers for visualisation by NS-EM 
(Figure 5.5), and to the ex vivo polymers for cryo-EM work (Figure 6.7). The bound 
4B12 Fab molecules increased the size of the polymers and were often visible as 
protrusions from the polymer chain. Whether complete subunit binding was achieved 
is difficult to assess from the micrographs, as the 2D projection shape of orientations 
orthogonal to the plane of the micrograph would appear the same if Fab was or was 
not bound. The intensity of such subunits does often seem to be brighter however, 
suggesting an increase in the protein component. The sample was incubated with 
three times excess of Fab for multiple hours, 4B12 has a sub-μM affinity for AAT 
(preliminary data from A. Jagger), and visual inspection of the chains provides 
confidence that occupancy is at least very high. 
The flexibility of the heat polymers was immediately apparent from the micrographs 
and further exemplified by eigenimages and class sums of tetramers (Figure 5.8). 
This flexibility and heterogeneity between images led to the choice to limit 
reconstruction to the dimer. In general, the flexibility of the polymer chain is 
comparable between the two polymer types. In some regions, the protruding Fab 
was lined up on one side of the chain whereas in some instances the Fab could be 
seen alternating on opposite sides of the chain. This latter case indicates the 
substantial flexibility of the inter-subunit linker, in which one monomer rotates 
approximately 180° relative to its neighbour. It is clear however that this latter 
arrangement is observed substantially less frequently, suggesting an angular 
preference. Previous work using NS-EM to study the ex vivo polymers with 4B12 Fab 
found the Fab protrusions nearly always on the same side of the polymer chain250. 
When a different liver sample was characterised by NS-EM in preparation for cryo-
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EM, the majority appeared to be on the same side but a few cases with alternating 
sides could be observed Figure 6.7). The difference between the two liver polymers 
may indicate heterogeneity between liver polymers from different patients102, or 
simply that they are permissible, but generally disfavoured relative rotation between 
subunits. Regardless, these extreme angles of rotations are apparent in both heat-
induced and liver polymer samples further supporting their similarity at an 
ultrastructure level. It is also important to remember that staining with uranyl acetate 
has a flattening effect129 and so if subunits are rotated by greater than 90°, it is 
possible that they could be flattened and appear like a 180° rotation.  
5.4.1.2  The two polymer types display similar angular relationships 
between subunits 
In this work, two NS-EM reconstructions have been determined for the 4B12-bound 
heat polymer sample using two different software approaches and two new 
reconstructions in a re-appraisal of the liver polymer sample. In combination with 
previous work primarily carried out by S. Faull250, these studies present the first EM 
structures of AAT polymers and the most thorough comparison of heat-induced and 
liver-derived polymers. The reconstructions are summarised in Table 5.3.  
A dimer structure of the labelled heat polymer was generated using IMAGIC with a 
64Å distance and 16° rotation between subunits. This was very similar to the IMAGIC 
models from the liver polymer dataset generated previously with respective 
parameters of 68Å/16° and 73Å/11°. The other heat dimer determined using Relion 
had a 67Å distance and a 59° rotation between subunits. At the resolution of the 
structures, this is indistinguishable from the liver dimer newly-determined using 
Relion with a 69Å distance and 60° rotation. Therefore, comparable reconstructions 
of dimers are observed between the two polymer species. As discrete angles are 
observed, as opposed to a continuum of angles, this suggests the inter-subunit 
linkage and/or the negative staining process favours certain subunit positions. This 
angular preference is common between the two polymer species and supports 
studies claiming their structural similarity69,76.  
The only different dimer species that was identified, was another liver-derived dimer 
with a 73Å distance and 88° rotation; no equivalent structure was found in the heat 
dataset. As the heat-induced polymer dataset contained around three times fewer 
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particles than the liver polymer dataset, this angular relationship may simply not be 
present in high enough frequency to form a reconstruction. An alternative is that the 
near-90° angle is not a favoured or permissible rotation between subunits in heat-
derived polymers, possibly reflecting a difference in the polymer linkage between 
heat-induced and those derived from liver. This seems an unlikely scenario however 
due to the presence of the ~180° chain inversions.  








+ 4B12 Fab IMAGIC 64 6,036 16 
Heat polymer 
+ 4B12 Fab Relion 67 6,923 59 
Liver polymer 
+ 4B12 Fab250 IMAGIC 73 3,749 11 
Liver polymer 
+ 4B12 Fab250 IMAGIC 68 4,371 16 
Liver polymer 
+ 4B12 Fab Relion 73 6,848 88 
Liver polymer 
+ 4B12 Fab Relion 69 9,239 60 
Table 5.3. Summary of the dimer models generated from the two image-processing 
softwares for two different samples. The liver polymer + 4B12 Fab, processed using 
IMAGIC, was carried out by Dr. S. Faull250. 
Multiple attempts were made to identify other dimer configurations embodied within 
both datasets, however these were unsuccessful. It is clear that other conformations 
exist, for example the big-angle particles identified from the heat polymer IMAGIC 
processing, however these are likely to represent minor species where too few 
images have been identified to generate a sensible reconstruction. It is also possible 
that the ‘stump’ models generated in the Relion processing workflows represent real 
dimer structures, where only one out of the two AAT subunits are labelled with Fab 
fragment. Most class averages in a 2D classification of the particles making up the 
‘stump’ structures show one subunit without any protruding Fab density (Figure 
5.15A). However, generally this subunit appears to be brighter, suggesting the Fab is 
indeed bound and is orthogonal to the plane of the micrograph. The presence of Fab 
is further supported by the fact that polymers were incubated with excess Fab, the 
interaction between 4B12 and AAT is stable during purification and the lack of 
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significant gaps in labelling on inspection of micrographs (Figure 6.12C). Even if the 
dimer was part unlabelled, it would be difficult to obtain useful information regarding 
the rotational relationship between subunits at this resolution.  
5.4.2 The C-terminal model is most consistent with the reconstructions  
The linkage between subunits in the pathological AAT polymer has been a subject of 
debate for more than 25 years. Out of a total of five models that have been 
proposed, the loop-β sheet A, β-hairpin and C-terminal models are deemed most 
likely to represent the polymer structure5,32,78,83-86. Linear versions of these models 
were created previously and used to test their fit into the two IMAGIC ex vivo 
polymers generated by Dr S. Faull’s work250. It was found that the C-terminal model 
was most consistent with both structures and the loop-β sheet A model with the 
minimal insertion was possible but inconsistent250. Similar conclusions were found in 
this study when the three polymerisation models (with the refined AAT/Fab 
interactions) were fit into the Relion ex vivo 60° and 88° models, the Relion heat 59° 
model and the IMAGIC heat 16° model. The differing inter-subunit angles allowed an 
assessment of how well the polymerisation models could accommodate such a 
structure. Therefore, the additional ex vivo NS-EM structures and the heat NS-EM 
structures have enabled a more thorough analysis of the fit of the polymer models, 
contributing towards resolving the controversy.  
The distance and angles between the subunits in the reconstructions meant that the 
linker of the loop-β sheet A model pulled the adjacent AAT subunit out of optimum 
positioning in the density. The loop-β sheet A model involves the exchange of the 
RCL between neighbouring subunits32. This was largely based on the ability of RCL 
peptides to block polymerisation but there is no structure for such a linkage and so 
the exact residues that are exchanged has not been explicitly defined32. It is currently 
proposed to be residues P8-P3 that swap and accordingly, this was modelled in this 
study73. The results of the fitting, combined with assertions that propose this linkage 
would not produce the known stability or flexibility of polymers, suggests that the 
loop-β sheet A model is unlikely to represent the linkage in heat or liver polymers91. 
Although RCL insertions to different extents could be tested, i) a longer RCL swap 
would further limit flexibility of the chain and ii) a shorter RCL swap could not justify 
the extreme stability of polymers to denaturant and heat.  
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The β-hairpin model, modified from that originally proposed78 by retaining an intact 
helix I, was adequately accommodated by the densities and thus on this data cannot 
be discounted as the linkage78. The model involves the exchange of the RCL and 
strand 5A; this linkage was observed in a crystal structure of a closed antithrombin 
dimer78. The dimer was formed by incubation at low pH and experiments in support 
of the structure, used denaturants to induce polymerisation. Considering 2C1 
reactivity towards heat and liver polymers, but not denaturant and acid polymers, the 
β-hairpin model seems unlikely to be relevant to Z-AAT liver polymers69,76, although 
there is evidence it may be applicable to at least one rare variant191. 
Fitting of the C-terminal model resulted in the highest correspondence between 
structure and density. This model describes the exchange of strands 1C, 4B and 5B 
between subunits and the self-insertion of the RCL86. A crystal structure of a closed 
AAT trimer, which was formed by heating and consequently recognised by 2C1, 
shows this linkage. It is the most flexible model – in keeping with the observed 
flexible nature of AAT chains – but the crystallised species was an atypical, 
disulphide-trapped form and its relevance to natural polymers was not 
established76,86. However, considering all the published data and the data presented 
here, the C-terminal model appears to be the most plausible out of the proposed 
models.  
As both the liver polymer and heat polymer structures were best explained by the C-
terminal model, this reinforced their structural similarity in addition to the 
comparisons described earlier. At the resolutions of the structures, the fitting results 
are only indicative; a definitive answer would require high-resolution cryo-EM data. It 
is possible that AAT subunits form polymers through an alternate mechanism, 
different from those presented in the models, but such a proposal could not be made 
with these data. Furthermore, liver AAT polymers resulting from different mutations 
may not necessarily have the same structure. The polymers in this study were 
isolated from a ZZ-AAT homozygote, and previously 2C1 has been shown to 
recognise AAT polymers resulting from a range of mutations including the 
predominant Z mutation and rarer King’s, Mpisa and Etaurisano mutations76,260. However, 
recently pathological polymers formed by the Trento mutation showed reduced 
recognition by 2C1 indicating a possible structural difference191. This means 
conclusions drawn from studies of ZZ-AAT polymers may not necessarily extrapolate 
to polymers formed by other mutations. On a similar note, it is generally believed that 
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pathological polymers of other serpins form by the same mechanism41. This would 
also need to be addressed as serpins have RCLs of varying length and a longer RCL 
would result in the loop-β sheet A model becoming more permissive.  
5.4.3 Improvements incorporated into the processing of the heat polymers 
compared to the ex vivo polymers using IMAGIC   
Image processing of the ex vivo AAT polymers using IMAGIC resulted in density that 
was very low resolution (around 30Å) and that failed to show the distinctive 
contoured density associated with the Ig domain. Accordingly, improvements to the 
workflow were incorporated for the heat-induced polymer. For the heat-induced 
polymer, linear regions of polymer were selected from the micrographs using the 
helical function of EMAN/Boxer254, providing a more efficient way to pick particles 
compared with the manual selection performed in the prior study. This introduced 
less bias into the selection process where previously only discernible dimers were 
picked. It also increased the dataset size, allowing a more robust classification and 
selection step at later stages of processing.  
Eigenimage analysis was used to guide the division of particles into subsets for the 
processing of both datasets. However, for the liver processing, the data were divided 
into subsets representing different distances between subunits. This difference was 
reflected in the major eigenimage, yet as the alignment of images was carried out 
against a reference with two subunits, it is likely this did not represent two 
populations that varied in inter-subunit distance. For this to be true, the eigenimage 
would have had to result after particle alignment to a reference of a single subunit. 
The difference in distance between subunits that was observed could be due to a 
different tilt of the projections and so the particles were classified by view rather than 
population. It is possible that the particles were over-classified and they are all 
consistent with a small-angle dimer reconstruction with an angle around 11° or 16°. 
Instead in the heat polymer processing, images were divided based on eigenimages 
representing the clear heterogeneity observed between the relative rotation of 
subunits due to the positioning of the Fab fragments. Only once this division had 
happened, did a sensible dimer model with density for both Fab fragments result 
indicating homogeneity of particles is important in obtaining reconstructions129.  
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5.4.4 Comparison between image processing of AAT polymers using IMAGIC 
and Relion  
IMAGIC and Relion are two image processing software packages for EM 
data121,122,162,259. They both align images in 2D and produce 3D reconstructions but 
are based on different algorithms and statistical methods. Image processing was 
initially carried out for the heat-induced polymer and liver polymer datasets in 
IMAGIC and then repeated in Relion.  
A major difference between the workflows was the number of particles used in image 
processing. Over eight times more particles and twice as many were used in the 
Relion processing of the liver and heat polymers respectively, in comparison to the 
IMAGIC processing. This increase in particle number was a result of automated 
particle picking, however theoretically autopicked particles could have been inputted 
into the IMAGIC software. The IMAGIC particles used were manually picked using 
EMAN254. Obvious stretches of polymer were selected which was both time-
consuming and tedious but reasonably accurate. Manual picking may have excluded 
rare but important views, limiting the reconstruction resolution and accuracy. In 
comparison, autopicking is much quicker and selects more particles. A certain 
amount of ‘junk’ particles are expected in autopicking however these are easily 
removed through rounds of 2D classification. It is also important to low-pass filter 
autopicking references to avoid picking noise141-143; for the Relion processing, 
autopicking references were filtered to 30Å to avoid this bias. 
In both processing pipelines, particle images were selected at the level of 2D and 3D. 
In IMAGIC, eigenimages analysis was useful in displaying heterogeneity between 2D 
particles and this directed the division of the particles into small-angle and big-angle 
subsets. Images were also selected based on 3D-error scores at the 3D 
reconstruction stage. In Relion, particle heterogeneity was sorted by 2D classification 
and 3D classification jobs. An important consideration when comparing the 
processing carried out for the AAT polymers is that the reconstructions obtained in 
IMAGIC were not replicated in Relion, either within a full processing pipeline or with a 
more limited re-appraisal of the identical particles and reconstructions from IMAGIC. 
Both software package utilise different approaches: IMAGIC implements MSA and 
eigenimages are used to show variations between images121 whereas Relion is 
based on ML methods259. This outcome was primarily addressed in the Relion 
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processing, where multiple attempts to reconstruct a small-angle dimer (like those 
generated from the IMAGIC processing) were made but all were unsuccessful. 
These included using the small-angle dimer as a reference for 3D classification to 
help selection of relevant particles and using the exact particles that constituted the 
IMAGIC reconstructions. It raises the question about the reliability of the IMAGIC 
models, especially considering the class averages of the liver polymer IMAGIC 
particles seem to resemble a dimer with an angle greater than 11-16° between the 
subunits (Figure 5.15B). This may represent limitations of the fundamental basis for 
particle reconstruction employed by IMAGIC, or the higher degree of subjective user 
choice in the processing pipeline; one of the stated intentions of the Relion 
developers is that it requires less decisions from the user that can impact the 
processing outcome122. For example, alignment of the tetramers against a 
rectangular stripe, with 2D classification according to specified eigenimages into 
classes with relatively few equally weighted members, would explicitly exclude tilt-
views or end-views, which would not be interpretable according to the decision tree 
used. While there is also a subjective decision process in choosing to progress or not 
a given 2D or 3D class in Relion, these classes are far less focussed, instead 
incorporating a variable number of images which are weighted according to a 
calculated probability score. It is clear that one by-product of this approach is that 
there are a proportion of particles that are ‘misclassified’ according to the shape 
represented by the total sum, but bear statistical features warranting their inclusion. 
Furthermore, the explicit treatment of heterogeneity favours inclusivity of classes by 
the user with reduced risk of influencing the outcome, if a 2D class is incorrectly 
selected.  
In general, the reconstructions generated by Relion had much better subunit 
definition and were solved to a higher resolution. The IMAGIC models were solved to 
a resolution of between 30-33Åat an FSC of 0.5 whereas the Relion models were 
solved to a resolution between 23-27Å. The highest resolution model was the liver 
60° dimer, probably explained by being the reconstruction with the most constituent 
particles (Figure 5.14). The subunits in the Relion models were better defined at the 
interface between AAT and the 4B12 Fab and displayed depressions in the density 
where the hole of the Fab structure was modelled. These subunits enabled a better 
model of the interaction between AAT and 4B12 Fab to be created, which was 
subsequently used to assess the fits of the polymerisation models into the 
reconstructions. The modelling of the single subunit gave conclusive results in the 
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positioning of the heavy and light chains of the Fab; this demonstrates the relatively 
high resolution achieved in this study using NS-EM. 
5.4.5 Addressing concerns about model bias 
Orientation determination of particles by projection matching requires a reference 
model. An incorrect starting model can bias or invalidate projection matching129, 
producing an incorrect reconstruction. It is difficult to tell the extent of reference bias 
on the final model. Therefore, it is important to use a reliable starting model, low-pass 
filter the reference to remove surface features and validate structures by other 
biochemical and biophysical experiments129. 
The processing workflow for each of the reconstructions discussed differed in the 
starting model for projection matching. The approach used was gradually adapted to 
reduce potential model bias: the starting model progressed from being a dimer 
model, to a ‘stump’ model and finally to a monomer model. This change reduced the 
influence of bias away from a specific angle of rotation and then from a specific 
distance between two subunits, finally to a reference unbiased for the angular 
relationship within a dimer. The starting models were always low-pass filtered to 
greater than, or equal to, 30Å to remove any higher-resolution features that could 
bias projection matching. 
In the IMAGIC processing of the heat-induced polymer, one liver dimer 
reconstruction, which had an 11° angle between subunits, was used as an initial 
model. Projection matching was iterated several times until convergence on a model 
with a 16° angle between subunits was achieved. The change in angle, and 
convergence on an angle, suggested that that the reconstruction was moving away 
from the initial model and was converging towards the model inherent in the 
experimental data. This was supported when projection matching was carried out 
against reference models constructed with angles between 0-60°. All the resulting 
reconstructions had inter-subunit angles closer to 16° than the reference model used 
for orientation determination. Although addressing model bias was not completed to 
the point of convergence on 16°, it does support the presence of a small-angle dimer 
within the data. Furthermore, there was a good match between the projections and 
the reprojections of the 16° reconstruction indicating reliability of the structure. In 
hindsight, it would have been best to not use a liver dimer model as a reference in 
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the heat-induced polymer processing for a study comparing the heat-induced and 
liver polymer dimer structures to limit the influence of model bias. However, this was 
the only dimer model available based on experimental data. A possible approach that 
could have been attempted given time would have been to try a monomer reference, 
or if this did not work the ‘stump’ reference, to allow the second subunit and hence 
rotation between subunits to purely come from the data. However, one of the likely 
sources of failed reconstructions using these ‘reduced’ models in Relion is that the 
AAT-Fab subunit is approximately the same length and shape as the AAT-AAT 
subunit at these resolutions (Figure 5.18). It may be therefore that there was an 
increased mis-assignment of Euler angles to some of the projections, confounding 
the reconstruction. An alternative approach, considered best practice, is to produce 
an ab initio model using the common line theorem to assign orientations to 
projections or from an experimental technique that directly provides orientations such 
as random conical tilt reconstruction (2.9.5)129. However, such approaches are 
difficult for small, heterogeneous and asymmetric samples and the flexible dimers 
considered here represent very poor subjects for such an analysis. 
 
Figure 5.18. Comparison of the dimensions and shapes of AAT/AAT and AAT/Fab. 
Electron density at 20Å was simulated from the atomic structures and measurements were 
made in Chimera.   
The ease of image processing with Relion facilitated more analysis about the 
influence of model bias and allowed more checks to be carried out. The heat polymer 
processing involved the 60° liver dimer as a reference for 3D classification, which 
produced a model very similar to the reference and required caution regarding model 
bias. The particles selected from this model however were refined against a single 
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subunit model, and the second subunit of the 59° dimer was entirely reconstructed 
from the data. This provided confidence that while the choice of reference might have 
enriched for components compatible with this angle, it did not dictate the consensus 
reconstruction of the final structure, which includes alignment and weighting of the 
contributions of individual components. Processing of the liver dimer used several 
rounds of 3D classification from the final 68,000 particles to select images. All these 
steps used either the stump model or a single subunit model as a reference. 
Therefore, the resulting 60° and 88° models were least influenced by references 
regarding their inter-subunit rotation. These models also reappeared in the search for 
extra reconstructions using a monomer reference highlighting their dominance in the 
dataset. In the early stages of the liver polymer and in the heat-induced polymer 
processing, a single subunit was used as a reference, however poorly defined 
models resulted. This indicated that if particles were sub-optimal (for example 
included junk particles or have low SNR) then projection matching struggled.  
Relion also provided the opportunity to obtain an ab initio reconstruction. Although 
this function is usually used to generate a starting model for projection matching that 
will later be refined, here it served a useful purpose to determine the influence of 
potential model bias. The images corresponding to the 59° heat-induced, 60° liver 
and 88° liver dimer all produced models comparable to the final refined 
reconstructions, providing further confidence of their existence in the data.  
Model bias was particularly apparent in the searches for extra dimer reconstructions 
within Relion. When the 16° IMAGIC heat-induced and 88° Relion liver dimers were 
used as references in the 3D classification of the heat polymer particles, a model 
similar to the reference was generated. However, the corresponding particles did not 
refine against a monomer, unlike the 59° Relion heat-induced dimer. Similar results 
were apparent when searching for other dimer structures in the liver dataset. 
Therefore, the model produced after 3D classification was strongly influenced by the 
reference. On the other hand, particles could not be forced to even refine against a 
dimer reference model. This most likely reflects the extra safeguards against bias 
present in the refinement algorithm as opposed to the 3D classification algorithm141.  
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5.4.6 Monoclonal antibodies aided EM studies 
In this study, a mAb has been used to aid visualisation and angular assignment of 
AAT polymers during image processing. This is a variation on the frequent use of 
antibodies in EM as an immunolabelling reagent to determine identity or location of a 
component within the electron density of a complex. For example, a gold-conjugated 
antibody has been used to confirm that polymers in a partially purified sample were 
formed by AAT3. Similarly, comparisons between antibody-bound and non-bound 
samples have been useful in determining location: outer capsid proteins were 
localised on bacteriophage capsids by analysing micrographs261 and a specific 
protein in a much larger secretion system complex was localised from the extra 
electron density apparent in class averages18. Antibody fragments are becoming a 
useful tool in cryo-EM studies of small proteins, helping to increase the effective 
mass of the protein and facilitating image alignment or stabilising certain 
conformational states262,263. The former is the reason why Fabs have been employed 
for cryo-EM studies of the AAT polymer in Chapter 6. Antibody fragments have also 
been employed in X-ray crystallography to help form favourable crystal contacts for 
proteins resistant to crystallisation264. A common concern when using antibodies in 
structural biology is whether antibody binding affects the structure of the protein 
being studied. In this case, it is unlikely that the binding of 4B12 Fab significantly 
alters polymer structure. There may be small conformational changes at the site of 
binding or even sites more distant229,235 however it was deemed unlikely to alter the 
region of interest – specifically, the linkage between subunits – in pre-formed 
polymers. 4B12 does not structurally discriminate between AAT species and 
polymers are so stable that they require 8M urea or heating to greater than 100°C to 
dissociate12,67,116,117. 
Nevertheless, image processing of the undecorated heat polymer was undertaken to 
address the possibility of antibody-induced structural changes in the polymer. A NS-
EM dataset was collected of this sample, however as expected there were difficulties 
with angular assignment and identifying the rotation between subunits (not shown). 
This was probably due to the featureless nature of AAT at low-resolution. The 
difficulties discussed, together with the finding that it was not possible to reconstruct 
the Relion 59° heat-induced dimer when using a reference lacking the Fab domains, 
highlights the importance of using the 4B12 Fab to label AAT polymers in EM 
structural determination. A more feasible approach to understand the interaction 
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between 4B12 Fab and AAT would be to solve a crystal structure of the complex. 
Obtaining diffracting crystals of this complex has proven elusive, and crystallisation 
trials are ongoing. A complex structure could also improve the accuracy of the fitting 
of the polymerisation models into the NS-EM reconstructions as currently the 4B12 
Fab-AAT interaction is a model based on epitope mapping data117. However, 
obtaining a crystal structure is not assured – it is a process dependent on the ability 
to form a regular repeating lattice, and sample heterogeneity and flexibility are 
confounding factors that can interfere with this process. Furthermore, a constrained 
crystal ‘snapshot’ would not represent any conformational mobility observable by EM.  
5.4.7 Conclusions and future directions 
This work has demonstrated that the structural comparison of heat-induced and ex 
vivo polymers by NS-EM is both feasible and informative. Low-resolution 
reconstructions were made of several dimer species, where each individual subunit 
in the Relion reconstructions had high enough definition to improve the modelling of 
the 4B12 Fab-AAT interaction. Generally speaking, the two polymer populations 
have components that can be said to be structurally similar at this resolution, in 
keeping with the common recognition by 2C176. Given the assumption that each 
sample contains a single polymer configuration, the observation of a directly 
equivalent structural component makes it likely that those configurations are the 
same.  
From a comparison of the loop-β sheet A, β-hairpin and C-terminal models of 
polymerisation, it was the latter that best fit the structures86. NS-EM can provide 
information on molecule shapes but the internal details are not revealed; at the 
resolution obtained, approximately 20Å and 30Å from the Relion and IMAGIC 
reconstructions, respectively, this correspondence is informative but not definitive. An 
assessment of the internal structural details of the polymers requires reconstruction 
from cryo-EM data. The cryo-EM structure of ex vivo polymers is addressed in 
Chapter 6. A further consideration regarding differences between NS-EM and cryo-
EM is the degree to which the sample is altered by the fixation technique used. 
Negative staining can cause structural artefacts such as distortion or flattening of 
structures due to the deposition of heavy atoms129,265. The properties of the stain can 
also affect the sample for example uranyl acetate has a low pH, which could cause 
sensitive proteins or complexes to disassemble, and it binds to lipid and nucleic acid 
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phosphate groups, which could induce sample aggregation266. Cryogenic freezing of 
samples yields a more native and hydrated structure, although particles present in 
very thin sections of ice, may still be structurally distorted if they are not fully 
embedded in the ice267.  
Of importance to the research into the mechanism of polymerisation of serpins, is the 
distinction between the different properties of polymers that are induced under 
different in vitro conditions (heating-, denaturant- or acid-induced). Different studies 
in the literature have used polymers made under different conditions to infer details 
of polymers and the mechanisms by which they polymerise32,69,72,75,92,268. Obtaining 
NS-EM structures for other artificial polymers labelled with 4B12 Fab, for example 
those induced by urea or acid, would now help inform in vitro studies of AAT 
polymerisation. The structural differences proposed on the basis on 2C1 
immunorecognition may be explained and published experiments could be re-
interpreted69. Preliminary NS-EM micrographs show that urea or acid-induced 
polymers are shorter and subunits are less bead-like. Furthermore, during this work, 
another lab member found a novel method to induce polymerisation artificially by 
incubation with 20% w/v MPD. MPD polymers were recognised by 2C1 and had 
similar appearance to heat-induced polymers by NS-EM and so these polymers 
could also be structurally characterised in more detail. An alternative method to 
heating – such as MPD incubation – that replicates the linkage in liver polymers, 
would be useful from a practical standpoint as it would allow the monitoring of 




6.0  Cryo-EM of ex vivo AAT polymers 
6.1  Introduction  
6.1.1  AAT accumulation in the liver 
Misfolded and polymerised Z-AAT is retained within hepatocytes as ER-derived 
intracellular inclusions. Inclusion bodies (IBs) were first identified around 1970 in 
autopsy studies of AATD patients269,270. Individuals had been diagnosed with early-
onset emphysema due to a circulating deficiency of AAT, but these studies showed 
they had also developed cirrhosis and suggested a common hereditary cause. The 
IBs from liver samples of individuals with AATD were then characterised and found to 
be rounded, single membrane-enclosed and of 1-20 µm in diameter271. They were 
periodic acid-Schiff (PAS)-positive indicating the presence of glycans and 
immunofluorescence studies showed they contained accumulated AAT271. This 
appeared to confirm that the plasma deficiency of patients resulted from 
accumulation rather than failure of AAT production; later it was found that 
degradation was also a major contributor. Although typically IBs are thought to 
contribute to liver cell toxicity due to the association with liver disease, it has been 
postulated that IB formation is a protective mechanism of the cell that maintains a 
functional secretory pathway105.  
6.1.2  Cryo-EM of ex vivo protein aggregates 
The difficulty in obtaining and/or working with small amounts of patient-derived tissue 
has meant many diseases have been studied by establishing in vitro models. The 
concern, however, is that there are structural differences between in vivo material 
and in vitro assembled molecules. This potential distinction is an important question 
regarding the structure of AAT polymers, and is addressed throughout this thesis. 
Questions regarding the comparability of in vivo and in vitro models have similarly 
been raised within Alzheimer’s disease research. In Alzheimer’s disease, for 
example, filaments of tau protein formed within human brains are much more 
effective than in vitro assembled filaments at inducing disease in mouse models272. 
Cryo-EM structures of tau filaments purified from the brain of a patient diagnosed 
with Alzheimer’s disease have recently been determined to 3.5Å resolution272. The 
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structures reveal differential lateral packing between protofilaments in paired helical 
and straight tau filaments. In contrast to AAT polymers, which are extremely flexible, 
tau filaments are helical and rigid, enabling the use of a helical reconstruction 
algorithm (such as that available in Relion). An alternative fold of tau filament has 
also recently been solved to 3.2Å resolution by cryo-EM273. These filaments were 
isolated from a patient with Pick’s disease, a neurodegenerative disorder 
characterised by frontotemporal dementia. These studies of filaments from patient 
samples are key to revealing how tau can adopt distinct folds in different 
neurodegenerative diseases (Figure 6.1); it is hypothesised that conformers of tau 
filaments give rise to the clinical phenotype that defines each disease272,273.   
 
Figure 6.1. Schematic of the folds of Tau protein in Pick’s disease and Alzheimer’s 
disease. The structure of the fold was determined from filaments isolated from brain samples 
of such patients. Figure reproduced from273. 
The aggregation of α-synuclein, which underlies neuropathological diseases such as 
dementia with Lewy bodies and Parkinson’s, has also been studied using cryo-EM. 
Fibrils were determined to 3.4Å resolution and revealed two composite 
protofilaments with a step-like β-sheet arrangement274. This structure was of human 
recombinant α-synuclein but allows hypotheses about the mechanism of fibril 
destabilisation by common mutations associated with Parkinson’s disease to be 
made. The authors postulate that a different fibril structure could be formed from 
mutated α-synuclein, highlighting the importance of studying disease mutations or 
patient samples. 
Lastly, advanced cryo electron tomography methods have allowed visualisation of 
aggregates of polyglutamine inclusions, like those formed in Huntington’s disease, in 
unperturbed cellular contexts. IBs of intact, transfected neurons from mouse brains, 
as well as transfected human cells, were found to consist of amyloid-like fibrils275. 
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The polyQ fibrils interacted with cellular membranes, in particular deforming the ER 
membrane275,276. These findings led the authors to hypothesise that the formation of 
fibrillar IBs (in addition to the toxic aggregates) contribute to cell pathology, rather 
than having a protective role275,276. Equivalent studies into AAT IBs may be useful in 
gaining insight into the role of IBs in liver pathology and the in situ structure of AAT 
aggregates inside cells. 
6.1.3  Aims of the AAT cryo-EM work 
The resolution of a 3D reconstruction that can be achieved using NS-EM images is 
limited by the grain size of the metal stain. The highest resolution achieved using NS-
EM is of a helicase at 18Å and this sample had the advantage of possessing 
rotational symmetry to aid in the reconstruction277. Cryo-EM under optimal conditions 
has the potential to achieve near atomic-resolution and now regularly achieves 5-8Å 
resolution, enough to resolve α-helices. Recently, resolutions of 2.2Å and 2.9Å have 
been obtained from structurally homogenous proteins, with thorough optimisation of 
all stages of the process278,279. 
This part of the project aimed to obtain a high-to-medium resolution structure of the 
ex vivo polymer using cryo-EM. Polymers were extracted from the liver tissue of a ZZ 
homozygote patient, characterised biochemically and prepared for cryo-EM studies. 
A structure would hopefully provide information on the nature and extent of the 




6.2  Methods 
6.2.1  Purification and characterisation of ex vivo polymers  
6.2.1.1  Extraction of ex vivo AAT polymers from liver samples 
Liver samples were obtained from the University of Birmingham BioBank. AAT 
polymers were extracted from liver samples of an ZZ AAT homozygote who had 
undergone an orthotropic liver transplant, using a protocol adapted from previous 
polymer extractions280,281. Frozen blocks of liver tissue, totalling approximately 7g, 
were thinly sliced and incubated at 37°C for 1 hour with rocking in 10ml of Hank’s 
balanced salt solution (modified with sodium bicarbonate without phenol red, calcium 
chloride and magnesium sulphate, Sigma-Aldrich) with 5 mg collagenase (type 1A, 
from Clostridium histolyticum, Sigma-Aldrich). Fibrous tissue was removed from the 
resultant suspension by filtering through BioPrepNylon synthetic cheesecloth with 50 
µm pore size (VWR). The filtrate was centrifuged at 3000 g at 4°C for 15 minutes. 
The pellet was resuspended in 3 ml of 0.25 M sucrose in 5mM EDTA, 50mM NaCl, 
50mM Tris pH 7.4 buffer that had been filtered, by sonicating on ice for 45 seconds 
at 2.5 microns using a soniprep 150 sonicator (MSE). The sample was layered onto 
the top of two 14ml 14x95mm centrifuge tubes (Beckman Coulter) containing a 0.3M-
1.3M sucrose gradient made up in buffer. The gradient was made using a Gradient 
Master Model 108 (BioComp) and was kept at 4°C for an hour before applying the 
sample. The sample was centrifuged at 25000 g for 2 hours at 4°C in an Optima L-
90K Ultracentrifuge (Beckman Coulter) with a SW 40 Ti rotor. The supernatant was 
discarded and the pelleted inclusion bodies were snap frozen using liquid nitrogen for 
storage overnight at -80°C. 
Half of the inclusion bodies were processed per preparation and transferred from the 
ultrafuge tube to a microcentrifuge tube. The pellet was resuspended and washed 5 
times with 500 µl of 5mM EDTA, 50mM NaCl, 50mM Tris pH 7.4 buffer by 
centrifuging at 16,000 g for 15 min at 4°C. After washing, the inclusion bodies were 
resuspended in fresh buffer and sonicated on ice for a total process time of 6 min of 
15 sec on /15 sec off pulses at 2.5 microns to release soluble polymer. The sample 
was centrifuged at 16,000 g for 15 min at 4°C and the supernatant retained and 
moved to a fresh microcentrifuge tube. This step was repeated until all visible 
insoluble material was removed.  
  
221 
6.2.1.2  Purification of ex vivo AAT polymers 
The supernatant released after sonication was diluted in 20mM Tris pH 8 prior to 
loading onto a pre-equilibrated 1 ml Hi Trap Q HP column (GE Healthcare). Protein 
was eluted by a 0-100% gradient of 20mM Tris, 1M NaCl, pH 8 over 20ml and 
fractions analysed by SDS-PAGE to identify the fractions containing AAT. 
6.2.1.3  Purification of ex vivo AAT polymers labelled with Fab 
(development from method 3.5.4.2) 
After incubation of ex vivo polymers with a three-fold molar excess of 4B12 Fab for 3 
hours, the sample was diluted into 20mM Tris pH 8 buffer. The sample was loaded 
and eluted from a 1ml Hi Trap Q HP column (GE Healthcare) as in 6.2.1.2. 
6.2.1.4  Deglycosylation of AAT 
AAT was deglycosylated by PNGase F and EndoH (NewEngland Biolabs) according 
to manufacturer’s instructions. A solution containing 20µg of AAT and 1µl of 
glycoprotein denaturing buffer made up to 10µl with water was denatured at 100°C 
for 10 min. The solution was briefly chilled on ice and centrifuged before adding 2µl 
Glycobuffer (buffer 2 for PNGaseF and buffer 3 for EndoH), 1µl PNGase F or Endo H 
and water up to 20µl total volume. 2µl 10% NP-40 was added for the PNGase 
reaction as PNGaseF is inhibited by SDS. The reaction was incubated at 37°C for 2 
hours and run on a SDS-PAGE. The negative control contained no deglycosylating 
enzymes.  
6.2.2 Preparation of samples for screening antibody strategies to reduce 
flexibility  
6.2.2.1  Double-labelling of heat polymers with Fab 
Three-fold molar excess of both 9C5 Fab and 4B12 Fab were incubated with heat-
induced polymer in PBS for 3 hours at room temperature. The sample was diluted to 
0.04 mg/ml in Tris-based buffer prior to application on grids for NS-EM imaging 
according to method 3.5.4.4. 
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6.2.2.2  Labelling of heat-polymers with Fab2 or mAb 
4B12 Fab2 was made using the Pierce Mouse IgG1 Fab and F(ab’)2 Preparation Kit 
(Thermo Scientific) according to the manufacturer’s instructions. Heat polymers were 
incubated at a 1:0.5 molar ratio with either 4B12 Fab2 or mAb for 3 hours at room 
temperature and prepared for NS-EM as in 6.2.2.1. 
6.2.3 Cryo-EM methods 
6.2.3.1  Freezing of grids 
The Vitrobot was pre-equilibrated to 4°C and 95-100% humidity for 30 min before 
freezing. Ethane gas was condensed into a copper vial, in the centre of a container 
pre-cooled to liquid nitrogen temperatures. The freezing process was started when a 
thin layer of solid ethane formed at the bottom of the vial. Lacey Carbon Films on 300 
Mesh Copper grids (Agar scientific), Quantifoil R 1.2/1.3 or UltrAuFoil R 1.2/1.3 
Holey Gold films on a 300 Gold mesh (Quantifoil) were glow-discharged at 30 mA for 
1 min. 3µl of purified sample at 0.7 mg/ml or 0.5 mg/ml in EM buffer was 
resuspended, applied and incubated for 30 sec before blotting once for 3-5 sec with 
a blot force 5, 10 or 15 and drain time of 0. The sample was then rapidly plunged into 
liquid ethane and transferred into a grid box, maintaining the grid at liquid nitrogen 
temperatures.  
6.2.3.2  Screening of grids 
Cryo grids were screened using a Tecnai 200 kV FEG with a Direct Electron (DE-20) 
direct detector. The sample was imaged at a nominal magnification of 29,000X, with 
a pixel size of 1.54Å at a defocus 1-4 µm using serialEM282. 
6.2.3.3  Data collection  
A dataset was collected on a FEI Tecnai G2 Polara with a 300kV FEG and a K2 
direct detector (Gatan). Areas suitable for data collection were first identified at low 
magnification by capturing a low magnification montage map (LMMM) followed by a 
medium magnification montage map (MMM). Images were collected using 
automated data collection where polygons of suitable holes were defined. A total of 
221 micrographs were collected at a nominal magnification of 200,000X and a 
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defocus range of 1-4 µm. The pixel size for images was 1.1Å. Each micrograph was 
taken over a 12 second exposure with 60 subframes captured every 0.2 sec. The 
dose per frame was 0.95 electrons per Å2 making a total dose of 57 electrons per Å2 
for the full 60 frames.  
6.2.3.4  Micrograph preparation 
Image processing was carried out within Relion v2.1141. Micrograph movies were 
motion-corrected using Motioncor2 from frame 1 to 60 with dose-weighting for initial 
processing and later, between frames 2 to 25 for processing of particles exposed to 
less electron damage. Defocus values were estimated between 0.5-5 μm for the 
aligned micrographs using CTFFIND-4.1. CTF fits were manually inspected and a 
total of 217 micrographs kept for further processing based on adequate CTF 
correction.   
6.2.3.5  Processing for reconstruction of the dimer  
6.2.3.5.1  Producing an initial cryo-EM dimer model 
Around 1000 dimer particles were manually picked from the micrographs and 
extracted into a 180-pixel (198Å) box from micrographs that had been motion-
corrected from frames 1-60. The extracted particles were subjected to 2D 
classification with a 196Å mask into 10 classes. Well-defined class averages, 
representing different views of the dimer, were selected and used as references for 
autopicking. Autopicking parameters were first optimised on four representative 
micrographs. The settings chosen for autopicking of the entire dataset were: a 60Å 
distance between particles, a 0.8 picking threshold, 1.1 background standard 
deviation and 40Å low-pass filter of the references. Around 103,000 particles were 
extracted for 2D classification into 100 classes from 2-25 frame motion-corrected 
micrographs. Classes (and corresponding particles) were selected for three further 
rounds of 2D classification and selection to obtain a more focussed dataset of 16,000 
particles. These particles were subjected to 3D classification into four classes using 
the 16° IMAGIC NS-EM model filtered to 50Å as an initial model. The resulting model 
with the closest resemblance to the expected appearance of the dimer had one well-
formed subunit. This was copied and duplicated onto the least-formed subunit using 
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Chimera9. This new initial model was used as a reference for another 3D 
classification. The best resulting model had two subunits of AAT/Fab shape. 
6.2.3.5.2  Refining the cryo-EM dimer model and a monomer model 
The new cryo-model was reprojected in a uniform angular distribution. Projections 
clearly depicting two subunits were selected as references for autopicking with 
parameters of 60Å distance between particles, a 0.5 picking threshold and 1.1 
background standard deviation. Around 247,000 extracted particles were reduced to 
108,000 good particles by three rounds of 2D classification and subset selection. 
Class averages were picked that visually resembled dimers with a ‘small-angle’ 
between subunits, leaving 93,000 particles. These particles were used as input into a 
3D classification to generate four classes. Particles corresponding to models with at 
least one well-formed subunit were selected (models 1 and 3). The process of 3D 
classification was repeated.  
Particles were grouped according to whether just one subunit was well-formed 
(23,000 particles, models 2 and 4) or whether a second subunit was appearing 
(15,000 particles, model 3). Further 3D classification of these groups did not produce 
models with differing characteristics. The 15,000 dimer particles were refined 
separately against the autopicking cryo dimer model and a single subunit reference. 
The resulting structures were analysed in Chimera9. Distance and angles between 
subunits were measured as in 5.2.2.5. A mask was made in Chimera by thresholding 
at a volume calculated from the molecular weight using an estimated density of 
1.2Å3/Da, erasing noise, applying a 10 standard deviation Gaussian filter and 
thresholding again. The mask was imported into Relion and a soft-edge of 20 pixels 
applied. The mask and half-map from the refine job was used in a post-process job 
to determine resolution by Fourier Shell Correlation (FSC). A similar approach was 
used for the 23,000 particles: they were refined against a single subunit reference, 
with a relaxed mask around the single subunit and subjected to post-processing for 
resolution estimation.  
6.2.3.6  Processing for reconstruction of the monomer 
The monomer reconstruction from the dimer processing pipeline was reprojected 
using the Relion_project command between 30-150° on the Euler sphere. These 
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served as references for autopicking using the parameters: 60Å distance between 
particles, a 0.5 picking threshold and 1.1 background standard deviation. Around 
253,000 particles were extracted in a 144-pixel box and sorted by four rounds of 2D 
classification and subset selection with 136Å circular masking to reach 63,000 
particles. The resolution limit in the E-step of the 2D classification was limited to 8Å 
and the background set to either zeros or random noise. Particles were further 
selected based on reconstructions after 3D classification. 3D refinement was carried 
out both on particles selected after 2D classification and 3D classification. A mask 
was made in Chimera by applying a threshold at a volume corresponding to 100 kDa 
molecular weight, erasing noise, applying a 10 standard deviation Gaussian filter and 
thresholding again. The mask was imported into Relion and a soft-edge of 20 pixels 
applied. The final resolution was calculated using the FSC as estimated by 
interpolating the FSC curves at values of 0.5 and 0.143, as both conventions are in 
routine use. Attempts to increase the reconstruction resolution by improving the 
alignments included altering the range of the alignment search (from 5 to 10 pixels), 
padding the images to 300 pixels, altering the T value between 1 and 4 and masking 








6.3  Results 
6.3.1  Extraction of ex vivo AAT polymers 
To enable structural and biophysical characterisation of the ex vivo AAT polymer, 
polymers were extracted from liver samples of patients with AATD. These patients 
had undergone orthotopic liver transplantations due to advanced liver failure 
associated with the accumulation of AAT polymers in IBs. The method used for 
polymer extraction was based on a published method but modified to avoid the use 
of detergents and denaturing reagents. This was to avoid any possible unwanted 
structural changes to the polymer structure as such reagents are known to induce 
polymerisation or depolymerisation. Instead, limited sonication in successive rounds 
was used to break open the IBs, releasing the soluble AAT polymer. Sonication at 
the amplitude and for the duration used has been shown to not induce 
depolymerisation and enabled isolation of AAT ex vivo polymers for NS-EM in work 
conducted previously (Dr S. Faull, personal communication).  
Polymers were extracted from a liver sample taken from a 46-year-old ZZ 
homozygote using the method summarised in Figure 6.2. The supernatant 
(containing the polymers) was run on an SDS-PAGE gel and showed that although 
there were many contaminating proteins still present, there was a dominant band 
present that was around the molecular size of AAT monomer at 52 kDa. One other 
band showing enrichment over the others (marked by an * in Figure 6.2) was sent for 
protein identification by trypsin digest and shotgun mass spectrometry analysis. It 
was found to be carbamoyl phosphate synthetase I (CPS1), an enzyme involved in 
the production of urea in the mitochondria. As the mitochondria and ER are both 
membrane bound organelles, it is not too surprising about the co-purification of CPS1 
and AAT. However, the enrichment of CPS1 in the AATD patient cirrhotic liver was 
not expected.  
6.3.2  Characterisation of ex vivo AAT polymers 
Due to the impurities in the sample, the extracted polymers were 
immunocharacterised by western blot analysis with an anti-AAT polyclonal antibody 
and the polymer-specific 2C1 mAb (Figure 6.3). The SDS-PAGE western blot 
confirmed that the predominant band in the supernatant was AAT. Furthermore, it 
suggested that this form of AAT carried immature glycosylation due to its 
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characteristic faster migration than the plasma monomeric M-AAT and plasma-based 
heat-induced polymer controls. Lastly, it showed that the liver polymers were non-
covalent and in the presence of SDS and reducing agent, dissociate into monomers. 
In keeping with its polymer specificity, 2C1 did not detect the monomeric forms of 
AAT. The non-denaturing (native) PAGE showed that all of the AAT in the liver 
sample was present as polymers. These liver polymers were detected by 2C1, as 
were the control heat polymers. This supports the notion that the two polymer types 
have structural similarities and provides additional evidence that 2C1 recognises 
pathological AAT polymers76. Of note is the differing appearance of the heat and liver 
polymers, where the heat polymers form a laddering pattern whereas the liver 
polymers are a smear. The liver polymers also appear to be of higher-order than the 
heat polymers. 
A sandwich ELISA was used to determine the concentration of AAT in the liver 
sample (Figure 6.4). With reference to a heat polymer standard curve and using 
3C11 (which recognises total AAT) as the detection antibody, a total amount of 3.2 
mg AAT was purified from 3.9 g of liver. When 2C1 was used as the detection 
antibody, a total amount of 1.3 mg AAT polymer was purified. The reason for the 
discrepancy could be due to the presence of AAT monomer (which 2C1 does not 
detect), however monomer was not significantly detected in the western blot. Instead, 
the difference could represent AAT polymers that are not recognised by 2C1, as has 
been documented recently191. It also may reflect the use of heat-induced polymers as 
a standard to quantify liver polymers. There would be discrepancies if the polymers 
differed in their presentation of the 2C1 epitope (for example due to polymer 
interactions); the 2C1 epitope is situated in the vicinity of helices E and F compared 
with 3C11, which is near helix A on the opposite side of AAT. Regardless, both these 
estimates are likely to be an underestimate of the amounts found in unprocessed 
liver due to sample losses in purification and incomplete polymer release after 
sonication; when the IB pellets were combined and re-sonicated, remaining AAT in 






Figure 6.2. Method of polymer extraction from liver samples. Liver samples were sliced and digested with collagenase. The digest was sonicated after 
filtering and ultracentrifuged in the presence of a sucrose gradient. The pelleted inclusion bodies were sonicated to release the AAT polymers and the 






Figure 6.3. Western blot analysis of the liver sample. The top panels show an SDS 
reducing gel with 0.4 µg of samples detected by a rabbit total anti-AAT antibody (left) and 
anti-polymer 2C1 (right). The bottom panels show a non-denaturing gel detected by a rabbit 
total anti-AAT antibody (left) and 2C1 (right). M corresponds to monomeric M-AAT, H 
corresponds to heat-induced polymer and ZZ corresponds to polymer isolated from the ZZ 
homozygote liver. The ZZ sample contains AAT polymer detected by 2C1 and a near-




Figure 6.4. Quantification of AAT polymer in the liver sample. Sandwich ELISAs of ex 
vivo liver sample (left) and heat polymer standard (right) with 3C11 (anti- total AAT, top) and 
2C1 (anti-polymer, bottom) as the detection antibody. Two or three points on the liver AAT 
graphs were used to interpolate the concentration from the linear region of the standard 
curves. Each graph summarises three datasets, error bars represent the standard deviation.  
The glycosylation state of the ZZ liver polymers was probed using enzymatic 
cleavage by the glycosidases, endoglycosidase H (EndoH) and PNGaseF. 
Glycosylation is the addition of sugars to proteins and occurs within the ER and the 
Golgi network. AAT is N-linked glycosylated on three residues: Asn46, Asn83 and 
Asn24734. N-linked glycosylation involves the attachment of a large sugar precursor 
comprised of N-acetylglucosamine (GlcNAc), mannose and glucose to Asn residues 
in the ER. These sugars are trimmed and added to within the Golgi network to 
diversify the glycan structures of secreted proteins. EndoH cleaves the glycosidic 
bond between GlcNAc sugars proximal to the Asn but is very specific for mannose-
rich oligosaccharides. PNGaseF on the other hand cleaves the glycosidic bond 
between GlcNAc and Asn and can cleave both high mannose and complex glycans. 




the type of glycan attached to proteins. ZZ-AAT liver polymers and plasma-derived 
M-AAT were incubated with the glycosidases and resolved on a denaturing gel 
(Figure 6.5). ZZ-AAT liver polymers were cleaved by both PNGaseF and EndoH to a 
shorter deglycosylated AAT whereas plasma monomer was only cleaved by 
PNGaseF. This indicates that the plasma protein has been processed to the complex 
glycan form by passage through the secretory system whereas ZZ-AAT liver 
polymers have high mannose glycans, as would be expected from proteins that have 
been retained in the ER. 
 
Figure 6.5. Deglycosylation of ZZ-AAT liver polymers. A) A schematic adapted from 283, 
illustrating the different glycan structures and their cleavage by EndoH and PNGaseF. B) A 4-
12% w/v acrylamide denaturing gel showing cleavage of plasma-derived M-AAT and ZZ AAT 





6.3.3  NS-EM of liver polymers with and without 4B12 Fab 
The polymers isolated from the liver explant tissue following sonication of IBs were 
subjected to dialysis using a membrane with a 300 kDa cut-off and imaged using NS-
EM with uranyl acetate. In the micrographs, the polymers appeared long and flexible 
with individual subunits well-delineated (Figure 6.6). This is similar to the ‘beads-on-
a-string’ appearance previously observed for polymers isolated from the plasma of a 
patient with the Siiyama AAT mutation81. Linear polymers were abundant with 
occasional circular polymers also present in the liver sample, as noted before. The 
liver polymers were also similar in appearance to the heat-polymers imaged by NS-
EM (Figure 5.3). Polymers were the predominant assembly in the liver sample 
however there were other irregular stained entities. These are likely to be protein 












Figure 6.6. A negative stain micrograph of ex vivo liver polymers. Sample was diluted to 





acetate and visualised using a Tecnai T12 microscope at 67,000X magnification. Micrograph 
taken at 1µm defocus. Scale bar, 50nm. 
As for the heat polymers, the ex vivo polymers were bound to 4B12 Fab and imaged 
by NS-EM (Figure 6.7). The Fabs added visible protrusions on the polymer chains 
providing extra confidence that these were AAT polymers and they were the 
predominant species present in the liver sample. Most of the 4B12 Fabs could be 
seen on one side the polymer but there were also polymers with Fabs on different 
sides. This is similar to what was observed for the heat polymers labelled with 4B12 












Figure 6.7. A negative stain micrograph of ex vivo liver polymers labelled with 4B12 
Fab. Sample was stained with 2% w/v uranyl acetate and visualised using a Tecnai T12 
microscope at 67,000X nominal magnification. Micrograph taken at 1µm defocus. Yellow and 
red arrows highlight where Fab fragments are lined up on the same or opposite sides of the 





6.3.4  Approaches to reduce polymer flexibility 
Polymer flexibility is likely to be a confounding factor in obtaining high-resolution 
dimer reconstructions, by reducing the number of usable particles and increasing 
mis-classification. NS-EM was used to assess whether the addition of different 
antibody fragments could reduce polymer flexibility. Polymer flexibility had been 
shown to be challenging in the image processing of the NS-EM reconstructions250. 
Limiting this flexibility would reduce sample heterogeneity and help achieve higher 
resolution in cryo-EM. Different approaches were trialled using heat-induced 
polymers as the target sample to spare precious liver polymer samples; any 
promising conditions could then be attempted with the liver polymers.  
The first approach undertaken was to label polymers with Fabs from different 
antibodies that would have different epitopes and could cause different structural 
effects on the polymer. Polymers were bound with excess 9C5 Fab, 2C1 Fab, 2E4 
Fab or 1A3 Fab. The antibody 1A3 was made in the hybridoma screen discussed in 
Chapter 4. It was shown to have a preference for polymers by ELISA, similar to 2C1. 
The antibody 2E4 has been identified in a previous hybridoma screen with a 
preference of Z-AAT over M-AAT. None of the Fabs tested made a noticeable 
difference to the flexibility of polymers.  Fabs can be seen on alternative sides of the 
polymer chain and polymer curvature is still apparent. A micrograph of polymers 
labelled with 1A3 Fab is shown as an example in Figure 6.8. 
Next, it was postulated that binding polymers with two Fab molecules (4B12 and 
9C5) could increase the linearity of polymers with respect to a single-Fab preparation 
by 9C5 compounding steric effects. Both 4B12 and 9C5 are known to be able to bind 
to the AAT subunit at the same time through ELISA competition assays116: they do 
not sterically block each other from binding to AAT and their epitopes must be 
sufficiently far apart. Heat polymers were labelled with 4B12 and 9C5 Fabs 
simultaneously and imaged by NS-EM. The polymers were easily visible with Fab-
like protrusions away from the main chain. The binding of two Fabs made the 
polymers more complex in appearance and it was difficult to interpret the relative 
positioning of the binding sites of the two Fabs on the AAT subunit as the 9C5 




the flexibility or increase the linearity of the polymers as tight turns and circular 
polymers can still be seen.  
The last approaches tested were the labelling of polymers with 4B12 mAb or 4B12 
Fab2 fragments. Fab2 fragments – lacking the Fc component but retaining the 
bivalency of the parent antibody - are produced by a similar method to the Fab, but 
mAb digestion with ficin is for longer (24 hours rather than 4 hours) and at a lower 
cysteine concentration (4mM rather than 25mM). 4B12 Fab2 production was 
confirmed by a denaturing gel, where Fab2 runs around 100 kDa (not shown). Both 
antibody variations have two binding sites for AAT, so in theory they could bind to 
two neighbouring AAT molecules within the polymer chain and could cause some 
rigidity. They were incubated sub-stoichiometrically with polymers (hence the 
presence of unbound polymers in the micrographs in Figure 6.8) to limit inter-chain 
binding of the antibody. For both samples, there appeared to be greater clumping of 
polymers indicating that the two AAT binding sites per 4B12 molecule were binding 
between chains. Therefore, after all these tests, the 4B12 Fab was retained as the 





Figure 6.8. Negative stain micrographs of heat-induced polymers labelled with different 
antibody fragments. Samples were incubated with either 3 times excess of 1A3 Fab or 4B12 
Fab/9C5 or at a 0.5 molar ratio of 4B12 mAb or 4B12 Fab2. Samples were stained with 2% 
uranyl acetate w/v and visualised using a Tecnai T10 or T12 microscope at 44,000X or 





6.3.5  Initial cryo-EM studies  
Initial cryo-EM studies were once again carried out using heat polymers labelled with 
4B12 Fab to spare the limited liver polymer sample. Sample preparation for cryo-EM 
is technically more difficult than NS-EM as grids must be quickly plunged into liquid 
ethane and maintained at liquid nitrogen temperatures for imaging. Vitrification of 
grids was achieved using a Vitrobot (FEI). There are multiple parameters (grid type, 
sample concentration, sample incubation time, blot time, blot force etc.) that should 
be optimised for a sample to achieve the right level of ice thickness; if the ice is too 
thick the signal will be weak, while thin ice results in particles that tend to lie along 
the plane of the ice surface. 
There are multiple support grids available that may be more or less suitable 
depending on sample characteristics. The heat polymer/4B12 sample was initially 
frozen on Lacey carbon grids. Lacey grids have a mesh of carbon film on a copper 
grid, with different size holes free of carbon in which the sample is imaged. Grids 
were imaged using a Tecnai 200 kV FEG microscope. Areas of carbon were included 
in the micrograph images to aid calculation of the CTF. 
The sample was first frozen after a 30 second sample pre-incubation, a 5 second blot 
time and 5 blot force on the Vitrobot. The micrographs showed that the sample was 
present within the holes of the carbon mesh and so this type of grid was suitable for 
future work. The contrast by cryo-EM is clearly much lower than NS-EM images 
however the polymers represent distinctive structures whose path could still be 
deciphered. Suitable ice thickness for imaging was present, however most of the grid 
was dry with no sample. To increase the number of carbon holes within the grid that 
could be used for data collection, the blot time was reduced to 4 seconds. The 
sample concentration was also reduced three times. The reduction in blotting time 
increased the number of holes with thin ice and the lowered concentration enabled 
clearer depiction of the polymer chains. The polymer spread was heterogeneous, as 
it appeared to cluster near the carbon but could also be seen in the holes. Smaller 
holes also seemed to have a higher concentration of sample. Images taken at 
different defoci are shown in Figure 6.9. Choosing the appropriate range of defocus 




see and pick particles and a low enough defocus to contain high frequency and 
therefore high-resolution information. At the highest defocus (3.5 µm) the polymer 
chains are easily visible with a high contrast against the background of ice (zoom, 
Figure 6.9). As images are taken closer to focus, it gets harder to decipher the 
polymer chains. From these images, the lowest defocus to confidently pick polymer 















Figure 6.9. Cryo-EM micrographs of heat polymer with 4B12 Fab bound. Micrographs  
were taken at a nominal magnification of 41,500X at different defoci on the Tecnai 200 kV 
microscope. Subframes from 2 to 18 were aligned using EMAN2251 and IMOD252 and 




As each sample behaves differently when freezing grids, the best freezing condition 
for the heat polymer/Fab sample could act as a guide, but not necessarily be the best 
condition for freezing of the liver polymer/Fab sample. Therefore, the freezing 
protocol of the liver sample was then optimised using Lacey grids. After 
systematically changing multiple freezing parameters, the ice thickness of the grids 
and the sample concentration remained highly variable. This irregularity combined 
with the appearance of non-ice crystals on a low magnification view of the grids 
(Figure 6.10) suggested that further sample purification might be required. The 
polymers had only been released from the sonication of IBs with no further 
purification and non-protein components would not be visible by PAGE. Therefore, it 
is likely that various cellular debris including lipids were present in the sample being 
applied to grids, and it may be that these were the source of the crystalline material. 
 
Figure 6.10. Unidentified crystals on Lacey grids of the ex vivo polymer labelled with 
4B12 Fab. Shown is an image from view mode on serial EM, where some crystals are 
highlighted by arrows. 
6.3.6  Extra purification of ex vivo polymers 
After the initial cryo-EM studies, it became apparent that to have the best chances of 




Previous attempts of purification using a 1ml Alpha1-Antitrypsin Select column and a 
custom anti-AAT rabbit polyclonal antibody column, which were both operated by 
gravity-flow, proved unsuccessful (not shown), as a high proportion of material was 
lost or did not bind to the column. This was particularly true for the rabbit antibody 
column where it seemed that the process of conjugation had compromised antibody 
affinity. 
As only small amounts of liver polymer were available, it was difficult to trial many 
different purification approaches. However, when a high-specification 
chromatography system became available to use, it was possible to try the Q-
sepharose column for purification of the liver polymer sample. This column is used 
routinely as the second step of AAT purifications and so the behaviour of AAT with 
the column was well-known. Small amounts of heat-induced polymer were first run to 
ensure detection of eluted material would be possible; an elution peak could be 
observed on loading only 50µg of purified protein. Therefore, based on the 
concentrations measured by ELISA, 150µg of liver polymer sample was loaded onto 
the Q-column and eluted using a 0-1M NaCl gradient. The absorbance trace showed 
a reasonably ‘messy’ elution, reflecting the high number of impurities present within 
the sample. Denaturing gels were run of the elution peaks: the peak containing AAT 
is highlighted in Figure 6.11A. Liver AAT eluted at 300 mM in the salt gradient 
compared to 340 mM for heat-induced polymers made from plasma monomeric AAT. 
The peak for the polymer was broad but only fractions in the defined peak were 
pooled for labelling by 4B12 Fab. The first peak in the elution contained a low 
molecular weight contaminant (gel not shown) and the third large peak was not 
visible on a gel, which might be the result of non-protein contaminants such as lipids 
that absorbed in the UV range. The purity of the resulting AAT polymer sample was 
much higher and this was apparent from NS-EM micrographs of the purified sample, 






Figure 6.11. Extra purification of ex vivo polymers. The elution profile (left) of the ex vivo 
sample from a Q-sepharose column. The trace in blue is the UV absorbance at 280nm, the 
conductivity (a proxy for salt concentration) is in grey. The peak highlighted by a red box and  
line was resolved by a 4-12% acrylamide denaturing gel (right) by loading 10 µl samples; 




sample before purification by the Q-sepharose column. B) The sample was visualised by NS-
EM with 2% w/v UA staining on a Tecnai T12 microscope at 67,000X nominal magnification. 
The previous approach to purifying labelled polymers consisted of dialysis using a 
membrane with a 300kDa molecular weight cut-off, following incubation with an 
excess of 4B12 Fab to remove unbound Fab. However, small particles could still be 
seen by NS-EM and so the efficiency of this approach was questionable (Figure 5.5). 
After observing that the AAT polymers from the liver could be bound by Q-column, it 
was hypothesised that this step could be used a second time in place of the dialysis 
step. This would require a lack of binding by the 4B12 Fab under the buffer 
conditions used or binding with a different strength to AAT (such that the Fab would 
elute at a different point in the salt gradient). It was also important to understand the 
effect of the 4B12 Fab on the concentration of salt at which the complex eluted.  
As a test run, small amounts of monomeric M-AAT from plasma and 4B12 Fab were 
bound and eluted from the Q-column on their own, followed by the monomer 
AAT/4B12 Fab pre-formed complex. The elution profiles are overlaid in Figure 6.12A, 
alongside corresponding denaturing gels to identify which protein was present within 
each fraction. The elution of the M-AAT sample showed a small peak followed by a 
much larger second peak. When corresponding fractions were run on a gel, no 
protein band was seen in the first peak and pure AAT monomer (with a little dimer) 
was in the second peak. The maximum of the peak for AAT was at a salt 
concentration of 260mM. The 4B12 Fab bound to the Q-column as well, so was 
negatively charged at pH 8. It was eluted from the column in a shouldered peak at a 
maximum salt concentration of 120mM. The 4B12 Fab therefore bound less strongly 
than AAT, which suggested that excess Fab could be purified away after incubation 
with AAT polymer. The pre-formed complex showed this to be true, where excess 
4B12 Fab was apparent from the denaturing gel in the first peak and both AAT/Fab 
(the complex) were present in the second larger peak. This also demonstrated that 
4B12 Fab binding to AAT did not alter the charge of AAT significantly as it was eluted 
at a similar salt concentration of 270mM.  
After establishing that the Q-column was a viable option to purify labelled polymers, 




then bound to the Q-column. The elution absorbance profile showed two clear peaks; 
when these were analysed by SDS-PAGE, the first was clearly free 4B12 Fab and 
the second was AAT labelled with 4B12 Fab in a 1:1 stoichiometry (Figure 6.12B). As 
there was free Fab, there was confidence that the AAT polymer was fully labelled 
and the purity of the sample was much higher. The improved sample was 









Figure 6.12. Labelling of ex vivo polymers with 4B12 Fab. A) The overlaid elution profiles 
(left) of monomeric M-AAT (red), 4B12 Fab (blue) and M-AAT/4B12 Fab complex (purple) 
from a Q-sepharose column. Corresponding 4-12% acrylamide denaturing gels loaded with 
20 µl of sample. B) The elution profile of ex vivo polymer labelled with excess 4B12 Fab from 
a Q-sepharose column. The trace in blue is the UV absorbance, the conductivity measure is 
in grey and the peak highlighted by a red box corresponds to AAT bound with 4B12 Fab, 
shown by the denaturing gel (right). C) The sample was visualised by NS-EM with 2% w/v UA 
staining on a Tecnai T12 microscope at 67,000X nominal magnification.  
6.3.7  Cryo-EM grid optimisation 
After improving the purity of the sample, optimisation of cryo-EM grids was 
recommenced. This was approached in a systematic way, optimising the grid type, 
sample concentration, blot force and blot time in order (Table 6.1). All grids were 
imaged using the Tecnai 200 kV FEG microscope. 
As starting freezing conditions, on recommendation from other cryo-EM users, the 
purified liver polymer/4B12 sample was applied at a concentration of 0.7 mg/ml with 
Vitrobot settings of 30 second sample incubation, 5 blot force and 5 sec blot time. 
The first parameter that was varied was the grid type and three grids were tested. 
The first type was the Lacey carbon grids that had previously been used in Figure 
6.9, which have different sized holes surrounded by carbon. At the conditions used, 
the larger holes were free from ice but in smaller and medium-sized holes the sample 
was present across the hole, if not slightly clustered near the carbon edges (Table 
6.1). Quantifoil 1.2/1.3 carbon grids were the second grid type tested, which have 
regular sized holes surrounded by carbon284. The polymers were also present within 
the holes and on the carbon edges. The last grid type was UltrAuFoil 1.2/1.3 gold 
grids that also have regular holes but no carbon285. Again, the polymer chains could 
clearly be seen within the holes. All grids would therefore be compatible with the 
sample to further optimise conditions for data collection. However, the advantages 
and disadvantages of the grid types were considered in deciding on the grid type to 
proceed with. The Quantifoil grids with regularly spaced holes are much easier for 
automated data collection and so the Lacey grids with irregular holes were 




beam with 50-fold less movement parallel to the beam than carbon Quantifoil285. This 
improves the quality of micrographs for image processing. However, they do not 
have any carbon to aid with focusing or CTF correction and so sample 
concentrations have to be higher to provide enough signal in the Fourier transform 
for CTF estimation. The gold grids were chosen to maximise the chances of 
obtaining high-resolution data.  
The next parameter that was optimised was the sample concentration. It is desirable 
to have the sample concentration as high as possible to maximise particle numbers 
per micrograph in data collection. However, it is also important to minimise the 
overlap of particles and visualise individual polymer chains for particle picking and 
image processing. In the testing of grid type, although the sample concentration 
varied between holes, overall the concentration was too high for particle picking. The 
concentration was reduced to 0.5 mg/ml. Micrographs showed much better polymer 
chain delineation with less overlap and the particle number per micrographs was still 
maximised (Table 6.1). The sample concentration was also high enough to provide 
adequate signal for CTF correction.  
Over half of the ice overage across the grid was thick and therefore the Vitrobot 
settings of blot force and blot time were next varied to obtain more suitable areas for 
data collection. Increasing the blot force did reduce ice thickness. The blot force was 
increased to 10 and 15; 10 blot force was deemed the best as at blot force 15, areas 
of the grid, particularly in the centre of squares, became dry. Other areas showed 
that thinner ice was pushing the sample into higher concentration regions. Finally, 
the ice thickness was fine-tuned by optimising the blot time to 3 seconds. This 








Starting conditions: 0.7 mg/ml sample, 30s sample incubation, 5 blot force, 5 sec 
blot time 
Parameter Variations Outcome 
1) Grid type 









a) 0.7 mg/ml 
(tried above in 1c) b) 0.5 mg/ml 





3) Blot force 
a) 5 blot force 
(tried above in 2b) 
b) 10 blot 
force 
 
b) 10 blot force 
 
 
c) 15 blot force 
 
4) Blot time 
a) 3 sec 
 




b) 4 sec 
 
c) 5 sec 
(tried above in 3b) 
Table 6.1. Summary of cryo-EM grid optimisation for the liver polymer/4B12 Fab 
sample. Grid type, sample concentration, blot force and blot time were varied sequentially. 
Micrographs were taken at a nominal magnification of 29,000X on the Tecnai 200 kV 
microscope. Subframes 2-17 were aligned EMAN2251 and IMOD252and corrected for the CTF 
using CTFFIND3253.  
6.3.8  Initial cryo-EM dataset collection  
Once suitable grid-freezing conditions for the gold grids were established, an initial 
small dataset was collected on the 300kV Tecnai Polara microscope equipped with a 
K2 direct detector, and with the help of Dr N. Lukoyanova. An overview of the ice 
thickness of the squares across the entire grid was captured through a low 
magnification montage map (LMMM). One example square is shown in Figure 6.13A. 
Holes towards the edge of the square had thicker ice and there were some thinner-
ice or empty squares in the centre. From the LMMM, around 20 squares were 
selected for collection of a medium magnification montage map (MMMM) to yield 
more detailed information about ice thickness. An example of even, thin ice is shown 
in Figure 6.13B and was taken from the centre of a square. The MMMM was used to 
draw polygons around holes that were suitable for data collection. One micrograph 
per hole was taken during automated data collection at a magnification that yielded a 
pixel size of 1.1Å. A representative micrograph (low-pass filtered to aid visualisation) 




over the background however, clumping together of chains is also apparent. The 
concentration of polymer across the grid also varied considerably. 
The dataset was processed using Relion v2.1122. A total of 60 subframes per 
micrographs were collected, with a dose of 0.95e-/Å2/frame (total dose of 57e-/Å2) 
and these were aligned using dose-weighting in MotionCorr2. The CTF was 
estimated by CTFFIND4. The match of the Thon rings between the Fourier transform 
of the micrograph and the theoretical CTF was visually inspected. Those that did not 
correlate were selected, and the parameters altered to aid re-fitting. If this still did not 
work, the micrographs were disregarded. An example of a good fit is shown in Figure 





Figure 6.13. Preliminary data collection. A) The low magnification montage map B) The 
medium magnification montage map C) A representative micrograph with a 50nm scale bar 
taken at nominal magnification 200,000X on the FEI Tecnai 300kV Polara microscope 
equipped with a K2 direct detector. Micrographs were taken over a 12s exposure with a total  
dose of 57e-/Å2 and the pixel size was 1.1Å. The 60 subframes were aligned using 
Motioncor2 within Relion v2.1122. Example polymers are boxed below. D) An example Fourier 




6.3.9  Processing workflow for the AAT/Fab dimer 
As for the NS-EM work, the dimer – the minimal polymeric unit – was selected for 
reconstruction to provide information on the linkage between subunits in the polymer. 
Around 1,000 clear dimer particles were manually picked from full-dose micrographs 
that had been motion- and CTF-corrected. The full-dose micrographs had higher 
contrast which helped with the manual picking and the coordinates of particles were 
then applied to lower-dose micrographs (25e-/Å2) to obtain particles in a 180x180 
pixel box with less particle damage. The particles were sorted by reference-free 2D 
classification into 10 classes (Figure 6.14). The class averages showed two subunits 
from a chain, each subunit of varying shape depending on the Fab position. Four 
classes (circled in Figure 6.14) were chosen that represented different views of the 
dimer and were used as references for autopicking. As the references were 
generated from the dataset, they would have the same grey intensity scale and 
would aid the autopicking function within Relion139. Initially, parameters for 
autopicking were set to a relatively high threshold to obtain the best particles in the 
dataset. These were optimised on a representative subset of four micrographs that 
varied in defocus and concentration of sample. The ~100,000 particles were sorted 
by 2D classification and manual subset selection, to yield a final 16,000 particles that 
formed classes with well-defined dimers (Figure 6.14). The class averages showed 
the presence of Fab on some AAT subunits and a heterogeneity in the rotation of 
subunits comparable to that observed with the NS-EM studies. The distance between 
the centre of masses of subunits was measured, using ImageJ, to be on average 
66Å. 
The 16,000 particles were used in maximum likelihood projection matching using one 
of the NS-EM ex vivo dimer models as a reference in 3D classification. At the time 
this was carried out, the Relion NS-EM work had not been completed and therefore a 
small-angle dimer from the IMAGIC processing was low-pass filtered to 50Å and 
used as the reference. The particles were divided among four models in an attempt 
to account for 3D heterogeneity, yet all models only had one adequately formed 
subunit in the dimer (Round 1, Figure 6.14). Model 3 stood out as having a better-




Chimera (top right of model 3, Figure 6.14) the shape complementarity was high. The 
region occupied by the 4B12 Fab contained a hole in the density positioned between 
the variable and constant domains of a Fab. This detail had not been observed in the 
NS-EM work and represented an unbiased characteristic of the Fab structure, 
indicating the data were converging on a physically reasonable solution. 
This model was used to create a new reference, now constructed from cryo-EM 
particles, for a second round of 3D classification against those same particles. It was 
hypothesised that the second subunit was not defined due to the NS-EM dimer failing 
to adequately represent the angle between the subunits in the cryo-EM data. The 
reference was created by duplicating and fitting the well-formed subunit on the 
poorly-formed subunit using Chimera. The reference was filtered to 50Å, effectively 
removing higher resolution features such as the ‘hole’ in the Fab density. For most of 
the generated models, a similar result of only one subunit forming was observed 
(Round 2, Figure 6.14). However, model 3 again did have density for the second 
subunit and encouragingly when the AAT/Fab atomic model was docked, the Fab 
hole was now also apparent for the top subunit. The distance and rotation between 
subunits were measured to be 65Å and 27°, respectively. Formation of the second 
subunit suggested this inter-subunit angle was present within the data. 
Autopicking had previously been carried out using a small number of references with 
a high picking threshold. The new cryo-EM model was re-projected on the Euler belt, 
and the projections used to re-pick the dataset with a lower threshold and therefore 
maximise the number of particles for processing. Projections that corresponded to 
end views and hence appeared as a single subunit were excluded from the 
references to focus on the dimer. Around 250,000 particles were picked and were 









Figure 6.14. Cryo-EM workflow for image processing of the dimer. References for 
autopicking were generated by manually picking 1,000 particles followed by 2D classification 
and selection. The whole dataset was autopicked for particles and these were sorted by 2D 
classification to yield a final 16,000 particles. These were subjected to 3D classification using 
a NS-EM model as a reference. One model was selected based on good subunit definition 
and used to generate a reference for a second round of 3D classification. Model 3 was 
selected to be the best and was reprojected around the Euler sphere to produce reprojections 
for autopicking. After 2D classification and selection, 93,000 particles were subjected to 3D 
classification. Particles belonging to models 1 and 3 were selected for another round of 3D 
classification. All reconstructions were thresholded to a volume corresponding to their 
molecular weight using Chimera (200kDa x 1.2Å3/Da).  
The 2D class averages represented a wide range of views of the dimer and multiple 
populations of dimer varying in the inter-subunit rotation (Figure 6.14). Most 
noticeable, were two class averages that appeared to have a near-180° angle 
between subunits such that the Fabs were on opposite sides of the AAT chain 
(Figure 6.15A). This conformation had been observed previously in NS-EM of the 
heat-induced polymer and ex vivo polymer. A simple overlay of two copies of the 
AAT/Fab atomic model on one of the projections showed excellent shape correlation. 
On close inspection, it appeared as if more internal details could be made-out in 
comparison to class averages where the subunits had a smaller rotation between 
them. The arrows in Figure 6.15A point to three circular areas of higher electron 
density that could, based on the superimposition, correspond to helices A, G and I in 
AAT. This conformation might rigidify the dimer allowing higher-resolution analysis. 
Furthermore, the classes highlight that the polymerisation model must have enough 
flexibility to accommodate a 180° flipping of the AAT chain. A quick assessment was 
carried out by perturbing the three proposed models using PyRosetta164 to yield a 
dimer with a +180 or -180° rotation between subunits (Figure 6.15B). Purely based 
on visual inspection, the loop-β sheet A model did not appear to accommodate such 
an angle in a conformation that would yield the projection view apparent in the class 
averages. The linkage meant that one subunit of the pair was rotated to a position 
that would represent a top view in a projection. The β-hairpin and C-terminal models 





Figure 6.15. Cryo-EM class averages of dimers with inverted subunits. A) AAT/Fab 
subunits (yellow) are superposed on one class average showing high shape complementarity 
(left). The class averages (right) show some internal details, highlighted by the arrows 
pointing to 3 helices in AAT. B) The three main polymerisation models were perturbed to have 
a -180° angle between subunits. 
Particles (93,000) were selected based on class averages that did not show such an 
extreme angle of rotation and used in a 3D classification job. The reference was 
made by averaging the two subunits from the previous model and fitting the 
averaged subunit back onto the model. Some of the 3D classes continued to display 
one nicely-formed subunit (Round 3, circled) but lacked the other. Images comprising 
these classes were selected and the 3D classification repeated several times (for 
example, Round 4, Figure 6.14). Model 3 in Round 4 was the closest to obtaining two 
resolved subunits but further 3D classification did not yield an improvement in the top 
subunit. The corresponding 15,000 particles were refined separately using either a 
dimer or a single monomer as references. The resulting reconstructions had a 0.99 




particles and not the reference chosen. The reconstruction was soft-masked and the 
resolution calculated to be 17Å or 20Å for FSC values of 0.143 and 0.5, respectively 
(Figure 6.16A). Fitting copies of the AAT/Fab atomic model into both subunits with 
Chimera yielded measurements of 68Å distance and 31° between subunits. 
Models 2 and 4 in Round 4 both displayed good fits of the atomic model to the 
bottom subunit; the corresponding particles were selected for 3D classification, 
where the good definition in the bottom subunit persisted and were refined against a 
monomer reference. An improved single subunit or monomer was obtained by 
masking out the other subunit. It had a clearer demarcation between the AAT and 
Fab within the subunit (Figure 6.16B). The structure had a resolution of 12Å or 15Å 
for FSC values of 0.143 and 0.5, respectively. However, internal details were still 
lacking. 
Numerous other attempts were made to generate a sensible dimer model but only 
one subunit was ever defined. A single subunit was used as a reference in 3D 
classification rounds to avoid biasing towards a particular inter-subunit angle. 
However, no output models possessed a substantially formed top subunit. The 60° 
and 88° ex vivo NS-EM models were used as references in the 3D classification of 
the 108,000 particles to help identify corresponding particles and focus 3D 
reconstruction. Further selection of particles by 2D classification (to 40,000 particles) 
prior to selection 3D classification also did not alter the results. It was reasoned the 
lack of definition in the second subunit was due to a spectrum of angles between 











Figure 6.16. Refinement of the dimer and single subunit from dimer particles. The side, 
top and back views are shown are for the dimer reconstruction (light blue, top panel) of the 
15,000 selected dimer particles. Atomic models of AAT/4B12 Fab (dark blue) are docked into 
the reconstruction with the central axes in pink used to make measurements. B) The same 
views are shown for the monomer reconstruction from 23,000 dimer particles, masking out 
the second subunit. The atomic model of AAT (pink) and 4B12 Fab (green) were fitted. FSC 
curves and plots of angular assignments are also shown for the reconstructions.  
6.3.10  Processing workflow for the AAT/Fab single subunit 
The difficulty in obtaining a complete dimer reconstruction led to an alternative 
approach in determining the polymerisation mechanism: attempt to obtain a high-
resolution structure of a single AAT/Fab subunit (~100kDa) from within the polymer. 
Reconstructing the single subunit would remove the problem of flexibility-derived 
heterogeneity between subunits, increasing the chances of achieving a higher 
resolution reconstruction. Resolving the path of the polypeptide chain would be 
sufficient to determine the strand swap between monomers within the polymer and 
which, if any, of the three polymerisation models are relevant to ex vivo 
material32,78,86. 
For the processing of the single subunit, two methods were proposed in parallel. The 
first was to extract monomers from already-picked dimers and the second was to 
pick monomers directly from the dataset. The first was not possible directly within 
Relion and was undertaken using Python scripts (written by Dr J. Irving) which 
transferred a translation centering the best-resolved subunit in 3D space to the 2D 
micrograph coordinates of the constituent particles. The purpose was to exploit the 
orientational information of the dimer. With simultaneous alignment and projection 
matching in the 3D classification step, effectively removing the orientational 
information from the dimer classification, the reconstructions all appeared quite 
messy and poorly-defined. When only projection matching was undertaken, which 




between the AAT and Fab. However, this approach again failed to provide the 
improvement in resolution sought after.  
The second method was to pick single subunit particles from the beginning. A one 
subunit model was made by erasing density for the second subunit from a 3D dimer 
model created in the previous workflow. It was centred, filtered to 30Å and 
reprojected in uniform projections around the Euler sphere. The reprojections were 
used as references for autopicking and with a low-picking threshold, around 250,000 
particles resulted. The particles were extracted into a 144-pixel (158Å) box and 
subjected to automated 2D classification and sorted several times to yield a final 
63,000 of the best particles. Good class averages could be seen, with a range of side 
views but also including some top views. There were streaks apparent in the 2D 
class averages and these have been documented to result from overfitting141. The 
suggested approach is to limit the resolution in the E-step of the 2D classification 
algorithm141. Accordingly, the alignments were limited to 8Å and the background of 
particles varied from zeros to random noise (shown in Figure 6.17). The former 
appeared to have no effect, whereas the streakiness was reduced with the random 
noise background.  
Particles selected solely on 2D classifications were subjected to a 3D refinement. 
The final structure fit the atomic AAT/Fab model very well in terms of shape 
complementarity and the structure refined to 9.8Å or 11.6Å with an FSC cut-off of 
0.143 or 0.5, respectively. Particles were further sorted and selected by 3D 
classification. This led to a structure with better definition at the boundary between 
AAT and the Fab (marked by the arrow in Figure 6.17), compared to the refined 3D 
structure produced straight after 2D classification. Despite the greater definition, the 
resolution failed to improve (9.6Å or 12.8Å with an FSC cut-off of 0.143 or 0.5, 
respectively) most likely due to significantly fewer particles in the latter 
reconstruction. An angular distribution plot showed there were preferred orientations, 
























Figure 6.17. Cryo-EM workflow for image processing of the single subunit. A single 
subunit was filtered to 30Å and reprojected to make references for autopicking. Particles were 
sorted by 2D selection to a final ~63,000. Different parameters (resolution limit and 




refined after 2D classification and also subjected to 3D classification for further particle 
section. After the latter route, refinement was carried out forming a model with greater 
definition around the binding point between AAT and 4B12 Fab. Reconstructions were 
thresholded to a volume corresponding to their molecular weight using Chimera (100kDa x 
1.2Å3/Da). 
Internal details still could not be distinguished and so it was reasoned that the failure 
to reach higher resolutions was due to the misalignment of particles. Various 
parameters within the Relion 2D and 3D classification steps were changed to 
optimise alignment. This included the sampling search range and step of alignments, 
the regularisation parameter T value (determines relative weight of the experimental 
data), using a reference filtered to 20Å rather than 30Å, padding of images to a 300-
pixel box (Figure 6.18A) and experimenting with masking in 2D and 3D (Figure 
6.18B, C). Padding of images has been proposed to improve the accuracy of 
alignment as the Fourier transform is sampled more finely however it did not 
significantly alter the resolution in this case. Elliptical masking and hand-drawn 
masking of particles was attempted to remove the effect of neighbouring subunits on 
alignment, however the 2D masks caused the 3D reconstructions to exhibit spikes as 
a result of overfitting. Tighter 3D masks also did not improve alignments. Lastly, the 
particles were extracted from full-dose micrographs. Although they would have more 
electron-induced damage preventing the attainment of the highest resolution, the 
SNR would be higher and would aid alignment. Unfortunately, no improvement in the 





Figure 6.18. Approaches trialed to improve alignment of single subunit images. On the 
left is an example class average in a 144-pixel box that had previously been used in 
reconstructions. A) shows a similar class padded into a 300-pixel box. B) shows a class with 
an outline of the elliptical mask applied and C) shows a hand drawn tighter mask drawn 
around the subunit to remove the influence of neighbouring subunits.  
6.3.11 Using the cryo-EM single subunit density to improve the AAT/4B12 Fab 
model and the polymerisation models  
The refined cryo-EM single subunit structure was used to model the AAT and 4B12 
Fab interaction using the same approach presented in 5.3.7. It was hoped the higher 
resolution of the reconstruction would make the modelling more reliable. The 
distribution of the scores of the fits of the 1000 models that were randomly perturbed 
and optimised into the density was again bi-modal (Figure 6.19A). Models with a low 
cross-correlation score had a visibly poor fit to the density. The top 15 models based 
on the approximate cross-correlation score reported by PyRosetta (score > 0.4) were 
analysed in Chimera. Three of these models were excluded as the AAT and Fab 
structures had collapsed into the centre of the EM density. All but one of the 
remaining 12 models showed a similar discrimination to that observed before, in 
which the Fab heavy and light chains favoured a particular orientation (Figure 6.19B). 
The exception was ranked as the 10th highest score. All top 12 models were in 
agreement with AAT in one orientation, indicating that the higher definition of the 
cryo-EM density provided greater confidence in comparison over the NS-EM density. 
The top scoring model was model 541 (Figure 6.19C). It showed a more feature-rich 
contour, including protruding density in the vicinity of a glycan that would be 




Model 541 was also compared to the two top models from the modelling of the 
subunit interaction carried out in the NS-EM density (Figure 6.19D). AAT in models 
329 and 787 was bound in two directions at almost 180° to one another, as this could 
not be distinguished based on the NS-EM density. Structural alignment was carried 
out in Chimera. Models 541 and 329 were more similar than models 541 and 787. In 
the former comparison, there is a small tilt of the Fab relative to AAT, such that in the 
cryo 541 model, the Fab is more perpendicular to AAT whereas in the latter, the Fab 
is at a drastically different angle relative to AAT. The equivalence of the 541 and 329 
models is supported by the NS-EM density-fitting studies of the different polymer 
forms, where the 329-based models consistently had a higher score than the 787-
based ones (Table 5.2).  
The subunit structure represented by model 541 was used to create refined Fab-
bound polymerisation models and repeat the fitting into the four new NS-EM 
densities made in Chapter 5. The C-terminal model of polymerisation had the highest 
cross-correlation score between the model and the density for all four structures 
(Table 6.2). Application of Dunn’s non-parametric multiple comparisons test showed 
this was significantly different (p < 0.0001) to the β-hairpin and loop-β sheet A 
models for the equivalent liver and heat polymer comparisons carried out in 5.3.8. An 
example of the fits of the polymerisation models into the liver 60° structure is shown 
in Figure 6.20. The shape complementarity between the C-terminal model and the 
60° structure is visibly high, with the Fab density providing important distance and 
geometry restraints. The linker also sits within the density. The next highest scoring 
model in this case is the β-hairpin model which also visibly fits well but the linkers are 
extended and out of the density. The worst scoring model is the loop-β sheet A 
model. Even with a minimally-inserted RCL, the linker is extended and appears to 
pull the second subunit out of the main area of density. Similar observations were 
made on analysis of the other reconstructions. These results most support the C-
terminal model of polymerisation, for both liver and heat polymers. However, a 
mechanism of polymerisation cannot be definitively concluded in the absence of 










Figure 6.19. Improving the modelling of the 4B12 Fab/AAT interaction using cryo-EM-
derived contour information. A) 1000 random models were created and fit as a rigid body 
into the cryo-EM density of the single subunit. The cross-correlation score measured the fit to 
the electron density and the histogram shows the spread of model fits. Example models with 
differing scores are shown. B) The top 12 models with AAT in blue, the heavy chain in red 
and the light chain in green. Glycans are in black and the average density is thresholded at a 
volume corresponding to 1.5x the expected molecular weight. C) The highest-scoring model, 
Model 541. D) Alignment between Model 541 and the two highest-scoring models from the 
modelling into the NS-EM density (Model 329 and Model 787). Carried out in Chimera.  
 
 
Table 6.2 Correlations of the fits of the updated polymerisation models using Model 
541 into the NS-EM densities. Modelling was carried out using PyRosetta and correlations 
were calculated between the models and the NS-EM structures. Values are the average of 10 
models, all runs had a standard deviation of ≤ 0.02 and the highest score for each structure is 












60° 34.60 39.13 42.29 
88° 39.08 40.37 43.43 
Heat 
polymer 
16° 33.47 33.98 35.09 






Figure 6.20. Fits of the cryo-influenced polymerisation models into the 60° liver 
polymer structure. AAT subunits are shown in red, blue with the neighbouring AAT linkage 
in orange and the Fab subunits are in teal. Modelling was carried out using PyRosetta and 






6.4  Discussion 
6.4.1  Biochemical characterisation of liver polymers 
Most research on the subject of AAT polymerisation has studied polymers that have 
been formed artificially47,66,68,69,72. Instead, this work aimed to study the structure of 
AAT polymers formed within a patient. This would provide the most physiologically 
relevant information towards understanding the polymerisation mechanism. There 
are three models of polymerisation (loop-β sheet A, β-hairpin and C-terminal 
models32,78,86) in contention, which differ in the linkage between neighbouring 
subunits. These are achievable in vitro but it is not known if they are relevant to the 
pathology of AATD. 
AAT polymers were isolated from liver samples of a 46-year-old ZZ male who had 
undergone an orthotopic liver transplant as treatment for the liver disease associated 
with AATD. The method of polymer extraction from the liver tissue avoided the use of 
reagents that are known to affect AAT polymerisation and instead used sonication to 
dissociate IBs and release the soluble polymer32,280,286. Due to the extreme stability of 
polymers47,67, it is believed that this method of extraction does not alter polymer 
structure (i.e. the linkage), however there is the possibility that sonication dissociates 
the polymers into smaller chains287.  
Separation of the components of the tissue extracted by denaturing gel showed the 
presence of a dominant protein band at the size of AAT in the liver sample and the 
identity was confirmed by western blot. The sample was contaminated with other 
proteins present at much lower concentrations (Figure 6.2). The identity of most of 
these was not established, except the second dominant band of carbamoyl 
phosphate synthetase 1 (CPS1) which was identified by proteomic analysis. CPS1 is 
involved in the production of urea. An association between this protein and AATD 
has not been studied, nor has there been a link established between the urea cycle 
and AAT. 
The liver polymers were found to have a high mannose glycosylation pattern in 




isolated from IBs has previously indicated AAT to be of the high mannose form which 
is susceptible to EndoH cleavage281,286,288. The glycosylation pattern gave confidence 
that the polymers originated in the ER and were suitable for structural 
characterisation. Immature glycosylation also explained the faster migration of liver 
Z-AAT on a denaturing gel compared to M-AAT as complete deglycosylation of both 
ZZ liver and M plasma monomer using PNGaseF removed the migration difference 
(Figure 6.5).  
A non-denaturing western blot gel (and NS-EM) showed that all the AAT extracted 
from the liver sample was in polymer form and that the polymers were recognised by 
2C1. This shows the sonication was not sufficiently harsh to dissociate chains into 
monomer. The mass of polymers isolated was quantified by ELISA.  Dissociation of 
the IB preparation yielded a total of 3.2 mg of polymer, representing the yield from 
3.9 g of liver. The insoluble material, pelleted after sonication, was re-sonicated a 
total of four times until complete depletion of AAT was achieved. Only small amounts 
of AAT could be seen after each repeated sonication (not shown) indicating that the 
majority of the polymer had been released after one sonication round. While not fully 
quantitative, the quantities recovered can give some indication of polymer burden. It 
is likely therefore 0.8 mg polymer/g liver is a slight underestimate for this ZZ patient. 
This is relatively similar to polymer extraction from another ZZ homozygote where 0.9 
mg polymer/g liver was recovered. Furthermore, isolation from two MZ heterozygotes 
yielded 0.6 and 0.2 mg polymer/g liver. Polymer levels from liver samples have not 
been quantified before but large heterogeneity between clinical manifestations of 
patients has already been documented102,289. 
6.4.2  Cryo-EM studies required further purification of liver polymers  
The isolated liver polymers were the major component of the sample but with protein 
and possibly other impurities that could not be detected by the methods used. 
Although EM is one of the few structural techniques that can mitigate the effect of 
heterogeneity and impurities, high sample purity aids with grid preparation as well as 
particle picking290. This was the first time that liver polymers had been studied using 




to optimise cryo-EM grids. Ice thickness and sample concentration across the grids 
was highly variable. Furthermore, non-ice crystals were observed. The composition 
of these were unknown but the crystals could contain other protein contaminants or 
components from membrane debris including lipids.  
Previous attempts to reduce the level of impurities using a commercial antibody-
based Alpha1-Antitrypsin Select column and a custom-made rabbit polyclonal 
antibody-conjugated resin were unsuccessful. This may have been due to properties 
of the column (conjugated antibody fragments not available to bind) or detection 
methods insensitive to the low amounts of material available for trial. Access to more 
patient material and a new chromatography system enabled another purification 
method to be trialled: the use of anion exchange chromatography. As with 
monomeric AAT, the liver AAT polymers bound tightly to the Q-sepharose column 
and were eluted in the salt gradient. The UV trace of the elution indicated the 
removal of many contaminants, including material able to absorb light at 280nm but 
unable to be detected by the Coomassie protein stain. The increased purity was 
clear from NS-EM (Figures 6.11 and 6.12).  
Following this successful chromatography step, a Q-sepharose column was also 
used to purify away excess 4B12 Fab following the Fab-labelling step. At pH 8.0, 
4B12 Fab eluted at a lower salt concentration, suggesting a less overall negative 
charge, and so could easily be separated from the polymer. The salt concentration at 
which labelled polymers were eluted barely changed relative to unlabelled liver 
polymer, indicating that 4B12 did not obscure any major negatively charged surface 
areas of AAT; 4B12 binds to helix A and I in an area which is predominantly neutral 
in charge and so if anything increases the strength of binding to the column117.  
After further purification, freezing in the subsequent optimisation process resulted in 
cryo-EM grids of more consistent ice thickness, highlighting the effect that impurities 




6.4.3  Additional differences identified between liver polymers and heat 
polymers 
Structural comparisons were made between heat-induced and liver polymers 
visualised by NS-EM in Chapter 5, however the use of cryo-EM highlighted a few 
other characteristics. As suggested previously, longer linear polymers were apparent 
in the NS-EM micrographs of the ex vivo polymer sample compared to the heat 
polymers. These ex vivo polymers are inconsistent with a SAXS study that 
characterised the solution structures of short-chain Z-AAT polymers formed by Pichia 
Pastoris95: the authors found that the trimer, tetramer and pentamer polymers were 
circularised, and proposed to therefore support the circular C-terminal model86. The 
observation of longer ex vivo polymers are supported by a non-denaturing western 
blot showing higher molecular weight protein in the liver sample (Figure 6.3). The 
isolation of longer polymers may support the notion that higher-order polymers are 
sequestered into IBs as a cellular protective mechanism whereas smaller polymers 
are secreted and/or degraded105,193. The western blot also highlights the differing 
appearance of the polymers on a denaturing gel; the heat polymers show a clear 
laddering pattern whereas the liver polymers appear as more of an indistinct ‘smear’ 
with low-molecular weight laddering at different positions to the heat polymer. As 
non-denaturing gels separate on the basis of charge as well as size, the immature 
glycosylation of AAT that has not left the ER may result in an altered running pattern 
on the gel and heterogeneity of glycosylation or other post-translational changes may 
contribute to the smear291. Notably, polymers of non-glycosylated recombinant AAT 
also resolve as a smear, possibly due to higher-order interactions between individual 
polymer chains117. 
Whilst trying to find a suitable purification scheme for the ex vivo polymers, heat-
induced polymers of plasma AAT were used as a surrogate to conserve material. 
Both polymer types were eluted from a Q-sepharose column, using the same buffer. 
The peaks of their elution differed somewhat and were at 300mM and 340mM salt 
concentration for the liver polymer and heat polymer, respectively. This suggests that 
the major polymer species in each have slightly different overall charges, with the 




compared to that between monomer (240mM NaCl) and polymer, and so is unlikely 
to be because of a markedly different conformation and is insufficient to support a 
difference in inter-subunit linkage. It is also probably not due to polymer length as 
polymers largely elute under narrow conditions in comparison to a broad size profile.  
It is most likely due to differences in glycosylation again, as the sialic acid sugar 
residues on the mature glycans of the heat polymer are negatively charged causing 
them to bind tighter to the column. This corroborates the finding that the isoelectric 
point of plasma AAT is more anodal than liver AAT281. 
Lastly, optimum cryo-EM freezing conditions differed between the two samples (10 
blot force, 3 sec blot for the liver polymer and 5 blot force, 4 sec blot for the heat 
polymer). This may be due to different behaviours of the sample in solution and with 
the grid (reflecting differences in sample including different glycosylation states) or 
due to the presence of other components in the liver polymer sample. Optimum 
freezing conditions are found by trial and error and vary between proteins, so it is 
difficult to draw any conclusions about differences between the two polymer 
species290. 
6.4.4  The loop-β sheet A model is not consistent with the extreme angle 
classes 
Dimer particles from the cryo-EM dataset were processed using Relion122. Relion 
was chosen after proving successful in producing well-defined reconstructions and 
dealing with heterogeneity in the NS-EM work. Particles were automatically picked 
using projections from a dimer model reconstructed from a limited subset of the cryo-
EM data, based on the cryo-EM data, which had a 27° angle between subunits. 
Sorting of the particles using 2D classification showed most particles with well-
resolved Fab domains appeared to have an acute angle between subunits, however 
two classes had an extreme angle – nearer 180° – between subunits (Figure 6.15A). 
Such an angle had been observed previously in the NS-EM heat polymer work 
(Figure 5.8C). The ability to detect these particles within the data gave confidence 
that the autopicking references and parameters were sufficient to detect relevant 




The classes with the extreme angle between subunits appeared to be of higher 
resolution than other classes, with possible elements of secondary structure 
identifiable. However, they represented only a very small proportion (2.5%) of the 
dataset and thus were insufficient to proceed to 3D reconstruction. Furthermore, 
identifying equivalent particles with the Fab domains orthogonal to the plane of the 
grid was likely to prove extremely challenging. The inability to manually ‘seed’ 
multiple distinct classes in Relion provides an impediment to this kind of analysis.  
Nonetheless, the classes definitively showed that the polymerisation model would 
have to be consistent with a complete flip of the AAT chain. Modelling studies 
showed that to maintain the inter-subunit linkage in the loop-β sheet A model of 
polymerisation, for a dimer with a rotation of 180° between subunits, one subunit had 
to be rotated out-of-plane (Figure 6.15B). This would create an end view of one 
AAT/Fab subunit. However, the extreme angle classes clearly represent a dimer with 
side views of both subunits. Therefore, the version of the loop-β sheet A model – with 
an insertion of P3-P8 of the RCL – is not compatible with this conformation of dimer 
and is unlikely to represent the linkage of polymers formed in vivo. Both the β-hairpin 
and C-terminal models could yield a dimer conformation with side views of both 
subunits in a 2D projection.  
6.4.5  There is a lack of a well-defined cryo-EM dimer reconstruction  
Cryo-EM is the only structural technique that has the capability to obtain high-
medium resolutions of a flexible, heterogeneous sample such as the AAT 
polymers259,292,293. However, conformational flexibility is still a major hurdle to 
overcome when attempting to obtain a complete reconstruction at a resolution 
sufficient to discern internal protein features. This is most likely the case for the 
labelled dimer reconstruction. 
When working with the initial set of 16,000 particles, which were selected based on 
their good definition after the first round of autopicking, a labelled dimer 
reconstruction was obtained but one subunit of the dimer was always more poorly 
formed than the other. The definition was improved by updating the reference model 




output model on the other subunit), but the definition was still unequal between 
subunits. At this stage, it was postulated that this could be due to the flexible linker 
between subunits or low particle number in the reconstruction. After re-picking and 
sorting the dataset to yield the final 93,000 small-angle dimers, 3D classification 
models continued to lack a top subunit with a resolved Fab domain. Further selection 
rounds and classification against a monomer and other dimer models offered no 
improvements to this region.  The best dimer reconstruction is shown in Figure 6.16A 
with a 31° angle between subunits and refined to 20Å. As the structure was obtained 
using a monomer reference, this dimer conformation is likely to be representative of 
a subset of the dataset rather than being the result of a biased input reference. 
However, the heterogeneity observed in the 2D classes and the poorly defined 
second subunit, especially in other models, may highlight a continuum of angles that 
is present between subunits in the native conditions of cryo-EM. A reconstruction 
from particles corresponding to dimers of slightly different rotations would be 
expected to lead to averaging out and degradation of subunit definition. In 
comparison, the application of NS may have rigidified the polymer and favoured the 
angles observed in the reconstructions presented in Chapter 5. To obtain a better 
reconstruction of the dimer, more particles with narrower classification will be needed 
to reduce the effect of the flexibility. Most reconstructions solved to resolutions of 3-
4Å are obtained from between 30,000-500,000+ particles294. The recent “multi-body 
refinement” function incorporated into Relion v3.0, which separates structures into 
rigid bodies for refinement, may also help generate improved reconstructions and 
provide insight into the principal conformational movements in the dimer295.  
The challenges imposed by polymer flexibility was anticipated for the image 
processing. Multiple approaches were taken to polymer preparation in order to 
optimise its characteristics for imaging and data processing. Alternate labelling 
strategies focused on decreasing the linearity of the polymers and/or introducing 
extra asymmetry. Both alterations would be expected to aid alignment. Fabs from 
different mAbs were bound to heat-induced polymers, but the flexibility of chains was 
unchanged. This was not surprising for mAbs that recognise AAT monomer, as one 
corresponding Fab molecule would likely bind one AAT molecule and not influence 




mAbs that only bound polymers, such as 1A3, could have a binding site that bridged 
two AAT subunits and consequently would reduce dimer flexibility. Polymers were 
also bound with 4B12 Fab and 9C5 Fab simultaneously. Both these antibodies can 
bind to a monomeric AAT at the same time and can bind to polymeric AAT so each 
subunit of the polymer was bound by both Fabs116. The linearity of the polymers was 
unchanged, but their complex decoration was apparent (Figure 6.8). It was difficult to 
infer the relative binding sites of the two Fabs on the AAT subunit, but they did not 
appear to bind diametrically opposite each other. It was also hard to know whether 
having two Fabs bound would help or hinder alignment as the two Fabs would 
appear similar in projections. Therefore, as the addition of 9C5 Fab did not decrease 
flexibility, this strategy was not pursued further. The binding of 4B12 Fab2 fragments 
or 4B12 mAb to polymers also did not influence flexibility. Both have two antigen-
binding sites and could bind and potentially generate a geometrically constrained 
4B12-AAT dimer subunit within a polymer. However, these methods appeared to 
increase heterogeneity, with Fab2 and mAb bridging between two polymers.  
A more complicated approach to extend the polymers on a grid that could be trialled 
in future work has been applied to the flexible titin molecule296. Titin molecules are 
long single polypeptides made up of multiple domains which have been observed to 
adopt varying conformations from a straight structure to a random coil. Extension of 
the molecules or 'molecular combing' as visualised by EM was achieved using 
centrifugation and liquid de-wetting steps. This produced shear flow and surface 
tension forces respectively, that resulted in a straightening of the molecules. Novel 
methods could also be developed that utilise linear scaffolds such as cationic 
polyelectrolytes to straighten the polymers.  
6.4.6  The cryo-EM single subunit allows refinement of the 4B12 Fab/AAT 
interaction  
The computational method taken to remove inter-subunit flexibility-derived 
heterogeneity was to focus on the structure of the 4B12 Fab/AAT single subunit from 
within polymer chain. At a high enough resolution (~8Å), the polymer linkage, which 




difference between the models would be at the top of β-sheet A to see whether the 
RCL was self-inserting (C-terminal model) and where the linkers leave and enter the 
main AAT body. 
A single subunit structure was determined to 12.8Å resolution. This provided the first 
observation of the characteristic ‘hole’ between the constant and variable domains of 
the Fab in the reconstructions. The better definition of the reconstruction allowed the 
4B12 Fab and AAT interaction to be refined. The cryo structure – unlike the NS-EM 
structure – could unambiguously determine the direction of AAT subunit and 
potentially revealed density for some of the AAT glycans. Cryo-EM is the most 
suitable structural method to resolve untrimmed glycans, and many have been 
observed before, particularly on viruses297. A higher resolution structure that resolved 
the glycans would be the first of AAT in glycosylated form.   
The tilt between the interacting Fab and AAT slightly changed between the cryo-EM 
541 model and the NS-EM 329 model. It has been documented that Fabs can bind to 
their antigens with a degree of flexibility and so this is likely to represent a variation in 
binding in different conditions226,298. Unfortunately, at the resolution obtained, no 
internal details that pointed towards a polymerisation model could be observed. It is 
likely the resolution was limited by poor alignment of particles; Relion estimated that 
particles could only be assigned accurate translations and rotations up to 3 pixels 
and 8 degrees, respectively. Difficulties with alignment is further supported by the 
radially extending streaks in the class averages. The low SNR of particles small in 
size would be a significant contributor to this, which again highlights the use of the 
4B12 Fab as a tool for doubling the AAT molecular weight for EM studies262. 
Furthermore, implicit in the reconstruction algorithms is the notion that the particle of 
interest is surrounded by solvent. However, as the subunit occurs sandwiched 
between density provided by adjacent subunits, this distinction between solvent and 
protein would be blurred somewhat. Attempts to improve the alignment within Relion 
did not work suggesting that the either the number of particles were limiting for a 
complex this size and/or the images were not of high enough quality to aid higher 




6.4.7  Approaches for improvement in the next cryo-EM dataset 
The preliminary work carried out has highlighted the challenges with structural 
reconstructions of the AAT polymer but also that it shows promise of feasibility. For 
example, reconstruction of the single subunit produced significant improvements in 
definition relative to the dimer. Application of new developments such as multi-body 
refinement and PCA to reveal motions in the sample may also prove useful295. 
Another dataset with more and better quality images will be essential to obtaining 
high resolution reconstructions. This is especially important when solving structures 
of small (100 kDa) complexes. Datasets that have obtained high resolution (greater 
than 4Å) for small proteins (< 150 kDa) have consisted of 1500-2500 micrographs, 
with greater than 500,000 particles narrowed down to the top 10% (50,000) of 
particles that constitute the final reconstruction127. The 3.2Å reconstruction of 
haemoglobin, which is 64 kDa, was generated from phase plate data and consisted 
of more than 175,000 particles299. The dataset of the ex vivo AAT polymer had just 
over 200 micrographs, with 108,000/63,000 particles, narrowed down to 
15,000/15,500 particles in the final dimer/monomer reconstructions, respectively. 
Separation of particles in groups based on heterogeneity had to be compromised 
with the number of particles in a structure. With a bigger dataset, it is hoped that 
higher resolution structures of the single subunit, the near planar dimer and the minor 
but well-defined species of the opposing-angle dimer will be obtained. Areas for 
improvement include sample preparation, grid preparation and data collection set-up. 
The sample has been efficiently purified from the liver tissue through two 
chromatography columns. However, polymers could be further purified according to 
size through a gel filtration column, but this may not directly influence attainment of a 
high-resolution structure. The most challenging feature of the sample is the flexibility; 
an approach to reduce this could have dramatic effects on reconstruction. As the 
polymers originate from a human, it is not possible to alter the fundamental basis of 
the polymerisation process to create a more favourable sample for structure studies. 
The existing antibody toolkit could prove useful but for different approaches to be 




There is a wide range of variations in grid preparation that could result in 
improvements in data quality. Issues apparent in the preliminary dataset included 
areas of high polymer concentration and sample aggregation that had to be 
discounted from analysis. A higher dilution of sample should be applied to grids and 
the sample buffer could be adapted to contain a higher salt concentration (up to 
500mM), which may reduce inter-polymer interactions. Concentrations of detergent 
such as Tween20, below its critical micelle concentration, may also facilitate 
spreading of the sample300. Linked to these points is the use of graphene oxide as a 
support layer on grids301. This will enable less sample to be used per grid, which is 
important given the small sample amounts available and would limit the 
dimensionality of projections. Most importantly, the ice thickness should be 
homogeneous in thickness to maximise the SNR from a small particle290. A lower blot 
force than the one used in this data collection on the Vitrobot is now recommended 
by most users, with optimisation primarily achieved by varying blotting time (personal 
communication, Sample Preparation course at Diamond, Oxford). 
Lastly, changes in the data collection set-up could prove essential in obtaining high 
resolution. Only a relatively small dataset was collected (200 micrographs). Routine 
data collection can now collect 2000+ micrographs. This would significantly increase 
the number of particles used for reconstruction. Furthermore, the use of a phase 
plate would aid in visualisation and alignment of small particles302.   
6.4.8  Future work  
After finalising the ex vivo polymer structure by cryo-EM, the logical next step would 
be follow the same process for the heat-induced polymer to reach a conclusion about 
their structural similarity at high-resolution. Significant competition for the available 
cryo-EM data collection time notwithstanding, use of such a sample could permit a 
wider exploration and optimisation of data collection parameters due to the ready 
availability of material. A longer-term goal is to determine 3D reconstructions of other 
ex vivo AAT polymer types to identify any structural differences in the linkage. These 
include other pathological mutations within AAT, for example the S mutation which is 




Furthermore, it has not been shown whether polymers from different serpinopathies 
have the same molecular structure. The generality of the polymerisation mechanism 
can be directly addressed by studying the structure of other serpin polymers, such as 
mutant neuroserpin, which is the basis for a rare form of hereditary dementia. Similar 
approaches to sample treatment and optimisation (e.g. binding neuroserpin-specific 
Fabs) could be applied to aid the EM structural determination. Polymerisation of 
neuroserpin has been studied biochemically and biophysically and shows similarity to 
the process observed with AAT: the process proceeds via an intermediate 
conformation and appears to occur as a result of a destabilised native state. In 
support of this, the H334D Kings mutation in AAT is homologous to a mutant of 
neuroserpin that polymerises in FENIB76. However, neuroserpin also readily forms 
the latent conformation, an inactive monomeric hyperstable state that AAT does 
not24,26. Thus, there are differences and it is unknown whether the polymerisation 






7.0 Conclusions and outlook 
7.1 The importance of studying AAT polymerisation 
Point mutations within the SERPINA1 gene, which encodes alpha1-antitrypsin (AAT), 
can lead to polymerisation of the protein in vivo. Polymer formation and retention in 
hepatocytes, the main site of their synthesis, predisposes individuals with AAT 
deficiency to liver cirrhosis42. Local polymerisation in the lungs, as well as the 
deficiency of functional circulating AAT, predisposes patients to emphysema42. The 
structure of the in vivo polymer, and in particular the inter-subunit linkage, is 
unknown. As almost all biophysical and biochemical studies of serpins to date have 
made use of in vitro polymers, there is an unresolved uncertainty as to what extent 
these data can be extrapolated to in vivo polymers32,78,86. It has already been shown 
that one type of polymer, produced using denaturant, is unlikely to be representative 
of pathological polymers69,76,117. This lack of understanding prevents a fully described 
polymerisation mechanism and is of direct relevance to attempts to develop 
therapeutic agents to prevent polymerisation in patients and develop diagnostic tools 
for quantifying polymer burden in an individual.  
This work has aimed to structurally characterise isolated pathological AAT polymers 
and compare such polymers to those formed by heating. This has been achieved 
through biochemical techniques, monoclonal antibodies and electron microscopy. 
7.2 AAT-specific monoclonal antibodies are useful 
investigative tools 
Over 30 novel AAT-specific mAbs were developed in a hybridoma screen. Many 
showed interesting conformational selectivity against AAT conformers but 1D9 stood 
out as the only, and first, monomer-selective antibody. Its preference for monomer 
over polymer, and definition of its epitope in atomic detail, provide further evidence of 
conformational changes that occur on polymerisation. From the 1D9 epitope, one 
such area of change is the RCL and s1C of AAT, which is predicted by all 
polymerisation models32,78,86. 1D9 also blocked heat-induced polymerisation and 




RCL/s1C to these mechanisms. There is general interest in the field in developing 
better tools to define biomarkers that predict disease severity, progression and 
outcome. The monomer-selectivity of 1D9 lends itself to such purposes, and raises 
the possibility that it may be suitable for applications in diagnosing AATD by 
accurately measuring monomer levels in patient plasma. The conditions to carry out 
this quantification, and the association between the levels of native AAT in circulation 
and disease, will now need to be investigated.  
Other mAbs of interest that require further characterisation in future projects are the 
2H2 and 1A3 antibodies. These show M-AAT specificity and polymer-specificity, 
respectively. In particular, the 2H2 mAb/Fab will be useful in studies investigating 
polymers from heterozygous MZ-AAT patients304. The previously-developed 4B12 
mAb has also been instrumental to the EM studies by providing extra signal and 
asymmetry in image processing. Clever engineering of AAT-specific mAbs could 
further aid sample behaviour, in particularly flexibility for cryo-EM work.  
7.3 Heat polymers and liver polymers have more similarities 
than differences 
In general, this work has supported the notion that heat-induced polymers and ex 
vivo polymers are structurally similar (based on 2C1 immunoreactivity) and therefore 
heat-induced polymers are a valid model for AATD research76. Qualitatively, heat-
induced polymers and ex vivo polymers appeared similar in NS-EM micrographs in 
terms of their flexibility, shape with bead-like subunits, and consistent labelling by 
4B12 Fab. The NS-EM reconstructions of both polymer types also had similar inter-
subunit distances and angular relationships and the fitting of the polymerisation 
models yielded similar results. Slight differences between the two polymer types 
included different proportions of linear and circular polymers, the length of polymers, 
differing charges (as evidenced by migration on non-denaturing PAGE and binding to 
anion-exchange resin) and a lack of equivalent heat polymer reconstruction with a 
subunit angle near to 90°. Most of these differences do not necessarily indicate an 
alternate polymer linkage. The most definitive evidence for heat-induced 
polymerisation and in vivo polymerisation resulting in different polymer structures is 




especially important considering the involvement of the RCL/s1C (the 1D9 epitope) in 
polymerisation. To definitively assess the validity of heat polymers as a model for ex 
vivo polymers, cryo-EM studies of the heat-induced polymer will need to be carried 
out.  
7.4 The C-terminal model of polymerisation is most 
consistent with ex vivo data  
Out of the three major polymerisation models, the C-terminal model was the highest-
scoring and the best-fitting into the NS-EM reconstructions86. It was also able to 
accommodate the near-anti-parallel arrangement of the AAT chain observed in a few 
of the well-defined cryo-EM 2D dimer classes. Furthermore, a comparative structural 
analysis between the 1D9-AAT complex and the models of polymerisation showed 
that the main impediment to binding would be steric clashes with neighbouring AAT 
subunits. The C-terminal model of polymerisation, with a single peptide linker and 
therefore the greatest flexibility, would be the most likely to accommodate the 
distortion of the chain required for recognition. Therefore, collectively these data 
support the C-terminal model of polymerisation over the loop-β sheet A and β-hairpin 
models. The initial cryo-EM studies have shown the feasibility in obtaining AAT 
density and resulted in the refinement of the single subunit model between AAT and 
4B12 Fab. Now that the purification protocol has been established, with a larger and 
higher quality cryo-EM dataset, with an increase in the number of images, 
optimisation of the concentration and spread of the polymers and ice thickness, it is 
hoped the nature and extent of intermolecular interactions in patient-derived 
polymers can be definitively determined from a dimer and/or single subunit 
structures. There is also the possibility of investigating alternative methods to limit 
polymer flexibility from the greater access to patient material. High-resolution 
electron density could reveal a new model of polymerisation, which could not be 
predicted at the resolution achieved in this work. Knowledge of the degree to which 
the AAT subunit structure is perturbed would be expected to yield insight into 
whether polymerisation proceeds from a native-like or substantially unfolded 
intermediate and predict testable ways in which polymerisation can be altered in vitro 
or in a cell model of disease. Lastly, once a cryo-EM workflow has been established, 




a MZ-AAT patient, patients with other AATD-mutations in other regions of the AAT 
molecule and of other serpins, for example neuroserpin. This would address the 
question of whether the polymerisation mechanism is applicable to a variety of 
mutations and serpins. Ultimately, this could extend the relevance of structure-based 
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